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The	immune	system		
The	term	immunity	historically	means	protection	from	infectious	disease.	The	cells	
and	molecules	responsible	for	immunity	constitute	the	immune	system,	and	their	
coordinated	 response	 towards	 foreign	 substances	 entering	 the	 body	 (antigen)	 is	
called	“immune	response”.	In	vertebrates,	defense	against	microbes	is	mediated	by	
early	reactions	of	the	innate	immunity	and	later	responses	of	adaptive	immunity.	
The	innate	immune	system	consists	of	macrophages,	monocytes,	natural	killer	cells	
(NK	cells),	dendritic	cells	(DCs)	and	neutrophils.	Adaptive	immunity	can	be	divided	
into	two	parts,	called	humoral	immunity	and	cell‐mediated	immunity.	The	effector	
cells	 of	 adaptive	 immunity	 are	 the	 B	 and	 T	 lymphocytes	 and	 antigen	 presenting	
cells	(APCs),	such	as	DCs,	macrophages	and	B	cells.	T	cells	and	B	cells	bear	highly	
specific	 receptors	 which	 recognize	 almost	 all	 known	 antigens	 and	 build	 up	 an	
immunological	memory.	DCs	are	component	of	innate	and	adaptive	immunity	and	
therefore	take	center	stage	in	immunity.		
Dendritic	cells	and	their	function	
Monocytes	represent	about	4–10%	of	peripheral	blood	leukocytes	in	humans	and	
mice.	 They	 are	 large	 phagocytic	 cells,	 which	 migrate	 in	 an	 amoeboid	 fashion.	
Monocytes	 originate	 from	 a	 myeloid	 precursor	 in	 the	 bone	 marrow	 1	 and	 are	
released	 in	 the	 circulation	 from	 where	 they	 enter	 the	 tissues.	 Besides	 myeloid	
progenitors,	 multi‐lymphoid	 progenitors	 exist	 that	 give	 rise	 to	 all	 lymphoid	 cell	
types,	including	monocytes,	macrophages	and	DCs	2.	The	half‐life	of	monocytes	in	
the	 blood	 is	 relatively	 short,	 about	 one	 day	 in	 mice	 3	 and	 3	 days	 in	 humans	 4.	
Different	 subsets	 termed	 “inflammatory	 monocytes”	 and	 “resident	 monocytes”	
coexist.	As	their	name	indicate,	inflammatory	monocytes	play	an	important	role	in	
inflammation,	 while	 resident	 monocytes	 are	 more	 linked	 to	 the	 steady‐state	
immune‐surveillance	of	non‐inflamed	tissues	and	clearance	of	inflammation	5‐7.	In	
the	tissues,	many	monocytes	develop	into	macrophages	and	others	become	DCs	8.	
DCs	are	the	most	potent	antigen‐presenting	cells	(APCs),	involved	in	the	induction	
of	 immunity	 and	 tolerance	 9.	 “Immature”	 DCs	 reside	 within	 epithelial	 and	
connective	 tissues	 in	 order	 to	 collect	 antigens,	 which	 might	 infect	 peripheral	
tissues.	 Immature	 DCs	 are	 in	 particular	 effective	 in	 antigen	 capture	 by	
phagocytosis	and	receptor‐mediated	uptake	10;	 11.	When	immature	DCs	encounter	
with	antigen,	they	process	the	antigen	into	small	peptides	which	are	presented	on	
major	 histocompatibility	 complex	 (MHC)	 class	 II	 molecules	 on	 the	 cell	 surface.	
During	this	process,	DCs	mature	and	migrate	from	the	tissues	to	the	lymph	nodes	
where	 they	 present	 the	 antigen	 to	 naïve	 lymphocytes	 to	 mount	 an	 immune	
response	 12‐14.	 Signatures	 of	mature	DCs	 are	 increased	 expression	 levels	 of	MHC	
class	II	molecules,	the	co‐stimulatory	molecules	CD80	and	CD86,	as	well	as	CD83.		
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It	 has	 become	 evident	 that	 different	 DC	 subsets	 exist,	 each	 with	 a	 particular	
distribution	and	specialized	function	in	the	immune	system	15.	There	are	two	major	
subsets	of	DCs	in	human	blood	and	lymph	nodes	(LNs),	myeloid	DCs	(MDCs)	and	
plasmacytoid	 DCs	 (pDCs).	 MDCs	 are	 found	 in	 most	 peripheral	 tissues	 and,	
following	antigen	exposure,	mature	and	migrate	to	LNs	and	secrete	high	levels	of	
interleukin	(IL)‐12	12.		
The	role	of	pDCs	in	directing	immune	responses	is	less	well	understood.	In	1994	it	
was	 discovered	 that	 monocytes	 differentiate	 into	 immature	 DCs	 in	 vitro	 by	
culturing	 blood	monocytes	 in	 the	 presence	 of	 IL‐4	 and	 GM‐CSF	 16;	 17.	 	 Since	 the	
numbers	of	DCs	that	can	be	isolated	from	the	blood	are	very	low,	this	is	the	most	
common	procedure	to	obtain	DCs	in	the	laboratory	and	for	clinical	research	9.	
A	successful	 immune	response	depends	on	the	capacity	of	 immune	cells	to	travel	
from	one	location	in	the	body	to	another	and	to	make	contact	with	other	immune	
cells.	Plasma	membrane	adhesion	molecules,	such	as	integrins,	selectins,	cadherins	
and	 syndecans	 are	 required	 for	 interactions	 of	 leukocytes	 (collective	 for	 all	
immune	 cells)	 with	 the	 endothelium	 or	 with	 other	 cell	 types	 and	 extracellular	
matrix	structures.	The	best	studied	family	of	adhesion	receptors	are	the	integrins.		
Integrins	
Integrins	 are	 a	 family	 of	 heterodimeric	 transmembrane	 receptors	 that	 regulate	
cell–adhesion	 and	 cell‐extracellular	matrix	 interactions.	 In	mammals	18α	and	8β	
subunits	are	known	that	assemble	in	24	different	heterodimers	with	distinct	ligand	
specificity	 (such	 as	 collagens,	 laminins,	 RGD‐containing	 proteins	 or	 cellular	
counter	receptors).	A	list	of	the	leukocyte	integrins	is	represented	in	Table	1.	
The	structure	of	the	α	and	β	chains	are	totally	distinct,	while	the	different	isoforms	
of	 the	 α	 and	 β	 chains	 share	 30‐45%	 structural	 homology,	 indicating	 that	 they	
derived	 from	 a	 common	 ancestral	 gene	 by	 gene	 duplication	 18.	 The	 crystal	
structure	 of	 a	 complete	 integrin	 complex	 has	 not	 been	 published	 yet.	 However,	
studies	of	the	extracellular	portion	have	revealed	that	α	and	β	chains	are	composed	
of	multiple	domains	(Figure	1).	The	cytoplasmic	tails	of	human	integrins	are	 less	
than	 75	 amino	 acids	 (AA)	 long,	 with	 exception	 of	 the	 β4	 chain	 that	 consists	 of	
around	1000	AA	19.	The	cytoplasmic	tails	of	the	β	chains	show	striking	homology,	
while	 the	 cytoplasmic	 tails	 of	 the	 α	 chains	 are	 highly	 divergent,	 except	 for	 a	
conserved	GFFKR	motif	close	to	the	transmembrane	region,	which	is	important	for	
association	with	the	β	cytoplasmic	tail	18.	Most	integrin	β	chains	contain	one	or	two	
NPxY/F	motifs	 (x	 is	any	AA),	which	are	part	of	a	phosphotyrosine‐binding	(PTB)	
domain.		
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Table	1.	The	leukocyte	integrins	
	
β‐chain	
	
α‐chain	
	
Name	 Ligands	
β1	 α1	 VLA‐1	
(CD49a/CD29)	
Collagen,	Laminin,	Tenascin	
	 α2	 VLA‐2	
(CD49b/CD29)	
Collagen,	Laminin,	Fibronectin,	Echovirus	
	 α3	 VLA‐3	
(CD49c/CD29)	
Collagen,	Laminin,	Fibronectin	
	 α4	 VLA‐4	
(CD49d/CD29)	
VCAM‐1,	MAdCAM‐1,	Fibronectin,	
Thrombospondin‐1	
	 α5	 VLA‐5
(CD49e/CD29)	
Fibronectin
	 α6	 VLA‐6		
(CD49f/CD29)	
Laminin	
β2	 αL	 LFA‐1	
(CD11a/CD18)	
ICAM‐1‐5
	 αM	 Mac‐1	
(CD11b/CD18)	
ICAM‐1,	ICAM‐2,	iC3b,	Fibrinogen,	Glucan,	
LPS,	Heparin,	Pathogens		
	 αX	 p150,95	
CD11c/CD18	
Fibrinogen,	iC3b,	LPS	
	 αD	 (CD11d/CD18) ICAM‐3
β3	 αV	 CD51/CD61 Fibronectin,	Osteopontin,	von	
Willebrand´s	factor,	PE‐CAM‐1,	
Vitronectin,	fibrinogen,	human	L1,	
Thrombospondin,	collagen,	Entactin	
β7	 α4	 LPAM‐1	
(CD49d/‐)	
MAdCAM‐1,	fibrinogen,		VCAM‐1	
	 αE	 CD103/‐ E‐cadherin
	
	
A	 large	 number	 of	 cytoskeletal	 and	 signaling	 proteins	 have	 been	 found	 that	
interact	with	 these	 specific	 sites	within	 the	α	 and	β	 chains	 (Table	 2).	 Binding	 of	
proteins	 like	 talin	 recruits	 other	 proteins	 that	 connect	 the	 integrin	 to	 the	
cytoskeleton,	which	is	essential	for	integrin	function.		
	
In	 mammals,	 integrins	 are	 expressed	 on	 virtual	 all	 cells	 within	 our	 body.	 Some	
integrins	are	 limited	to	certain	cell	 types,	such	as	the	 leukocyte	specific	 integrins	
β2	and	β7	integrins	that	are	crucial	for	the	proper	function	of	our	immune	system	
(Table	1)	20.	The	β2	integrins	are	comprised	of	four	members,	αLβ2	(CD11a/CD18;	
LFA‐1;	 ITGAL),	 αMβ2	 (CD11b/CD18;	 Mac‐1;	 ITGAM),	 αXβ2	 (CD11c/CD18;	
p150.95;	ITAX)	and	αDβ2	(CD11d/CD18;	ITAD)	19.	β2	integrins	recognize	members	
of	 the	 intercellular	adhesion	molecule	(ICAM)	family	19.	Furthermore,	αLβ2	binds	
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junctional‐adhesion	molecule	(JAM)	1‐3,	expressed	on	endothelial	cells	21;	22.	αDβ2	
can,	 besides	 ICAM‐3,	 also	 interact	 with	 VCAM‐1	 23,	 while	 αMβ2	 and	 αXβ2	
additionally	 interact	with	 polysaccharides	 24;	 25.	 β7	 integrins	 are	 expressed	 on	 T	
cells	 and	 DCs	 (αEβ7)	 26	 and	 to	 a	 specific	 set	 of	 memory	 T	 cells	 (α4β7)	 27.	
Leukocytes	 also	 express	 β1	 integrins	 and	 α4β1	 is	 in	 particular	 important	 in	
immune	responses.		
The	 most	 studied	 leukocyte‐integrin	 is	 leukocyte‐function‐associated	 antigen‐1	
(LFA‐1).	 LFA‐1	 is	 important	 for	 lymphocyte	 adhesion	 to	 the	 endothelium,	 T	 cell	
priming,	and	delivery	of	co‐stimulatory	signals	and	cytotoxic	activity	via	 immune	
synapses	 28‐35.	 The	 importance	 of	 LFA‐1	 and	 other	 β2	 integrins	 is	 highlighted	 in	
leukocyte	 adhesion	 deficiency	 (LAD)	 syndrome	 type	 I	 where	 mutations	 of	 the	
integrin	 β2	 subunit	 lead	 to	 lack	 of	 responsiveness	 of	 immune	 cells,	 causing	 life‐
threatening	infections	36	
Integrin	Regulation	
To	 date,	 several	 mechanisms	 have	 been	 postulated	 to	 contribute	 to	 integrin	
activity.	 At	 the	 molecular	 level,	 transient	 modifications	 of	 adhesion	 are	
accomplished	by	conformational	 changes	of	 the	 integrin	 from	a	bent	down	 to	an	
upright	 conformation,	 leading	 to	 low‐	 and	 high‐affinity	 states	 for	 the	 ligands,	
respectively.	 A	 second	 mechanism	 proposes	 organization	 of	 integrins	 into	
multimolecular	assemblies	at	the	cell	surface	that	 locally	augment	its	avidity	(i.e.	
valency)	 37;	 38.	 Moreover,	 ligand	 binding	 can	 further	 be	 increased	 by	 dynamic	
redistribution	of	 integrins	 in	the	cell	membrane	to	 increase	the	chances	of	 ligand	
encounter	39;	40.	These	mechanisms	seem	to	be	highly	interlinked	and	contribute	to	
adhesion	strengthening	in	vivo	41‐43.	
Inside‐out	signaling	(prior	to	ligand	binding)	
Integrins	 on	 circulating	 leukocytes	 are	 mainly	 inactive	 or	 in	 an	 intermediate	
affinity	 state	 and	 their	 activity	 is	 tightly	 controlled	 by	 signaling	 through	 other	
membrane	receptors	when	required.	Inside‐out	signaling	refers	to	the	process	by	
which	cellular	activation	results	in	augmentation	of	the	adhesive	properties	of	the	
ectodomain	 of	 the	 integrin	 44.	 These	 conformational	 changes	 are	 induced	 by	
binding	of	 the	cytoskeletal	protein	 talin	which	causes	dissociation	of	 the	α	and	β	
cytoplasmic	domains	45;	46.	Electron	microscopic	and	crystallographic	studies	have	
characterized	a	bent,	extended	and	intermediate	conformation	of	the	β2	integrin,	
which	 are	 thought	 to	 reflect	 different	 affinities	 to	 the	 ligand	 47;	 48	 (Figure	 1).	
Signaling	via	G‐protein	coupled	receptors	leads	to	the	extension	of	the	low	affinity	
form	 of	 LFA‐1	 in	 lymphocytes	 within	milliseconds	 49‐51.	 The	 pathway	 leading	 to	
integrin	 activation	 includes	 activation	 of	 phospholipases	 (PLC)/protein	 kinase	 C	
(PKC)	and	the	GTPase	Rap1.		
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Figure	1:	 Schematic	 representation	 of	 the	 integrin	 structure	 and	 conformations.	There	 are	
three	distinct	 integrin	 conformations:	bent	 (left),	 intermediate	 (middle)	and	upright	 (right),	
with	distinct	ligand	affinities.	Molecules	are	not	drawn	to	scale	
	
	
Rap1	 is	 a	 small	 G‐protein	 which	 has	 been	 implicated	 in	 the	 regulation	 of	 integrins	 in	
lymphocytes	 52.	 In	 B	 cells,	 inside‐out	 signaling	 of	 LFA‐1	 was	 regulated	 by	 RhoA,	 acting	
downstream	of	PKC	53,	consistent	with	other	studies	54.		
Besides	 talin,	 the	 β2	 chain	 associates	 with	 a	 variety	 of	 cytoplasmic	 proteins,	 including	
Kindlin‐3,	α‐actinin,	filamin,	vinculin	and	RACK	1	that	mediate	changes	related	to	inside‐out	
signaling	55	(Table	2).			
Several	adaptor	proteins,	such	as	 linker	 for	activated	T	cells	 (LAT),	Src	homology	2	(SH2)	
domain	 containing	 leukocyte	 protein	 of	 76kDa	 	 (SLP76),	 adhesion‐	 and	 degranulation‐
promoting	 adapter	 protein	 (ADAP),	 and	 Src‐kinase‐associated	 phosphoprotein	 of	 55kDa	
(SKAP55/SKAP1)	 are	 proposed	 to	 be	 involved	 in	 LFA‐1	 activation56‐60.																													
Integrin	 activation	 by	 inside‐out	 signaling	 can	 also	 be	 mediated	 by	 other	 cell	 surface	
receptors	such	as	the	TCR	complex	35,	or	by	addition	of	phorbol	esters	that	mimic	natural	
agonists	that	activate	protein	kinase	C	61;	62.	Extended	intermediate	and	high‐affinity	LFA‐1	
express	 a	 Ca2+	 dependent	 epitope	 at	 the	 genu	 of	 the	 α	 chain,	 that	 is	 recognized	 by	 the	
antibody	NKI‐L16,	a	valuable	tool	in	mapping	the	conformation	and	activity	of	LFA‐1	63.		
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Table	2.	Established	Integrin	Binding	Partners		
	 Name	 Function Integrin/tail
Cytoskeletal	
Proteins	
Talin‐1	 Actin‐binding	 β1,	αIIbβ3	64‐
66	
	 α‐actinin	 Actin‐binding β1,	β2	67;	68	
	 Filamin	 Actin‐binding β1,	β2,β7	66;	
69	
	 Paxillin	 Signal	transduction	
adaptor	protein	
β1	70	
	 Actin	 Cytoskeleton α2	71	
	 Myosin‐X	 Motor	protein β1	72	
	 Tensin	 Actin‐binding β		73	
Intracellular	
signaling/scaffolding	
proteins	
Cytohesin‐1 ARF	guanine	
nucleotide	exchange	
factor	
β2	74;	75	
	
	 Kindlin‐1‐3 FERM‐domain	
containing	proteins	
β1,	β2,	β3	76‐
78	
	 FAK	 Focal	adhesion	kinase	 β1,	β370	
	 ILK	 Integrin‐linked	kinase	 β179	
	 β3‐endonexin Cytoplasmic	protein β380	
	 ICAP‐1	 Integrin	binding	
protein	
β181	
	 Rack1	 Activated	PKC	
receptor	
β,	β2,	β5	82	
	 RapL	 Rap1	interacting	
protein	
αL	37	
	 WAIT‐1	 Scaffolding	protein α4β7,	αEβ1		
83	
	 RanBPM	 Scaffolding	protein		 β1,	β2	84	
	 JAB‐1	 Transcriptional	
coactivator	
β2	85	
	 14‐3‐3	 Signaling	protein β2	86	
Chaperon	proteins	 Calreticulin Calcium‐binding	
chaperon	in	ER	lumen	
α,α6β1	87;	88	
	 Calnexin	 Calcium‐binding	
chaperon	in	ER	
membrane	
β1,α6	89	
	
	 BiP	 Chaperon	in	ER	lumen αIIbβ390	
Tetraspanins	 CD9	 Tetraspanin	 αIIbβ3,		
α2β1,	α3β1,		
α4β1,		α4β1,		
α5β1,		α6β1	
91‐93	
	 CD53	 Tetraspanin α4β1	94	
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	 CD63	 Tetraspanin α3β1,		α4β1,		
α6β1,		β1,		
αLβ2	94‐96	
	 CD81	 Tetraspanin α3β1,		α6β1,	
β1		95;	97,	
α4β1	94		
	 CD82	 Tetraspanin α3β1	98;	99
	 CD151	 Tetraspanin	 α3β1,	α6β1	
100	
Others	 CD47/IAP‐40 Membrane	protein αVβ3,		
αIIbβ3,		α2β1	
101	
	 CD98	 T	cell	activation	
antigen	
β1	102	
	 CD147	 Membrane	protein	 α3β1,		α6β1		
103	
	 DNAM‐1 Membrane	protein αLβ2	104	
	 CD36	
	
Membrane	protein αIIbβ3		105
α3β1	and	
α6β1	106	
	 uPAR	 Urokinase	receptor	 αLβ2,		αMβ2	
107	
	
Outside‐in	signaling	(downstream	of	ligand	binding)	
Integrins	are	bidirectional	signaling	receptors	that	transmit	signals	inside‐out	and	
outside‐in	108.	Outside‐in	signaling	refers	to	the	process	by	which	engagement	of	an	
integrin	 by	 its	 ligand	 transmits	 signals	 through	 the	 integrin	 that	 influences	
intracellular	 signaling	 events.	 The	 molecular	 mechanisms	 leading	 to	 outside‐in	
signaling	 are	 still	 unclear.	 In	 T	 cells,	 macroclustering	 of	 LFA‐1	 at	 the	 ICAM‐1	
nucleation	site	follows	initial	ligand	encounter	and	leads	to	adhesion	strengthening	
46.	Moreover,	outside‐in	signaling	causes	cell	spreading,	migration	and	chemotaxis	
in	 leukocytes,	 as	 well	 as	 production	 of	 reactive	 oxygen	 species	 and	 release	 of	
cytokines	and	cytotoxic	granules	in	macrophages	and	neutrophils	109.	In	β1	and	β3	
integrins	 focal	 adhesion	 kinase	 (FAK),	 and	 in	 β1	 integrins	 also	 integrin‐linked	
kinase	 (ILK),	 are	 associated	with	 outside‐in	 signaling	pathways	 70;	 79;	 87;	whether	
they	are	involved	in	β2	signaling	is	not	known.	The	Src	and	Syk	protein	kinases	are	
involved	in	outside‐in	signaling	in	β2	integrins	in	leukocytes	and	in	β3	integrins	in	
platelets.	 The	 transcriptional	 co‐activator	 JAB‐1	 binds	 to	 the	 cytoplasmic	 part	 of	
the	 integrin	 α	 chain.	 In	 the	 steady‐state,	 JAB‐1	 localized	 to	 the	 nucleus	 and	 the	
cytoplasm,	but	 the	nuclear	pool	of	 JAB‐1	 increases	upon	LFA‐1	cross‐linking	and	
phosphorylation,	 resulting	 in	 activation	 of	 the	 transcription	 factor	 AP‐1	 85.	
Cytohesin‐1	plays	a	dual	role	in	integrin	regulation	by	interacting	with	the	β	chain	
of	 LFA‐1.	 It	 plays	 a	 role	 in	
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inside‐out	 signaling,	 since	 overexpression	 leads	 to	 increased	 adhesiveness	 and	
integrin	clustering	on	the	cell	surface	75;	110.	But	it	also	has	implications	for	outside‐
in	 signaling.	 Cytohesin‐1	 stimulated	 expression	 of	 Erk	 in	 Jurkat	 cells	 and	 upon	
treatment	with	ICAM‐1	cytohesin‐1	became	phosphorylated	111.		
Besides	 conformational	 changes,	 inside‐out	 signaling	 and	 outside‐in	 signaling	
induce	 changes	 in	 the	 lateral	 mobility	 of	 integrins.	 Earlier	 studies	 reported	
increased	lateral	mobility	of	LFA‐1	upon	activating	by	phorbol	ester	or	cytokines,	
which	 in	 turn	 increased	 integrin	 aggregation	 into	 high‐avidity	 clusters	 and	
adhesion	 strengthening49;	 112‐114.	 Inside‐out	 and	 outside‐in	 signaling	 events	 can	
occur	concurrently	44,	which	makes	it	difficult	to	dissect	those	pathways	from	each	
other	 during	 adhesion	 events.
	
Leukocyte	trafficking	
One	of	the	most	intriguing	features	of	the	immune	system	is	the	capacity	to	be	at	
the	 right	 spot	 at	 the	 right	 moment.	 The	 capillary	 nature	 of	 our	 blood	 and	 the	
lymphatic	 system	allows	 immune	 surveillance	 to	 take	place	 even	 at	 the	 smallest	
tissue	regions	within	our	body.	While	naïve	lymphocytes	migrate	from	the	blood	to	
the	 lymph	nodes	via	the	high	endothelial	venules,	 they	rely	on	DCs	to	sample	for	
antigen	in	the	periphery	to	deliver	it	to	the	lymph	nodes	for	lymphocyte	activation	
115.		Most	DCs	do	not	circulate	and	therefore	cannot	enter	the	lymph	nodes	via	the	
blood.	 Instead,	 they	 travel	 from	 the	 tissues	 to	 the	 lymph	 nodes	 via	 the	 afferent	
lymphatics	 115.	 Trafficking	 of	 immune	 cells	 is	 orchestrated	 by	 the	 expression	 of	
small	 chemotactic	 molecules	 (chemokines)	 and	 the	 expression	 of	 their	 cognate	
receptors,	 seven‐fold	 membrane	 spanning	 G‐protein	 coupled	 receptors	 (GPCRs)	
116.	Chemokine	receptor	expression	changes	during	cell	differentiation	and	among	
cell	 types,	 which	 guides	 cells	 specifically	 to	 certain	 sites.	 A	 list	 of	 chemokine	
receptors	 expressed	 during	 DC	 differentiation	 and	 maturation	 is	 presented	 in	
Table	3.	
While	monocytes	and	 immature	DCs	express	CCR1,CCR2,CCR5	and	CXCR1,	which	
are	 required	 for	 pro‐inflammatory	 chemotaxis	 in	 the	 tissues,	 maturing	 DCs	
upregulate	CCR7,	the	receptor	for	the	lymphoid	chemokines	CCL19	and	CCL21	115.	
In	the	absence	of	the	chemokines	CCL19	and	CCL21,	secreted	by	lymph	node	and	
lymphatic	endothelial	cells,	trafficking	of	mature	DCs	via	the	afferent	lymphatics	to	
the	 lymph	 nodes	 was	 impaired	 in	 mice117,	 highlighting	 the	 importance	 of	 these	
chemokines	in	the	DC	lifecycle.		
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Table	3:	Chemokine	Receptors	expressed	during	DC	differentiation	and	maturation	
	
Chemokine	
Receptor	
Chemokines	and	Aliases Cell	Type	
CCR1	 CCL3	(MIP‐1α),	CCL5	(RANTES),	
CCL6	(C‐10),	CCL7	(MCP‐3),	CCL8	
(MCP‐2),	CCL13	(MCP‐4),	CCL14	
(HCC‐1),	CCL15	(MIP‐1	Δ),	CCL16	
(HCC‐4),	CCL23	(MPIF)	
Monocytes,	immature	DCs
CCR2	 CCL2	(MCP‐1),	CCL6	(C‐10),	
CCL7(MCP‐3),	CCL8	(MCDP‐2),	
CCL13	(MCP‐4)	
Monocytes,	immature	DCs
CCR3	 CCL6	(C‐10) Monocytes	
CCR4	 CCL17	(TARC),	CCL22	(MDC) Mature	DCs	
CCR5	 CCL3	(MIP‐1), CCL4	(MIP‐1β),	CCL5	
(RANTES)	,	CCL14	(HCC‐1)	
Monocytes,	immature	DCs	
CCR6	 CCL20	(MIP‐3	α)	 Immature	DCs	
CCR7	 CCL19	(MIP‐3	β),	CCL21	(6Ckine) Mature	DCs		
CCR8	 CCL1	(I‐309) Immature	DCs	
CXCR1	 CXCL8	(IL‐8) Monocytes,	immature	DCs
CXCR4	 CXCL12	(SDF‐1	α/β)	 Monocytes,	mature	DCs	
CX3CR1	 CX3CL1	(Fractalkine)	 Monocytes	
	
	
Besides	giving	chemotactic	cues,	chemokine	signaling	by	GPCRs	transduce	inside‐
out	 signals	 leading	 to	 integrin	 activation	 by	 increasing	 affinity	 and	 valency,	 as	
illustrated	during	 leukocyte	extravasation	 49;	 51.	At	sites	of	 infection,	 tissue	 injury	
and	at	lymphoid	organs,	rolling	leukocytes	must	rapidly	adhere	to	the	endothelium	
to	withstand	the	shear	forces	of	the	blood	stream.	This	process	follows	a	cascade	of	
adhesive	 interactions	 and	 signaling	 events:	 tethering	 along	 the	 endothelium,	
rolling,	firm	adhesion	and	transmigration	118;	119.			
The	initial	tethering	to	and	rolling	on	the	endothelium	are	classically	regarded	as	
mediated	 by	 selectins	 (E‐,	 P‐,	 and	 L‐selectin)	 and	 their	 ligands	 (P‐selectin‐
glycoprotein	ligand	1	(PSGL1)),	α4	integrins	and	CD44	120‐123.	In	monocytes	and	T	
lymphocytes,	 rolling	 is	mainly	mediated	by	VLA‐4	121;	 124;	 125.	LFA‐1	also	supports	
rolling	in	the	presence	of	E‐selectin	and	ICAM‐1	on	neutrophils	126.	Similarly,	αLβ2	
can	 mediate	 rolling	 and	 adhesion	 when	 transfected	 into	 K562	 cells,	 however	 it	
does	not	play	a	role	 in	peripheral	blood	 lymphocytes	and	 Jurkat	cells	 127;	 128.	The	
endothelium	 plays	 an	 active	 role	 in	 regulating	 rolling,	 by	 upregulation	 the	
expression	 of	 selectins	 and	 ICAM‐1	 and	 the	 secretion	 of	 chemokines	 during	
inflammation	 21;	 129,	 which	 slows	 down	 rolling	 neutrophils	 to	 a	 speed	 of	
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5μm/second.	 LFA‐1	 and	 Mac‐1	 play	 an	 important	 during	 those	 slow	 rolling	
processes	130;	131			
During	 the	 tethering	 and	 rolling	 process,	 leukocytes	 become	 exposed	 to	
endothelium‐presented	 chemokines.	 Endothelial	 cells	 present	 self‐secreted	
chemokines	 and	 chemokines	 produced	 by	 other	 cells	 on	 their	 cell	 surface	 132,	
partially	 by	 immobilization	 via	 glycosaminoglycans	 133;	 134.	 Dependent	 on	 the	
leukocyte	 subset	 and	 endothelial	 ligands	 expressed,	 α4	 integrins	 such	 as	 VLA‐4	
(α4β1)	or	α4β7	and	 the	β2	 integrins,	LFA‐1	 (αLβ2)	and	Mac‐1	 (αMβ2)	and	 their	
counter	 ligands	 of	 the	 immunoglobulin	 supergene	 family	 VCAM‐1	 (CD106),	
MAdCAM‐1	 and	 ICAM‐1	 (CD54),	 mediate	 firm	 adhesion	 events.	 Circulating	
leukocytes	 such	 as	 T	 cells	 and	 neutrophils	 have	 their	 integrins	 largely	 in	 an	
inactive	 state	 prior	 to	 chemokine	 encounter,	 to	 prevent	 nonspecific	 interactions	
with	the	tissue.		
Transmigration	of	leukocytes	through	venular	walls	is	the	final	step	in	the	process	
of	 leukocyte	 extravasation	 and	 occurs	 through	 two	 different	 routes.	 In	 the	
paracellular	route,	leukocytes	exploit	several	endothelial	junctions	molecules	such	
as	 platelet/endothelial‐cell	 adhesion	 molecule	 1	 (PECAM1),	 junctional	 adhesion	
molecule	(JAM)	A,B	and	C	as	well	as	endothelium	expressed	ICAM‐1	and	ICAM‐2	21,	
in	order	 to	pass	 the	endothelium	via	 cell‐cell	 junctions.	The	paracellular	 route	 is	
mediated	 by	 ICAM‐1	 ligation	 followed	 by	 translocation	 of	 apical	 ICAM‐1	 to	
caveolae	and	F‐actin	rich	region	and	transport	to	the	basal	plasma	membrane	135.	
This	process	is	associated	in	vivo	with	areas	with	thin	endothelial	linings	136.	Upon	
crossing	of	the	endothelial	cell	layer,	leukocytes	still	have	to	cross	the	endothelial	
basement	 membrane	 and	 the	 pericyte	 sheath	 to	 enter	 the	 tissues	 or	 secondary	
lymphoid	organs	(Figure	2).	
As	 mentioned	 above,	 DCs	 follow	 a	 different	 trafficking	 route	 than	 lymphocytes.	
Once	 monocytes	 have	 crossed	 the	 endothelial	 lining	 of	 the	 blood	 vessels	 they	
reside	as	immature	DCs	in	the	tissues.	In	contrast	to	monocytes	that	clearly	require	
integrins	during	 the	process	of	 transendothelial	migration,	 the	role	of	 integrin	 in	
the	 life	 cycle	 of	 DCs	 during	 migration	 to	 the	 lymph	 nodes	 and	 during	 antigen	
presentation	 to	naïve	 lymphocytes	 is	 less	well	understood.	During	differentiation	
of	in	vitro	cultured	monocytes	towards	immature	DCs,	LFA‐1	remains	expressed	at	
similar	levels,	but		only	monocytes	express	extended	and	functional	LFA‐1	137.	As	a	
consequence,	binding	of	DCs	to	ICAM‐1	is	negligible	while	binding	to	ICAM‐2	and	‐
3	occurs	in	an	integrin‐independent	manner,	and	is	mostly	mediated	by	the	C‐type	
lectin	DC‐SIGN138;	139.	Whether	integrins	on	DCs	play	a	role	is	controversial.	Several	
studies	showed	that	the	major	ligands	for	LFA‐1	and	VLA‐4	(ICAM‐1	and	VCAM‐1)	
are	 present	 in	 the	 lymphatic	 tissues	 and	 are	 upregulated	 during	 inflammation,	
suggesting	 that	 interactions	 with	 integrins	 on	 immune	 cells	 and	 the	 lymphatic	
endothelial	 cells	 takes	 place.	 On	 the	 other	 hand,	 it	 was	 reported	 that	 DCs	 from	
integrin	knock‐out	mice	migrate	from	the	tissue	to	the	lymph	nodes	similar	to	wild	
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type	DCs,	 suggesting	 that	 integrins	are	not	essential	 for	migration	of	DCs	 in	vivo.	
While	on	 two‐dimensional	 surfaces	 locomotion	 is	 strictly	dependent	on	 integrin‐
anchorage	 to	 the	 substrate,	 in	 three‐dimensional	 environments,	 such	 as	 the	
interstitium,	 integrins	 might	 be	 used,	 but	 are	 not	 required	 140;	 141.	 DCs	 cells	 are	
prototypes	 of	 this	 type	 of	 integrin‐independent	 migration,	 called	 amoeboid	
migration	142.	The	driving	force	of	amoeboid	migration	are	protrusions	formed	at	
the	leading	edge	and	contraction	of	the	cell	body	by	actomyosin	140.		
Different	 trafficking	 routes	 expose	 monocytes	 and	 DCs	 to	 environments	 with	
different	 physiological	 conditions	 that	 require	 adaptations	 (Figure	 2).	While	 the	
blood	stream	exposes	lymphocytes	to	high	shear	stress	values	in	the	range	of	1‐4	
dynes/cm2	 143;	 144,	 the	 shear	 stress	 values	 of	 the	 lymphatics	 are	 much	 lower,	
approximately	 0.08	 dynes/cm2	 115.	 	Moreover,	 the	 lymphatic	 endothelium	 has	 a	
different	anatomy	than	the	highly	sealed	blood	vessels.	The	 initial	 lymphatics	are	
specialized	in	draining	of	the	lymph	from	the	tissues,	and	the	larger	lymph	vessels	
that	contain	little	valves	propel	the	lymph	forward	towards	the	lymph	nodes.		
	
	 	
	
	
Figure	2:	Leukocyte	Trafficking.	Monocytes	in	the	bloodstream	migrate	during	the	process	of	
leukocyte	extravasation	 into	 the	peripheral	 tissues,	where	 they	reside	as	 immature	DCs	until	
they	 encounter	with	antigen.	Upon	antigen	uptake,	 they	mature	and	migrate	 via	 the	 initial	
lymphatics	into	larger	lymphatic	vessels	and	eventually	to	the	lymph	nodes,	where	they	present	
antigen	to	naïve	lymphocytes.			
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The	 anatomy	 of	 the	 lymphatic	 vessels,	 with	 overlapping	 cell‐cell	 junctions	 that	
work	as	valves,	direct	the	lymph	flow	from	the	tissue	to	the	lymph	nodes	and	not	
backwards.	
Compartmentalization	of	the	plasma	membrane	
	
Regulation	 of	 adhesion	 has	 its	 origin	 at	 the	molecular	 scale,	 in	 the	 plane	 of	 the	
plasma	membrane,	where	processes	 are	 dynamic	 and	 heterogeneous	 and	 lateral	
diffusion	of	integrins	facilitates	the	encounter	with	ligand.	
The	 plasma	 membrane	 is	 a	 prerequisite	 for	 life	 by	 compartmentalizing	 cellular	
processes.	 Mammalian	 membranes	 are	 composed	 of	 glycerol‐based	 lipids,	
sphingolipids	 and	 cholesterol	 145.	 The	 first	 two	 classes	 contain	 many	 different	
examples,	 and	 for	 each	 type	 of	 lipid	 there	 can	 be	 many	 species,	 because	 of	 the	
variation	 in	 length	 and	 degree	 of	 unsaturation	 in	 the	 hydrocarbon	 chains.	
Glycerophospholipids	 are	 the	 main	 component	 of	 biological	 membranes	 and	
consist	of	glycerol,	to	which	two	fatty	acids	and	a	phosphoric	acid	are	attached	as	
esters.	Spingolipids	contain	a	backbone	of	sphingoid	bases,	a	set	of	aliphatic	amino	
alcohols	 that	 includes	 sphingosine.	 The	 head‐group	 either	 contains	
phosphocholine	(sphingomyelin)	or	a	carbohydrate	structure	(glycosphingolipid).	
A	 sphingolipid	with	 a	 head‐group	 consisting	 of	 a	 hydrogen	 atom	 only	 is	 termed	
ceramide.	 Sphingolipids	 have	 longer	 carbon‐atom	 chains	 due	 to	 higher	 levels	 of	
saturated	lipids	and	therefore	exhibit	stronger	lateral	cohesion	within	the	plane	of	
the	 membrane	 146.	 	 Sterols,	 like	 cholesterol,	 are	 a	 subgroup	 of	 steroids	 with	 a	
hydroxyl	group	at	the	3‐position	of	the	A‐ring,	giving	the	molecule	a	flat	and	rigid	
structure.	The	hydroxyl	group	on	the	A‐ring	is	polar.	The	rest	of	the	aliphatic	chain	
is	 non‐polar.	Most	 of	 the	 sterols	 are	 present	 in	 the	 plasma	membrane,	 and	 only	
little	amounts	in	intracellular	membranes.		
The	 plasma	 membrane	 consist	 of	 two	 asymmetric	 leaflets,	 each	 containing	
hundreds	of	different	lipids	147	and	proteins.	Sphingolipids	are	mostly	found	in	the	
outer	 membrane,	 while	 gycerophospholipides	 (including	 the	 signaling	 lipid	
phosphatidylinositol)	 are	 restricted	 to	 the	 inner	 leaflet	 148.	 Cholesterol	 and	
sphingolipids	 preferentially	 interact	 with	 each	 other,	 thereby	 forming	 a	 liquid	
ordered	(Lo)	phase	in	contrast	to	the	surrounding	liquid‐disordered	phase	(Ld)	in	
artificial	membranes	 149.	Due	 to	a	 lack	of	 experimental	evidence,	 the	existence	of	
these	 lo	 domains	 in	 native	membranes,	 also	 referred	 to	 as	 lipid	 rafts,	 has	 been	
under	 dispute.	 However,	 the	 development	 of	 high	 resolution	 techniques	 has	
revealed	 that	raft	domains	are	much	smaller	 in	size	 than	 in	artificial	membranes	
150‐152.	 The	 smaller	 size	 has	 recently	 been	 explained	 by	 the	 presence	 of	 integral	
membrane	 proteins	 attached	 to	 the	 cytoskeleton	 that	 act	 as	 obstacles,	 thereby	
limiting	the	size	of	these	lipid	domains	153.		
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Now,	 four	 decades	 after	 the	 initial	 fluid	 mosaic	 model	 postulated	 that	 proteins	
move	 freely	 within	 a	 sea	 of	 lipids	 154,	 it	 becomes	 clear	 that	 proteins	 and	 lipids	
rather	 function	 in	 concert	 and	 this	 interaction	 tightly	 regulates	 biological	
processes,	 such	 as	 signaling,	 adhesion	 and	 membrane	 trafficking	 155.	 The	
development	 of	 high	 resolution	 imaging	 techniques	 revealed	 that	 the	membrane	
itself	is	highly	compartmentalized	and	dynamic	155.	Lateral	domain	formation	most	
likely	results	from	the	preferential	 interaction	between	lipids,	proteins	as	well	as	
lipids	 and	proteins	 145.	 The	 best	 described	 plasma	membrane	 compartments	 are	
lipid	 rafts	 and	 tetraspanin	 enriched	microdomains	 (TEMs).	 Besides,	 actin‐driven	
confinement	zones,	lectin	microdomains	and	inner	rafts	remarkably	contribute	to	
plasma	membrane	 compartmentalization.	 In	 order	 to	 understand	 how	 adhesion	
events	are	orchestrated	 in	 space	and	 time,	 it	 is	 crucial	 to	 investigate	 integrins	 in	
the	context	of	their	native	plasma	membrane	environment.		
Integrins	 interact	 with	 different	 plasma	 membrane	 compartments,	 and	 this	
interaction	regulates	integrin	affinity	and	avidity	(see	chapter	2).	LFA‐1	shows	an	
intriguing	 organization	 in	 nanodomains	 (100‐150nm)	 containing	 either	 high‐
affinity	 (extended)	 or	 inactive	 (bent	 conformation)	 LFA‐1	 on	 monocytes	 137;	 156.	
Active	LFA‐1	nanoclusters	are	recruited	to	contact	sites	of	monocytes	and	T	cells	
137.	 These	 nanodomains	 reside	 in	 proximity	 to	 domains	 enriched	 in	 GPI‐APs,	
without	physically	intermixing.	Disrupting	this	proximity	by	depleting	cholesterol	
from	 lipid	 rafts	 prevents	 the	 formation	 of	 ligand‐induced	 nucleation	 sites.	
Moreover,	 25‐30%	 of	 LFA‐1	 on	 monocytes	 resides	 in	 a	 high	 affinity	 state,	 as	
determined	 by	 the	 activation	 reporter	 antibody	 L16,	 and	 functional.	 However,	
during	in	vitro	differentiation	of	monocytes	towards	DCs,	LFA‐1	function	and	high	
affinity	 conformation	 are	 lost,	 and	 LFA‐1	 in	 the	 plasma	 becomes	 randomly	
organized	(Figure	3).	Therefore,	the	organization	of	LFA‐1	in	nanoclusters	is	linked	
to	LFA‐1	function.	
	
Aim	of	the	thesis	
DCs	 play	 a	 fundamental	 role	 in	 the	 initiation	 of	 the	 immune	 response.	 Their	
precursors,	 monocytes,	 cross	 in	 the	 process	 of	 transendothelial	migration	 the	
blood	vessels	to	reside	as	immature	DCs	in	the	tissues.	They	constitutively	scan	our	
body	 for	 invading	 pathogens	 or	 transformed	 body	 cells,	 pick	 up	 and	 process	
antigen	 and	 subsequently	migrate	 to	 the	 lymph	 nodes,	 to	 form	 contacts	 with	
naïve	 lymphocytes	 in	 order	 to	 mount	 an	 immune	 response.	 To	 all	 these	 events	
adhesion	and	migration	are	fundamental.	However,	the	role	that	LFA‐1	plays	in	DC	
migration	 and	 adhesion	 is	 controversial.	 In	 vitro	 cultured	 DCs	 show	
downregulation	of	LFA‐1	 function,	and	evidence	 for	a	role	during	 translymphatic	
migration	 to	 the	 lymph	nodes	 or	 during	 antigen‐presentation,	 on	 the	 side	 of	 the	
DC,	is	still	missing.		
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Figure	 3:	 LFA‐1	 related	 changes	 during	 DC	 differentiation.	 LFA‐1	 function,	 as	 well	 as	
organization	in	nanoclusters	is	lost	during	DC	differentiation,	despite	similar	expression	levels	
of	LFA‐1	in	monocytes	and	DCs.	The	loss	of	LFA‐1	function	is	associated	with	a	general	change	
from	a	pro‐adhesive	to	a	migratory	phenotype.			
	
	
The	 aim	 of	 thesis	 was	 to	 investigate	 how	 LFA‐1	 function	 and	 cell	 surface	
organization	are	regulated	in	the	context	of	the	plasma	membrane	environment	in	
monocytes	 and	 DCs.	 Moreover,	 we	 investigated	 whether	 high	 affinity	 and	
functional	 LFA‐1	 could	 be	 restored	 on	 DCs.	 Chapter	 2	 describes	 the	 different	
plasma	membrane	compartments	and	how	they	interact	with	integrins	to	regulate	
their	affinity	and	avidity.	Moreover,	 this	chapter	 introduces	 two	new	concepts	 in	
integrin	 regulation:	 proximal	 compartmentalization	 at	 the	 nanoscale	 level	 and	
lateral	mobility.	In	chapter	3	we	used	proteomics	to	identify	novel	LFA‐1	binding	
partners	 during	 DC	 differentiation.	 We	 show	 that	 the	 LFA‐1	 interactome	
dynamically	 changes	 during	 differentiation	 of	 monocytes	 towards	 DCs	 and	
identified	several	novel	LFA‐1	binding	candidates.	In	chapter	4	we	show	that	the	
lymphoid	chemokine	CCL21	restores	high	affinity	and	functional	LFA‐1	on	DCs	 in	
vitro	 and	 that	ex	vivo	DCs	 show	elevated	 levels	of	high	affinity	LFA‐1.	Chapter	5	
demonstrates	 that	 infection	 of	 mature	 DCs	 with	 herpes	 simplex	 virus	 type	 1	
increases	β2	 integrin‐mediated	adhesion,	 including	LFA‐1,	 and	 immobilization	of	
DCs.	This	occurred	via	degradation	of	the	cytohesin‐1	deactivating	protein	CYTIP.	
In	 chapter	 6	 and	 7	 we	 used	 single	 dye	 tracking	 studies	 to	 investigate	 LFA‐1	
dynamics	in	the	membrane	of	monocytes.	Chapter	6	describes	how	conformational	
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state	and	dynamics	are	coupled	and	how	 the	extracellular	environment	can	shift	
the	balance	between	mobile	and	immobile,	as	well	as	inactive	and	active	LFA‐1	by	
adjusting	extracellular	calcium	levels.	Finally,	in	chapter	7	we	report	that	the	lipid	
environment	 of	 the	 plasma	 membrane	 affects	 the	 structure	 and	 function,	 and	
consequently	 conformation	 and	 dynamics	 of	 LFA‐1.	
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Summary	
Integrins	are	transmembrane	adhesion	receptors	that	are	fundamental	to	
all	aspects	of	multicellular	 life,	by	mediating	cell‐matrix	and	cell‐cell	 interactions.	
More	than	two	decades	of	research	have	explored	the	main	mechanisms	of	integrin	
regulation:	affinity	and	avidity.	In	view	of	recent	findings	that	the	cell	membrane	is	
highly	 compartmentalized	 and	 heterogeneous,	 the	 question	 is	 emerging	 how	
integrin	 function	 is	 regulated	 in	 the	 context	 of	 the	 native	 plasma	 membrane	
environment.	 Classical	 biochemical	 and	 novel	 biophysical	 approaches,	 including	
superresolution	 optical	 techniques,	 have	 revealed	 a	 distinct	 organization	 of	
integrins	 in	 proximity	 to	 plasma	 membrane	 compartments	 that	 is	 crucial	 for	
integrin‐mediated	 functions.	 Moreover,	 molecular	 conformation	 and	 lateral	
diffusion	of	 integrins	 in	native	membranes	seem	highly	 interlinked,	underscoring	
the	 important	 role	 of	 receptor	 mobility	 for	 adhesion	 events.	 In	 this	 review	 we	
discuss	 how	 different	 plasma	 membrane	 compartments	 such	 as	 lipid	 rafts,	
tetraspanin	enriched	microdomains	and	galectin	lattices	modulate	integrin	affinity	
and	 avidity.	 Finally,	 we	 introduce	 two	 new	 concepts	 in	 integrin	 regulation:	
nanoscale	 proximity	 to	membrane	 compartments	 and	 lateral	mobility	within	 the	
cell	membrane.		
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Introduction	
Adhesion	 to	 the	 extracellular	 matrix	 and	 cell‐cell	 interactions	 are	
fundamental	 processes	 that	 require	 tight	 regulation.	 In	 general,	 adhesive	
interactions	are	controlled	by	regulated	expression	of	 integrins	and	 their	 ligands	
on	 different	 cell	 types/tissues	 or	 during	 different	 stages	 of	 cell	 differentiation.	
Integrins	 are	 a	 family	 of	 heterodimeric	 transmembrane	 (TM)	 receptors	 that	
regulate	cell	adhesion.	In	mammals	a	pool	of	18α	and	8β	subunits	can	assemble	in	
24	different	heterodimers,	binding	to	specific	ligands,	such	as	collagens,	laminins,	
RGD‐containing	proteins	or	cellular	counter	receptors.	
Two	main	mechanisms	have	been	commonly	postulated	 to	 contribute	 to	
integrin	 activity.	 At	 the	 molecular	 level,	 transient	 modifications	 of	 adhesion	 are	
accomplished	 by	 conformational	 changes	 of	 the	 integrin	 from	 bent	 down	 to	
upright	 conformations	 leading	 to	 low‐	 and	 high‐affinity	 states	 for	 the	 ligands,	
respectively.	Integrin	activation	via	affinity	changes	requires	separation	of	α	and	β	
cytoplasmic	 tails	 and	 opening	 of	 the	 extracellular	 ligand‐binding	 domain	 in	
response	to	activating	signals	such	as	T	cell	receptor	(TCR)	ligation	or	chemokine‐
signaling	(the	so‐called	“inside‐out	signaling”)	1‐4.	Binding	of	extracellular	ligand	to	
high‐affinity	 integrins	 subsequently	 induces	 the	 recruitment	 of	 signaling	 and	
scaffold	 proteins	 from	 the	 cytosol	 and	 the	 anchoring	 of	 the	 integrin	 to	 the	
cytoskeleton	(the	so‐called	“outside‐in	signaling”)	5;	6.		
A	 second	 mechanism	 proposes	 activation	 by	 dynamic	 reorganization	 of	
integrins	 into	multimolecular	assemblies	at	the	cell	surface	that	 locally	augments	
its	avidity	(i.e.	valency)	7;	8.	In	the	literature,	redistribution	patterns	of	integrins	are	
commonly	 referred	 to	 as	 clustering	 and	 linked	 to	 integrin	 activation.	 The	
recruitment	of	integrins	to	adhesion	sites	following	ligand	encounter	results	in	µm‐
sized	domains,	stabilized	by	anchorage	to	 the	cytoskeleton.	Although	affinity	and	
avidity	 regulation	 of	 integrins	 are	 often	 described	 as	 independent	 mechanisms,	
with	the	relative	contribution	of	clustering	and	conformation	changes	being	hotly	
debated	9;	10,	more	recent	evidence	suggests	that	they	might	be	highly	interlinked	
and	both	contribute	to	adhesion	strengthening	in	vivo	11;	12.	
Given	 that	 affinity	 and	 avidity	 modulation	 of	 integrins	 occur	 at	 the	 cell	
surface,	 these	 mechanisms	 cannot	 be	 understood	 without	 taking	 into	
consideration	the	contribution	of	 the	membrane	environment	where	 the	 integrin	
molecules	are	embedded.	This	is	particularly	important	since	abundant	data	in	the	
past	decade	indicate	that	the	plasma	membrane	(PM)	is	highly	compartmentalized	
in	 space	 and	 time	 13;	 14	 	 (Box	 1)	 and	 that	 this	well‐defined	 organization	 appears	
fundamental	 to	 biological	 processes	 such	 as	 cell	 adhesion,	 signaling	 and	
endocytosis.	 In	 the	 particular	 case	 of	 integrins,	 interactions	 with	 lipid	 rafts,	
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tetraspanins	(TSPAN),	galectin	lattices	and	the	actin	cytoskeleton	have	been	widely	
documented.	Still,	most	of	 the	studies	so	 far	have	underestimated	 the	role	of	 the	
spatiotemporal	compartmentalization	of	 these	molecular	components	on	integrin	
function.		
PM	compartments	such	as	 lipid	rafts	have	been	 frequently	characterized	
based	on	their	biochemical	properties,	as	detergent	resistant	membranes	(DRMs),	
and	the	participation	of	proteins	with	these	fractions	has	been	used	as	evidence	for	
their	interaction.	However,	these	studies	lacked	information	about	the	spatial	and	
temporal	characteristics	of	these	PM	compartments	and	their	interactions.	Recent	
advances	 in	 optical	 microscopy	 have	 greatly	 facilitated	 the	 study	 of	 PM	
compartments	and	revealed	heterogeneous	domains	in	terms	of	size,	composition	
and	 diffusion	 properties	 15;	 16	 (Box	 2).	 In	 2009,	 Eggeling	 et	 al.	 used	 STEDFCS	 to	
provide	 convincing	 evidence	 for	 cholesterol‐driven	 compartmentalization	 17.	
Besides	other	techniques	(Box	2),	NSOM	has	greatly	improved	the	mapping	of	the	
nanoscale	organization	of	the	PM	with	∼50‐100	nm	resolution.	With	this	approach,	
Manzo	et	al.	have	also	detected	heterogeneous	behavior	of	sphingolipid	diffusion	
that	 is	 consistent	 with	 compartmentalization	 18.	 Using	 NSOM,	 Van	 Zanten	 et	 al.	
found	 that	 cholera	 toxin‐β	 (CTxB)	 binding	 to	 GM1	 induces	 coalescence	 of	 CTxB‐
GM1	 into	 nanodomains	 smaller	 than	 120	nm.	Although	 the	 term	 “rafts”	 remains	
controversial,	the	existence	of	lipid	and	protein	nanodomains	at	the	cell	membrane	
is	now	widely	accepted	19;	20.	
The	 organization	 of	 membrane	 receptors	 in	 preformed	 nanoscale	
assemblies	regulates	their	encounter	with	ligands	12;	21	as	well	as	their	association	
with	 signaling	 molecules	 eventually	 leading	 to	 fusion	 into	 larger	 signaling	
platforms	 22‐24,	 demonstrating	 a	 spatio‐functional	 relationship	 of	 the	 various	 PM	
domains.	 In	 addition,	 these	 processes	 are	 highly	 dynamic	 and	 interactions	 are	
probably	 transient,	 such	 that	 lateral	mobility	 of	 different	 components	within	 the	
cell	 membrane	 is	 important	 for	 defining	 compartmentalization	 and	 function.	
Therefore,	besides	affinity	and	avidity,	both	the	proximity	of	integrin	molecules	to	
other	membrane	domains	and	their	lateral	mobility	must	play	a	regulatory	role	in	
integrin	 function.	 In	 this	 review	 we	 will	 discuss	 on	 how	 different	 PM	
compartments	 modulate	 integrin	 affinity	 and	 avidity	 and	 introduce	 two	 new	
concepts	 in	 integrin	 regulation:	 proximal	 compartmentalization	 at	 the	 nanoscale	
level	and	lateral	mobility	(Fig.1).		
How	PM	compartments	regulate	integrin	affinity	and	avidity	
a) The	role	of	lipid	rafts:		
Modulation	of	the	affinity	of	integrins	for	their	ligands	involves	conformational	
changes	 that	 encompass	 the	 entire	 heterodimer,	 from	 the	 unclasping	 of	 the	
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cytoplasmic	 tails,	 the	 separation	 of	 the	TM	 regions,	 to	 the	 opening	 of	 the	 heads.	
Avidity	changes	are	commonly	referred	to	clustering	and	aggregation	of	integrins	
at	ligand	binding	sites	that	locally	enhance	the	number	of	formed	bonds.	While	it	is	
generally	accepted	that	several	PM	 lipid	and	protein	compartments	 interact	with	
integrins,	their	exact	role	in	regulating	affinity	and/or	avidity	changes	are	difficult	
to	grasp.	Recently,	some	studies	have	provided	evidence	for	the	involvement	of	PM	
compartments	regulating	these	processes.	
	
Figure	1:	Representative	overview	of	the	mechanisms	regulating	integrin	function	in	the	PM.	
Integrin	function	is	classically	regulated	by	conformational	changes	(affinity),	as	well	by	local	
enrichment	 of	 receptor	 density,	 leading	 to	 increased	 avidity.	 Integrin	 nanodomains	 are	
preorganized	 assemblies	 prior	 to	 ligand	 encounter	 that	 reside	 proximal	 to	 other	 PM	
compartments	at	the	nanoscale.	This	tight	organization	in	proximity	to	PM	compartments	is	a	
prerequisite	 for	 the	 onset	 of	 adhesion.	 Moreover,	 different	 integrin	 conformations	 show	
distinct	mobility	patterns	that	greatly	determine	the	chance	of	ligand	encounters.	The	sum	of	
these	regulatory	events	allows	successful	adhesion	to	take	place.	Molecules	are	not	drawn	to	
scale.		
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Box	1	The	plasma	membrane	nanodomains	
Lipid	 rafts.	 Lipid	 (or	 membrane)	 rafts	 are	 defined	 as	 “small	 (10–200	 nm),	
heterogeneous,	 highly	 dynamic,	 sterol‐	 and	 sphingolipid	 enriched	 domains	 that	
compartmentalize	 cellular	 processes.	 Small	 rafts	 can	 sometimes	 be	 stabilized	 to	
form	 larger	platforms	 through	protein–protein	and	protein–lipid	 interactions”	 19;	
25.	 Lipid	 rafts	 have	 been	 shown	 to	 play	 an	 important	 role	 in	 various	 biological	
phenomena,	 ranging	 from	 cell	 adhesion,	 to	 pathogen	 binding,	 endocytosis	 and	
immune	 cell	 signaling.	 In	 virtue	 of	 their	 lipid	 anchor,	
glycosylphosphatidylinositolanchored	 proteins	 (GPI‐APs)	 were	 among	 the	 first	
molecules	to	be	identified	as	“official”	raft	components.	
Caveolae.	One	of	the	first	structures	found	in	the	plasma	membrane	of	eukaryotic	
cells	 were	 caveolae	 26.	 These	 small	 (~60	 nm)	 flask‐shaped	 membrane	
invaginations	 consist	 mainly	 of	 the	 caveolin	 protein,	 which	 binds	 cholesterol.	
Caveolae	have	been	implicated	in	a	range	of	cellular	functions,	such	as	cholesterol	
transport,	endocytosis	and	signal	transduction.	
Inner	 membrane	 microdomains.	 Phosphorylated	 phosphatidylinositol	
derivatives	 (PIPs)	 greatly	 contribute	 to	 the	negative	 charge	and	 asymmetry	 and,	
importantly,	 the	differential	 targeting	and	 trafficking	 of	 signaling	proteins	 to	 the	
plasma	 membrane	 27;	 28.	 PIP2	 is	 the	 dominant	 lipid	 in	 cholesterol‐independent	
microdomains	(70nm)	of	 the	 inner	 leaflet	 29.	PIP2	clusters	 in	the	 inner	 leaflets	of	
the	 PM	 are	 highly	 dynamic	 23.	 Also	 Ras	 GTPases	 associate	 with	 different	 PM	
microdomains	 in	 the	 inner	 leaflet	via	a	 lipid	anchor	 that	 is	highly	diverse	among	
different	 Ras	 isoforms	 30.	 The	 coupling	 of	 raft	 domains	 at	 the	 outer	 and	 inner	
leaflets	 is	 thought	 to	 be	 important	 for	 signal	 transduction	 via	 lipid	 rafts.	
Nevertheless,	 little	 is	 known	 about	 how	 the	 outer	 and	 inner	 microdomains	 are	
organized	 with	 respect	 to	 each	 other	 and	 how	 signals	 are	 transduced	 over	 the	
asymmetric	bilayer.		
Tetraspanins	 and	TEMs.	 Tetraspanins	 are	 a	 family	 of	 integral	 proteins	 mainly	
localized	at	the	plasma	membrane	and	able	to	interact	with	one	another	and	with	
numerous	 other	 TM	 proteins,	 thereby	 assembling	 a	 network	 of	 molecular	
interactions	 also	 called	 the	 tetraspanin‐enriched	microdomains	 (TEMs)	 31.	 TEMs	
cover	 in	 average	 an	 area	 of	 200‐400nm2.	 Small	 clusters	 of	 tetraspanins,	 each	
specifically	linked	to	an	interacting	molecule,	move	within	the	plasma	membrane,	
often	 interacting	 with	 other	 domains,	 either	 tetraspanin‐enriched	 or	 lipid	 rafts,	
and	 possibly	 exchanging	 some	 of	 their	 components.	 The	 association	 of	
tetraspanins	 with	 integrins	 is	 well	 documented,	 although	 there	 is	 still	 little	
mechanistic	insight	into	how	tetraspanins	facilitate	integrin‐mediated	adhesion.	
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Transient	confinement	zones.	Transient	confinement	zones	(TCZ)	within	the	PM	
are	 supposedly	 formed	 by	 a	 membrane‐associated	 actin	 mesh	 network	 32;	 33.	
Indeed,	 increasing	 evidence	 is	 clearly	 pointing	 towards	 an	 active	 role	 of	 cortical	
actin	in	the	formation	and	dynamics	of	membrane	nanodomains.	Interestingly,	the	
diffusion	 rate	 of	 lipids	 in	 the	 plasma	 membrane	 is	 5–100	 times	 slower	 than	 in	
artificial	 bilayers,	 suggesting	 that	 long‐range	 interactions	 between	 lipids	 and	
proteins	or	lipid	and	the	extracellular	matrix	may	be	responsible	for	this	reduction.	
Movement	of	phospholipids	at	the	single‐molecule	level	with	a	temporal	resolution	
of	 25	 μs	 demonstrated	 that	 phospholipids	 undergo	 hop	 diffusion	 in	
compartmentalized	plasma	membranes,	proposing	the	intriguing	concept	that	TM	
proteins	 anchored	 to	 the	 actin	 cytoskeleton	 meshwork	 would	 act	 as	 “rows	 of	
pickets”	 to	 temporarily	 confine	 diffusing	 phospholipids.	 This	 has	 shifted	 the	
original	paradigm	of	the	plasma	membrane	as	two‐dimensional	continuum	fluid	to	
the	new	“partitioned	fluid,”	where	proteins	and	lipids	diffuse	within	TCZs.	
Galectin	 lattices:	 Galectins	 are	 members	 of	 the	 lectin	 family	 that	 bind	 to	 b‐
galactoside‐containing	glycans	and	are	defined	by	a	conserved	CRD	domain.	They	
are	abundant	proteins	that	are	present	in	the	cell	nucleus,	in	the	cytoplasm,	as	well	
as	 in	 secreted	 form	 bound	 to	 the	 cell	 surface.	 Dimeric	 and	 pentameric	 galectin	
specifically	 bind	 Gal‐GlcNA	 branched	 tetraantennary	 N‐glycans	 on	 cell	 surface	
proteins,	 thereby	 forming	 microdomains	 (lattices),	 that	 crosslink	 or	 segregate	
molecules	within	the	PM	34;	35.	Binding	affinity	to	cell	surface	receptors	depends	on	
the	 number	 of	 N‐glycosylation	 sites	 and	 the	 specificity	 of	 glycan	 –	 galectin	
interactions,	 that	result	 in	 formation	of	homo‐	or	heterogeneous	galectin	 lattices.	
The	size	of	galectin	lattices	has	not	been	determined	yet.	However,	a	characteristic	
of	 galectin	 lattices	 is	 the	 slow	 and	 restricted	 diffusion	 rate	 of	 trapped	 surface	
receptors	 36.	 Importantly,	 galectins	 not	 only	 crosslink	 glycoproteins,	 but	 also	
glycolipids	 that	 contain	 highly	 branched	 N‐glycans.	 Therefore,	 besides	 forming	
microdomains	 themselves,	 lectin	 microdomains	 might	 organize	 other	 PM	
compartments	within	the	membrane.		
A	 functional	 link	 between	 lipid	 rafts	 and	 integrins	 was	 demonstrated	
when	antibody‐enhanced	clustering	of	the	ganglioside	GM1	in	Jurkat	cells	induced	
significant	 resistance	 to	 shear	 stress	 and	 adhesion	 strengthening	 on	 fibronectin	
(FN).	Affinity	changes	were	determined	as	increased	binding	capacity	of	α4β1	and	
α5β1	 to	 soluble	 FN	 and	 VCAM‐1	 37.	 Moreover,	 Leitinger	 et	 al	 reported	 that	 raft	
localization	correlated	with	the	affinity	state	of	LFA‐1.	Inactive	LFA‐1	was	tethered	
away	from	rafts	by	the	cytoskeleton,	while	high‐affinity	LFA‐1	translocated	to	lipid	
rafts	 38.	 Additionally,	 Singh	 et	 al	 reported	 that	 enzymatic	 removal	 of	 sialic	 acid	
specifically	 from	 sphingolipids	 disrupted	 ganglioside‐cholesterol	 containing	
domains	and	 this	 coincided	with	 the	 loss	of	 an	activation	 reporter	 epitope	on	β1	
integrins,	highlighting	an	important	role	of	lipid	rafts	in	β1	affinity	regulation	39.	
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Box	2	New	microscopy	techniques	to	address	PM	compartments	
Förster	 resonance	energy	 transfer	 (FRET):	Förster	 resonance	 energy	 transfer	
(FRET)	is	capable	of	detecting	proximity	between	two	fluorophores	(a	donor	and	
an	acceptor)	below	the	optical	resolution.	FRET	is	capable	of	detecting	proximity	
between	 two	 fluorophofluorophore	 distances,	 typically	 1‐10nm,	 and	 the	 spectral	
overlap	 between	 donor	 and	 acceptor.	 The	 basis	 for	 data	 interpretation	 is	 that	
clustering	 stabilizes	 inter‐particle	 distances.	 FRET	 efficiencies	 that	 are	
independent	of	 the	 fluorophore	densities	have	been	 interpreted	as	 indicative	 for	
the	 existence	 of	 clusters	 40;	 41.	 In	 recent	 years,	 time	 resolved	 FRET	 as	 combined	
with	 fluorescence	 lifetime	 imaging	 and	 appropriate	 theoretical	 modeling,	 is	
providing	more	depth‐inside	in	the	size	of	nanodomains	in	both	model	systems	as	
well	as	in	living	cells	42.	HomoFRET	in	combination	with	fluorescence	polarization	
anisotropy	 (a	 technique	 that	 measures	 rotational	 diffusion	 using	 changes	 in	
fluorescence	polarization	that	are	due	to	fluorophore	rotation)	revealed	that	GPI‐
anchored	proteins	and	other	 lipid‐modified	proteins	 form	cholesterol‐dependent,	
nanoscale	clusters	43;	44.		
Single	 particle	 tracking	 (SPT):	 SPT	 allows	 to	 track	 with	 high	 precision	 the	
diffusion	 of	 individual	microscopic	 particles	 attached	 to	 relevant	molecules.	 The	
coordinates	(x,	y,	z)	over	a	series	of	time	steps	allow	generating	trajectories	with	
nanometer	 precision,	 which	 can	 be	 analyzed	 to	 identify	 modes	 of	 motion	 or	
heterogeneities	 in	 the	motion	 of	 the	 particles.	 Individual	 fluropohores,	 quantum	
dots,	gold	or	polystyrene	particles	have	been	used	extensively	to	characterize	the	
diffusion	 of	 individual	 receptors	 and	 lipids	 on	 the	 cell	 membrane	 32;	 45;	 46.	
Depending	 on	 the	 experimental	 conditions,	 either	 epi	 or	 total	 internal	 reflection	
fluorescence,	 TIRF	 (based	 on	 evanescent	 wave	 illumination,	 ~150	 nm	 into	 the	
sample,	 that	 is	 created	 by	 a	 totally	 internally	 reflected	 beam	 at	 the	 glass–water	
interface)	can	be	used	to	excite	the	fluorophores	or	quantum	dots.	
Fluorescence	correlation	spectroscopy	(FCS):	FCS	is	a	technique	that	measures	
diffusion	 of	 a	 few	molecules	 by	 correlating	 the	 fluorescence	 signal	 of	 a	 diffusing	
fluorophore	with	 time.	 The	 analysis	 provides	 the	 average	 number	 of	 fluorescent	
particles	 and	 average	 diffusion	 time,	 as	 the	 particle	 traverses	 the	 illumination	
volume.	Commonly,	FCS	is	employed	under	confocal	excitation	using	linear	or	two‐
photon	 approaches.	 	 The	 light	 is	 focused	 on	 a	 sample	 and	 the	 measured	
fluorescence	 intensity	 fluctuations	 (due	 to	 diffusion	 and/or	 aggregation)	 are	
analyzed	 using	 the	 temporal	 autocorrelation.	 FCS	 has	 been	 used	 in	 live	 cells	 to	
reveal	cholesterol‐	and	sphingolipid‐based	nanoscale	domains,	into	which	proteins	
and	lipids	dynamically	partition	or	assemble	with	a	timescale	of	tens	to	hundreds	
of	milliseconds	47.	
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Stimulated	 emission	 depletion	 (STED):	 STED	 creates	 a	 nanometric	 optical	
region	by	 first	exciting	 fluorophores	 to	an	excited	state	over	a	diffraction‐limited	
region	using	a	pulsed	 laser.	A	 second	pulsed	 laser	 illuminates	 the	 sample	with	 a	
doughnut‐shape	like	pattern	in	a	wavelength	that	depletes	the	excited	state	of	the	
fluorescent	molecules	back	to	the	ground	state.	Fluorescence	is	effectively	detected	
only	from	the	hole	of	the	doughnut,	providing	images	with	a	resolution	of	~30nm.	
So	far,	the	technique	has	been	mainly	applied	in	neurobiology	by	the	Hell’s	group,	
delivering	 important	 information	 on	 the	 study	 of	 syntaxin	 clusters	 and	
acetylcholine	 receptors	 on	 fixed	 cultured	 neurons,	 as	well	 as	 to	 the	 dynamics	 of	
synaptic	vesicles	over	small	fields	of	view	at	high	speeds	48;	49.		More	recently,	STED	
has	 been	 also	 combined	with	 FCS	 to	 observe	 nanoscale	 dynamics	 of	 membrane	
lipids	and	GPI‐anchored	proteins	in	living	cells	17.		
Photoactivated	localization	microscopy	and	stochastic	optical	reconstruction	
microscopy	(PALM	and	STORM):	These	super‐resolution	microscopy	techniques	
use	 stochastically	 photoactivated	 fluorescent	 probes	 to	 reconstitute	 a	 full	 image	
from	 individual	 point	 spread	 functions.	 The	main	 difference	 between	 PALM	 and	
STORM	resides	on	the	type	of	fluorophores	used	for	photoactivation:	PALM	relies	
on	autofluorescent	proteins,	while	STORM	uses	organic	switchable	dyes	(from	the	
cyanine	 family).	 The	 ascertainable	 localization	 accuracy	depends	 strongly	 on	 the	
total	 number	 of	 photons	 being	 detected.	 Especially	 PALM/FPALM	 can	
quantitatively	 map	 relative	 molecular	 densities	 with	 very	 high	 localization	
accuracy	 over	 wide	 fields	 and	 in	 living	 cells.	 PALM/FPALM	 has	 been	 used	 to	
reconstruct	 images	 of	 various	 proteins	 in	 thin	 cellular	 sections	 and	 near	 the	
surfaces	 of	 whole,	 fixed	 cells	 50,	 to	 study	 the	 organization	 of	 different	 proteins	
within	 adhesion	 complexes	 51	 and	 to	 track	 large	 populations	 of	 single	 proteins	
molecules	in	the	plasma	membrane	of	living	cells	52.	
Near‐field	 scanning	 optical	microscopy	 (NSOM):	 NSOM	 is	 a	 super‐resolution	
technique	 that	 exploits	 the	 evanescent	 wave	 exiting	 from	 a	 subwavelength	
aperture	 probe	 to	 locally	 excite	 fluorophores	 near	 the	 surface	 of	 a	 sample.	 The	
optical	 resolution	 depends	 on	 the	 aperture	 diameter	 of	 the	 probe,	 typically	
between	50	 to	 100nm.	 Since	 the	 probe	 needs	 to	 be	 positioned	 very	 close	 to	 the	
sample	(<10nm),	an	independent	feedback	mechanism	is	used,	which	generates	a	
simultaneously	 topographic	 image	 in	 perfect	 registry	 with	 the	 superresolution	
optical	counterpart	16.	Single‐molecule	NSOM	has	been	recently	used	to	 	visualize	
the	nanolandscape	of	ganglioside	GM1	after	tightening	by	its	 ligand	cholera	toxin	
on	intact	fixed	monocytes,	demonstrating	a	raft‐based	compositional	connectivity	
at	the	nanometer	scale	crucially	mediated	by	cholesterol	20.		
NSOM	 has	 been	 also	 exploited	 to	 capture	 the	 spatio‐functional	 relationship	
between	 the	 integrin	 receptor	 LFA‐1	 involved	 in	 leukocyte	 adhesion	 and	 raft	
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components	 (GPI‐APs)	 21.	More	 recently	 NSOM	 has	 been	 combined	with	 FCS	 on	
living	 cells	 to	 provide	 ultra‐small	 illumination	 volumes	 and	 to	 reveal	 nanoscale	
heterogeneities	on	the	diffusion	of	specific	lipids	on	the	cell	membrane	18.		
a) The	role	of	tetraspanins:	
In	 addition	 to	 lipid	 rafts,	 other	 PM	 organizers	 such	 as	 TSPANs	 have	 been	
shown	 to	 influence	 the	affinity	and/or	avidity	 state	of	 integrins,	 although	a	clear	
integrin‐TSPAN	interface	has	not	been	mapped	yet.	Besides	direct	 interactions	of	
CD151	 and	 CD81	 with	 β1	 integrins,	 TSPAN‐integrin	 interactions	 are	 rather	
mediated	 by	 secondary	 interactions	 within	 larger	 tetraspanin‐enriched	
microdomains	 (TEMs)	 53‐55.	 While	 in	 previous	 studies	 integrin	 regulation	 by	
TSPANs	 has	 been	 regarded	 solely	 as	 a	 post‐ligand	 binding	 phenomenon,	 more	
recent	 papers	 demonstrated	 also	 a	 role	 for	 TSPANs	 in	 stabilizing	 high‐affinity	
conformations	of	integrins	prior	to	ligand	binding	56‐58.	The	use	of	laminin	coated‐
beads	in	combination	with	a	magnetic	trap	in	fibroblasts	allowed	direct	probing	of	
adhesion	 strength	and	demonstrated	a	 regulatory	 role	of	 the	CD151	cytoplasmic	
tail	in	α6β1	adhesion	strengthening	57.	CD151	is	also	involved	in	stabilization	of	the	
active	 conformation	 of	 α3β1	 and	 ligand	 binding	 to	 laminin	 in	 human	 lung	
adenocarcinoma	 and	 Cos‐7	 cells.	 Dissociating	 CD151	 from	 α3β1	 by	 an	 antibody	
against	CD151	clearly	reduced	ligand‐binding	capacity	and	resulted	in	the	loss	of	a	
β1	activation	reporter	epitope	58.	In	another	study,	stable	expression	of	the	TSPAN	
CD9	in	CHO	cells	upregulated	the	expression	of	high‐affinity	α5β1,	as	determined	by	
expression	of	β1‐ligand‐induced	binding	sites	upon	binding	 to	the	 ligand	mimetic	
peptide	 RGDS.	 These	 changes	 on	 the	 activation	 state	 of	 α5β1	 were	 accompanied	
with	a	strong	association	with	CD9	and	enhanced	the	migratory	phenotype	on	FN,	
indicating	that	CD9	may	play	a	role	in	stabilizing	the	high	affinity	conformation	of	
α5β1	56.		
TEMs	are	often	recruited	together	with	integrins	to	large	cell‐cell	contacts,	
emphasizing	an	important	role	of	TEMs	in	avidity	regulation	of	adhesion	receptors.	
So	led	ablation	of	CD151	to	altered	subcellular	distribution	of	α6	and	reduction	in	
α6	dependent	 tumor	cell	 invasion	 59.	Avidity	 regulation	by	TSPANs	has	also	been	
described	 in	 the	 case	 of	 CD81	 for	 LFA‐1	 and	 VLA‐4.	 Triggering	 CD81	 with	
antibodies	 increased	 LFA‐1	 avidity,	 assessed	 by	 binding	 to	 ICAM‐3,	 without	
exposing	 an	 activation	 reporter	 epitope	 on	 β2	 60.	 Moreover,	 CD81	 regulated	 the	
ability	of	VLA‐4,	but	not	of	LFA‐1,	 to	generate	critical	binding	avidity	 to	high	and	
medium	 density	 ligand	 VCAM‐1	 under	 shear	 stress,	 without	 altering	 the	 affinity	
state	 of	VLA‐4	 61.	 Interestingly,	 to	 date	 there	 is	 no	 evidence	of	 direct	 interaction	
between	CD81	and	LFA‐1,	therefore	it	has	been	suggested	that	avidity	regulation	of	
LFA‐1	by	CD81	most	 likely	 involves	additional	binding	partners.	Finally,	CD9	and	
CD63	 are	 involved	 in	 regulating	 cytoskeletal	 organization	 by	 recruiting	 actin	 to	
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ligand‐bound	αIIbβ3,	which	is	especially	important	for	force‐generation	during	cell	
spreading/motility	 and	 clot	 retraction	 in	 platelets	 62.	 Although	 not	 the	 specific	
focus	 of	 this	 review,	 it	 is	 important	 to	 mention	 that	 local	 increase	 in	 integrin	
avidity	 can	 also	 be	 achieved	 by	 directed	 delivery	 of	 integrins	 to	 adhesion	 sites.	
Both	TSPANs	and	lipid	rafts	are	involved	in	integrin	turnover	mediating	recycling	
and	 endocytosis	 63‐65.	 Comprehensive	 reviews	 have	 been	 recently	 published	 that	
addressed	 the	 importance	 of	 integrin	 trafficking	 in	 the	 regulation	 of	 adhesion	 66	
and	 that	 highlighted	 the	 role	 of	 lipid	 rafts	 and	 caveolae	 in	 mediating	 integrin	
internalization	and	recycling	67.		
b) The	role	of	inner	membrane	interactors:	
Whereas	increasing	information	shapes	our	view	on	how	compartments	of	the	
PM	outer	 leaflet	regulate	 integrin	 function,	 the	 involvement	of	 the	 inner	 leaflet	 is	
less	 well	 understood.	 Kindlin‐3	 and	 talin	 are	 both	 essential	 to	 mediate	 integrin	
activation	by	inducing	conformational	changes	via	binding	to	the	β	cytoplasmic	tail	
at	 slightly	 overlapping	 regions,	 although	 their	 sequential	 binding	 order	 is	 still	
unclear	68.	Recent	work	indicated	that	both	talin	and	kindlin‐3	require	anchoring	to	
the	 PM	 inner	 leaflet	 lipids	 via	 phosphatidylinositol	 4,5‐bisphosphate	 (PIP2),	 in	
order	to	facilitate	their	interactions	with	integrins	68‐70.	Along	the	same	line,	Ye	et	
al	 showed	 that	 binding	 of	 the	 talin	 head	 domain	 to	 the	 integrin	 αIIbβ3	 tail	 is	
sufficient	for	integrin	activation	even	in	the	absence	of	kindlin.	However,	efficient	
talin‐induced	 activation	 required	 a	 membrane‐binding	 site	 on	 talin	 and	 the	
insertion	of	the	integrins	in	a	lipid	membrane	71.	Also	the	small	GTPase	Rap1	and	
its	 effector	 RapL	 appear	 to	 be	 important	 activation	 signals	 for	 β1,β2	 and	 β3	
integrins	 7.	 Upon	 TCR	 signaling	 they	 translocate	 to	 the	 inner	 membrane,	 in	 a	
manner	dependent	 on	 the	 PH	domain	 of	 SKAP1	 and	 the	PI3K	pathway	 72.	 These	
experiments	 thus	evidenced	once	more	 an	 important	 role	 of	membrane	 lipids	 in	
integrin	 function.	 Improvement	 of	 inner	 raft	 isolation	 procedures,	 as	 well	 as	
advances	 in	 microscopy	 will	 hopefully	 facilitate	 the	 study	 of	 the	 inner	 leaflet	
microdomains	and	their	role	in	mediating	cell	adhesion	processes.		
c) The	role	of	galectin	lattices:	
In	eukaryotes,	glycosylation	is	a	widespread	post‐translational	modification	of	
proteins	 and	 lipids.	 Galectins	 play	 an	 important	 role	 in	 regulating	 receptor	
clustering	by	cross‐linking	proteins	and	lipids	within	the	PM	35.	Up	to	30%	of	the	
molecular	weight	of	an	integrin	depends	on	its	glycosylation	73,	therefore	it	is	likely	
that	 	 interactions	with	galectins	 regulate	 integrin	 clustering	 during	 cell	 adhesion	
and	 migration.	 For	 example,	 galectin‐3	 (Gal‐3)	 interactions	 with	 N‐
Acetylglucosaminyltransferase	V	(Mgat5)‐modified	N‐glycans	at	the	cell	surface	of	
mammary	 carcinoma	 cells	 promote	 α5β1	 integrin	 activation	 and	 cell	 motility,	
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possibly	via	 integrin	clustering	within	focal	contacts	74.	Likewise,	Gal‐3	promoted	
clustering	of	α3β1	and	α6β4	integrins	enhancing	cell	adhesion	and	motility	likely	by	
virtue	 of	 the	 multivalency	 of	 Gal‐3	 75	 leading	 to	 integrin	 clustering.	 In	 contrast,	
association	of	Gal‐3	with	α2β1	integrin	in	Madin‐Darby	canine	kidney	cells	inhibited	
ligand‐induced	 α2β1	 clustering	 76.	 Hence,	 the	 effect	 of	 galectin	 binding	 appears	
strictly	dependent	on	its	target	protein	and	its	specific	environment.			
Modification	 of	 the	 glycosylation	 enzyme	 machinery,	 i.e.	 in	 response	 to	
metastatic	transformation	or	during	cell	differentiation/	activation,	allows	cells	to	
dynamically	 modify	 the	 glycosylation	 profile	 of	 their	 cell	 surface	 lipids	 and	
proteins	77.	As	such,	modulation	of	cell	surface	glycans	and	the	presence	of	cross‐
linking	 galectins	 might	 present	 a	 so	 far	 underestimated	 mechanism	 in	 the	
regulation	of	cell	surface	proteins	in	general	and	integrins	in	particular.		
	Nanoscale	organization	and	proximity	of	 integrin	and	PM	components	as	a	
novel	regulator	of	integrin	function		
Activation	 of	 integrins	 by	 affinity	 and	 avidity	 mechanisms	 is	 clearly	
subject	 to	 regulation	 by	 PM	 compartments.	 However,	 how	 exactly	 PM	
compartment	 –	 integrin	 interactions	 are	 regulated	 in	 space	 and	 time	 to	
dynamically	 assemble	 into	 signaling	 adhesion	 platforms,	 is	 a	 field	 of	 emerging	
interest.	In	the	last	years	it	became	clear	that	the	organization	of	some	integrins	in	
small	 nanodomains	 prior	 to	 ligand	 activation	 and	 their	 nanoscale	 proximity	 to	
certain	PM	compartments	are	essential	for	successful	adhesion	events	(Figure	2).			
In	some	cases,	certain	proteins	seem	to	act	as	gate‐keepers	that	regulate	
the	 entry	 and	 exit	 of	 integrins	 and/or	 other	 molecular	 interactors	 into	 PM	
compartments.	For	instance,	the	GPI‐anchored	protein	CD24	includes	β1	integrin	in	
raft	domains,	 but	 excludes	 the	 chemokine	 receptor	CXCR4	 from	 these	 regions	 78.	
Crosslinking	 of	 the	GPI‐anchored	 ectoenzyme	CD157	 induced	 translocation	 of	 β1	
and	 β2	 integrins	 into	 lipid	 rafts	 followed	 by	 onset	 of	 integrin‐related	 signaling	
cascades.	 In	 contrast,	 CD4	 triggering	 induced	 association	 of	 LFA‐1	 and	
phosphatidylinositol	 3‐kinase	 (PI3‐K)	 in	 lipid	 rafts	 followed	 by	 redistribution	 of	
LFA‐1	to	GM3	rich	lipid	rafts	79.	The	interaction	of	LFA‐1	with	the	ganglioside	GM3	
transiently	sequestered	LFA‐1	from	PI3‐K	and	adhesion	regulating	proteins,	such	
as	PKCzeta,	RhoA	and	Cytohesin‐1,	resulting	in	the	termination	of	LFA‐1	mediated	
adhesion	80.		
A	more	 complex	 example	 of	 underlying	 connectivity	between	 lipid	 rafts,	
the	 cytoskeleton	 and	 integrins	 has	 been	 reported	 in	 platelets.	 Upon	 triggering	 of	
αIIbβ3,	PIP2	and	several	cytoskeletal	regulatory	proteins	 localized	 to	 lipid	rafts,	as	
determined	by	association	with	DRMs,	thereby	modifying	 locally	the	composition	
of	these	microdomains.	Even	though	only	a	small	fraction	of	αIIbβ3	localized	to	rafts	
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upon	ligand	binding,	disruption	of	rafts	inhibited	αIIbβ3‐mediated	force	generation	
necessary	 for	 fibrin	 clot	 retraction	 81.	 Partial	 localization	 of	 palmitoylated	 β4	
integrins	and	their	signaling	partners,	as	observed	for	α6β4	and	Src	 family	kinase	
(SFK),	 was	 responsible	 for	 their	 raft	 localization	 in	 keratinocytes	 82.	
Palmitoylation‐defective	α6β4	did	not	activate	SFK	signaling	and	failed	to	promote	
phosphorylation	 of	 β4	 in	 response	 to	 EGF‐signaling,	 highlighting	 the	 functional	
importance	of	the	local	preassembly	of	SFK	and	β4	in	lipid	rafts.		
Another	example	of	how	the	nanoscale	organization	specifically	regulates	
integrin	 function	 has	 been	 demonstrated	 by	 chemokine‐induced	 inside‐out	
signaling	under	shear	stress	conditions	83.	Rapid	chemokine	signaling	depended	on	
clustering	of	 chemokine	 receptor	 subunits	 (Gαi)	 in	proximity	 to	 integrins	 in	 lipid	
rafts,	prior	to	chemokine	receptor	signaling.	Depletion	of	cholesterol	prevented	the	
association	 of	 Gαi	 subunits	 with	 lipid	 rafts	 and	 subsequent	 VLA‐4	 avidity	
upregulation.	 This	 is	 particularly	 interesting,	 since	 LFA‐1	 avidity	 regulation	was	
not	 affected	 under	 the	 same	 conditions.	 This	 suggests	 that	 one	 specific	
chemokine/receptor	 pair	 can	 activate	 multiple	 integrins,	 but	 the	 coupled	 Gαi	
subunits	 may	 be	 segregated	 within	 distinct	 compartments	 at	 the	 nanoscale,	
allowing	differential	integrin	regulation.		
Aside	 from	 lipid	 raft‐type	of	 nanoscale	 interactions	with	 integrins,	 some	
workers	have	postulated	 a	 close	 relationship	at	 the	nanoscale	between	 integrins	
and	 tetraspanins	 nanoplatforms.	 Palmitoylation	motifs	 in	 several	 integrin	 chains	
can	 target	 integrins	 to	 TEMs	 31,	 suggesting	 a	 dynamic	 interplay	 between	 these	
molecules.	 Using	 advanced	 analytical	 fluorescence	 techniques,	 including	 single	
molecule	 approaches	 Barreiro	 et	 al	 provided	 evidence	 for	 the	 existence	 of	
endothelial	 adhesive	 platforms	 containing	 nanoclusters	 of	 VCAM‐1	 and	 ICAM‐1	
sustained	 by	 TSPANs	 84.	 Interestingly,	 to	 date	 no	 data	 is	 available	 for	 a	
preorganization	 of	 integrins‐TSPANs	 in	 proximity	 prior	 to	 ligand	 encounter	 and	
remains	to	be	determined.			
Novel	 biophysical	 approaches	 in	 combination	 with	 nanopatterning	
techniques	 have	 also	 demonstrated	 the	 importance	 of	 nanoclustering	 of	 integrin	
ligands	influencing	the	spatial	coordination	of	integrins	in	processes	related	to	cell	
spreading,	adhesion	and	migration	85‐87.	In	contrast	to	the	mature	phase	of	integrin	
mediated	adhesion	where	 the	 importance	of	 integrin	microclustering	 is	 clear	 for	
enhancing	 avidity,	 nanopatterning	 techniques	 have	 allowed	 to	 determine	 the	
minimal	 density	 of	 integrin	 ligands	 and	 their	 physical	 separation	 necessary	 to	
initiate	 cell	 adhesion	 86;	 87.	 Using	 these	 approaches,	 it	 has	 been	 shown	 that	 focal	
contacts	 and	 actin	 stress	 fiber	 formation	 requires	 that	 integrins	 are	 closer	 than	
70nm	from	each	other	85.	Interestingly,	these	spatial	scales	also	correspond	to	the	
organization	 of	 the	 integrin	 LFA‐1	 in	 resting	 monocytes.	 Indeed,	 using	
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transmission	electron	microscopy	and	super	resolution	NSOM,	we	discovered	that	
LFA‐1	 organizes	 in	 small	 nanoclusters	 of	 ~70nm	 on	 monocytes	 prior	 to	 ligand	
binding	12;	20;	21;	88.		
	
Figure	 2:	 Schematic	 representation	 of	 events	 that	 contribute	 to	 regulate	 integrin	 function	
prior	 and	 during	 ligand	 encounter.	 Integrins	 exist	 in	 the	 bent	 and	 various	 extended	
conformations	 in	 the	 PM,	 associated	 with	 PM	 compartment	 such	 as	 TEMs,	 lipid	 rafts	 or	
galectin	 lattices.	 Within	 the	 plane	 of	 the	 membrane,	 integrins	 are	 highly	 mobile	 which	
facilitates	the	chance	of	meeting	 its	 ligand.	In	the	case	of	LFA‐1,	a	small	 fraction	of	extended	
LFA‐1	 is	 preanchored	 to	 the	 cytoskeleton	 leading	 to	 transient	 immobilization	 and	 slowing	
down	 of	 lateral	 mobility.	 Cytoskeletal	 and	 signaling	 components	 are	 associated	 with	 PM	
compartments	and	reside	proximal	to	integrins	to	allow	rapid	onset	of	adhesion.	Upon	ligand	
encounter,	 integrins	 assemble	 into	 larger	 nucleation	 sites,	 by	 further	 recruitment	 of	 PM	
compartments	 and	 the	 cytoskeleton.	Mobile	 nanoclusters	 diffuse	 in	 a	 random/non‐directed	
fashion	 towards	nucleation	 sites	and	 further	 increase	adhesion	 strengthening.	Molecules	are	
not	drawn	to	scale.	
Overall,	 we	 observed	 three	 different	 avidity	 patterns	 during	
differentiation	of	monocytes	into	antigen‐presenting	DCs:	ligand‐independent	pro‐
active	nanodomains,	ligand‐triggered	microsized	macroclusters	on	monocytes,	and	
random	 distribution	 of	 individual	 low‐affinity	 LFA‐1	 molecules	 on	 DCs.	
Importantly,	 in	 monocytes	 25‐30%	 of	 LFA‐1	 nanoclusters	 exclusively	 contained	
high	 affinity	 LFA‐1,	 emphasizing	 that	 affinity	 and	 avidity	 phenomena	 are	 not	
mutually	 exclusive	 mechanisms.	 Moreover,	 this	 indicates	 that,	 at	 least	 in	
monocytes,	 integrin	 organization	 at	 the	 nanometer	 scale	 and	 prior	 to	 ligand	
binding	 might	 already	 pre‐set	 an	 efficient	 scenario	 not	 only	 for	 enhancing	 the	
strength	 of	 ligand	 binding	 upon	 its	 encountering	 but	 also	 by	 securing	 a	 fast	
temporal	 response.	 Besides	 LFA‐1,	 MAC‐1	 also	 showed	 a	 ligand‐independent	
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clustered	 phenotype	 but	 this	 was	 maintained	 throughout	 DC	 differentiation	 12,	
suggesting	integrin‐specific	nanoscale	organization	mechanisms.		
Novel	 optical	 imaging	 techniques	 now	 offer	 the	 possibility	 to	 directly	
visualize	protein‐protein	and/or	protein‐lipid	interactions	in	intact	membranes	at	
the	nanometer	scale	(Box	2).	Recently,	using	dual	color	excitation/detection	NSOM	
we	demonstrated	that	on	resting	monocyte,	LFA‐1	nanodomains	reside	within	100	
nm	 proximity	 from	 GPI‐anchored	 proteins	 and	 GM1	 enriched	 domains,	 without	
physical	 intermixing,	 forming	 hotspot	 regions	 for	 cell	 adhesion	 nucleation	 20;	 21.	
Upon	 ligand‐encounter,	 LFA‐1	 and	 GPI‐anchored	 proteins	 are	 recruited	 to	 form	
larger	 adhesion	 platforms	 that	 show	 a	 clear	 nanoscale	 colocalization	 21.	 These	
results	 suggest	 that	 this	 well‐defined	 architecture	 in	 distinct	 but	 proximal	
nanodomains	may	constitute	a	generic	mechanism	exploited	by	the	cell	to	rapidly	
and	 efficiently	 aggregate	 and/or	 segregate	 distinct	 nanodomains	 into	 larger	
functional	cell	surface	assemblies	when	required.	
	
Lateral	mobility	of	integrins:	a	renewed	interest	and	an	emerging	player		
The	role	of	lateral	mobility	on	integrin	regulation	has	been	recognized	for	
decades,	 and	 directly	 correlated	 to	 the	 capability	 of	 integrins	 to	 cluster	 and	
increase	their	avidity	state.	Earlier	studies	using	single	particle	tracking	(SPT)	on	
resting	 leukocytes	 suggested	 that	 LFA‐1	 is	 actively	 confined	 by	 cytoskeleton	
attachment	through	the	cytoplasmic	tails	of	the	receptor,	constraining	its	mobility	
and	 ligand	binding	ability	 85.	Treatment	of	cells	with	adhesion	activating	phorbol	
ester	 or	 chemokines	 resulted	 in	 an	 increased	 lateral	 mobility,	 which	 in	 turn	
increased	the	chance	of	ligand	encounters	and	facilitated	integrin	aggregation	into	
high‐avidity	clusters	85‐87.	These	findings	led	to	the	proposition	that	in	the	inactive,	
low	affinity	state,	LFA	is	tethered	to	the	cytoskeleton.	Release	from	this	constraint	
would	allow	motility,	thus	leading	to	LFA‐1	clustering	10.		
However,	 more	 recent	 evidence	 has	 challenged	 this	 paradigm.	 For	
instance,	SPT	experiments	using	micron	beads	 labeled	with	a	Fab	 fragment	of	an	
LFA‐1	 binding	 antibody	 revealed	 that	 resting	 T	 cells	 also	 contain	 open	 and	
extended	 LFA‐1	 conformations	 as	 opposed	 to	 the	 accepted	 view	 that	 on	 resting	
cells	 LFA‐1	 is	 in	 a	 bent	 down,	 inactive	 conformation	 11.	 Only	 a	 fraction	 of	 this	
conformation	of	LFA‐1	was	pre‐anchored	to	the	cytoskeleton	that	increased	upon	
phorbol	ester	treatment	or	TCR	ligation	11.	Interestingly,	this	work	also	showed	a	
large	 fraction	 of	 low‐affinity	 conformations	 poorly	 anchored	 to	 the	 cytoskeleton	
and	mobile	on	resting	T	cells	11.	Supporting	these	findings,	Gaborski	et	al	showed	
that	 β2	 integrins	 (LFA‐1	 and	Mac‐1)	 are	 also	mobile	 on	 resting	 neutrophils	with	
little	cytoskeleton	hindrance	of	integrin	mobility	88.	The	discrepancy	between	the	
earlier	results,	where	LFA‐1	was	found	immobile	and	attached	to	the	cytoskeleton,	
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and	 these	 more	 recent	 data	 might	 be	 related	 to	 the	 methodology	 used.	 Indeed,	
initial	SPT	experiments	were	performed	using	large	beads	(40–1000	nm)	coupled	
to	 integrins	 through	 full	 antibody	 linkages,	 having	 the	 potential	 of	 inducing	
artificial	clustering	and/or	cytoskeleton	anchorage	87.	In	contrast,	the	more	recent	
SPT	 data	 used	 Fab	 fragments	 to	 reduce	 crosslinking	 11.	 Similarly,	 fluorescence	
recovering	 after	 photobleaching	 (FRAP)	 as	 used	 by	 Gaborski	 et	 al	 has	 been	
performed	using	Fab	fragments	in	combination	with	small	organic	dyes.	By	using	
this	approach,	the	recovered	diffusions	were	closer	to	those	of	TM	proteins	freely	
diffusing	within	the	membrane	88.		
		
Recently,	we	used	single	dye	 tracing	 (SDT)	 to	 follow	 the	diffusion	of	 the	
extended	conformation	of	LFA‐1	on	resting	monocytes	89.	A	large	fraction	of	these	
pre‐existing	 extended	 LFA‐1	 diffused	 freely	 on	 the	 cell	 membrane	 without	
cytoskeletal	 interactions.	Moreover,	using	micropattern	 techniques	 together	with	
single	molecule	fluorescence	approaches	we	showed	that	recruitment	of	LFA‐1	to	
ligand	regions	occurred	via	random	encounters,	without	cytoskeleton	assistance	89.	
More	 recent	work	 from	 our	 group	 identified	 three	 different	 diffusion	 profiles	 of	
LFA‐1	 nanoclusters	 on	monocytes:	 10%	was	 immobile,	 30%	was	 slow	 and	 60%	
fast	mobile	 (90,	chapter	6).	The	overall	diffusion	of	 these	nanoclusters	depended	
on	 LFA‐1	 conformation,	 with	 low	 affinity	 integrins	 diffusing	 essentially	 in	 a	
random	fashion,	while	primed	nanoclusters	exhibited	immobile,	slowly	mobile	and	
random	 diffusion	 on	 the	 surface	 of	 monocytes	 (90,	 chapter	 6).	 Altogether	 these	
results	demonstrated	 that	 in	 resting	 cells,	 integrins	 are	 largely	mobile	with	 little	
interaction	with	the	cytoskeleton.		
In	view	of	these	results,	a	new	concept	of	integrin	regulation	via	mobility	
is	 emerging.	 Given	 the	 fact	 that	 different	 conformational	 states	 of	 LFA‐1	 with	
multiple	 diffusion	 profiles	 exist	 in	 resting	 cells,	 it	 is	 highly	 probable	 that	 low‐
affinity	unanchored	LFA‐1	may	serve	as	a	pool	 that	 freely	diffuses	 to	 the	sites	of	
adhesion,	 initiated	by	subsets	of	anchored	primed	LFA‐1.	The	properly	anchored	
and	primed	integrins	are	thus	suited	to	work	as	nascent	adhesion	sites	that	evolve	
into	adhesion	clusters	by	the	recruitment	of	mobile	 integrins	that	 freely	move	to	
the	sites	of	pre‐anchored	integrins	to	reinforce	adhesion	(Fig.	2).		
Outlook	
More	than	two	decades	ago,	affinity	and	avidity	have	been	proposed	as	the	
main	 regulatory	 mechanisms	 of	 integrin	 activity.	 Although	 these	 models	 have	
greatly	contributed	to	our	understanding	of	integrin	function,	we	now	realize	that	
integrin	regulation	is	more	complex	and	cannot	be	interpreted	solely	based	on	the	
current	models.	We	strongly	believe	 that	LFA‐1	dynamic	diffusion	within	 the	PM	
(mobility)	 as	 well	 as	 its	 localization	 in	 proximity	 to	 specific	 lipid	 and	 protein	
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nanodomains	essentially	contribute	to	the	regulation	of	LFA‐1	adhesive	properties	
as	well,	modulating	 its	 interaction	with	other	membrane	 components,	 structural	
rearrangements,	 anchoring	 to	 the	 actin	 cytoskeleton	 and	 signal	 transduction.	 All	
these	processes	occur	within	 the	PM	plane	and	are	 likely	 to	be	 influenced	by	 the	
local	 physico‐chemical	 properties	 of	 the	 lipid	 bilayer	 that	 can	 further	 play	 an	
important	 role	 in	 fine	 tuning	 integrin	 activity.	 Underscoring	 this	 notion,	 recent	
findings	 identified	a	conserved	lysine/arginine	(so	called	“snorkeling	residue”)	at	
the	 PM/cytosolic	 interface	 of	 integrins	 that	 interacts	 with	 phospholipid	
headgroups	 thereby	 maintaining	 a	 critical	 crossing	 angle	 of	 the	 integrin	 TM	
segment	that	restricts	 integrin	signaling	91.	Moreover,	Contreras	et	al	revealed	an	
intriguing	 complexity	 of	 protein‐lipid	 interactions	 in	 the	 PM	 that	 we	 are	 just	
starting	 to	 understand,	 by	 demonstrating	 that	 a	 specific	 sphingomyelin	 species	
alters	 activity	 and	 clustering	 of	 a	 membrane	 protein	 by	 interaction	 of	 the	 lipid	
headgroup	and	backbone	with	a	signature	motif	in	the	protein	TM	segment	92.		
So	 far,	 detailed	 studies	 of	 integrin	 nanoscale	 organization	 have	 been	
limited	by	the	lack	of	suitable	techniques	with	high	spatial	resolution.	However,	in	
the	past	decade,	enhancements	in	spatial	resolution	have	progressed	at	a	fast	pace	
in	 the	 fluorescence	 microscopy	 field	 with	 	 the	 advent	 of	 	 super‐resolution	
techniques	 such	 as	NSOM	 93;	 94,	 STED,	 PALM/STORM	 95	 and	 GSDIM	 96.	 They	will	
allow	us	to	look	at	cell	adhesion	events	at	a	detailed	level	that	was	not	affordable	
before.	 To	 understand	 the	 interplay	 between	 integrins,	 signaling	 or	 cytoskeletal	
proteins	 and	 PM	 lipids,	 higher	 multiplex	 imaging	 will	 also	 be	 needed.	 New	
generation	hyperspectral	microscopes	that	can	acquire	the	full	emission	spectrum	
of	the	sample	rather	than	depending	on	filters	97,	will	make	it	possible	to	increase	
the	 number	 of	 fluorophores	 that	 can	 be	 used	 to	 simultaneously	 detect	 the	
localization	 and	dynamic	behavior	of	 several	molecules.	As	 imaging	 technologies	
continue	to	improve,	we	will	be	able	to	answer	questions	at	spatiotemporal	scales	
that	were	previously	inaccessible.	
The	 integration	 of	 information	 from	 biochemistry,	 immunology	 and	
biophysical	 disciplines	 will	 be	 fundamental	 to	 take	 the	 new	 challenge	 of	
understanding	how	the	interplay	between	affinity,	avidity,	mobility	and	proximity	
of	integrins	finely	regulates	cell	adhesion.	
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Abbreviations:	
LFA‐1,	 lymphocyte	 function‐associated	 antigen‐1;	 PM,	 plasma	 membrane;	 TM,	
transmembrane;	DRM,	detergent	resistant	membrane;	TSPAN,	tetraspanin;	Gal‐3,	
galectin‐3,	 TEM,	 tetraspanin	 enriched	 microdomain;	 FN,	 fibronectin;	 IS,	
immunological	synapse;	SDT,	single	dye	tracking.	
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Summary	
	
Integrins	 are	 transmembrane	 adhesion	 receptors	 that	 are	 essential	 for	
cell‐matrix	 and	 cell‐cell	 interactions.	 Recently,	 we	 demonstrated	 that	 during	
differentiation	of	human	DCs	from	monocyte	precursors,	LFA‐1	binding	capacity	is	
lost,	 although	 the	 integrin	 expression	 levels	 were	 maintained	 at	 similar	 levels,	
suggesting	 a	 differential	 regulation	 of	 LFA‐1	 activity	 in	 the	 course	 of	 DC	
differentiation.	The	molecular	mechanism	behind	this	difference	in	LFA‐1	function	
in	 monocytes	 and	 DCs	 however	 remains	 elusive.	 To	 identify	 specific	 protein	
binding	 partners	 responsible	 for	 the	 change	 in	 LFA‐1	 function	 during	 DC	
differentiation,	 we	 compared	 proteins	 co‐immunoprecipitated	 (IP)	 with	 LFA‐1	
from	primary	human	monocytes	and	 in	vitro	 cultured	DCs	using	highly	 sensitive	
quantitative	 mass‐spectrometry.	 Our	 results	 show	 a	 unique	 signature	 of	 LFA‐1	
interacting	 molecules	 in	 monocytes	 and	 DCs.	 Among	 the	 identified	 proteins	 we	
found	components	of	integrin	signalling	pathways,	as	well	as	cytoskeletal	proteins,	
among	 which	 were	 established	 and	 potentially	 novel	 LFA‐1	 binding	 partners.	
Interestingly,	DC	differentiation	was	accompanied	by	an	overall	increase	in	LFA‐1	
associated	proteins.	The	here	presented	LFA‐1	 interactome	in	monocytes	and	DC	
provides	an	excellent	starting	point	to	further	improve	our	understanding	of	LFA‐1	
regulation	and	function	during	the	DC	lifecycle.		
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Introduction	
Integrins	 form	 a	 family	 of	 heterodimeric	 transmembrane	 receptors	 that	
regulate	 cell–adhesion	 and	 cell‐extracellular	 matrix	 interactions.	 Lymphocyte	
function‐associated	 antigen	 1	 (LFA‐1,	 αLβ2)	 is	 a	 leukocyte	 specific	 integrin	 that	
mediates	 firm	 arrest	 of	 leukocytes	 on	 the	 endothelium	 during	 migration	 and	
establishes	cell‐cell	contacts	such	as		the	DC‐T	cell	immunological	synapse	1.	At	the	
molecular	 level,	 transient	 modifications	 of	 adhesion	 are	 accomplished	 by	
conformational	 changes	of	LFA‐1	 from	a	bent	down	 inactive	 to	an	upright	 active	
conformation	 with	 an	 open	 headpiece,	 leading	 to	 low‐	 and	 high‐affinity	 for	 its	
major	 ligand	 ICAM‐1	 2.	 These	 conformational	 changes	 are	 induced	 by	 binding	 of	
the	cytoskeletal	protein	Talin	as	the	terminal	step	in	a	process	termed	“inside‐out”	
signaling3.	 In	 the	 context	 of	 cell‐adhesion,	 integrins	 can	 also	 deliver	 “outside‐in”	
signals	that	control	cell	proliferation,	survival,	gene	induction,	differentiation	and	
cell	motility.	To	achieve	these	diverse	biological	functions,	 integrins	are	recruited	
into	 molecular	 complexes	 containing	 numerous	 cytoskeletal	 and	 signaling	
molecules	 4.	 These	 interactions	 can	 be	 direct	 or	 indirect	 in	 context	 of	 larger	
macromolecular	 assemblies,	 such	 as	protein	 or	 lipid	microdomains	 (reviewed	 in	
chapter	 2).	 Binding	 of	 proteins	 to	 the	 cytoplasmic	 domains	 of	 integrins	 is	
dependent	on	the	specific	molecular	structure	of	the	integrin	subunit,	as	well	as	its	
conformational	state	5.	A	number	of	cytoskeletal	and	signalling	proteins	have	been	
found	to	interact	with	specific	motifs	within	the	integrin	α	chains	and	mainly	with	
the	β	chains	6‐8.	
Most	 integrin‐binding	 partners	 have	 been	 identified	 to	 associate	 with	
integrins	 upon	 ligand	 binding.	 So	 far,	 over	 180	 proteins	 from	 different	 cellular	
systems	have	been	described	to	be	recruited	to	focal	adhesion	complexes	9.	A	focal	
adhesion	 network	 has	 been	 created	 based	 on	 those	 proteins,	which	 has	 already	
been	 successfully	 applied	 to	 identify	 key	 regulatory	 proteins	 during	 adhesion	 to	
different	ligands	10.		
Pre‐organization	of	receptors	in	assemblies	in	the	plasma	membrane	(PM)	
is	 thought	 to	 facilitate	 ligand	 encounter	 and	 to	 promote	 the	 rapid	 onset	 of	
signalling	events	11‐13.	However,	little	is	known	about	the	organization	of	integrins	
within	 the	 cell	 membrane	 prior	 to	 ligand	 encounter.	 Recently,	 Laudanna	 et	 al	
summarized	 proteins	 that	 are	 involved	 in	 integrin	 regulation,	 retrieved	 from	
different	experimental	contexts	in	a	network	of	pro‐adhesive	molecules	consisting	
of	64	members	14.	How	exactly	the	molecular	assembly	of	 integrins	varies	among	
cell	 types/differentiation	 state	 and	how	 this	 relates	 to	 integrin	 function	 remains	
elusive.		
Recently,	we	have	shown	that	during	in	vitro	differentiation	of	monocytes	
towards	 immature	monocyte‐derived	DCs	 (moDCs),	 LFA‐1	 remains	 expressed	 at	
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similar	 levels,	 but	 only	 monocytes	 express	 primed	 and	 functional	 LFA‐1.	
Interestingly,	with	the	loss	of	LFA‐1	function	during	DC	differentiation,	also	the	cell	
surface	organization	of	LFA‐1	changed	from	defined	nanoclusters	towards	random	
distributed	LFA‐1	15.		
To	understand	the	regulation	of	LFA‐1	function	during	the	differentiation	
of	monocytes	to	DCs,	we	used	in	this	study	selective	IP	of	LFA‐1	coupled	to	highly	
sensitive	 mass‐spectrometry	 (MS)	 analysis	 to	 identify	 proteins	 associated	 with	
LFA‐1	on	primary	human	monocytes	and	 in	vitro	 cultured	moDCs	prior	 to	 ligand	
encounter.	Our	results	show	a	unique	signature	of	LFA‐1	 interacting	proteins	 for	
monocytes	 and	 DCs,	 that	 contains	 both	 already	 described	 and	 potentially	 novel	
LFA‐1	binding	partners	which	may	have	important	implications	for	the	regulation	
of	adhesive	properties	of	these	cell	types.	
Materials	and	Methods	
Cells	
Human	monocytes	 were	 obtained	 from	 buffy	 coats	 of	 healthy	 donors	 and	 were	
purified	 using	 Ficoll	 density	 centrifugation.	 DCs	 were	 generated	 from	 adherent	
peripheral	blood	mononuclear	 cells	by	 culturing	 in	 the	presence	of	 interleukin‐4	
(300U/ml)	 and	 GM‐CSF	 (450U/ml)	 (both	 from	 Strathmann,	 Hamburg	 Germany).	
moDCs	were	cultured	for	6	days	to	obtain	immature	moDC.	
	
Immunoprecipitation		
Monocytes	and	imDCs	were	sufficiently	washed	with	PBS	and	subsequently	lysed	
directly	in	the	flask	with	lysis	buffer	(20mM	Tris	pH	8,	150mM	NaCl,	1	mM	CaCl2,	
1mM	MgCl2)	 containing	 1%	 Bry97	 or	 1%	 NP40	 +	 0.5%	 sodium	 deoxycholate	 +	
0.1%	 SDS	 (RIPA	 buffer),	 in	 the	 presence	 of	 protease	 (Complete,	 Roche)	 and	
phosphatase	inhibitors	(Phosphostop	Roche).	After	30	min	lysis	on	ice,	cell	lysates	
were	 cleared	 by	 centrifugation	 at	 14000g	 for	 15	 min.	 First,	 cell	 lysates	 were	
precleared	with	BSA‐coated	protein	G	sepharose	beads	(GE	Healthcare),	 followed	
by	 empty	 protein	 G	 sepharose	 beads	 in	 the	 presence	 of	 1/1000	 volume	 heat	
inactivated	goat	 serum,	and	 finally	by	preclearing	with	mouse	 IgG1	 coated	 (2ug)	
protein	G	 sepharose	beads.	Each	 step	was	performed	at	4°C	 for	1	hour.	Proteins	
were	 then	 immunoprecipitated	by	adding	beads	coated	with	5μg	of	 specific	anti‐
CD11a	antibody	(SPV‐L7	16)	or	5μg	unspecific	mouse	IgG1	isotype	antibody	to	400	
μl	lysate.	After	2	h	incubation	under	constant	agitation	at	4°C,	beads	were	washed	
five	times	 in	Brij97	or	RIPA	lysis	buffer.	The	immunoprecipitates	were	separated	
by	SDS‐PAGE	under	reducing	conditions.	Proteins	 in	the	gel	were	visualized	with	
colloidal	coomassie	staining	(Invitrogen).		
	
Western	Blotting	
Proteins	 were	 separated	 by	 SDS‐PAGE	 and	 transferred	 to	 PVDF	 membranes	
(Millipore,	 Bedford,	 MA).	 Subsequently,	 proteins	 were	 detected	 by	
immunoblotting.	 After	 labeling,	 Western	 blots	 were	 scanned	 by	 the	 Odyssey	
imager	(LI‐COR	Biosciences).	
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Microscopy	
For	 co‐capping	experiments,	day	6	monocyte‐derived	 imDCs	were	 stained	at	4°C	
with	5μg/ml	anti–LFA‐1	mAb	(clone	NKI‐L15	or	TS2/4)	and	5ug/ml	mAbs	against	
Galectin‐3,	CD44,	CD71,	and	CD13.	Isotype‐specific	controls	were	always	included.	
Secondary	 staining	 was	 performed	 with	 Alexa	 488–conjugated	 goat	 anti–mouse	
IgG2a	and	Alexa	647–conjugated	goat	anti–mouse	IgG1.	Patching	was	 induced	by	
incubation	at	15°C	for	1	h,	followed	by	fixation	with	1%	PFA.	Cells	were	mounted	
onto	 poly‐l‐lysine–coated	 glass	 coverslips.	 Cells	 were	 analysed	 by	 Olympus	
FV1000	 Confocal	 Laser	 Scanning	 Microscope	 and	 signals	 were	 collected	
sequentially	 to	 avoid	 bleed	 through.	 The	 Pearson	 correlation	 coefficient	 was	
calculated	 by	 applying	 the	 Image	 J	 (http://rsb.info.nih.gov/ij/,)	 plug‐in	 JACoP	 17	
and	 reflects	 the	 amount	 of	 LFA‐1	 co‐localizing	 with	 Galectin‐3,	 CD44,	 CD13	 or	
CD71	separately	for	each	cell.	
	
Sample	preparation	for	LC‐MS/MS	experiments		
Protein	 samples	 were	 loaded	 on	 a	 8%	 SDS	 PAGE	 gel,	 followed	 by	 a	 short	
electrophoresis	period	of	5	minutes,	 stained	with	colloidal	Coommassie	blue	and	
divided	into	a	single	gel	slice	per	sample.	Gel	slices	were	treated	with	dithiothreitol	
(DTT)	 and	 iodoacetamide	 and	 digested	 by	 trypsin	 18.	 Digested	 samples	 were	
acidified	to	a	final	concentration	of	0.1	%	TFA	and	purified	by	STAGE	tips	19.	
	
Liquid	chromatography	tandem	mass	spectrometry	
Peptide	sequencing	experiments	were	performed	by	LC‐MS/MS	using	a	nano	HPLC	
Agilent	 1100	 LC	 system	 connected	 to	 a	 7‐Tesla	 linear	 ion	 trap	 ion	 cyclotron	
resonance	Fourier	 transform	 (LTQ‐FT	Ultra)	mass	 spectrometer	 (Thermo	Fisher,	
Bremen,	 Germany)	 and	 measured	 as	 described	 previously	 18.	 Peptides	 were	
separated	 on	 15	 cm	100	 μm	 ID	 PicoTip	 columns	 (New	Objective,	Woburn,	 USA)	
packed	with	3	μm	Reprosil	C18	beads	(Dr.	Maisch	GmbH,	Ammerbuch,	Germany)	
using	a	120	min	gradient	 from	12%	buffer	B	 to	40%	buffer	B	 (buffer	B	 contains	
80%	 acetonitrile	 in	 0.5%	 acetic	 acid)	 with	 a	 flow‐rate	 of	 300	 nl/min	 The	 mass	
spectrometer	was	operated	with	a	spray	voltage	of	2.2	kV,	and	data	was	acquired	
in	a	data‐dependent	mode	with	full‐scan	MS	spectra	of	intact	peptides	(m/z	350–
1500)	 with	 an	 automated	 gain	 control	 accumulation	 target	 value	 of	 1,000,0000	
ions	 in	 the	 Fourier	 transform	 ion	 cyclotron	 resonance	 cell	 with	 a	 resolution	 of	
50,000.	The	four	most	abundant	ions	were	sequentially	isolated	and	fragmented	in	
the	 linear	 ion	 trap	 by	 applying	 collisionally	 induced	 dissociation	 using	 an	
accumulation	 target	 value	 of	 10,000,	 a	 capillary	 temperature	 of	 100°C,	 and	 a	
normalized	 collision	 energy	 of	 27%.	 A	 dynamic	 exclusion	 of	 ions	 previously	
sequenced	 within	 180	 s	 was	 applied.	 All	 unassigned	 charge	 states	 and	 singly	
charges	 ions	 were	 excluded	 from	 sequencing.	 A	 minimum	 of	 200	 counts	 was	
required	for	MS2	selection.	Maximum	injection	times	were	set	at	500	ms	and	400	
ms	respectively	for	FT	MS	and	IT	MS/MS	measurements.	
	
	
Protein	identification	and	quantification	
Raw	 spectrum	 files	 were	 processed	 for	 identification	 by	 the	 Andromeda	 search	
engine	 20	 and	 quantification	 according	 to	 the	 iBAQ	 method	 21	 with	 MaxQuant	
version1.2.0.18	 22.	 (http://maxquant.org/).	 Peak	 lists	 were	 generated	 using	 the	
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default	 setting	 that	 extracted	 the	 top	 6	MS	MS	peaks	 per	 100	Da.	 Proteins	were	
identified	by	searching	peak	lists	with	Andromeda	against	the	human	International	
Protein	Index	(IPI)	database	version	3.68	(ftp://ftp.ebi.ac.uk/pub/databases/IPI/)	
supplemented	 with	 frequently	 observed	 contaminants	 using	 the	 target	 decoy	
approach.	Search	parameters	for	protein	identification	specified	a	mass	tolerance	
of	 7ppm	 for	 the	 parental	 peptide	 and	 0.5	 Da	 for	 fragmentation	 spectra	 and	 a	
trypsin	 specificity	 allowing	 up	 to	 3	 miscleaved	 sites.	 Carbamidomethylation	 of	
cysteines	 was	 specified	 as	 a	 fixed	 modification,	 and	 oxidation	 of	 methionine,	
deamidation	 of	 glutamine	 and	 asparagine,	 and	 acetylation	 of	 the	 protein	 N‐
terminus	were	set	as	variable	modifications.	The	required	minimal	peptide	length	
was	set	at	6	amino	acids.	Peptide	validation	by	establishing	 false	discovery	rates	
(FDR)	was	performed	by	MaxQuant	as	described	22.	We	accepted	peptides	(charge	
state	>1,	nr	variable	modifications	<4)	with	peptide	FDR	of	1	%	and	proteins	with	a	
protein	PEP<0.002	and	protein	FDR	of	1	%.		
Proteins	 were	 quantified	 by	 label	 free	 quantification	 using	 the	 intensity‐	 based	
absolute	quantification	(iBAQ)	21.	Protein	intensities	were	calculated	by	MaxQuant	
as	 the	 sum	 of	 all	 identified	 peptide	 intensities	 (extracted	 ion	 chromatograms)	
divided	 by	 the	 number	 of	 theoretically	 observable	 peptides.	 Protein	 intensities	
were	determined	 for	duplicate	measurements,	normalised	by	median	 iBAQ	value	
and	averaged.	
	
In	silico	analysis	
The	PANTHER	Classification	System	(Pathway	version	7;	www.pantherdb.org)	was	
used	 to	classify	 the	proteins	according	 to	 their	predicted	protein	classes.	Protein	
classification	 was	 achieved	 using	 published	 experimental	 evidence	 and	
evolutionary	 relationships	 23.	 The	 predicted	 protein	 classes	 were	 further	
summarized	by	the	authors	into	larger	categories.		
	
The	Ingenuity	pathways	analysis	(IPA)		
The	 Ingenuity	 pathways	 analysis	 (IPA)	 software	 (Ingenuity	 Systems,	 Redwood	
City,	 CA)	 is	 a	 bioinformatics	 tool	 that	 puts	 experimental	 data	 in	 relation	 to	
published	 research	 by	 identifying	 relationships,	 mechanisms,	 functions,	 and	
pathways	 of	 relevance	 through	 easy	 dynamic	 pathway	 modelling.	 To	 generate	
biological	 networks,	 the	monocyte	 and	 DC	 datasets	were	 uploaded	 into	 the	 IPA	
software	and	protein	networks	were	created	and	scored	based	on	a	Fisher’s	exact	
test.	The	score	for	each	network	gives	an	indication	of	the	likelihood	of	these	genes	
associating	 into	 the	 network	 by	 random	 chance.	 Each	 network	 is	 displayed	 as	
nodes	 representing	 genes	 and	 edges	 which	 represent	 the	 interactions	 between	
genes.	The	‘‘IPA	Path	Designer’’	mode	was	used	to	generate	final	network	images.	
	
Antibodies	
The	 following	 primary	 antibodies	 were	 used	 for	 Western	 blotting	 and	 confocal	
analysis:	mouse	anti‐human	LFA‐1	(clone	NKI‐L15	and	TS2/4,	hybridoma),	rabbit	
anti‐human	 LFA‐1	 (EP1285Y,	 Abcam),	 rat‐anti	 Galectin‐3	 (clone	 M3/38,	
Biolegend),	mouse	anti‐human	CD13	(clone	WM15,	biolegend),	mouse	anti‐human	
CD44	 (clone	G44‐26,	 BD	biosciences),	mouse	 anti‐human	Talin‐1	 (Sigma),	 rabbit	
anti‐human	GPI	(Santa‐Cruz),	mouse	anti‐	Actin	(clone	AC‐40,	Sigma),	mouse	anti‐
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human	 Thrombospondin‐1(Thermo	 Scientific,	 Clones	 D4.6	 +	 A6.1	 +	MBC	 200.1),	
rabbit‐anti	 human	 Kindlin‐3	 (T‐12,	 Santa	 Cruz)	 IRDye	 conjugated	 secondary	
antibodies	 for	 Western	 blotting	 were	 obtained	 from	 LI‐COR	 Biosciences,	 and	
Alexa‐647	 conjugated	 secondary	 antibodies	 for	 flow	 cytometry	 and	 confocal	
analysis	 were	 from	 Invitrogen.	 For	 LFA‐1	 immunoprecipitation	 studies,	 an	
antibody	directed	specifically	against	the	αL	chain	was	used	(clone	SPV‐L7).	
	
Results	
Isolation	of	LFA‐1	associated	proteins	in	monocytes	&	DCs	
Isolation	of	 integrin	complexes	by	 IP	 followed	by	MS	analysis	have	been	
successful	 tools	 in	 identifying	 integrin‐associated	 proteins	 in	 physiological	
processes,	such	as	focal	adhesion	formation	10.	To	investigate	whether	the	loss	of	
LFA‐1	function	and	nanoclusters	during	DC	differentiation	is	reflected	in	changes	
in	 the	 LFA‐1	 interactome,	 we	 performed	 IPs	 of	 LFA‐1	 from	monocytes	 and	 DCs	
followed	 by	 quantitative	 MS	 (Fig	 1).	 First,	 we	 isolated	 endogenous	 LFA‐1	 from	
adherent	primary	human	monocytes	and	in	vivo	generated	adherent	moDCs,	in	the	
absence	 of	 a	 LFA‐1	 ligand.	 The	 LFA‐1	 complexes	were	 purified	 by	 beads	 coated	
with	a	specific	antibody	directed	at	the	αL	chain	of	LFA‐1.	As	control,	we	included	
non‐specific	 isotype‐matched	 antibody‐coated	 beads.	 Previously,	 cross‐linkers	
such	as	DTBP	have	been	used	to	stabilize	integrin	complexes	prior	to	IP	10.	In	our	
study,	DTBP	did	not	lead	to	an	increase	in	LFA‐1	associated	proteins	in	monocytes	
and	 DCs,	 as	 visualized	 by	 silver	 staining	 (data	 not	 shown)	 and	 therefore	 the	
experiments	were	performed	without	the	addition	of	cross‐linkers.		
Western	blotting	(WB)	confirmed	that	protein	levels	of	LFA‐1	remained	expressed	
at	 similar	 levels	 throughout	 DC	 differentiation	 (Fig.	 2A).	 The	 IP	 from	 the	 same	
number	 of	monocytes	 and	DCs	was	 slightly	more	 efficient	 in	monocytes	 than	 in	
DCs	 (Fig.	 2B).	 As	 expected,	 protein	 visualization	 by	 colloidal	 coomassie	 staining	
demonstrated	 co‐immunoprecipitation	 of	 the	 LFA‐1	 β‐chain	 and	 in	 addition,	
already	 revealed	 several	 proteins	 specifically	 present	 in	 the	precipitate	 of	 either	
monocytes	or	DCs	(Fig.	2C).	
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Identification	of	LFA‐1	associated	proteins	in	monocytes	&	DCs	
The	 whole	 protein	 content	 present	 in	 both	 the	 control	 and	 LFA‐1	 fraction	 was	
subjected	to	nano	liquid	chromatography	tandem	mass	spectrometry	(LC‐MS/MS)	
and	proteins	were	quantified	applying	the	 label	 free	 iBAQ	method	21.	For	protein	
quantification,	the	iBAQ	values	were	normalized	to	the	average	protein	expression	
for	 each	 cell	 type	and	experiment.	The	normalized	 IBAQ	values	 for	αL	and	β2	 in	
monocytes	 were	 higher	 than	 in	 DCs,	 which	 can	 be	 explained	 by	 a	 lower	 total	
protein	content	in	monocytes	than	in	DCs	(data	not	shown).		
The	 association	of	proteins	with	 the	 IP	product	 can	be	greatly	 influenced	by	 the	
choice	 of	 detergent	 for	 cell	 lysis.	 Therefore	 to	 retrieve	 a	 large	 number	 of	 LFA‐1	
binding	partners,	we	performed	the	experiment	several	times,	exploiting	both	mild	
and	 stringent	 lysis	 buffers.	 Proteins	 were	 considered	 enriched	 when	 the	 ratio	
between	 specific	 LFA‐1	 IP	 and	 control	 IP	 was	 >2,	 or	 when	 proteins	 were	
specifically	found	in	the	IP	fraction	but	completely	absent	in	the	control.	Candidate	
binding	 partners	 of	 LFA‐1	 were	 identified	 in	 monocytes	 and	 DCs	 in	 four	
independent	experiments,	from	multiple	donors.			
	
Day0: monocytes Day6: imDCs
IP anti-CD11a from monocytes and  immature DCs 
using L7 antibody 
SDS-PAGE & 
Colloidal Coomassie staining
In-gel digestion of whole protein 
content with trypsin
LS-MS/MS measurement
Protein Identification & 
database research
Identification of enriched proteins 
By IBAQ
+ IL-4+ GM-CFS Fig.	 1: Experimental	 flow	 chart	
for	enrichment	and	identification	
of	LFA‐1	complexes	in	monocytes	
and	 imDCs.	 Adherent	monocytes	
and	 imDCs	 were	 lysed,	 followed	
by	enrichment	of	LFA‐1	by	IP	and	
separation	 by	 SDS‐PAGE.	 The	
protein	content	was	visualized	by	
colloidal	 coomassie	 labeling,	
excised	 in	 one	 piece	 and	
subjected	 to	 MS	 analysis	 and	
protein	identification.		
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Fig.	2:	Detection	of	LFA‐1	and	associated	proteins.	Immunolabeling	of	A)	LFA‐1	in	cell	lysates	
of	equal	amounts	of	monocytes	(day0)	and	immature	DCs	on	day	3	and	7	of	DC	differentiation,	
B)	 of	 immunoprecipitated	 LFA‐1,	 from	 monocytes	 and	 day	 6	 immature	 DCs.	 C)	 Colloidal	
coomassie	 staining	of	SDS‐PAGE	gels	 from	 immunoprecipiated	LFA‐1	 in	monocytes	and	DCs.	
LFA‐1	was	enriched	using	mAb	(clone	SPV‐L7)	directed	against	αL.	mIgG1	coated	beads	were	
included	as	control	IP.	
For	 further	 analysis	 only	 proteins	were	 selected	 that	were	 found	 enriched	 in	 at	
least	2	experiments	in	monocytes	or	DCs	(Fig.	3A).	Using	those	criteria,	a	total	of	
81	 proteins	 in	 monocytes	 and	 150	 proteins	 in	 DCs	 were	 identified	 as	 LFA‐1	
binding	 candidates	 (Supplementary	Table	1).	Detection	of	 peptides	of	αL	and	β2	
from	 all	 four	 individual	 experiments	 confirmed	 that	 LFA‐1	 was	 highly	 enriched	
over	the	isotype	control‐IP	in	all	experiments	(Fig.	3B).			
The	relative	expression	levels	of	enriched	proteins	in	control	–	and	LFA‐1‐fraction	
was	 calculated	 based	 on	 the	 normalized	 iBAQ	 values	 from	 each	 experiment	 for	
monocytes	 and	 DCs	 and	 used	 to	 determine	 which	 proteins	 were	 specifically	
precipitated	 (Supplementary	 Figure	 1).	Most	 established	 LFA‐1	 binding	 partners	
were	 detected	 in	 the	 LFA‐1	 fraction	 and	 not	 in	 the	 control	 fraction,	 further	
confirming	 the	 specificity	 of	 the	 IP.	 	 Several	 proteins	 (31)	 associated	with	 both	
LFA‐1	 from	monocytes	 and	 DCs	 suggesting	 their	 importance	 for	 LFA‐1	 function	
regardless	of	cell	type	(Figure	4).		
Categorization	of	identified	proteins	
To	 categorize	 binding	 candidates	 according	 to	 their	 reported	 function,	 we	 used	
PANTHER	 (www.pantherdb.org)	 Gene	 OntologyTM.	 Consistent	 with	 integrin	
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function	a	large	number	of	identified	proteins	mainly	mapped	to	the	GO	categories	
signal	transduction	and	cytoskeletal	reorganization	(20%).	Many	proteins	however	
also	mapped	 to	 the	 categories	 transcriptional	 regulation,	protein	biosynthesis	and	
metabolic	 enzymes	 that	 are	 less	 easily	 explained	 by	 LFA‐1	 function	 based	 on	
current	 knowledge,	 but	 that	 could	 also	 represent	 some	 nonspecific	 co‐
immunoprecipitated	 components	 (Supplementary	 Figure	 2).	 Overall,	 the	
distribution	 of	 binding	 candidates	 among	 the	 protein	 classes	 was	 similar	 in	
monocytes	 and	 DCs.	 During	 DC	 differentiation	 we	 observed	 a	 small	 increase	 in	
proteins	 involved	 in	 transcriptional	 regulation,	 including	 large	 ribosomal	 and	
histone	complexes,	which	most	likely	bind	nonspecific	to	LFA‐1	IP	complexes.		
	
Fig.	3:	Overlap	of	LFA‐1	associated	proteins	during	DC	differentiation.	A)	Venn	diagram	shows	
the	amount	of	proteins	enriched	in	monocytes	and	DCs	and	overlapping	protein	numbers.	Only	
proteins	were	selected,	which	were	in	at	least	two	(of	four)	experiments	enriched	in	monocytes	
or	DCs.	B)	Peptide	counts	are	shown	for	each	individual	mass	spectrometric	exemplary	for	the	
α	and	β	chain	of	LFA‐1	in	monocytes	and	DCs.	The	numbers	of	peptides	detected	in	the	mIgG1‐
control	IP	are	shown	in	brackets.		
Validation	of	LFA‐1	binding	partners	in	monocytes	&	DCs	
Next,	we	sought	to	validate	some	of	the	 identified	candidate	proteins	by	Western	
Blotting	&	Confocal	Microscopy.	We	selected	several	established	and	novel	binding	
partners	 for	 validation	 including	 the	 novel	 binding	 partner	 Thrombospondin‐1	
(monocytes	and	DCs),	the	established	partners	Kindlin‐3	and	Talin‐1,	as	well	as	the	
novel	binding	partner	Galectin‐3	in	DCs	only.	WB	analysis	was	consistent	with	the	
results	from	the	MS	(Fig.	5	A‐C).	Furthermore,	we	examined	the	co‐distribution	of	
LFA‐1	 and	 CD44,	 CD13	 and	 Galectin‐3	 on	 DCs,	 by	 mAb	 patching	 and	 confocal	
microscopy	 (Figure	 6A).	 When	 co‐capping	 was	 induced,	 LFA‐1	 colocalized	 with	
Galectin‐3	 with	 a	 Pearson´s	 coefficient	 of	 0.85	 (Fig.	 6B).	 CD13	 and	 CD44	 also	
showed	significantly	higher	Pearson´s	coefficient	(0.8	and	0.72)	than	the	non‐LFA‐
1	 associated	protein	CD71	 (0.52),	 indicating	 that	 these	proteins	 indeed	 reside	 in	
B
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complexes	 together	 with	 LFA‐1	 in	 the	 PM.	 Thus,	 our	 data	 confirm	
Thrombospondin‐1	 and	 Galectin‐3	 as	 novel	 binding	 partners	 of	 LFA‐1,	 however	
further	experiments	are	required	to	elucidate	their	role	in	LFA‐1	function.		
	
	
	
Fig.	5:	Validation	 of	MS	 results	 for	 selected	proteins	by	WB.	A)	 Immunoblotting	 of	 selected	
proteins	in	lysates	of	equal	numbers	of	monocytes	and	DCs	from	the	same	donor.	GPI	serves	as	
loading	control.	Protein	complexes	of	LFA‐1	and	A)	TSP‐1	in	monocytes	immature	DCs	(day6)	
and	C)	Talin‐1,	Kindlin‐3	and	Galectin‐3	in	imDCs	(day6)	were	co‐immunoprecipitated.	LFA‐1	
was	 enriched	 using	 mAb	 (clone	 SPV‐L7)	 directed	 against	 αL.	 mIgG1	 coated	 beads	 were	
included	as	control	IP.	
Fig.	 4:	 Quantitative	 heat‐maps	
display	 relative	 expression	 of	
LFA‐1	associated	proteins	shared	
by	 monocytes	 and	 DCs.	 The	
values	are	average	values	from	2‐
4	 experiments.	 LFA‐1	 was	
enriched	 using	mAb	 (clone	 SPV‐
L7)	 directed	 against	 αL.	 mIgG1	
coated	 beads	 were	 included	 as	
control	IP.	
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Fig.	6:	 LFA‐1	 co‐patches	with	 selected	 binding	 candidates	 on	DCs.	 (A)	Confocal	microscopy	
analysis	of	copatching	of	LFA‐1	(NKI‐L15	 labeled)	and	Galectin‐3,	CD44	and	CD71	on	 imDCs	
(day6).	 Receptor	 co‐patching	 and	 staining	 were	 performed	 as	 described	 in	 Material	 and	
Methods.	Antibodies	against	LFA‐1	 (clones:	NKI‐L15	and	TS2/4)	and	CD71	are	positive	and	
negative	markers	for	co‐localization,	respectively.	Results	are	representatives	of	multiple	cells	
in	two	independent	experiments.		(B)	To	quantify	the	degree	of	co‐localization	between	LFA‐1	
and	binding	candidates,	Pearson´s	coefficient	was	calculated.	The	values	can	vary	between	0	
and	1	 (1	=	100%	 colocalization).	Co‐patching	and	 staining	were	performed	as	described	 in	
Materials	and	Methods.	
	
In‐silico	reconstruction	of	the	LFA‐1	protein	network	
Having	confirmed	the	validity	of	our	proteomics	data	by	WB	we	wanted	to	
narrow	 down	 the	 list	 of	 binding	 candidates	 by	 pathway	 analysis	 and	 literature	
mining	to	reconstruct	a	LFA‐1	network	in	monocytes	and	DCs.		
First,	to	analyze	the	potential	binding	candidates	in	the	context	of	existing	
protein‐	networks,	ingenuity	pathway	analysis	(IPA)	was	performed	on	the	full	list	
of	 enriched	 proteins	 in	 monocytes	 and	 DCs.	 Furthermore,	 we	 included	 several	
“rescued”	 proteins,	 which	 have	 an	 established	 role	 in	 integrin	 function	 and	
adhesion	and	were	found	enriched	in	one	of	our	MS,	but	due	to	the	stringency	of	
our	selection	criteria	(see	Figure	3A)	were	discarded	in	first	place).		
LFA‐1 CD71DIC merge
LFA‐1 CD13DIC merge
LFA‐1 Gal3DIC merge
LFA‐1 CD44DIC merge
LFA‐1 LFA‐1DIC merge
A imDC B
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Table	 1:	 Selection	 of	 enriched	 proteins	 from	 the	 monocyte	 data‐set	 related	 to	 integrin	
function.	 Enriched	 proteins	 shared	 by	 monocytes	 and	 DCs	 are	 indicated	 in	 red.	 Enriched	
proteins	 that	were	 found	 in	 one	MS,	 but	 included	 to	 the	 list	 based	 on	 their	 evident	 role	 in	
integrin	 function,	are	marked	with	 *.	The	 column	named	 “found	 enriched”	describes	 in	how	
many	experiments	this	protein	was	found	enriched	(maximum	4	experiments).		
	
	
	
monocytes	
	
	
Protein	AcNR	
	
	
HGNC	
symbol	
	
	
	
Protein	Name	
	found	
enriched	
out	of	4	
exp.	
	 	 Adhesion	Receptors 	
IPI00025380	 ITGAL Integrin	alpha‐L 4
IPI00291792	 ITGB2 Integrin	beta‐2 4
IPI00029741	 ITGB5 Integrin	beta‐5 2
IPI00645887	 ITGAM Integrin,	alpha	M	 2
	 	 Signalling	and	Scaffolding		Proteins 	
IPI00019345,	
IPI00008964	
RAP1A,	
RAB1B	
Ras‐related	protein	Rap‐1A&B 2,2
IPI00010270	 RAC2 Rac2	 2
IPI00328296,	
IPI00307688	
GIPC2,
GIPC3	
PDZ	domain‐containing	protein	GIPC2	&	GIPC3 2,*
IPI00013212	 CSK	 C‐Src	kinase *
IPI00018597	 SYK	 Spleen	tyrosine	kinase *
IPI00013219	 ILK	 Integrin‐linked	protein	kinase *
IPI00299048,	
IPI00009342	
IQGAP1,	
IQGAP2	
Ras	GTPase‐activating‐like	protein	IQGAP1	&2 *
IPI00021263	 YWHAZ	 14‐3‐3	protein	zeta/delta *
IPI00183400	 CSNK1A1	 Casein	kinase	I	isoform	alpha 2
IPI00022449	 DOCK2 Dedicator	of	cytokinesis	protein	2 2
	 	 Cytoskeletal	Proteins 	
IPI00021428	 ACTA1 Actin	 3
IPI00894498	 ACTB Beta‐actin 3
IPI00909772	 AP2M1 Adapter‐related	protein	complex	2	mu	subunit 2
IPI00646773	 GSN	 Gelsolin	 2
IPI00012555	 FCN1 Ficolin‐1 2
IPI00420004	 MYO1G Myosin‐IG	 2
IPI00027341	 CAPG Actin	regulatory	protein	CAP‐G 2
IPI00930688	 TUBA1B	 Tubulin	alpha‐1B	chain 2
IPI00022488	 HPX	 Beta‐1B‐glycoprotein 3
IPI00219365	 MSN	 Moesin	 3
IPI00024067	 CLTC Clathrin	heavy	chain	1 3
	 	 Sectreted	Proteins 	
IPI00296099	 THBS1 Thrombospondin‐1 2
IPI00219219	 LGALS1	 Galectin‐1 2
IPI00641737	 HP	 Haptoglobin 2
	 	 Other	 	
IPI00218918	 ANXA1 Annexin	A1 2
IPI00011229	 CTSD Cathepsin	D *
IPI00017376	 SEC23B	 Protein	transport	protein	Sec23B 2
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Table	2:	Selection	of	enriched	proteins	 from	 the	 imDC	data‐set	related	 to	 integrin	 function.	
Enriched	proteins	shared	by	monocytes	and	DCs	are	 indicated	 in	red.	Enriched	proteins	 that	
were	found	in	one	MS,	but	included	to	the	list	based	on	their	evident	role	in	integrin	function,	
are	marked	with	*.	The	column	named	“found	enriched”	describes	 in	how	many	experiments	
this	protein	was	found	enriched	(maximum	4	experiments).		
	
imDCs	
	
	
Protein	AcNR	
	
	
HGNC	
symbol	
	
	
	
Protein	Name	
	found	
enriched	
out	of	4	
exp.	
	 	 Adhesion	Receptors 	
IPI00291792	 ITGB2	 Integrin beta2 4	
IPI00025380	 ITGAL	 integrin	alpha	L	 4	
IPI00029741	 ITGB5	 Integrin	beta‐5 3	
IPI00174442	 FAM98A	 Protein	FAM98A 2	
	 	 	 	
	 	 Signalling	and	Scaffolding		Proteins 	
IPI00003479	 MAPK1	 Mitogen‐activated	protein	kinase	1 2	
IPI00022449	 DOCK2	 Dedicator	of	cytokinesis	protein	2 2	
IPI00019345,	
IPI00008964,	
IPI00016342	
RAB1A,	
RAB1B,	
RAB7A	
Ras‐related	protein	Rap‐1A,1B	&	7a 2,2,2	
IPI00218187	 PPP1CC	 Protein	phosphatase	1C	catalytic	subunit 2	
IPI00011644	 PTPRE	 Receptor‐type	tyrosine‐protein	phosphatase	epsilon 2	
IPI00926935	 GNAI2	 Galphai2	protein	 2	
IPI00792352	 RAN	 RAN	 2	
IPI00010402	 SH3BGRL3	 SH3	domain‐binding	protein	1 2	
IPI00021327	 GRB2	 Adapter	protein	GRB2 2	
IPI00000816	 YWHAE	 14‐3‐3	epsilon *	
IPI00021263	 YWHAZ	 14‐3‐3	protein	zeta/delta 2	
IPI00013890	 SFN	 14‐3‐3	sigma *	
IPI00013219	 ILK	 Integrin‐linked	kinase *	
IPI00022508	 SKAP2	 Src	kinase	associated	phosphoprotein	2 *	
	 	 	 	
	 	 	 	
	 	 Cytoskeletal	Proteins 	
IPI00307162	 VCL	 Vinculin *	
IPI00220278	 MYL9	 20	kDa	myosin	light	chain 2	
IPI00219365	 MSN	 Moesin *	
IPI00856116	 PALLD	 Palladin *	
IPI00604523	 MYL12A	 Myosin	regulatory	light	chain	12B	 3	
IPI00298994	 TLN1	 Talin	1 *	
IPI00397834	 FERMT3	 Kindlin‐3 *	
IPI00926581	 MYH14	 MYH14	variant	protein 2	
IPI00554711	 JUP	 Desmoplakin	3 2	
IPI00006091	 DMD	 Dystrophin 2	
IPI00013933	 DSP	 Desmoplakin 2	
IPI00024067	 CLTC	 Clathrin	heavy	chain	1 2	
IPI00018235	 PEF1	 Peflin 2	
IPI00940292,	
IPI00219840	
AP1B1,	
AP2S1	
Adaptor	protein	complex	AP‐1	subunit	beta‐1	&	sigma	 2,2	
IPI00216691	 PFN1	 Profilin	1 2	
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Gene	IDs	of	all	81	identified	proteins	(plus	rescued	proteins:	CSK,	SYK,	ILK,	
IQGAP1	 &	 IQGAP	 2,	 GIPC3,	 14‐3‐3	 protein	 zeta/delta	 and	 Cathepsin	 D)	 in	
monocytes	 and	 150	 (plus	 YWHAE,	 SFN,	 ILK,	 SKAP2,	 VCL,	 MSN,	 TLN1,	 FERMT3,	
SNX9	and	CD44)	in	DCs	were	uploaded	to	Ingenuity	software,	of	which	87	and	152	
could	 be	 mapped	 using	 Ingenuity’s	 knowledge	 database.	 The	 Ingenuity’s	
knowledge	database	contains	predefined	networks	of	protein‐protein	interactions	
assigned	 to	 biological	 processes.	 We	 determined	 which	 of	 these	 predefined	
networks	showed	the	highest	overlap	with	our	data	sets.	The	resulting	top	scoring	
networks	for	monocytes	and	DCs	are	shown	in	supplementary	figure	3	A‐B.	These	
networks	 were	 related	 to	 a	 number	 of	 functions	 including	 cell	 movement,	 cell	
morphology,	cell‐to‐cell	signaling	and	cellular	assembly	and	organization.		
Then,	we	investigated	whether	the	proteins	were	associated	with	specific	
canonical	 pathways	 pre‐defined	 in	 IPA.	 Significantly	 overrepresented	 in	 both	
monocytes	and	DC	IPs	were	pathways	describing	“integrin	signaling”	(p=5.62E‐08;	
p=1.53E‐13	 respectively)	 and	 “actin‐cytoskeleton	 signaling”	 (p=1.16E‐06	 and	
(p=6.3E‐10	respectively),	confirming	selective	precipitation	of	proteins	involved	in	
integrin	 signaling	 and	 the	 importance	 of	 the	 cytoskeleton	 for	 integrin	 function.	
imDCs	
	
	
Protein	AcNR	
	
	
HGNC	
symbol	
	
	
	
Protein	Name	
	found	
enriched	
out	of	4	
exp.	
IPI00005159	 ACTR2 Actin‐like	protein	2 2	
IPI00005969,	
IPI00026182,	
IPI00218782	
CAPZA1,	
CAPZA2,	
CAPZB	
CapZ	alpha‐1	&2 3,2,2	
IPI00550234	
IPI00005160,	
IPI00925052,	
IPI00871870,	
IPI00414554			
ARPC5,
ARPC1B,	
ARPC4,	
ARPC3,	
ARPC5L	
Actin‐related	protein	2/3	complex	subunit 1B,3,4,	5	&	5L	 2,2,3,2,3	
IPI00012011	 CFL1	 Cofilin‐1	 2	
IPI00017704	 COTL1	 Coactosin‐like	protein 2	
IPI00007752	 TUBB2C Tubulin	beta‐2	chain 2	
	 	 Sectreted	Proteins 	
IPI00296099	 THBS1 Thrombospondin‐1 2	
IPI00219219,	
IPI00465431,	
IPI00472523,	
LGALS1,
LGALS3,	
LGALS9,	
LGALS9B	
Galectin‐1,	3,	9	&	9B 2,2,2,2	
	 	 	 	
	 	 Other	 	
IPI00290566	 TCP1	 T‐complex	protein	1	 2	
IPI00016608	 TMED2 Membrane	protein	p24A 2	
IPI00221224	 ANPEP Alanyl	aminopeptidase	(CD13) 2	
IPI00218918	 ANXA1 Annexin	A1 2	
IPI00295741	 CTSB	 Cathepsin	B	 2	
IPI00001883	 SNX9	 Sorting	nexin	9 *	
IPI00305064	 CD44	 CD44	 *	
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Specifically	 overrepresented	 in	 monocytes	 were	 “virus	 entry	 via	 endocytic	
pathways”	(p=1.55E‐08),	“caveolar	mediated	endocytosis	signaling”	(p=8.36E‐08)	
and	 in	 iDCs	 “EIF2	 signaling”	 (p=6.95E‐27)	 and	 interestingly	 now	 “clathrin‐
mediated	endocytosis	signaling”	(p=1.38E‐10)	instead	of	caveolar.		
Next,	we	turned	to	literature	mining	to	extract	proteins	from	the	full	lists	
of	 enriched	proteins	 from	monocytes	 and	DCs	 (supple.	 table	 1)	which,	 based	 on	
experimental	evidence	 from	the	 literature	are	established	or	could	potentially	be	
important	 for	 integrin	 function	 (Table	 1&2).	 We	 selected	 33	 enriched	 proteins	
from	 the	 monocytes	 (Table	 1)	 data	 set	 and	 48	 from	 DCs	 (Table	 2)	 (including	
“rescued	proteins”	as	indicated).	We	were	particularly	interested	in	creating	a	high	
confidence	network	of	LFA‐1	interacting	proteins	and	to	predict	“missing	protein	
links”	 for	 each	 cell	 type.	 For	 this	 purpose	 we	 first	 created	 a	 base	 network	 for	
monocytes	 and	 DCs	 based	 on	 highly	 confident	 nodes	 derived	 from	 the	 full	
protein	lists	of	each	cell	type,	respectively	(suppl.	table	I).	We	then	used	the	build	
function	in	IPA	to	expand	these	networks	by	adding	additional	nodes	from	the	IPA	
database	 that	 with	 high	 confidence	 interact	 with	 one	 of	 the	 network	 proteins	
(suppl.	 fig.	4	A‐B).	The	 resulting	networks	 show	both	 the	 location	of	 the	binding	
candidates	within	the	cell	and	their	connections	for	each	cell	type.		
Finally,	we	generated	a	full	network	of	LFA‐1	binding	candidates	showing	
binding	partners	from	both	monocytes	and	DCs	as	well	as	the	cell	specific	ones.	To	
this	end	we	first	prepared	a	base‐network	of	those	proteins	from	our	list	detected	
in	the	significant	canonical	pathways	of	both	monocytes	and	DCs.	Additional	nodes	
were	 added	 from	 our	 	 protein	 lists	 (of	 monocytes	 and	 DCs)	 and	 from	 the	 IPA	
database	 to	 further	 enrich	 the	 network.	 We	 then	 overlaid	 the	 specific	 binding	
candidates	 of	 monocytes	 and	 DCs	 onto	 this	 network	 and	 highlighted	 the	 nodes	
accordingly.	The	 generated	network	was	 restricted	 to	direct	protein‐connections	
for	 better	 visualization.	 This	 network	 demonstrates	 how	 highly	 confident	 LFA‐1	
binding	candidates	from	both	cell	type	differentially	interact	with	key	components	
of	LFA‐1‐function	related	pathways	(Fig.	7).	
Of	 all	 genes	 in	 the	 network,	 GRB2,	 SRC	 and	 14‐3‐3	 protein	 zeta/delta	
represent	 the	 most	 connected	 nodes	 having	 a	 total	 of	 20,	 18	 and	 17	 edges	
respectively.	These	findings	suggest	a	crucial	importance	of	these	proteins	in	LFA‐
1	function	in	monocytes	and	DCs.		
Membrane	proximal	LFA‐1	binding	candidates			
Finally,	since	we	were	especially	interested	in	interactions	that	might	influence	cell	
surface	 organization	 of	 LFA‐1,	 we	 focused	 on	 the	 membrane	 proximal	 binding	
partners	 of	 LFA‐1	 during	 DC	 differentiation.	 We	 used	 the	 IPA	 network	 tool	 to	
visualize	proteins	 from	monocytes	and	DCs	associated	with	 the	PM	and	 included	
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direct	and	 indirect	protein‐connections,	without	 the	addition	of	extra	nodes	 (Fig.	
8).	 The	 resulting	 network	 shows	 a	 unique	 signature	 of	 interacting	 proteins	 in	
monocytes	 and	 DCs	 and	 provides	 insight	 in	 the	 different	 regulation	 of	 LFA‐1	
proximal	to	the	PM	in	monocytes	and	DCs.		
Discussion		
We	have	previously	shown	that	LFA‐1	undergoes	dramatic	changes	in	function	and	
cell	surface	distribution	during	DC	differentiation.	In	monocytes,	LFA‐1	resides	in	
discrete	 nanoclusters	 within	 the	 cell	 membrane,	 of	 which	 25‐30%	 exclusively	
contain	 extended	 LFA‐1.	 During	 differentiation	 towards	 DCs,	 LFA‐1	 becomes	
inactive	 (bent)	 and	 randomly	 distributed.	 15.	 The	 processes	 underlying	 these	
dramatic	changes	are	totally	unknown.	The	purpose	of	 this	study	was	 to	 identify	
proteins	differentially	associated	with	LFA‐1	during	DC	differentiation,	to	get	more	
insight	 in	 the	 molecular	 events	 leading	 to	 the	 loss	 of	 function	 and	 cell	 surface	
organization	of	LFA‐1	in	DCs.	
The	cytoplasmic	tails	of	integrins	are	rather	short,	containing	40‐60	amino	
acids,	 and	 they	 do	 not	 possess	 any	 enzymatic	 activity	 of	 their	 own.	 Instead,	
multiple	 adaptor	 proteins	 bind	 to	 specific	 sites	 on	 the	 α	 or	 β	 chain	 to	 mediate	
integrin	activation	or	clustering,	or	to	serve	as	nucleation	sites	for	the	assembly	of	
cytoplasmic	 protein	 complexes	 5.	 Previous	 studies	 of	 integrin	 binding	 partners	
have	so	 far	 identified	more	 than	40	proteins	by	classical	biochemical	assays	 that	
directly	interact	with	the	α	or	β	chain	5;	8;	24;	25.		
In	the	present	study,	by	selective	IP	of	the	αL	chain	of	LFA‐1	coupled	with	highly	
sensitive	 MS	 analysis,	 we	 identified	 already	 >150	 LFA‐1	 associated	 proteins	 in	
monocytes	and	DCs	in	the	steady‐state	only.	This	indicates	that	in	the	steady‐state	
many	proteins	are	localized	in	vicinity	to	integrins	potentially	to	facilitate	the	onset	
of	 integrin‐associated	 signaling	 cascades.	 In	 the	 following,	 we	 will	 restrict	
ourselves	 by	 only	 discussing	 a	 selection	 of	 those	 proteins	 that	 have	 been	
designated	 as	 integrin	 binding	 partners	 or	 to	 play	 a	 role	 in	 integrin	 related	
functions.		
Signaling	proteins	
Activation	 of	 integrins	 is	 triggered	 by	 signals	 derived	 from	 chemokine	
receptors,	 T	 cell	 receptor	 or	 during	 selectin‐mediated	 rolling,	 inducing	 complex	
inside‐out	 and	 outside	 in	 signaling	 pathways	 14;	 26‐28.	 These	 pathways	 include	
among	 many	 other	 proteins	 the	 recruitment	 of	 protein	 kinases,	 phospholipases	
and	small	GTPases	29;	30.	Concordantly,	we	identified	the	GTPases	Rac2	and	Rap1	in	
our	datasets	that	are	known	to	integrate	signals	from	cell	surface	receptors	to	the	
cytoskeleton	 7;	 31;	 32.	 Rap1	 plays	 an	 essential	 role	 in	 inside‐out	 signaling,	 as	
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highlighted	 in	 human	 leukocyte	 adhesion	 deficiency	 syndrome	 III	 that	 can	 be	
caused	 by	 a	 defect	 in	 Rap1	 33.	 Moreover,	 LFA‐1	 and	 Rap1	 reside	 together	 in	
recycling	vesicles,	and	 it	 is	currently	under	debate	whether	these	vesicles	can	be	
delivered	 to	 adhesion	 sites	 upon	 signaling7;	 34;	 35.	 Interestingly,	 we	 found	 Rap1	
associated	with	LFA‐1	in	monocytes	and	DCs,	independent	of	the	difference	in	LFA‐
1	function	among	the	two	cell	types.		
	
Fig.	7:	Network	of	key	components	of	LFA‐1	binding	
candidates	derived	from	the	monocyte‐	and	DC	data	
sets.	 A	 network	 was	 generated	 by	 combining	 the	
overlap	 of	 the	 top	 canonical	 pathways	 from	
monocytes	 and	DCs,	 plus	 further	 enrichment	 of	 the	
network	with	enriched	proteins	from	monocytes	and	
DCs	 identified	 in	 this	 study,	as	well	as	 from	 the	 IPA	
database.	 The	 binding	 candidates	 of	monocytes	 and	 DCs	were	 overlaid	 onto	 this	 network.	
Yellow	nodes	represent	proteins	enriched	in	monocytes,	blue	nodes	enriched	proteins	from	DCs,	
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green	nodes	are	proteins	enriched	in	both	cell	types.	White	nodes	indicate	proteins	added	from	
the	 IPA	 data‐base.
Fig.	8:	Primary	network	of	LFA‐1	binding	candidates	 in	monocyte‐	and	DCs	proximal	 to	 the	
PM.	A	network	was	generated	solely	based	on	 the	binding	candidates	 in	monocytes	and	DCs	
associated	with	 the	PM.	 Straight	 lines	 indicate	 direct	 and	 dotted	 lines	 indirect	 interactions	
among	 components.	 The	 binding	 candidates	 of	monocytes	 and	DCs	were	 overlaid	 onto	 this	
network.	Yellow	nodes	represent	proteins	enriched	in	monocytes,	blue	nodes	enriched	proteins	
from	DCs,	green	nodes	are	proteins	enriched	in	both	cell	types.	
Small	 GTPases	 are	 activated	 by	 guanine‐nucleotide	 exchange	 factors	
(GEFs).	 We	 identified	 the	 GEF	 for	 Rac1/2,	 DOCK2,	 associated	 with	 LFA‐1	 in	
monocytes	 and	 DCs,	 but	 to	 a	 higher	 extent	 enriched	 in	 monocytes.	 	 DOCK2	
functions	in	both	T	and	B	lymphocytes	as	a	docking/scaffold	protein,	participating	
in	 affinity	modulation	 of	 integrins	 36;	 37,	 while	 it	 also	 plays	 a	 role	 in	 chemokine	
induced	 integrin	 activation	 38.	 The	 fact	 that	we	 found	DOCK2	 and	Rac2	 together	
with	 LFA‐1	 in	 monocytes,	 could	 point	 towards	 a	 more	 prominent	 role	 the	
GEF/GTPase	pair	in	monocytes,	potentially	in	interaction	of	chemokine‐stimulated	
monocytes	with	the	endothelium.		
The	 interactions	 of	 LFA‐1	 with	 the	 signaling	 protein	 14‐3‐3	 regulates	 LFA‐1–
mediated	cell	adhesion	and	spreading	and	increased	interactions	of	these	proteins	
in	murine	DCs	led	to	increased	cell	recruitment	29;	39;	40.	14‐3‐3	proteins	are	present	
as	dimers,	and	the	14‐3‐3	αβ	and	δζ	isoforms	were	previously	shown	to	associate	
with	the	cytoplasmic	tail	of	the	β	chain	of	LFA‐1	through	phosphorylated	tyrosine	
39.	The	association	of	14‐3‐3	with	LFA‐1	proteins	in	monocytes	and	DCs	shows	that	
a	pool	of	the	14‐3‐3	protein	complex	associates	with	the	β	chain	in	both	cell	types	
independent	of	ligand	triggered	phosphorylation.		
Cytoskeletal	proteins	
Cytoskeletal	 proteins	 are	 essential	 for	 integrin	 inside‐out	 signaling	 and	
adhesion	 strengthening,	 as	 well	 as	 cell	 force	 generation	 during	 migration.	 Cell	
migration	 is	 a	 coordinated	 event	 involving	 protrusion	 in	 the	 lamellipodium,	
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adhesion	to	the	extracellular	matrix,	myosin	II‐driven	contraction	of	the	cell	body,	
and	 adhesion	 disassembly	 at	 the	 cell	 rear	 41.	 We	 found	 several	 proteins	 that	
regulate	 actin	 dynamics,	 such	 as	 components	 of	 the	 Arp2/3	 complex	 42,	 F‐actin	
capping	proteins,	gelsolin	and	cofilin	in	monocytes	and	DCs.	Cytoskeletal	proteins	
are	 also	 associated	with	 endocytosis	 and	 vesicle	 transport,	 therefore	 they	 could	
potentially	be	derived	from	vesicular	pools	of	LFA‐1.		
The	 most	 proximal	 signaling	 event	 leading	 to	 integrin	 activation	 is	 the	
binding	of	the	cytosolic	actin‐interacting	proteins	kindlin‐3	and	talin‐1.	Strikingly,	
we	found	these	proteins	associated	with	LFA‐1	in	DCs	and	could	confirm	their	CO‐
IP	 by	 WB.	 The	 binding	 of	 talin‐1	 and	 kindlin‐3	 to	 integrins	 is	 related	 to	 the	
separation	 of	 the	 cytosplasmic	 tails	 and	 the	 TM	 region	 leading	 to	 integrin	
extension;	 therefore	 these	proteins	are	classically	 thought	 to	 interact	with	active	
(extended)	 integrins.	 However,	 our	 results	 are	 in	 line	with	 the	 observation	 that	
talin	 interacts	with	 inactive	 integrins	 in	 neutrophils	 43	 and	might	 point	 towards	
additional	roles	of	talin	and	kindlin‐3	in	LFA‐1	regulation.		
Secreted	proteins	
Interestingly,	 we	 also	 identified	 the	 serum‐derived	 protein	 haptoglobin	
and	 secreted	 proteins	 such	 as	 Galectin‐1	 and	 Galectin‐3,	 which	 bind	 to	 the	 cell	
surface.	Although	haptoglobin	was	identified	as	a	ligand	for	Mac‐1	in	monocytes	44,	
functional	implications	of	this	interaction	are	not	known.	Galectins	are	associated	
with	an	increased	migratory	phenotype	of	cancer	cells	and	other	cells	such	of	DCs	
45‐47.	 They	 bind	 to	 cell	 surface	 glycoproteins	 such	 as	 integrins	 and	may	 thereby	
modulate	 their	 organization	 in	 the	 PM	 and	 receptor	 function	 48.	 Galectin‐3‐α3β1	
interactions	 are	 involved	 in	 inducing	 lamellipodia	 formation	 by	 activating	 Rac1	
signaling	 in	epithelial	 cells	 47.	Moreover,	 it	was	 recently	 shown	 that	extracellular	
Galectin‐3	 triggered	 the	disruption	of	 adhesion	plaques,	 leading	 to	enhanced	cell	
migration	on	laminin	49.	It	is	tempting	to	speculate	that	the	association	of	Galectin‐
3	with	 LFA‐1	 in	DCs	 could	 favor	 the	migratory	 phenotype	 of	 DCs,	 in	 contrast	 to	
pro‐adhesive	monocytes.		
Novel	Binding	Partners	
Besides	 already	 described	 integrin‐binding	 partners,	 we	 found	 a	 set	 of	
novel	 proteins	 that	 might	 be	 involved	 in	 integrin	 regulation.	 CD13	
(Aminopeptidase	 N)	 albeit	 highly	 enriched	 in	 both	 monocytes	 and	 DCs,	 only	
precipitated	 together	 with	 LFA‐1	 in	 DCs.	 The	 association	 of	 integrins	 with	
metalloproteases	has	been	demonstrated	to	play	a	role	in	degrading	ECM	but	also	
modulating	 receptor	 activity	 50	 suggesting	 it	 could	 have	 a	 similar	 function	 here.	
Interaction	 of	 integrins	 with	 membrane	 ectoenzymes	 is	 less	 well	 investigated.	
Membrane‐bound	 ectoenzymes	 are	 involved	 in	 leukocyte	 activation	 and	
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trafficking,	by	triggering	calcium	influx,	cytoskeletal	rearrangements	and	 integrin	
activation	 51;	 52.	 Also,	 blocking	 of	 CD13	 resulted	 in	 a	 reduction	 of	 peritoneal	
leukocyte	 infiltration	 in	 the	 murine	 model	 of	 peritonitis.	 Taken	 together,	 these	
findings	indicate	an	important	role	for	CD13	in	leukocyte	trafficking	53.	Its	selective	
association	with	 LFA‐1	 in	 DC	 thus	makes	 it	 an	 interesting	 candidate	 for	 further	
investigation.		
Interestingly,	we	found	Thrombospondin‐1	(TSP‐1)	associated	with	LFA‐1	
in	 monocytes	 and	 DCs.	 TSPs	 are	 components	 of	 the	 extracellular	 matrix;	 they	
comprise	 a	 family	 of	 calcium‐binding	 glycoproteins	 that	 have	 important	 roles	 in	
angiogenesis,	vascular	biology,	connective	tissues	and	immune	response	54.	TSP‐1	
was	shown	to	be	recognized	by	several	cell	surface	receptors,	including	β3	and	β1	
integrins,	CD36	and	CD47	(IAP)	55	thereby	stimulating	several	signaling	pathways.	
It	will	thus	be	interesting	to	further	investigate	the	binding	of	TSP‐1	to	LFA‐1	and	
its	possible	effects	on	downstream	signaling.	
Proteins	associated	with	integrin	turnover	
Besides	 the	 α	 and	 β	 chain	 of	 LFA‐1,	 we	 also	 identified	 integrin	 β5	 as	 binding	
candidate	 of	 LFA‐1	 in	monocytes	 and	 DCs.	 This	 association	 suggests	 that	 LFA‐1	
resides	 in	 complexes	 with	 other	 integrins	 in	 the	 membrane.	 Potentially,	 these	
complexes	could	be	nucleation	sites	for	endocytosis,	as	β5	integrins	were	reported	
to	be	involved	in	integrin	turnover	56.	The	set‐up	of	our	experiment	did	not	allow	
discriminating	between	vesicular	and	cell‐surface	proteins;	therefore	many	of	the	
proteins	 found	 as	 integrin	 binding	 candidates	 might	 be	 important	 for	 integrin	
turnover	 during	 cell	migration	 and	might	 associate	with	 LFA‐1	 during	 vesicular	
trafficking.	In	line	with	this,	we	also	identified	members	of	the	GIPC	family	(GIPC2	
and	 GIPC3),	 of	 which	 GIPC1	 functions	 as	 an	 adaptor	 protein	 in	 β5	 mediated	
endocytosis	in	monocytes	57.	Both	in	monoyctes	and	DCs	we	identified	clathrin	and	
components	 of	 the	 adaptor	 protein	 AP‐2	 complex	 indicating	 a	 dominant	 role	 of	
clathrin‐mediated	 endocytosis	 in	 both	 cell	 types.	 Interestingly,	 in	monocytes	 the	
canonical	pathway	“caveolar	mediated	endocytosis	signaling”	was	enriched,	while	
in	 DCs	 “clathrin‐mediated	 endocytosis	 signaling”	 dominated.	 Accordingly,	 we	
found	components	associated	with	 caveolae,	 such	as	 ILK	and	 the	F‐actin	binding	
protein	 IQGAP1	58	and	 IQGAP2	 in	monocytes	only.	The	association	of	LFA‐1	with	
clathrin	 and	 caveolin	 might	 indicate	 that	 LFA‐1	 recycling/endocytosis	 is	
differentially	regulated	in	monocytes,	where	LFA‐1	is	functional	active.	This	would	
be	 in	 line	 with	 recent	 studies	 showing	 that	 active	 and	 inactive	 integrins	 follow	
different	 endocytosis	 routes	 59,	 however	 whether	 this	 holds	 true	 for	 LFA‐1	 on	
monocytes	will	require	further	evaluation.		
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Shared	and	distinct	proteins	‐	conclusions	
Monocytes	 and	 DCs	 shared	 a	 set	 of	 30	 proteins,	 while	 the	 majority	 of	
proteins	 were	 different	 among	 these	 cell	 types.	 This	 suggests	 that	 during	 DC	
differentiation,	 major	 changes	 in	 the	 preassembly	 of	 signaling	 and	 cytoskeletal	
proteins	occur,	that	could	reflect	adaptations	of	LFA‐1	function	during	the	DC	life	
cycle.	 Indeed,	 during	 in	 vivo	 differentiation	 of	 monocytes	 towards	 DCs,	 the	
environmental	 requirements	 change.	 While	 LFA‐1	 on	 monocytes	 is	 in	 a	 pro‐
adhesive	 state	 and	 can	 readily	 encounter	 with	 its	 ligand	 under	 the	 high	 shear	
stress	 of	 the	 blood	 stream	 60,	 the	 role	 of	 DC‐LFA‐1	 during	 trans‐lymphatic	
migration	 to	 the	 lymph	 nodes,	 where	 low	 shear	 stress	 values	 prevail	 61,	 is	 less	
understood.	Our	group	recently	showed	that	LFA‐1	on	in	vitro	cultured	monocyte‐
derived	DCs	is	inactive	15,	but	LFA‐1	can	be	reactivated	by	CCL21	62	via	inside‐out	
signaling.	 In	 line	 with	 this	 we	 found	 an	 increase	 in	 proteins	 related	 to	 actin	
polymerization	 and	 inside‐out	 signaling	 associated	 with	 LFA‐1	 in	 DCs	 in	 the	
current	 study.	 This	 supports	 the	 notion	 that	 different	 signaling	 pathways	 are	
preassembled	to	regulate	LFA‐1	function	in	monocytes	and	DCs.		
Furthermore,	 we	 found	 an	 increase	 in	 PM	 associated	 proteins	 in	 DCs.	
Several	transmembrane	receptors	and	secreted	proteins	associated	with	LFA‐1	in	
DCs.	Especially	Galectin‐3	has	the	potential	 to	modify	cell	surface	organization	of	
integrins	 in	 the	PM,	 thereby	altering	 integrin	 function.	Association	of	LFA‐1	with	
secreted	or	cell	surface	proteins	might	have	functional	consequences,	and	could	for	
example	 lead	 to	 the	 loss	 of	 LFA‐1	 nanodomains	 observed	 in	 monocytes,	 due	 to	
steric	hindrance.			
In	general,	the	networks	created	on	basis	of	identified	binding	candidates	showed	
a	high	degree	of	connectivity	 in	each	cell	 type,	 suggesting	 that	 those	 interactions	
may	also	exist	in	vivo.	However,	we	should	consider	that	these	proteins	most	likely	
only	 present	 of	 small	 fraction	 of	 all	 LFA‐1	 interacting	 proteins;	 relating	 to	 those	
that	are	most	resistant	to	cell	lysis.	Moreover,	further	biochemical	analysis	will	be	
needed	to	validate	the	identified	LFA‐1	binding	partners.			
Taken	 together,	 our	 results	 strongly	 support	 the	 notion	 that	 the	 steady‐
state	 LFA‐1	 interactome	 dynamically	 changes	 during	 DC	 differentiation.	 In	 our	
study	we	identified	known	integrin‐binding	partners	that	associated	with	LFA‐1	in	
either	monocytes	or	DCs,	as	well	as	several	novel	binding	partners	that	might	be	
responsible	for	the	change	in	LFA‐1	function	during	the	DC	lifecycle.		
Abbreviations:	
LFA‐1,	 lymphocyte	 function‐associated	 antigen‐1;	 PM,	 plasma	 membrane;	 IP,	
immunoprecipitation;	 MS,	 mass‐spectrometry;	 iBAQ,	 intensity‐	 based	 absolute	
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quantification;	moDC,	monocyte‐derived	Dendritic	cell;	imDC,	 immature	DC;	WB,	
Western	Blotting;	LC	MS/MS,	liquid	chromatography	tandem	mass	spectrometry.	
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Supplementary	Information		
Suppl.	Table	1:	A	list	of	all	enriched	proteins	identified	in	the	data‐set	of	monocytes,	including	
gene	 HGNC	 symbol	 and	 common	 proteins	 names,	 as	 well	 as	 indication	 of	 the	 number	 of	
experimental	enrichments	in	the	LFA‐1	fraction.	The	column	named	“found	enriched”	describes	
in	how	many	experiments	(maximum	4	experiments)	this	protein	was	found	enriched.		
	 Protein	
AcNR	
HGNC	
symbol	
Protein	Name #	found	
enriched	
1	 IPI00000105	 MVP	 Major	vault	protein 2	
2	 IPI00025380	 ITGAL	 Integrin	alpha‐L 4	
3	 IPI00291792	 ITGB2	 Integrin	beta‐2 4	
4	 IPI00003865	 HSPA8	 Heat	shock	cognate	71	kDa	protein 3	
5	 IPI00019038	 LYZ	 Lysozyme	C 3	
6	 IPI00021428	 ACTA1	 Actin 3	
7	 IPI00022488	 HPX	 Hemopexin 3	
8	 IPI00024067	 CLTC	 Clathrin	heavy	chain	1 3	
9	 IPI00179330	 RPS27A	 ubiquitin	and	ribosomal	protein	S27a	precursor 3	
10	 IPI00186290	 EEF2	 Elongation	factor	2 3	
11	 IPI00215637	 DDX3X	 ATP‐dependent	RNA	helicase	DDX3X 3	
12	 IPI00219365	 MSN	 Moesin 3	
13	 IPI00299571	 PDIA6	 Protein	disulfide‐isomerase	A6 3	
14	 IPI00479186	 PKM2	 Pyruvate	kinase	isozymes	M1/M2 3	
15	 IPI00604590	 NME2	 Nucleoside	diphosphate	kinase 3	
16	 IPI00744476	 IGLV2‐8	 IGL@	protein 3	
17	 IPI00790342	 RPL6	 60S	ribosomal	protein	L6 3	
18	 IPI00894498	 ACTB	 Beta	actin	variant	 3	
19	 IPI00947127	 LDHA	 lactate	dehydrogenase	A	isoform	3 3	
20	 IPI00000874	 PRDX1	 Peroxiredoxin‐1 2	
21	 IPI00006091	 DMD	 Dystrophin 2	
22	 IPI00008964	 RAB1B	 Ras‐related	protein	Rab‐1B 2	
23	 IPI00010270	 RAC2	 Ras‐related	C3	botulinum	toxin	substrate	2 2	
24	 IPI00012555	 FCN1	 Ficolin‐1 2	
25	 IPI00013163	 MNDA	 Myeloid	cell	nuclear	differentiation	antigen 2	
26	 IPI00013933	 DSP	 Desmoplakin 2	
27	 IPI00016610	 PCBP1	 Poly(rC)‐binding	protein	1 2	
28	 IPI00017376	 SEC23B	 Protein	transport	protein	Sec23B 2	
29	 IPI00018971	 TRIM21	 52	kDa	Ro	protein 2	
30	 IPI00019345	 RAP1A	 Ras‐related	protein	Rap‐1A 2	
31	 IPI00022246	 AZU1	 Azurocidin 2	
32	 IPI00022449	 DOCK2	 Dedicator	of	cytokinesis	protein 2 2	
33	 IPI00024911	 ERP29	 Endoplasmic	reticulum	protein	ERp29 2	
34	 IPI00027230	 HSP90B1	 Endoplasmin 2	
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	 Protein	
AcNR	
HGNC	
symbol	
Protein	Name #	found	
enriched	
35	 IPI00027341	 CAPG	 Macrophage‐capping	protein 2	
36	 IPI00027444	 SERPINB1	 Leukocyte	elastase	inhibitor 2	
37	 IPI00027462	 S100A9	 Protein	S100‐A9 2	
38	 IPI00027834	 HNRNPL	 Heterogeneous	nuclear	ribonucleoprotein	L 2	
39	 IPI00029741	 ITGB5	 Integrin	beta‐5 2	
40	 IPI00031691	 RPL9	 60S	ribosomal	protein	L9 2	
41	 IPI00183400	 CSNK1A1	 Casein	kinase	I	isoform	alpha 2	
42	 IPI00217030	 RPS4X	 40S	ribosomal	protein	S4 2	
43	 IPI00218918	 ANXA1	 Annexin	A1 2	
44	 IPI00219018	 GAPDH	 Glyceraldehyde‐3‐phosphate	dehydrogenase 2	
45	 IPI00219219	 LGALS1	 Galectin‐1 2	
46	 IPI00221089	 RPS13	 40S	ribosomal	protein	S13 2	
47	 IPI00221091	 RPS15A	 40S	ribosomal	protein	S15a 2	
48	 IPI00293423	 PRF1	 Perforin‐1 2	
49	 IPI00294739	 SAMHD1	 SAM	domain	and	HD	domain‐containing	protein	1 2	
50	 IPI00296099	 THBS1	 Thrombospondin‐1 2	
51	 IPI00296713	 GRN Granulin 2	
52	 IPI00296909	 PARP4	 Poly	[ADP‐ribose]	polymerase	4 2	
53	 IPI00303476	 ATP5B	 ATP	synthase	subunit	beta 2	
54	 IPI00305383	 UQCRC2	 Cytochrome	b‐c1	complex	subunit	2 2	
55	 IPI00328296	 GIPC2	 PDZ	domain‐containing	protein	GIPC2 2	
56	 IPI00329512	 SNRPB	 Small	nuclear	ribonucleoprotein‐associated	proteins	B	and	B		 2	
57	 IPI00384938	 IGHG1	 Putative	uncharacterized	protein	DKFZp686N02209 2	
58	 IPI00387116	 IGKV3‐20	 Ig	kappa	chain	V‐III	region	NG9	(Fragment) 2	
59	 IPI00399007	 IGHG2	 Putative	uncharacterized	protein	DKFZp686I04196 2	
60	 IPI00414554	 ARPC5L	 Actin‐related	protein	2/3	complex	subunit	5‐like	protein 2	
61	 IPI00414676	 HSP90AB1	 Heat	shock	protein	HSP	90‐beta 2	
62	 IPI00420004	 MYO1G	 Myosin‐Ig 2	
63	 IPI00440493	 ATP5A1	 ATP	synthase	subunit	alpha 2	
64	 IPI00465248	 ENO1	 Alpha‐enolase 2	
65	 IPI00470528	 RPL15	 60S	ribosomal	protein	L15 2	
66	 IPI00554711	 JUP Junction	plakoglobin 2	
67	 IPI00641737	 HP Haptoglobin 2	
68	 IPI00643920	 TKT cDNA	FLJ54957 2	
69	 IPI00644431	 DDX39A	 cDNA	FLJ55484 2	
70	 IPI00645887	 ITGAM	 integrin	alpha	M	 2	
71	 IPI00646773	 GSN Gelsolin 2	
72	 IPI00654755	 HBB Hemoglobin	subunit	beta 2	
73	 IPI00745872	 ALB Serum	albumin 2	
74	 IPI00746851	 ITGB2	 Integrin	beta	 2	
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Suppl.	Table	2:	A	 list	of	all	 enriched	proteins	 identified	 in	 the	data‐set	of	 imDCs	 including	
gene	 HGNC	 symbol	 and	 common	 proteins	 names,	 as	 well	 as	 indication	 of	 the	 number	 of	
experimental	enrichments	in	the	LFA‐1	fraction.	The	column	named	“found	enriched”	describes	
in	how	many	experiments	(maximum	4	experiments)	this	protein	was	found	enriched.		
	
	 Protein	
AcNR	
HGNC	
symbol	
Protein	Name #	found	
enriched	
75	 IPI00760846	 MYO18A	 Myosin‐XVIIIa 2	
76	 IPI00796333	 ALDOA	 45	kDa	protein 2	
77	 IPI00872350	 GALC	 Galactocerebrosidase 2	
78	 IPI00909772	 AP2M1	 cDNA	FLJ53069 2	
79	 IPI00930688	 TUBA1B	 Tubulin	alpha‐1B	chain 2	
80	 IPI00937615	 RP11‐
864I4.1	
Elongation	factor	1‐gamma 2	
81	 IPI00939667	 TPP1	 Tripeptidyl‐peptidase	1 2	
 
	 Protein	
AcNR	
HGNC	
symbol	
Protein	Description #	found	
enriched	
1	 IPI00807428	 N/A	 Putative	uncharacterized	protein 4	
2	 IPI00291792	 ITGB2	 Integrin	beta‐2 4	
3	 IPI00025380	 ITGAL	 Integrin	alpha‐L 4	
4	 IPI00604523	 MYL12A	 Myosin	regulatory	light	chain	MRCL3	variant 3	
5	 IPI00029741	 ITGB5	 Integrin	beta‐5 3	
6	 IPI00218782	 CAPZB	 cDNA FLJ60094 3	
7	 IPI00744476	 IGLV2‐8	 IGL@	protein 3	
8	 IPI00024911	 ERP29	 Endoplasmic	reticulum	protein	ERp29 3	
9	 IPI00291467	 SLC25A6	 ADP/ATP	translocase	3 3	
10	 IPI00395627	 CACYBP	 Calcyclin‐binding	protein 3	
11	 IPI00293303	 LGMN	 Legumain 3	
12	 IPI00376798	 RPL11	 60S	ribosomal	protein	L11 3	
13	 IPI00218414	 CA2	 Carbonic	anhydrase	2 3	
14	 IPI00299571	 PDIA6	 Protein	disulfide‐isomerase	A6 3	
15	 IPI00419880	 RPS3A	 40S	ribosomal	protein	S3a 3	
16	 IPI00871827	 RPL7	 Putative	uncharacterized	protein	RPL7	 3	
17	 IPI00465248	 ENO1	 Alpha‐enolase	of	Alpha‐enolase 3	
18	 IPI00925052	 ARPC4	 Putative	uncharacterized	protein	ARPC4 3	
19	 IPI00646240	 HIST2H2BF	 Histone	H2B 3	
20	 IPI00005969	 CAPZA1	 F‐actin‐capping	protein	subunit	alpha‐1 3	
21	 IPI00027107	 TUFM	 Tu	translation	elongation	factor 3	
22	 IPI00746851	 ITGB2	 Integrin	beta	 3	
23	 IPI00011107	 IDH2	 Isocitrate	dehydrogenase	[NADP] 3	
24	 IPI00032139	 SERPINB9	 Serpin	B9 2	
25	 IPI00554711	 JUP	 Junction	plakoglobin 2	
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	 Protein	
AcNR	
HGNC	
symbol	
Protein	Description #	found	
enriched	
26	 IPI00216873	 ERI1 3‐5	exoribonuclease	1 2	
27	 IPI00003479	 MAPK1	 Mitogen‐activated	protein	kinase	1 2	
28	 IPI00018206	 GOT2 Aspartate	aminotransferase 2	
29	 IPI00646917	 NUDT21	 Cleavage	and	polyadenylation	specificity	factor	subunit	5	 2	
30	 IPI00009802	 VCAN Isoform	V0	of	Versican	core	protein 2	
31	 IPI00016608	 TMED2	 Transmembrane	emp24	domain‐containing	protein	2 2	
32	 IPI00152240	 TMEM167A	 Transmembrane	protein	167A 2	
33	 IPI00216171	 ENO2 Gamma‐enolase 2	
34	 IPI00887169	 IGLV1‐47	 Putative	uncharacterized	protein 2	
35	 IPI00017510	 MT‐CO2	 Cytochrome	c	oxidase	subunit	2 2	
36	 IPI00025329	 RPL19	 60S	ribosomal	protein	L19 2	
37	 IPI00011937	 PRDX4	 Peroxiredoxin‐4 2	
38	 IPI00375531	 NME1	 Isoform	2	of	Nucleoside	diphosphate	kinase	A 2	
39	 IPI00556231	 N/A Actin/actin‐like	family	protein 2	
40	 IPI00007853	 IFI30 Gamma‐interferon‐inducible	lysosomal	thiol	reductase 2	
41	 IPI00472523	 LGALS9B	 Galectin‐9B 2	
42	 IPI00300074	 FARSB	 Phenylalanyl‐tRNA	synthetase	beta	chain 2	
43	 IPI00022449	 DOCK2	 Dedicator	of	cytokinesis	protein	2 2	
44	 IPI00926581	 MYH14	 myosin,	heavy	chain	14	isoform	3 2	
45	 IPI00296099	 THBS1	 Thrombospondin‐1 2	
46	 IPI00219910	 BLVRB	 22	kDa	protein 2	
47	 IPI00412607	 RPL35	 60S	ribosomal	protein	L35 2	
48	 IPI00006091	 DMD Dystrophin 2	
49	 IPI00021327	 GRB2 Growth	factor	receptor‐bound	protein	2 2	
50	 IPI00025815	 TARDBP	 TDP43	 2	
51	 IPI00005171	 N/A HLA	class	II	histocompatibility	antigen 2	
52	 IPI00010415	 ACOT7	 Cytosolic	acyl	coenzyme	A	thioester	hydrolase 2	
53	 IPI00026302	 RPL31	 60S	ribosomal	protein	L31 2	
54	 IPI00019345	 RAP1A	 Ras‐related	protein	Rap‐1A 2	
55	 IPI00013933	 DSP Desmoplakin 2	
56	 IPI00291006	 MDH2	 Malate	dehydrogenase 2	
57	 IPI00303476	 ATP5B	 ATP	synthase	subunit	beta 2	
58	 IPI00299000	 PA2G4	 Proliferation‐associated	protein	2G4 2	
59	 IPI00644708	 TIAL1	 TIA‐1	related	protein	isoform	2 2	
60	 IPI00219757	 GSTP1	 Glutathione	S‐transferase	P 2	
61	 IPI00013163	 MNDA	 Myeloid	cell	nuclear	differentiation	antigen 2	
62	 IPI00018235	 PEF1 Peflin	 2	
63	 IPI00027270	 RPL26	 60S	ribosomal	protein	L26 2	
64	 IPI00023505	 FCGR2A	 Low	affinity	immunoglobulin	gamma	Fc	region	receptor	II‐a	 2	
65	 IPI00550021	 RPL3 60S	ribosomal	protein	L3 2	
66	 IPI00604590	 NME2	 Nucleoside	diphosphate	kinase 2	
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	 Protein	
AcNR	
HGNC	
symbol	
Protein	Description #	found	
enriched	
67	 IPI00465431	 LGALS3	 Galectin‐3 2	
68	 IPI00022793	 HADHB	 Trifunctional	enzyme	subunit	beta 2	
69	 IPI00290566	 TCP1	 T‐complex	protein	1	subunit	alpha 2	
70	 IPI00024067	 CLTC	 Clathrin	heavy	chain	1 2	
71	 IPI00186290	 EEF2	 Elongation	factor	2 2	
72	 IPI00000874	 PRDX1	 Peroxiredoxin‐1 2	
73	 IPI00221091	 RPS15A	 40S	ribosomal	protein	S15a 2	
74	 IPI00796333	 ALDOA	 45	kDa	protein 2	
75	 IPI00026202	 RPL18A	 60S	ribosomal	protein	L18a 2	
76	 IPI00939163	 HSPH1	 Heat	shock	protein	105	kDa 2	
77	 IPI00334587	 HNRNPAB	 Heterogeneous	nuclear	ribonucleoprotein	A/B 2	
78	 IPI00013917	 RPS12	 40S	ribosomal	protein	S12 2	
79	 IPI00793696	 N/A	 19	kDa	protein 2	
80	 IPI00027834	 HNRNPL	 Heterogeneous	nuclear	ribonucleoprotein	L 2	
81	 IPI00021263	 YWHAZ	 14‐3‐3	protein	zeta/delta 2	
82	 IPI00219219	 LGALS1	 Galectin‐1 2	
83	 IPI00219155	 RPL27	 60S	ribosomal	protein	L27 2	
84	 IPI00297492	 STT3A	 Dolichyl‐diphosphooligosaccharide‐protein	glycosyltransferase	
subunit	STT3A	
2	
85	 IPI00013468	 BUB3	 Mitotic	checkpoint	protein	BUB3 2	
86	 IPI00641829	 SNORD84	 Spliceosome	RNA	helicase	BAT1 2	
87	 IPI00219840	 AP2S1	 AP‐2	complex	subunit	sigma 2	
88	 IPI00008964	 RAB1B	 Ras‐related	protein Rab‐1B 2	
89	 IPI00011644	 PTPRE	 Receptor‐type	tyrosine‐protein	phosphatase	epsilon	precursor	 2	
90	 IPI00218187	 PPP1CC	 IGamma‐2	of	Serine/threonine‐protein	phosphatase	PP1‐
gamma	catalytic	subunit	
2	
91	 IPI00220278	 MYL9	 Myosin	regulatory	light	polypeptide	9 2	
92	 IPI00168728	 IGHG3	 FLJ00385	protein	 2	
93	 IPI00387116	 IGKV3‐20	 Ig	kappa	chain	V‐III	region	NG9	 2	
94	 IPI00007144	 RPL26L1	 60S	ribosomal	protein	L26‐like	1 2	
95	 IPI00550234	 ARPC5	 Actin‐related	protein	2/3	complex	subunit	5 2	
96	 IPI00012382	 SNRPA	 U1	small	nuclear	ribonucleoprotein	A 2	
97	 IPI00940292	 AP1B1	 adaptor‐related	protein	complex	1	beta	1	subunit	isoform	b	 2	
98	 IPI00027350	 PRDX2	 Peroxiredoxin‐2 2	
99	 IPI00294779	 VDAC3	 Voltage‐dependent	anion‐selective	channel	protein	3	 2	
100	 IPI00174442	 FAM98A	 Protein	FAM98A 2	
101	 IPI00294911	 SDHB	 Succinate	dehydrogenase	[ubiquinone]	iron‐sulfur	subunit	 2	
102	 IPI00307092	 KARS	 Isoform	Mitochondrial	of	Lysyl‐tRNA	synthetase 2	
103	 IPI00011549	 TRAF1	 TNF	receptor‐associated	factor	1 2	
104	 IPI00001639	 KPNB1	 Importin	subunit	beta‐1 2	
105	 IPI00878470	 N/A	 8	kDa	protein 2	
106	 IPI00221224	 ANPEP	 Aminopeptidase	N 2	
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AcNR	
HGNC	
symbol	
Protein	Description #	found	
enriched	
107	 IPI00216691	 PFN1 Profilin‐1 2	
108	 IPI00477313	 HNRNPC	 Heterogeneous	nuclear	ribonucleoproteins	C1/C2 2	
109	 IPI00215914	 ARF1 ADP‐ribosylation	factor	1 2	
110	 IPI00005159	 ACTR2	 Actin‐related	protein	2 2	
111	 IPI00926935	 GNAI2	 Galphai2	protein 2	
112	 IPI00550069	 RNH1 Ribonuclease	inhibitor 2	
113	 IPI00005160	 ARPC1B	 Actin‐related	protein	2/3 complex	subunit	1B 2	
114	 IPI00304171	 H2AFY	 Core	histone	macro‐H2A.1 2	
115	 IPI00011253	 RPS3 40S	ribosomal	protein	S3 2	
116	 IPI00453473	 HIST1H4E	 Histone	H4 2	
117	 IPI00902560	 VDAC2	 Voltage‐dependent	anion‐selective	channel	protein	2 2	
118	 IPI00016342	 RAB7A	 Ras‐related	protein	Rab‐7a 2	
119	 IPI00419585	 PPIA Peptidyl‐prolyl	cis‐trans	isomerase	A 2	
120	 IPI00796337	 PCBP2	 poly(rC)	binding	protein	2	isoform	a 2	
121	 IPI00012011	 CFL1 Cofilin‐1 2	
122	 IPI00017704	 COTL1	 Coactosin‐like	protein 2	
123	 IPI00291764	 HIST1H2AK	 Histone	H2A	type	1 2	
124	 IPI00218918	 ANXA1	 Annexin	A1 2	
125	 IPI00010896	 AL844216.1	 Chloride	intracellular	channel	protein	1 2	
126	 IPI00216587	 RPS8 40S	ribosomal	protein	S8 2	
127	 IPI00026182	 CAPZA2	 F‐actin‐capping	protein	subunit	alpha‐2 2	
128	 IPI00221088	 RPS9 40S	ribosomal	protein	S9 2	
129	 IPI00221092	 RPS16	 40S	ribosomal	protein	S16 2	
130	 IPI00456758	 RPL27A	 60S	ribosomal	protein	L27a 2	
131	 IPI00219038	 H3F3B	 Histone	H3.3 2	
132	 IPI00329512	 SNRPB	 Small	nuclear	ribonucleoprotein‐associated	proteins	B	and	B		 2	
133	 IPI00021840	 RPS6 40S	ribosomal	protein	S6 2	
134	 IPI00217030	 RPS4X	 40S	ribosomal	protein	S4 2	
135	 IPI00792352	 RAN member	RAS	oncogene	family 2	
136	 IPI00010402	 SH3BGRL3	 SH3	domain‐binding	glutamic	acid‐rich‐like	protein	3 2	
137	 IPI00296526	 NAGK N‐acetylglucosamine	kinase 2	
138	 IPI00655650	 RPS26	 40S	ribosomal	protein	S26 2	
139	 IPI00414554	 ARPC5L	 Actin‐related	protein	2/3	complex	subunit	5‐like	protein	 2	
140	 IPI00183626	 PTBP1	 Polypyrimidine	tract‐binding	protein	1	isoform	a 2	
141	 IPI00031691	 RPL9 60S	ribosomal	protein	L9 2	
142	 IPI00007752	 TUBB2C	 Tubulin	beta‐2C	chain 2	
143	 IPI00746004	 RPS27L	 40S	ribosomal	protein	S27‐like	protein 2	
144	 IPI00218606	 RPS23	 40S	ribosomal	protein	S23 2	
145	 IPI00215719	 RPL18	 60S	ribosomal	protein	L18;Ribosomal	protein	L18 2	
146	 IPI00555744	 RPL14	 Ribosomal	protein	L14	variant 2	
147	 IPI00871870	 ARPC3	 Putative	uncharacterized	protein	ARPC3	 2	
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Suppl.	Fig.1:	Quantitative	heat‐maps	display	relative	expression	of	LFA‐1	associated	proteins	
in	monocytes	or	DCs.	The	values	are	average	values	from	2‐4	experiments.	LFA‐1	was	enriched	
using	mAb	(clone	SPV‐L7)	directed	against	αL.	mIgG1	coated	beads	were	 included	as	control	
IP.	
	
	
	
	
	
	
	
	
	
	 Protein	
AcNR	
HGNC	
symbol	
Protein	Description #	found	
enriched	
148	 IPI00295741	 CTSB	 Cathepsin	B 2	
149	 IPI00479743	 N/A	 Isoform	1	of	POTE	ankyrin	domain	family	member	E	 2	
150	 IPI00018219	 TGFBI	 Transforming	growth	factor‐beta‐induced	protein	ig‐h3	 2	
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Suppl.	Fig.	2:	Summary	of	LFA‐1	binding	
candidates	 into	 protein	 classes.	
PANTHERTM	 analysis	 was	 performed	 on	
the	 set	 of	 proteins	 present	 in	 LFA‐1	
complexes	 in	 monocytes	 and	 DCs.	 The	
protein	 classes	 were	 further	 summarized	
into	 the	 following	 protein	 categories:	
signal	 transduction,	 cytoskeletal	
reorganization,	transcriptional	regulation,	
protein	 biosynthesis,	 metabolic	 enzymes	
and	others.		
	
	
	
	
	
	
	
	
	
	
	
	
	
Top 1 network in monocytes
Associated Network Function: Cellular Movement, Antigen Presentation, 
Cell-To-Cell Signaling and Interaction
Chapter	3	
89 
 
	
Suppl.	Fig.3:	Ingenuity	Pathway	Analysis	networks	of	LFA‐1	binding	candidates.	The	top	one	
network	 for	monocytes	and	DCs	 is	 shown.	 (A)The	monocyte	network	has	a	 score	 of	53	and	
contains	 29	 proteins	 from	 our	 list.	 (B)The	 DC	 network	 has	 a	 score	 of	 40	 and	 contains	 35	
proteins	 from	 our	 list.	 Shaded	 nodes	 indicate	 proteins	 from	 our	 list,	 white	 nodes	 indicate	
proteins	 added	 by	 IPA	 to	 enrich	 the	 network.	 Straight	 lines	 indicate	 direct	 interactions.	
Symbols	represent	the	protein	class,	as	indicated	in	the	figure	legend.	
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Monocyte-derived protein networkA
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Suppl.	 Fig.4:	 Primary	 network	 of	 LFA‐1	 binding	 candidates	 in	A)	monocyte	 and	B)	DCs.	 A	
network	was	 generated	 based	 on	 the	 binding	 candidates	 identified	 in	monocytes	 and	 DCs.	
Additional	 nodes	were	 added	 from	 the	 IPA	 database	 to	 enrich	 the	 network.	 Straight	 lines	
indicate	 direct	 interactions	 among	 components.	 Binding	 candidates	 derived	 from	 the	
monocyte	dataset	were	overlaid	with	the	monocyte	network,	and	vice	versa	for	DC.	Grey	nodes	
represent	identified	LFA‐1	binding	candidates.		
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Abstract	
	
Dendritic	Cells	(DCs)	are	the	most	potent	antigen	presenting	cells,	involved	in	the	
induction	 of	 immunity	 and	 tolerance.	 Recently	 we	 demonstrated	 that	 during	
differentiation	of	human	DCs	from	monocyte	precursors,	LFA‐1	binding	capacity	is	
lost,	although	the	integrin	expression	levels	were	maintained	constant,	suggesting	
a	different	regulation	mechanism	of	this	integrin	on	different	cell	types.	However,	
the	 exact	 role	 of	 LFA‐1	 in	 DC	 adhesion	 and	 migration	 remains	 obscure.	
Chemokines	are	potent	regulators	of	 integrin	 function,	 influencing	migratory	and	
adhesive	properties	of	leukocytes.	Here,	we	show	that	upon	vaccination	of	cancer	
patients	with	 human	DCs,	 cells	 that	 have	migrated	 in	 vivo	 into	 the	 lymph	 nodes	
upregulated	 the	 active	 form	 of	 LFA‐1.	We	 further	 demonstrate	 that	 exposure	 of	
human	DCs	to	the	lymphoid	chemokine	CCL21	specifically	restores	the	high	affinity	
form	of	LFA‐1	and	induces	binding	to	its	ligand	ICAM‐1	under	low	shear	stress.	Our	
data	 indicate	 that	 on	 DCs	 LFA‐1	 may	 function	 as	 an	 inducible	 anchor	 during	
lymphatic	transmigration	or	within	the	lymph	nodes.	A	thorough	understanding	of	
the	adhesive	events	during	 the	DC	 life	 cycle	will	help	 to	 improve	 the	outcome	of	
DC‐based	anti‐tumor	clinical	trials.		
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Introduction	
Dendritic	cells	(DCs)	are	the	most	potent	antigen‐presenting	cells	(APCs),	involved	
in	the	induction	of	immunity	and	tolerance1.	DCs	presenting	foreign	or	self‐antigen	
migrate	 to	 the	 lymph	 node,	 a	 spatially	 defined	 compartment	 that	 facilitates	
encounter	 of	 APCs	with	 rare	 Ag‐specific	 naive	 T	 and	 B	 cells.	 DCs	 originate	 from	
precursor	 cells	 in	 the	 blood	 (e.g.	monocytes)	 and	 are	 recruited	 to	 the	 tissues	 by	
transendothelial	 migration	 mediated	 by	 integrin‐dependent	 arrest	 2.	 Several	
clinical	studies	exploit	monocyte‐derived	DC	(moDCs)	vaccines	to	induce	antigen‐
specific	response	in	cancer	patients	3.			
Integrins	are	transmembrane	α/β	heterodimers	that	regulate	cell‐cell	and	
cell‐extracellular	 matrix	 interactions.	 Lymphocyte	 function‐associated	 antigen	 1	
(LFA‐1,	 αLβ2)	 is	 a	 leukocyte	 specific	 integrin	 that	 mediates	 firm	 arrest	 on	 the	
endothelium	 and,	 within	 tissues,	 cell	 tethering	 and	 the	 formation	 of	 the	
immunological	 synapse	 4.	 LFA‐1	 shifts	 between	 bent,	 low	 affinity	 and	 variable	
extended	conformations	with	high	affinity	to	its	ligand	ICAM‐1	and	to	lesser	extend	
also	to	ICAM‐2	and	ICAM‐3	5.	Ligand	binding	can	further	be	increased	by	dynamic	
redistribution	of		LFA‐1	in	the	cell	membrane,	a	phenomenon	designated	as	avidity	
regulation	 6,	 7.	 In	 circulating	 leukocytes,	 LFA‐1	 remains	 largely	 inactive	 but	
becomes	activated	by	endothelium‐presented	chemokines	through	signalling	via	G	
protein‐coupled	receptors	(GPCRs)	and	application	of	shear	stress,	resulting	in	the	
extension	of	the	molecule	followed	by	immediate	ligand	binding	8.		
The	 role	 of	 integrin	 activation	 in	 transendothelial	 migration	 has	 been	
widely	studied	9.	Homing	of	DCs	via	the	afferent	lymphatics	to	the	lymph	nodes	is	
still	not	completely	understood	and	was	assumed	to	passively	follow	the	intrinsic	
flow	 of	 the	 lymph.	 However,	 the	 discovery	 that	 trafficking	 via	 the	 afferent	
lymphatics	to	the	lymph	nodes	is	impaired	in	the	absence	of	the	chemokines	CCL19	
and	CCL21	in	mice	10	has	provided	evidence	that	this	process	is	highly	regulated.	
CCL19	 and	 CCL21,	 originating	 from	 lymph	 node	 and	 lymphatic	 endothelial	 cells,	
bind	 to	 their	 cognate	 receptor	 CCR7,	 highly	 expressed	 on	 mature	 DCs	 and	 to	 a	
lesser	extent	on	immature	DCs 11.	In	addition,	within	the	lymph	nodes	murine	APCs	
were	shown	to	strongly	bind	CCL21	to	their	surface	and	attract	naive	lymphocytes,	
in	 the	 absence	 of	 antigen	 12.	 Besides	 chemokines,	 recent	 studies	 point	 to	 an	
involvement	of	 the	 integrin	 ligands	VCAM‐1	and	 ICAM‐1	 in	homing	 to	 the	 lymph	
nodes	 and	 in	 translymphatic	migration,	 suggesting	 an	 active	 role	 for	 VLA‐4	 and	
LFA‐1	in	the	DC	life	cycle	13.		
Recently	we	have	shown	that	during	 in	vitro	differentiation	of	monocytes	
towards	immature	moDCs	LFA‐1	remains	expressed	at	similar	levels,	but	that	only	
monocytes	express	primed	and	functional	LFA‐1	7,	which	is	thought	to	facilitate	the	
extravasation	 of	 monocytes	 to	 underlying	 tissues.	 As	 a	 consequence,	 binding	 of	
DCs	to	ICAM‐1	is	negligible	while	binding	to	ICAM‐2	and	‐3	occurs	in	an	integrin‐
independent	manner,	being	completely	mediated	by	DC‐SIGN	14;	15.		
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Here,	 we	 investigated	 the	 effect	 of	 the	 lymph	 node	 chemokine	 CCL21	 on	 LFA‐1	
function	on	human	 immature	 and	mature	moDCs	 in	vitro	 as	well	 as	 after	 in	vivo	
migration	 to	 the	 lymph	 nodes	 of	 melanoma	 patients	 vaccinated	 with	 tumor	
antigen‐loaded	moDCs.	Our	results	demonstrate	an	important	role	for	CCL21	in	the	
regulation	 of	 DC	 adhesive	 processes	 by	 modulating	 LFA‐1	 function.	 A	 thorough	
understanding	of	the	adhesive	events	during	the	DC	life	cycle	will	help	to	improve	
the	outcome	of	DC‐based	anti‐tumor	clinical	trials.		
	
Methods	
	
Monoclonal	Antibodies	and	Chemokines	
The	mouse	mAbs	against	αL	integrin:	NKI‐L15	7;	16,	NKI‐L16	16	and	TS	2/4	(kindly	provided	
by	E.	Martz).	Anti‐CCR7	(clone	150503)	and	the	polyclonal	ab	Anti‐CCL21	were	 from	R&D	
Systems	 (Minneapolis,	 MN,	 USA).	 Anti‐CD86‐PE	 (clone	 2331)	 was	 obtained	 from	 BD	
(Franklin	Lakes,	NJ,	USA).	Recombinant	CCL21	was	obtained	 from	R&D	Systems	and	 from	
Peprotech	(London,	UK).	
	
Cells		
Human	monocytes	 were	 obtained	 from	 buffy	 coats	 of	 healthy	 donors	 and	 were	 purified	
using	 Ficoll	 density	 centrifugation.	 DC	 were	 generated	 from	 adherent	 peripheral	 blood	
monocnuclear	cells	(PBMCs)	by	culturing	in	the	presence	of	 interleukin	4	(500	U/mL)	and	
granulocyte‐monocyte	 colony‐stimulating	 factor	 (both	 800	 U/mL;	 Strathmann	 Biotec,	
Hamburg,	Germany)	17.	Immature	DCs	were	matured	with	LPS	(1µg/ml)	from	Sigma	(Saint‐
Louis,	MI,	USA).		
	
Patients	
Eligibility	criteria	included	stage	III	melanoma	according	to	AJCC	criteria	19,	scheduled	for	
radical	 lymph	 node	 dissection,	 HLA‐A2.1	 phenotype,	 and	 melanoma	 expressing	 the	
melanocyte‐associated	 antigens	 gp100	 and	 tyrosinase.	 The	 study	 was	 approved	 by	 our	
Institutional	Review	Board,	 and	written	 informed	consent	was	obtained	 from	all	 patients.	
Clinicaltrials.gov	identifier	NCT00243594.	
	
Treatment	schedule	and	DC	preparation	for	vaccination	
Preparation	of	DCs	used	in	the	study	including	melanoma	stage	III	patients	was	performed	
as	 already	 reported	 18.	 Briefly,	 at	 day	 ‐7	 autologous	 peripheral	 blood	 mononuclear	 cells	
were	obtained	by	leukapheresis	for	DC‐culturing	with	IL‐4	and	GM‐CSF	(Cellgenix,	Freiburg,	
Germany).	 	On	day	5,	DCs	were	 loaded	with	a	KLH	and	tumor	associated	antigen	peptides	
and	 labeled	with	SPIO	by	adding	100	µg	Ferumoxide/mL	(Endorem;	Laboratoire	Guerbet,	
Villepinte,	 France)	 19.	On	day	 7,	DC	were	matured	with	 autologous	monocyte‐conditioned	
medium	 supplemented	with	prostaglandin	E2	 (10	µg/mL;	Pharmacia	&	Upjohn,	 Erlangen,	
Germany)	 and	 10	 ng/mL	 recombinant	 tumor	 necrosis	 factor‐α	 (Cellgenix)	 for	 48	 h	 as	
described	previously	20.	At	day	9,	mature	DCs	were	loaded	with	tumor‐associated	antigen‐
peptides	and	subsequently	labeled	with	111In‐oxine	(Covidien,	Dublin,	Ireland)	in	0.1	mol/L	
Tris‐HCl	(pH	7.0)	for	15	min	at	room	temperature	as	described	previously	21.		At	day	9	the	
patient	received	a	single	 injection	of	15x10e6	111In‐labeled‐	and	SPIO‐labeled	DCs	directly	
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into	 an	 inguinal	 lymph	 node	 of	 the	 region	 that	 was	 to	 be	 resected.	 I.n.	 injections	 were	
performed	under	ultrasound	guidance	by	an	experienced	radiologist.	Scintigraphic	imaging	
of	the	lymph	node	region	was	performed	90	minutes	after	i.n.	 injection	and	72	hours	after	
i.n.	injection,	before	dissection	of	the	regional	lymph	nodes.	Radiolabeled	lymph	nodes	were	
resected	 from	 the	 surgical	 specimen	 under	 guidance	 of	 a	 gamma	 probe	 (Europrobe®,	
Eurorad,	 Strasbourg,	 France).	 The	 lymph	 nodes	 were	 processed	 as	 described	 below.	 The	
patient	received	three	more	vaccinations	at	days	14,	28	and	42.		
Cell	suspensions	were	made	from	resected	radiolabeled	 lymph	nodes.	The	 lymph	
node	tissue	was	cut	into	small	 fragments	in	Hanks	Balanced	Salt	Solution	medium	(GIBCO,	
Invitrogen,	Burlington,	ON,	Canada)	with	50	µg/mL	collagenase	type	1A,	10	µg/mL	DNase,	
and	1	µg/mL	trypsin	 inhibitor	 (Sigma).	The	 fragments	were	 incubated	 for	30	min	at	37°C.	
For	the	 isolation	of	DCs,	 the	 large	fragments	were	left	to	settle	down,	and	the	supernatant	
was	transferred	to	a	fresh	tube.	SPIO+	DC	were	isolated	with	the	use	of	a	Dynal	MPC	magnet	
(Invitrogen)	22.		
	
Fluorescent	Bead	Adhesion	Assay	
Carboxylate‐modified	 streptavidin‐coated	 TransFluorSpheres	 (488/645	 nm,	 1µmØ;	
invitrogen)	were	 coated	with	 ICAM‐1‐Fc,	 and	 the	 bead	 adhesion	 assay	was	 performed	 as	
described	23.	Briefly,	 the	 fluorescent	beads	were	coated	with	biotinylated	goat	anti‐human	
Fc	 antbodies	 and	 subsequently	 with	 ICAM‐1‐Fc	 chimeras.	 This	 guarantees	 the	 outwards	
orientation	 of	 the	 ICAM‐1	molecules	with	 respect	 to	 the	 bead	 surface.	 After	 each	 coating	
step,	 several	 thorough	 washing	 steps	 ensure	 that	 the	 excess	 of	 unbound	 molecules	 is	
washed	 away.	 For	 the	 incubation,	 a	 ratio	 of	 20	 beads	 per	 cell	was	 used.	 The	 blocking	 or	
stimulating	 Abs	 were	 preincubated	with	 the	 cells	 before	 adding	 the	 ligand‐coated	 beads.	
Adhesion	was	determined	as	 the	percentage	of	cells	 that	bound	fluorescent	beads	by	 flow	
cytometry	on	an	FACSCalibur	(BD).		
	
Flow	Cytometry		
For	 flow	 cytometry	 analysis,	 cells	 were	 incubated	 (30	 min,	 4°C)	 in	 PBS,	 0.5%	 BSA,	 and	
0.01%	 sodium	 azide,	 with	 different	 mAbs	 (5	 µg/ml),	 followed	 by	 incubation	 with	 FITC‐
labeled	goat	anti‐mouse	IgG	antibody	(GAM‐FITC;	Zymed,	South	San	Francisco,	CA,	USA)	for	
30	min	at	4°C.	The	relative	fluorescence	intensity	was	measured	on	a	FACSCalibur.	Isotype‐
specific	 controls	were	 included.	 For	 detection	 of	 surface‐bound	 CCL21,	 2x10e5	DCs	were	
incubated	 for	 15	min	 at	 37°C	with	 1µg/ml	 CCL21	 in	medium	 containing	 10%	 FCS.	 After	
incubation,	DCs	were	washed	two	times	with	PBS	and	fixed	with	1%	PFA	in	PBS,	followed	by	
surface	 staining	 of	 CCL21.	 In	 “reactivation	 assays”	 2x10e5	DCs	were	 incubated	 for	 5	min	
with	 1µg/ml	 CCL21	 in	 medium	 containing	 10%	 FCS,	 immediately	 span	 down	 and	
resuspended	in	antibody	solution.		
	
In	vitro	flow	assays	
Whole	 white	 blood	 cells	 (PBMCs)	 or	 mature	 DCs	 were	 resuspended	 in	 RPMI	 1640	
(supplemented	with	1mM	CaCl2,	1mM	MgCl2,	and	10%FCS)	at	0.5x10e6	cells/ml.	In	blocking	
experiments,	 anti‐	 αL	 integrin	 antibody	 NKI‐L15	 (10	 µg/ml)	 was	 included.	 Cover	 slips	
(40mm	Menzel,	Braunschweig,	Germany)	were	coated	with	10 µg/ml	Protein	A	(Sigma)	for	
2	 hours	 at	 37°C.	 Coverslips	 were	 washed	 with	 PBS;	 Protein	 A	 coated	 coverslips	 were	
overlaid	with	10µg/ml	recombinant	 ICAM‐1	Fc	 (R&D	systems);	or	with	10µg	 ICAM‐1‐Fc	+	
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2µg	CCL21/ml;	or	with	2µg/ml	CCL21	only	and	assembled	 in	a	37C	Focht	 flow	chamber,	
mounted	 on	 an	 inverted	 phase‐contrast	microscope	 (Axiovert	 35M	 Zeiss)	 connected	 to	 a	
camera	(Variocam,	PCO	computer	Optics	GmbH,	Kelheim,	Germany).	Cells	were	perfused	at	
physiological	 shear	 stress	 rates	 (1.5‐0.1	dyne/cm2)	 for	60	 sec.	After	washing	 for	1‐5	min,	
adherent	cells	were	monitored	by	imaging	5	microscopic	fields	(1,673	mm2)	and	adherent	
cells	were	quantified.		
	
Results	
	
LFA‐1	is	inactive	on	immature	and	mature	moDCs		
We	 have	 previously	 shown	 that	 during	 in	 vitro	 differentiation	 of	 monocytes	
towards	 immature	moDCs,	 LFA‐1	 remains	 expressed	 at	 constant	 levels,	whereas	
binding	to	ICAM‐1	is	gradually	lost	7.		
To	determine	 the	differences	between	monocytes,	 immature	and	mature	
moDCs	 in	 terms	 of	 LFA‐1	 expression	 and	 activation	 status,	 we	 measured	 the	
binding	capacity	of	monocytes	and	moDCs	to	ICAM‐1	Fc	coated	fluorescent	beads	
(Fig.	 1A).	 More	 than	 40%	 of	 monocytes	 spontaneously	 bound	 ICAM‐1,	 and	 this	
interaction	was	predominantly	LFA‐1	mediated,	as	shown	by	the	effective	block	in	
the	 presence	 of	 an	 anti‐	 αL	 blocking	mAb.	 In	 contrast,	 both	 immature	 and	 LPS‐
matured	moDCs	showed	a	basal	aspecific	binding	of	10%,	which	was	not	mediated	
by	LFA‐1.	To	investigate	whether	the	loss	of	ICAM‐1	binding	during	differentiation	
was	 due	 to	 downregulation	 of	 LFA‐1	 expression,	 we	 determined	 the	 expression	
levels	of	total	LFA‐1	by	flow	cytometry.	As	shown	in	Figure	1B,	the	expression	level	
of	LFA‐1	on	monocytes,	immature	and	mature	moDCs	is	similar.	However,	by	using	
the	 αL	 specific	 activation	 reporter	 antibody	 NKI‐L16,	 we	 observed	 that	 only	
monocytes	 expressed	LFA‐1	 in	 an	 active	 state,	while	 both	 immature	 and	mature	
moDCs	 completely	 lack	 the	 activation	 reporter	 epitope.	 Activation	 of	 DCs	 with	
other	 stimuli,	 such	 as	 TLR‐3	 ligand	 polyI:C	 or	 the	 cytokine	 TNF	 alpha	 always	
resulted	 in	 mature	 DCs	 bearing	 inactive	 LFA‐1	 (data	 not	 shown).	 These	 results	
demonstrate	 that	LFA‐1	 is	 stably	expressed	 throughout	differentiation	of	 in	vitro	
cultured	moDCs,	but	the	ligand	binding	capacity	of	LFA‐1	is	lost.		
	
LFA‐1	is	active	on	DCs	migrated	to	the	human	lymph	node	in	vivo	
To	 determine	whether	 activation	 of	 LFA‐1	 on	moDCs	 occurs	 in	 vivo,	we	
exploited	 tumor‐antigen	 loaded	mature	moDCs	 that	were	 transferred	 in	 vivo	 for	
vaccination	purposes	in	melanoma	stage	III	patients	21.	These	patients	underwent	
lymph	node	resection,	allowing	us	to	obtain	lymph	nodes	72	hours	after	injection	
of	moDCs	and	to	recover	the	injected	moDCs	by	magnetic	isolation.		
Prior	 to	 antigen	 loading	 with	 tumor	 peptides,	 immature	 moDCs	 were	
labeled	with	superparamagnetic	iron	oxide	particles	(SPIO)	as	well	as	radionuclids	
(Indium)	 for	 monitoring	 of	 these	 cells	 in	 the	 body	 by	 MRI	 and	 scintigraphy,	 as	
described	 elsewhere	 18.	 The	 patients	 received	 SPIO‐	 and	 Indium‐labeled	 tumor‐
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antigen	 loaded	matured	moDCs,	 which	were	 injected	 intra‐nodally.	 At	 72	 hours	
post	 injection,	 the	lymph	nodes	adjacent	to	the	injection	site	appeared	to	contain	
Indium+	DCs,	as	visualized	by	scintigraphy	(Fig.	2A),	and	were	resected.	While	the	
lymph	 node	 of	 the	 injection	 site	 contained	 a	 residual	 depot	 of	 injected	 moDCs,	
~40%	 of	 injected	 DCs	 left	 the	 injection	 site	 and	 could	 be	 found	 in	 the	 adjacent	
lymph	nodes,	 as	 determined	 by	 the	 ratio	 of	 SPIO+	moDCs	 between	 the	 injection	
site	and	the	adjacent	lymph	nodes	(Fig.	2A).	From	cell	suspensions	of	the	resected	
lymph	node	areas	SPIO+	cells	were	isolated	(Fig.	2B).	Analysis	by	flow	cytometry	
showed	 that	 these	 SPIO‐labeled	 cells	 were	 positive	 for	 the	 marker	 CD86,	
confirming	that	mature	moDCs	were	specifically	recovered	from	the	lymph	nodes	
(Fig	 2C).	 Interestingly,	 while	 no	 significant	 differences	 were	 observed	 in	 the	
expression	 levels	 of	 CD86	 and	 total	 LFA‐1	 on	 SPIO+	 moDCs	 before	 and	 after	
injections,	the	SPIO+	moDCs	that	migrated	to	and	were	recovered	from	the	lymph	
node	expressed	high	 levels	of	active	LFA‐1	 (Fig.	2C).	SPIO	 labelling	alone	had	no	
effect	on	 the	activation	 level	of	LFA‐1,	as	shown	by	 the	absence	of	 the	activation	
reporter	epitope	on	 in	vitro	cultured,	mature	SPIO+	moDCs	before	 injection	(Fig.	
2C).	 To	 note,	 the	 mature	 phenotype	 of	 the	 SPIO+	 DCs	 prior	 injection	 was	 also	
determined	 by	 staining	 with	 the	 alternative	 maturation	 marker	 CD83	 (data	 not	
shown).	
	
Figure	 1:	 LFA‐1	 binding	
capacity	 is	 lost	 during	
differentiation	 of	 monocytes	
towards	 mature	 moDCs.	 (A)	
Adhesion	of	human	monocytes,	
immature	 and	 mature	 moDCs	
was	determined	using	 	ICAM‐1‐
Fc	coated	 fluorescent	beads	 for	
30	 min	 at	 37°C.	 The	 %	 of	
adhesion	 represents	 the	
amount	 of	 cells	 that	 have	
bound	 beads	 as	 calculated	 by	
flow	 cytometry.	 NKI‐L15	 mAb	
(10	 µg/ml)	 was	 used	 to	 block	
LFA‐1.	 The	 data	 represent	 the	
average	 +/‐SD	 of	 three	
independent	experiments.	P**	=	
0.0026	 relative	 to	 binding	 of	
moDCs	 to	 ICAM‐1‐Fc	 coated	
beads	 in	 the	presence	of	LFA‐1	
blocking	 antibody.	 (B)	 The	
expression	 levels	 of	 total	 (NKI‐
L15)	 and	 active	 (NKI‐L16+)	
LFA‐1	 were	 assessed	 by	 flow	
cytometry.	 Mean	 fluorescent	
intensity	 is	 indicated.	 (Isotype	
control,	 grey	 ;	 anti‐LFA‐1	
antibodies,	black).	
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Figure	2:	Isolated	ex	vivo	moDCs	restored	
high	affinity	LFA‐1	after	migration	to	the	
lymph	 nodes.	 (A)	 In	 vivo	 scintigraphy	 3	
days	after	vaccination	showing	migration	
of	 the	moDCs	 from	 the	 injection	 site	 to	
two	 adjacent	 lymph	 nodes	 (1=injection	
side,	 2=adjacent	 lymph	 nodes).	 (B)	 Dot	
plot	 of	 SPIO+	 moDCs	 isolated	 from	 cell	
suspensions	 of	 resected	 lymph	 nodes	
determined	by	flow	cytometry.	(C)	Surface	
expression	 of	 the	DC	maturation	marker	
CD86	 (black)	 on	 the	 isolated	 SPIO+	 DCs	
compared	 to	 isotype	 control	 (grey).	
Surface	 expression	 of	 	 active	 LFA‐1	
(black)	 compared	 to	 isotype	 control	
(grey)	 on	 in	 vitro	 cultured	 SPIO‐labeled	
moDCs	before	 (D)	and	after	 (E)	 injection	
and	migration	to	the	lymph	nodes.			
	
	
	
	
	
	
These	 results	 demonstrate	 that	 human	mature	 moDCs	 injected	 and	migrated	 in	
vivo	 to	 the	 lymph	node	either	during	migration	or	within	 the	 lymph	node	milieu	
restore	active	NKI‐	L16+	LFA‐1	
	
CCL21	strongly	binds	to	DCs	and	induces	active	LFA‐1		
The	 lymphoid	 chemokine	 CCL21	 is	 known	 to	 be	 abundantly	 present	 in	 lymph	
nodes	and	has	recently	been	 found	 to	bind	 to	 the	surface	of	murine	APCs	and	 to	
induce	a	general	β2	integrin	activation	epitope	on	immature	DCs	12;	 24.	Therefore,	
we	investigated	whether	CCL21	was	responsible	for	the	upregulation	of	the	LFA‐1	
activation	epitope	NKI‐L16	on	human	DCs.	
First	of	all,	we	tested	whether	CCL21	also	binds	to	the	surface	of	human	moDCs.	As	
expected,	 the	 expression	 level	 of	 the	 CCL21	 receptor	 CCR7	 on	 human	 moDCs	
increases	 upon	 maturation	 with	 LPS	 (Fig.	 3A).	 Upon	 loading	 of	 moDCs	 with	
saturating	 concentration	 of	 CCL21,	we	were	 able	 to	 detect	 the	 chemokine	 at	 the	
cell	surface	by	flow	cytometry.	Interestingly,	immature	and	mature	moDCs	bound	
similar	amounts	of	CCL21	to	their	surface	(Fig.	3B).	Recently,	Bax	and	colleagues	25	
suggested	that	the	cell	surface	glycan	polysialic	acid	could	mediate	the	interaction	
of	 CCL21	 with	 mature	 DCs,	 thereby	 modulating	 DC	 migration.	 Therefore	 we	
investigated	 whether	 and	 to	 what	 extent	 binding	 of	 CCL21	 to	 the	 DCs	 was	
dependent	 on	 polysialic	 acid.	 As	 indicated	 in	 figure	 3C,	 blocking	 of	 CCR7	 with	
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saturating	concentration	of	anti‐CCR7	blocking	antibody	decreased	CCL21	binding	
only	slightly,	suggesting	that	CCR7	is	probably	more	important	 for	signaling	than	
for	capturing	the	chemokine	to	the	cell	surface.	In	addition,	we	show	that	binding	
of	CCL21	to	immature	as	well	as	mature	DCs	was	partially	blocked	by	the	addition	
of	soluble	polysialic	acid.	To	determine	whether	and	to	which	extent	DCs	 in	vivo	
bind	 CCL21	 to	 their	 surface,	we	measured	 surface‐bound	 endogenous	 CCL21	 on	
human	 DCs	 from	 lymph	 node	 suspensions	 (Fig.	 3D).	 Flow	 cytometric	 analysis	
revealed	 that	 also	 in	 vivo	mature	DCs,	 characterized	 by	 the	 expression	 of	 CD86,	
had	endogenous	CCL21	bound	to	their	surface.	
Signaling via chemokine receptors transmits a series of intracellular signals	that	
can	 result	 in	 the	 induction	 of	 high	 affinity	 integrins.	 As	 shown	 in	 Fig.	 4A,	 both	
immature	 and	mature	moDCs	upregulated	 the	 LFA‐1	 activation	 reporter	 epitope	
upon	stimulation	with	CCL21,	compared	to	untreated	cells.	Importantly,	the	overall	
expression	levels	of	LFA‐1	were	not	altered	upon	CCL21	treatment,	thus	excluding	
that	 an	 increase	 in	 the	 NKI‐L16	 epitope	 on	 CCL21‐treated	 DCs	 was	 due	 to	
upregulation	 of	 total	 LFA‐1.	 Despite	 variation	 in	 expression	 levels	 of	 total	 and	
active	 LFA‐1	 among	 donors,	 reactivation	 of	 LFA‐1	 by	 CCL21	 was	 consistently	
detected	as	a	1.7‐2	fold	increase	in	the	expression	levels	of	NKI‐L16+	active	LFA‐1,	
as	determined	for	a	total	of	8	donors,	whereas	the	levels	of	total	LFA‐1	remained	
similar	(Fig.	4B).	
These	data	indicate	that	CCL21	strongly	binds	to	the	cell	surface	of	human	moDCs	
and	modulates	LFA‐1	activation	by	inducing	the	high	affinity	state.		
	
DCs	bind	to	ICAM‐1	immobilized	with	CCL21	under	in	vitro	flow	conditions	
To	determine	whether	exposure	of	moDCs	to	CCL21	could	also	restore	the	LFA‐1‐
mediated	 binding	 to	 ICAM‐1,	 we	 performed	 a	 dynamic	 binding	 assay	 at	
physiological	flow	conditions.		
Under	application	of	shear	stress,	binding	of	LFA‐1	to	its	ligand	requires	induction	
of	 active	 LFA‐1	 and	 instantaneous	 encounter	 with	 the	 ligand	 8.	 Hence,	 we	
performed	an	in	vitro	flow	assay	by	perfusing	mature	moDCs	on	an	ICAM‐1	coated	
surface	in	the	presence	of	shear	stress.	Since	application	of	forces	can	already	lead	
to	 adhesion	 strengthening	 via	 LFA‐1	 26,	 we	 first	 determined	 the	 adhesive	
behaviour	 of	 mature	 moDCs	 to	 ICAM‐1	 at	 increasing	 shear	 stress	 (Fig.	 5A).	 In	
contrast	to	monocytes,	which	express	active	LFA‐1,	the	binding	of	moDCs	to	ICAM‐
1	could	only	be	detected	at	shear	stress	below	0.5	dyne/cm2,	thus	excluding	that	
application	of	 shear	stress	on	 its	own	could	activate	LFA‐1	on	moDCs.	Moreover,	
moDCs	showed	a	significantly	lower	binding	to	ICAM‐1	with	respect	to	monocytes,	
further	 highlighting	 the	 intrinsic	 differences	 in	 LFA‐1	 binding	 capacity	 on	 these	
two	cell	types.	Interestingly,	when	CCL21	was	immobilized	together	with	ICAM‐1,	
adhesion	 of	 mature	 moDCs	 was	 significantly	 increased	 with	 respect	 to	 ICAM‐1	
alone	(Fig.	5B,	C).	 Importantly,	 the	effect	of	CCL21	on	DC	binding	 to	 immobilized	
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ICAM‐1	was	only	observed	 at	 low	shear	 stress	values.	 Furthermore,	 this	 binding	
was	 exclusively	 mediated	 by	 LFA‐1,	 as	 blocking	 with	 an	 anti‐αL	 antibody	
completely	abrogated	moDC	adhesion.	Perfusion	of	mature	moDCs	on	CCL21	alone	
did	not	lead	to	unspecific	adhesion	(Fig.	5C).		
These	results	show	that	CCL21	specifically	restores	LFA‐1	binding	capacity	in	vitro	
under	low	shear	stress	that	resembles	the	shear	stress	prevailing	in	the	lymphatics	
27;	28.		
	
Discussion	
During	 the	 differentiation	 of	 monocytes	 into	 DCs	 and	 the	 subsequent	 DC	
maturation,	major	 changes	 in	 LFA‐1	 adhesive	 properties	 occur.	 In	 this	 study	we	
demonstrate	that	monocytes	and	in	vitro	cultured	moDCs	express	LFA‐1	at	similar	
levels,	but	in	contrast	to	monocytes,	LFA‐1	on	both	immature	and	mature	moDCs	
appears	 to	 be	 in	 a	 low‐affinity	 conformation	 and	 unable	 to	 bind	 to	 its	 ligands.	
Furthermore,	we	demonstrated	that	human	mature	moDCs	that	have	migrated	 in	
vivo	to	the	lymph	nodes	upregulate	LFA‐1	active	state.	Finally,	exposure	of	moDCs	
to	the	lymphoid	chemokine	CCL21	restored	high	affinity	LFA‐1	and	promoted	LFA‐
1‐mediated	binding	to	ICAM‐1	at	low	shear	stress.	
The	importance	of	CCR7	and	its	ligands	CCL19	and	CCL21	lays	in	attracting	mature	
DCs	as	well	as	CCR7‐expressing	subsets	of	immature	DCs	to	the	afferent	lymphatics	
and	eventually	to	the	draining	lymph	nodes	29;	30.	In	vivo	migration	of	skin‐derived	
DCs	 to	 the	 lymphatic	 vessels	 failed	 when	 applying	 an	 anti‐CCL21	 blocking	
antibody,	 highlighting	 the	 importance	 of	 this	 chemokine	 in	 skin	 DC	 homing	 31.	
Chemokines	are	highly	charged	molecules	 that	besides	signalling	via	GPCRs	have	
been	 described	 to	 be	 adsorbed	 onto	 the	 cell	 surface	 of	 endothelium	 8	 as	well	 as	
murine	splenic	DCs	12.	
Figure	 3:	 MoDCs	
express	 CCR7	 and	
bind	CCL21	to	their	
surface.	 (A)	
Expression	of	CCR7	
on	 immature	 and	
mature	moDCs	was	
determined	by	flow	
cytometry	 (CCR7,	
black;	 isotype	
control,	 grey).	 (B)	
Immature	 and	
mature	 moDCs	
were	 incubated	
with	 1	 µg/ml	
CCL21	 for	 60	 min	
at	 37	 °C	 as	
described	 in	
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Materials	 and	methods.	The	 presence	 of	 bound	 CCL21	 to	 the	 cell	 surface	 of	untreated	 cells	
(grey	histogram)	and	of	CCL21‐loaded	 cells	 (black	 line)	was	determined	by	 flow	 cytometry.	
Isotype	controls	(dotted	line)	were	always	taken	along.	One	representative	donor	out	of	three	
was	shown.	Mean	fluorescent	intensity	is	indicated.		
	
	
Figure	4:	CCL21	 induces	expression	of	active	
LFA‐1	 on	 human	 immature	 and	 mature	
moDCs.	MoDCs	were	 incubated	with	1	µg/ml	
CCL21	 for	 5	 min	 at	 37	 °C	 as	 described	 in	
Materials	 and	 Methods.	 Mean	 fluorescent	
intensity	 of	 total	 LFA‐1,	 determined	 by	 the	
non‐blocking	 non‐activating	 anti‐αL	 mAb	
TS2/4,	 and	 active	 LFA‐1,	 determined	 by	 the	
NKI‐L16	 mAb,	 without	 and	 with	 CCL21	
stimulation,	were	assessed	by	 flow	cytometry.	
Changes	 in	 the	 mean	 fluorescent	 intensity	
(MFI)	 are	 displayed	 as	 relative	 to	 untreated	
samples	 (expression	 levels	 in	 untreated	 cells	
were	set	as	=	1,	 indicated	by	the	dotted	 line).	
The	 data	 represent	 the	 average	 +/‐	 SD	 of	 8	
independent	 experiments.	 P***	 <	 0.0001	
relative	to	the	untreated	sample.		
	
	
	
Figure	 5:	 LFA‐1	 on	 human	 mature	
moDCs	mediates	 binding	 to	 ICAM‐1‐Fc	
co‐immobilized	with	CCL21	at	low	shear	
stress.	 (A)	 Adhesion	 of	 mature	 moDCs	
and	 monocytes	 to	 ICAM‐1	 was	
determined	 at	 increasing	 shear	 stress	
(0.2‐1.5	 dyne/cm2).	The	 data	 represent	
the	average	number	of	adherent	cells	of	
5	 microscopic	 fields	 +/‐	 SD	 of	 two	
independent	experiments.	P***	<	0.0001,	
P**	 =	 0.0011	 relative	 to	 adhesion	 of	
monocytes.	 	 (B)	 Adhesion	 of	moDCs	 to	
ICAM‐1	 is	 enhanced	 by	 CCL21.	Mature	
moDCs	were	perfused	on	ICAM‐1	coated	
surfaces	 with	 or	 without	 co‐
immobilization	 of	 CCL21.	 Adhesion	
specificity	 was	 determined	 in	 the	
presence	 of	 the	 blocking	 anti‐LFA‐1	
antibody	 NKI‐L15	 (10	 µg/ml).	 The	
number	 of	 adherent	 moDCs	 were	
determined	 at	 a	 shear	 stress	 of	 0.2	
dyne/cm2.	 The	 data	 represent	 the	
average	of	5	representative	microscopic	
fields	+/‐	 SD.	The	 binding	 of	moDCs	 to	
ICAM‐1‐Fc	 in	 the	 presence	 of	
immobilized	 CCL21	 was	 set	 as	 100%	
and	corrected	for	the	low	unspecific	binding	of	moDCs	to	Protein	A	coated	glass	alone.	P***	<	
Chapter	4	
109	
 
0.0001	relative	to	moDCs	adherent	to	ICAM‐1‐Fc	alone.	One	representative	experiment	out	of	
three	is	shown.		
	
	
In	 this	 study,	we	expand	 this	observation	 to	 the	human	setting	and	show	that	at	
saturating	concentrations	CCL21	strongly	bound	to	 the	surface	of	both	 immature	
and	mature	human	moDCs	(Fig.	3B).	Interestingly,	binding	of	CCL21	to	DCs	seems	
to	be	independent	on	the	maturation	state.	In	fact,	we	also	performed	time‐course	
experiments	with	different	concentrations	of	CCL21	and	consistently	observed	no	
differences	in	binding	of	the	exogenous	chemokine	between	immature	and	mature	
DCs	 (data	 not	 shown).	 The	 expression	 levels	 of	 CCR7	 are	 known	 to	 show	donor	
variation	and	do	 increase	upon	DC	maturation	11.	Therefore,	binding	of	CCL21	to	
DCs	cannot	solely	be	mediated	by	the	interaction	with	CCR7.	As	suggested	by	Bax	
et	al	25	polysialic	acid,	which	is	highly	expressed	at	the	cell	surface	of	mature	DCs,	
seems	 to	 be	 an	 alternative	 anchoring	moiety	 for	 capturing	 CCL21.	However,	 our	
data	indicate	that	CCL21	also	strongly	binds	to	immature	DCs,	which	express	very	
low	 levels	 of	 CCR7	 and	 polysialic	 acid,	 suggesting	 that	most	 likely	 an	 additional	
capturing	moiety	for	CCL21	is	present	at	the	cell	surface	of	DCs.	In	this	study,	we	
show	that	binding	of	CCL21	to	immature	as	well	as	mature	DCs	could	be	partially	
blocked	by	the	addition	of	soluble	polysialic	acid,	which	could	prevent	CCL21	from	
binding	 to	 the	 cell	 surface	 explaining	 the	 partial	 block	 of	 CCL21	 binding	 to	
immature	DCs	in	the	presence	of	soluble	polysialic	acid	(Fig.	3	C).	In	fact,	binding	of	
CCL21	to	heparan	sulfate	moiety	on	the	cell	surface	has	already	been	reported	32,	
thus	 revealing	 a	 third	 possible	 capture	moiety	 for	 CCL21	 that	 could	 explain	 our	
observations.	
Binding	of	CCL21	to	the	cell	surface	of	murine	DCs	was	shown	to	trigger	antigen‐
independent	 tethers	of	T	cells	 in	an	LFA‐1	dependent	 fashion	 thereby	 increasing	
the	 scanning	 behavior	 of	 T	 cells	 towards	 rare	 antigen	 12.	 In	 this	 study	 we	
specifically	 focused	 on	 the	 effect	 of	 CCL21	 on	 the	 LFA‐1	 expressed	 on	 moDCs,	
revealing	a	potential	role	of	LFA‐1	in	human	DC	adhesion	and	migration.		
A	reactivation	stimulus	specific	for	LFA‐1	on	DCs,	such	as	the	chemokines	CXCL8,	
CXCL12	or	CCL21	described	for	other	leukocytes	33;	34,	had	not	been	identified	yet.	
Our	 results	 demonstrate	 for	 the	 first	 time	 that	 CCL21	 specifically	 restores	 the	
active	LFA‐1	conformation	on	both	immature	and	mature	moDCs,	as	recognized	by	
the	reporter	antibody	NKI‐L16	(Fig.	4).	Our	results	support	and	further	extend	the	
findings	by	Quast	and	colleagues	who	reported	 that	CCL19,	 induces	a	general	β2	
integrin	activation	epitope	on	mature	human	moDCs	24.	The	mode	of	activation	of	
β2	 integrins	 by	 chemokines	 is	 not	 completely	 understood,	 however	 it	 includes	
several	 intracellular	proteins	 that	directly	and	 indirectly	bind	the	β2	cytoplasmic	
tail	34‐40.		Among	those,	the	guanine‐exchange	factor	cytohesin‐1	has	been	shown	to	
play	an	essential	role	in	the	induction	of	CCL19‐dependent	conformational	changes	
of	 the	 β2	 subunit	 in	 mature	 moDCs	 24.	 However,	 since	 cytohesin‐1	 expression	
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levels	on	immature	moDCs	are	very	low,	a	role	in	the	CCL21‐dependent	activation	
of	 LFA‐1	 needs	 further	 investigation.	 Differences	 between	 CCL19	 and	 CCL21	
signalling	 pathways	 41	 as	 well	 as	 the	 existence	 of	 a	 cytohesin‐1	 independent	
integrin	regulation	could	also	be	responsible	for	LFA‐1	reactivation	in	moDCs.		
Optimal	 activation	 of	 integrins	 by	 chemokines	 in	 lymphocytes	 is	 facilitated	 by	
externally	 applied	 forces	 such	 as	 shear	 stress	 42.	We	 observed	 that	moDCs	were	
able	 to	 bind	 to	 ICAM‐1	 in	 a	 LFA‐1	 dependent	manner	 and	 significantly	 stronger	
when	CCL21	was	co‐immobilized	with	ICAM‐1	at	low	shear	stress	(Fig.	5B‐C).	Since	
low	shear	forces	prevail	in	the	lymphatics	and	lymph	nodes	27;	28,	it	is	tempting	to	
speculate	 that	 affinity	 upregulation	 of	 LFA‐1	 by	 CCL21	might	 be	 relevant	 for	DC	
trafficking	towards	and	perhaps	within	the	lymph	nodes.		
Our	 data	 provide	 a	 link	 between	 CCL21	 and	 LFA‐1	 adhesion	 strengthening	 that	
could	at	least	partially	explain	the	importance	of	CCL21	during	DC	translymphatic	
migration.	 This	 idea	 is	 further	 supported	 by	 the	 observation	 that	 activated	
lymphatic	endothelial	 cells	express	a	similar	 repertoire	of	adhesion	molecules	as	
vascular	 endothelial	 cells,	 where	 the	 arrest	 of	 leukocytes	 is	 mediated	 by	 the	
integrins	 VLA‐4	 and	 LFA‐1	 9.	 In	 fact,	 blocking	 of	 ICAM‐1	 and	 VCAM‐1	 13,	 or	
knocking‐down	ICAM‐1	43	impairs	DC	trafficking	to	the	lymph	nodes.	However,	the	
contribution	 of	 integrins	 in	 DC	 (trans‐)	migration	 remains	 controversial	 since	 it	
was	 shown	 that	 a	 knock‐down	 of	 all	 integrins	 in	 murine	 DCs	 did	 not	 impair	
migration	 of	 DCs	 from	 the	 periphery	 to	 the	 secondary	 lymphoid	 organs	 44.	
Nevertheless,	 Quast	 et	 al	 have	 shown	 that	 although	 phenotypically	 similar,	
migration	of	integrin‐null	and	integrin	bearing	murine	DCs	within	the	interstitium	
is	molecularly	distinct	24.	While	integrin	bearing	DCs	require	cytohesin‐1	and	RhoA	
signaling,	 integrin‐null	 DCs	 use	 a	 cytohesin‐1	 independent,	 RhoA	 dependent	
signalling	 pathway	 for	 migration.	 Therefore	 integrins	 should	 not	 be	 per	 se	
considered	as	force	transducers	for	 leukocyte	migration	but	rather	as	specifically	
inducible	anchors	that	play	a	crucial	role	during	cell‐cell	interactions.		
Within	 the	 lymph	nodes	CCL21	 is	highly	 expressed	by	 stromal	 cells	 in	 the	T	 cell	
zone	guiding	DCs	via	the	paracortex	to	the	areas	surrounding	the	high	endothelial	
venules	45.	MoDCs	restored	high	affinity	LFA‐1	after	migration	to	the	lymph	nodes	
(Fig	 2C),	 suggesting	 a	 role	 for	 CCL21	 in	 this	 process.	 Interestingly,	 lymph	 node	
resident	 human	DCs	 also	 express	 endogenous	 CCL21	 on	 the	 cell	 surface,	 further	
highlighting	the	relevance	of	our	study	in	the	in	vivo	situation.	
Taken	together,	our	results	strongly	support	the	notion	that	LFA‐1	on	DCs	plays	an	
important	 role	 during	 the	 DC	 lifecycle,	 most	 likely	 in	 events	 where	 CCL21	 is	
involved,	 such	as	adhesion	during	homing	 to	 the	 lymph	nodes	or	during	 cell‐cell	
interactions	between	migrated	DCs	and	lymph	node	resident	leukocytes.		
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Abstract	
	
Immune	responses	require	spatial	and	temporal	coordinated	interactions	between	
different	 cell	 types	 within	 distinct	 microenvironments.	 This	 dynamic	 interplay	
depends	 on	 the	 competency	 of	 the	 involved	 cells,	 predominantly	 leukocytes,	 to	
actively	migrate	 to	defined	 sites	of	 cellular	 encounters	 in	 various	 tissues.	Due	 to	
their	 unique	 capacity	 to	 transport	 antigen	 from	 the	 periphery	 to	 secondary	
lymphoid	tissues	for	the	activation	of	naïve	T‐cells,	dendritic	cells	(DCs)	play	a	key	
role	 in	the	 initiation	and	orchestration	of	adaptive	immune	responses.	Therefore,	
pathogen‐mediated	 interference	 with	 this	 process	 is	 a	 very	 effective	 way	 of	
immune‐evasion.	 CYTIP	 (cytohesin‐interacting	 protein)	 is	 a	 key	 regulator	 of	 DC	
motility.	 It	 has	 previously	 been	 described	 to	 control	 LFA‐1	 deactivation	 and	 to	
regulate	 DC	 adherence.	 CYTIP	 expression	 is	 upregulated	 during	 DC	 maturation,	
enabling	their	transition	from	the	sessile	to	the	motile	state.	Here,	we	demonstrate	
that	 upon	 infection	 of	 human	 monocyte‐derived	 DCs	 with	 herpes	 simplex	 virus	
type	1	(HSV‐1),	CYTIP	is	rapidly	degraded	and	as	a	consequence	beta‐2	integrins,	
predominantly	LFA‐1,	are	activated.	Furthermore	we	show	that	the	impairment	of	
migration	in	HSV‐1‐infected	DCs	is	in	part	due	to	this	increased	integrin‐mediated	
adhesion.	 Thus,	 we	 propose	 a	 new	 mechanism	 of	 pathogen‐interference	 with	
central	aspects	of	leukocyte	biology.	
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Introduction	
	
Rapid	migration	of	immune	cells	is	pivotal	for	the	initiation	of	innate	and	adaptive	
immune	 responses.	 Leukocytes	 circulate	 through	 the	 whole	 body,	 reaching	 and	
guarding	all	tissues.	Therefore,	the	ability	to	infiltrate	any	type	of	tissue	is	crucial	
for	 their	 function.	 The	 mechanisms	 of	 leukocyte	 migration	 are	 fundamentally	
different	from	those	of	other	cell	types1.	While	on	two‐dimensional	(2D)	surfaces	
their	 locomotion	 is	 strictly	 dependent	 on	 integrin‐mediated	 anchoring	 to	 the	
substratum,	 in	 three‐dimensional	 (3D)	 environments	 such	 as	 the	 interstitium,	
integrins	can	be	used	but	are	not	a	prerequisite2‐4.	
Dendritic	 cells	 (DCs)	 are	 prototypic	 examples	 of	 leukocytes	 migrating	 through	
miscellaneous	3D	environments	in	an	adhesion‐independent	manner5.	Due	to	their	
surpassing	qualification	 to	acquire,	process	and	present	antigens,	DCs	play	a	key	
role	in	the	initiation	and	orchestration	of	immune	responses.	This	ability	depends	
on	 the	 dynamic	 interaction	 with	 other	 immune	 cells,	 primarily	 T‐cells,	 in	
secondary	 lymphatic	 organs	 and	 tissues.	 Upon	 activation	 by	 danger	 signals	 of	
pathogenic	 origin	 and	 pro‐inflammatory	 cytokines,	 DCs	 mature,	 become	 motile	
and	start	 to	migrate	chemotactically	 to	draining	 lymph	nodes.	Rather	 than	solely	
following	preformed	tracks	formed	by	integrin	ligands	which	would	restrict	their	
mobility,	DCs	are	able	to	flexibly	adapt	their	migration	from	integrin‐dependent	to	
integrin‐independent	 modes1.	 This	 plasticity	 allows	 them	 to	 directly	 follow	
chemokine	gradients,	making	their	locomotion	fast	and	versatile5.		
However,	 although	 adhesion	 is	 not	 required	 for	 leukocyte	 migration	 in	 3D,	 a	
surplus	 restrains	 their	 locomotion.	 Strong	 activation	 of	 adhesion	 receptors	
immobilizes	 leukocytes,	 causing	 adhesive	 arrest6.	 Therefore,	 integrin‐mediated	
adhesion	 can	 be	 a	 determinant	 of	 leukocyte	 mobility	 and	 has	 to	 be	 tightly	
controlled.	 The	 individual	 integrin	 repertoire	 of	 a	 given	 cell	 determines	 its	
behavior	 in	 different	 microenvironments7.	 Integrins	 of	 the	 beta‐2	 (β2)	 family,	
consisting	of	 the	β	 subunit	CD18	 that	 combines	with	 the	4	 different	α	 chains	αL	
(CD11a),	 αM	 (CD11b),	 αX	 (CD11c),	 and	 αD	 (CD11d),	 are	 found	 exclusively	 on	
leukocytes7	 where	 they	 play	 crucial	 roles	 in	 the	 attachment	 to	 endothelia,	
diapedesis	and	T‐cell	effector	functions8.	The	integrin	αLβ2	(CD11a/CD18	or	LFA‐
1)	is	expressed	constitutively	on	all	leukocytes,	whereas	all	other	β2	integrins	are	
restricted	to	various	subsets.	
Importantly,	 integrins	are	not	 constitutively	 active7;	 instead,	 their	 ligand	binding	
capacity	is	regulated	by	integration	of	intra‐	and	extracellular	signals	through	so‐
called	 inside‐out	 signaling9.	 Cytohesin‐1	 is	 expressed	 mainly	 in	 hematopoietic	
cells10	 and	 was	 shown	 to	 be	 an	 intracellular	 interaction‐partner	 of	 CD1811.	 The	
binding	 of	 cytohesin‐1	 to	 the	 intracellular	 tail	 of	 CD18	 results	 in	 increased	 β2	
integrin	 affinity10‐13.	 This	 cytohesin‐1‐mediated	 LFA‐1	 activation	 is	 regulated	 by	
the	cytohesin‐interacting	protein	(CYTIP),	which	is	exclusively	expressed	in	cells	of	
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the	 hematopoietic	 lineage	 and	 is	 upregulated	 during	 DC	 maturation14.	 CYTIP	 is	
recruited	 to	 the	 cell	 cortex	 by	 integrin	 signaling	 and	 interacts	 with	 cytohesin‐1.	
Subsequently,	the	complex	translocates	from	the	plasmamembrane	to	the	cytosol,	
thereby	 interrupting	 the	activation	of	LFA‐114.	Recently	 it	was	shown	that	CYTIP	
regulates	leukocyte	trafficking15	and	the	adherence	of	DCs	to	fibronectin16	as	well	
as	T‐cell	detachment	and	T‐cell	priming16;	17.		
Herpes	 simplex	 virus	 type	 1	 (HSV‐1)	 is	 the	 prototypic	member	 of	 the	 large	 and	
diverse	 family	 of	 herpesviridae,	 including	 several	 human	 pathogens18.	 HSV‐1‐
infections	 affect	 the	 majority	 of	 the	 adult	 population	 worldwide	 and	 are	
responsible	for	a	variety	of	diseases,	ranging	from	mild	localized	infections	to	life‐
threatening	 variants	 in	 newborns	 or	 immune‐compromised	 individuals19.	
Moreover,	HSV	infections	are	related	to	HIV	transmission,	and	co‐infected	patients	
have	 a	 higher	 plasma	 viral	 load.	 Thus,	 understanding	 the	 viral	 immune‐evasion	
mechanisms	 is	 of	 great	 importance	 for	 the	 development	 of	 new	 therapies.	 Since	
DCs	 are	 the	 most	 important	 stimulators	 of	 antiviral	 immune	 responses	 by	
activating	 cytotoxic	 T	 lymphocytes,	 HSV‐1	 has	 evolved	 multiple	 strategies	 to	
inhibit	normal	DC	function20.		
In	 the	present	 study	we	provide	 evidence	 that	 by	 rapid	degradation	 of	 CYTIP	 in	
DCs,	 HSV‐1	 activates	 β2	 integrins,	 predominantly	 LFA‐1,	 thereby	 enhancing	
integrin‐mediated	adhesion	and	impeding	DC	migration.	This	hijacking	of	the	CD18	
activation	pathway	interferes	with	central	aspects	of	DC	biology	such	as	homing	to	
the	T‐cell	areas	of	lymph	nodes	and	T‐cell	priming.	Therefore,	our	findings	suggest	
a	novel	mechanism	of	viral	immune‐escape	strategies	
	
Materials	and	methods	
	
Antibodies	
The	following	monoclonal	antibodies	against	the	human	antigens	were	used:	
CD83,	CD86,	HLA‐DR,	CCR7,	CD11a,	CD11b,	CD18	(BD	Biosciences,	Franklin	Lakes,	USA);	rat	
anti‐CYTIP	 clone	 2F9	 and	 rat	 anti‐cytohesin‐1	 clone	 7H2	 (kind	 gift	 from	 E.	 Kremmer,	
Helmholtz	 Center	 Munich,	 Germany);	 anti‐activated	 CD11/CD18	 clone	 mAB24	 (Hycult	
Biotech,	Uden,	Netherlands);	 anti‐activated	CD11b	 clone	CBRM1/5	 (Biologend,	 San	Diego,	
USA);	 anti‐β‐actin	 (Sigma‐Aldrich,	 Deisenhofen,	 Germany);	 blocking	 antibodies	 against	
integrin	αL	(NKI‐L15)	and	αM	(Bear‐1)	were	supplied	by	C.G.	Figdor;	β2	integrin	activating	
KIM185	 (kindly	 provided	 by	M.	 Robinson,	 Celltech,	 Slough,	 UK);	 HRP‐conjugated	 anti‐rat,	
anti‐mouse	 and	 anti‐rabbit	 antibodies	 (Cell	 Signaling	 Technology,	 Danvers,	 USA);	 isotype	
controls	and	PE‐labeled	secondary	antibodies	(BD).	
	
Viruses	
HSV‐1	strain	17+	 (HSV‐1)	was	 the	wild‐type	 laboratory	strain	used,	 from	which	 the	strain	
HSV‐1/17+/CMV‐EGFP/UL43	 (HSV‐1	 EGFP),	 the	 ICP0	 deletion	 mutant	 dl1403	 (HSV‐1	
ΔICP0)	and	the	vhs	deletion	mutant	pR20.5/vhs	(HSV‐1	Δvhs)	were	derived.	UV‐inactivated	
virus	(HSV‐1	UV)	was	generated	by	irradiation	of	HSV‐1	virions	with	UV	light	(1.200	J	cm‐2).	
Virus	 stocks	were	 prepared	 and	virus‐titer	was	 determined	 as	 previously	described21.	 All	
strains	were	obtained	from	BioVex	Ltd.,	Oxford,	United	Kingdom.	
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Generation	of	dendritic	cells	
DCs	were	generated	as	described	previously22.	
	
HSV‐1‐infection	of	dendritic	cells	
Mature	DCs	were	harvested	and	adjusted	to	a	concentration	of	107	cells/mL	in	RPMI1640	
(Lonza,	 Basel,	 Switzerland)	 supplemented	 with	 20	 mM	 HEPES	 (Lonza).	 Virus	 was	 added	
with	 a	 multiplicity	 of	 infection	 (MOI)	 of	 1	 for	 1	 hour	 at	 37°C.	 Subsequently,	 DCs	 were	
cultured	 in	 DC	 medium	 until	 further	 used.	 Where	 indicated,	 DMSO	 (Sigma)	 or	 MG‐132	
(Merck,	 Darmstadt,	 Germany)	 was	 added	 for	 the	 rest	 of	 the	 culture	 time.	 MnCl2,	 EDTA	
(Sigma)	 or	 blocking/activating	 antibodies	 (20	 µg/mL)	were	 added	 at	 the	 indicated	 time‐
points	postinfection	in	the	respective	experiments.	
Expression	analysis	using	Affymetrix	gene	chips	
See	supplemental	methods.	
	
Flow	cytometry	analyses	
See	supplemental	methods.	
	
Western	blot	analyses	
See	supplemental	methods.	
	
Fibronectin‐adhesion	assays	
96‐well	maxisorb	plates	(Nunc)	were	coated	with	20	µg/mL	fibronectin	(Sigma)	 in	PBS	at	
4°C	 over‐night	 and	 blocked	 with	 0.01%	 gelatine	 (Sigma)	 in	 PBS	 for	 2	 hours	 at	 room‐
temperature.	DCs	were	harvested	at	 the	 respective	 time‐points	postinfection,	washed	and	
adjusted	to	4x105	cells/mL	in	RPMI	1640.	Subsequently,	wells	were	washed	and	100	µl	of	
the	 DC	 suspension	 was	 added.	 Cells	 were	 allowed	 to	 adhere	 for	 45	 min	 at	 37°C.	 After	
adhesion,	 wells	 were	 washed	 and	 the	 number	 of	 adherent	 cells	 was	 determined	 by	
measuring	β‐glucuronidase	activity	as	described	previously22.	
	
ICAM‐adhesion	assay	
96‐well	 maxisorb	 plates	 were	 coated	 with	 4	 µg/mL	 goat	 anti‐human	 IgG,	 Fc	 specific	
(Jackson	ImmunoResearch,	Suffolk,	UK)	in	PBS	over	night.	Wells	were	blocked	with	1%	BSA	
in	PBS	for	30	min	at	37°C.	After	washing,	100	µl	of	500	ng/mL	ICAM‐1‐Fc	in	PBS	was	added	
for	1	hour	at	37°C.	Adherence	and	quantification	of	DCs	was	performed	as	described	for	the	
fibronectin‐adhesion	assay.	
	
siRNA	transfections	
See	supplemental	methods23.	
	
Transwell	migration	assays	
See	supplemental	methods.	
3D	migration	assay	
DCs	 were	 embedded	 into	 a	 collagen	 matrix	 (PureCol®,	 Inamed	 BioMaterials;	 final	
concentration	 1.7mg/mL;	 0.45x106	 cells/mL)	 which	 remained	 uncoated,	 or	 contained	
fibronectin	 (Roche,	 final	 concentration	 20	 µg/mL)	 or	 Dynabeads®	 Protein	 G	 (Invitrogen,	
Karlsruhe,	 Germany;	 final	 concentration	 in	matrix	 75	 µg/mL)	 coated	with	 ICAM‐1	 Fc	 (20	
µg/mL)	in	custom‐made	migration	chambers.	Polymerized	gels	were	overlaid	with	medium	
containing	 2	 µg/mL	 CCL19	 (R&D	 Systems,	 Minneapolis,	 USA).	 Migration	 of	 DCs	 was	
recorded	 by	 bright‐field	 time‐lapse	 videomicroscopy	 at	 37°C	 using	 inverted	 DM	 IL	
microscopes	 (Leica	 Microsystems,	 Wetzlar,	 Germany)	 fitted	 with	 10x/0.22	 HI	 PLAN	
objectives	and	STC‐405	cameras	(Sentech,	Carrollton,	USA),	beginning	90	min	postinfection.	
Cells	were	imaged	at	a	frame	rate	of	2	min	up	to	180	frames,	controlled	by	custom‐written	
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software.	 Computer‐assisted	 cell	 tracking	 was	 performed	 as	 described	 previously24	 with	
custom‐written	 software.	 The	 average	 speed	 was	 calculated	 as	 the	 step	 length/min	
including	non‐moving	periods	of	30	randomly	selected	cells	in	every	single	experiment.	
	
T‐cell‐adhesion	assay	
See	supplemental	methods.	
	
Statistical	analysis	
Data	were	analyzed	using	 two‐tailed	Student’s	 t	 test	 and	ANOVA	with	 the	 Instat	 software	
(Graphpad,	San	Diego,	USA).	Differences	were	considered	as	significant	at	P	values	less	than	
.05.	Asterisks	depict	P	values	in	the	figures.	***	indicates	P	≤	.001;	**	P	≤	.01;	*	P	≤	.05;	and	
ns,	not	significant.	
	
Results	
	
HSV‐1‐infection	 of	 mature	 DCs	 leads	 to	 increased	 integrin‐mediated	
adhesion	to	fibronectin.	
Previously,	we	have	demonstrated	 that	 the	 chemotaxis	 of	HSV‐1‐infected	human	
monocyte‐derived	 DCs	 towards	 CCL19	 is	 drastically	 reduced22.	 Since	 increased	
adhesion	 leads	 to	 adhesive	 arrest	 and	 thereby	 impairs	 leukocyte	 migration,	 we	
addressed	the	question	whether	HSV‐1‐infection	of	DCs	alters	their	adherence	 to	
proteins	 of	 the	 extracellular	matrix	 (ECM).	We	 chose	 fibronectin	 as	 a	 prototype	
ligand	for	numerous	cell	adhesion	molecules	with	wide	distribution	in	vertebrate	
tissues25.	
To	 determine	 the	 efficiency	 of	 infection,	 mature	 DCs	 were	 infected	 with	 HSV‐1	
virions	 expressing	 EGFP	 and	 analyzed	 by	 fluorescence‐activated	 cell	 sorting	
(FACS)	at	the	indicated	time‐points.	As	shown	in	supplementary	figure	S1,	DCs	are	
efficiently	infected	even	at	early	time‐points.	
In	 order	 to	 investigate	 the	effect	 of	HSV‐1‐infection	on	 their	 adhesion,	DCs	were	
either	 infected	with	HSV‐1	wildtype	virions,	UV‐inactivated	HSV‐1	virus	particles	
or	treated	with	equivalent	amounts	of	virus	dilution	buffer	(mock).	UV‐inactivated	
virus	particles	are	 taken	up	 into	the	cell,	but	expression	of	viral	genes	 is	averted	
(as	assayed	by	FACS	 for	GFP	expression,	data	not	 shown).	At	 the	 indicated	 time‐
points	postinfection,	fibronectin‐adhesion	assays	were	performed	(figure	1A).	Two	
hours	postinfection	 there	was	no	difference	 in	adherence	 to	 fibronectin	between	
all	three	conditions	detectable,	whereas	at	all	later	time‐points	the	HSV‐1‐infected	
DCs	showed	a	significant	increase	in	their	adhesion	compared	to	mock‐infected	as	
well	as	to	HSV‐1	UV‐infected	DCs.	
As	 a	 tool	 to	 investigate	 whether	 this	 augmented	 adherence	 is	 due	 to	 integrin‐
mediated	 binding	 to	 fibronectin,	 manganese	 (Mn2+)	 or	 EDTA	 were	 added,	
respectively	(figure	1B).	Mn2+	is	a	potent	stimulator	of	β1	and	β2	integrin	affinity	
maturation26,	 whereas	 EDTA	 blocks	 binding	 of	 integrins	 to	 their	 ligands	 by	
chelation	of	divalent	cations.	While	 the	addition	of	Mn2+	 to	HSV‐1‐infected	DCs	4	
hours	 postinfection	 had	 no	 effect,	 EDTA	 was	 able	 to	 completely	 abolish	 the	
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adhesion	(figure	1B).	To	ensure	that	the	adhesion	to	fibronectin	is	specific	and	not	
due	 to	 a	 general	 increase	 in	 adhesiveness,	we	 allowed	DCs	 to	 adhere	 to	 gelatin‐
coated	wells	as	a	control.	Quantification	of	adherent	cells	revealed	that	adhesion	of	
infected	 DCs	 to	 gelatin	 is	 not	 strengthened	 (figure	 1B).	 These	 data	 demonstrate	
that	HSV‐1	gene	products	actively	influence	the	adhesion	of	DCs	to	ECM	proteins,	
and	 that	 the	 increase	 in	 fibronectin‐adherence	 is	 specific	 and	 mediated	 by	
integrins.		
	
The	expression	profile	of	CYTIP	in	mature	DCs	is	strongly	reduced	by	HSV‐1‐
infection.	
Recently,	 it	 has	 been	 shown	 that	 the	 cytohesin‐interacting	 protein	 (CYTIP)		
regulates	 the	 adhesion	 of	 DCs	 to	 fibronectin,	 and	 that	 the	 loss	 of	 fibronectin‐
adherence	 of	 mature	 DCs	 depends	 on	 increased	 CYTIP	 expression16.	 To	 obtain	
initial	 information	 regarding	 the	 consequences	of	HSV‐1‐infection	of	mature	DCs	
on	 their	 gene	 expression,	 Affymetrix	 gene‐chip	 analyses	were	 performed	 (figure	
2A).	At	 the	 indicated	 time‐points,	 total	RNA	was	extracted	 from	HSV‐1	EGFP	and	
mock‐infected	 DCs	 and	 profiled	 on	 Affymetrix	 Human	 Genome	 U133A	 arrays.	
Interestingly,	 CYTIP‐specific	mRNA	was	 amongst	 the	most	 prominently	 reduced	
mRNA	species	in	HSV‐1‐infected	DCs.	As	early	as	8	hours	postinfection,	a	dramatic	
reduction	of	CYTIP	mRNA	could	be	observed	(figure	2A,	upper	panel)	as	compared	
to	the	mRNA	expression	level	in	uninfected	DCs.	Other	expression	profiles,	such	as	
the	mRNA	 levels	 of	 GAPDH,	were	 not	 significantly	 influenced	 by	HSV‐1‐infection	
and	remained	almost	constant	both	 in	HSV‐1‐	and	mock‐infected	cells	 (figure	2A,	
lower	 panel).	 Thus,	 CYTIP	 expression	 is	 specifically	 downregulated	 in	 HSV‐1‐
infected	DCs.	
	
Infection	of	mature	DCs	with	HSV‐1	leads	to	rapid	downregulation	of	CYTIP.	
To	evaluate	 the	 information	obtained	 from	the	gene	profiling	analysis,	we	 tested	
whether	 CYTIP	 protein	 levels	 are	 affected	 by	 HSV‐1‐infection.	 From	 previous	
studies	 it	 is	well	 established	 that	 CYTIP	 indirectly	 regulates	 the	 adhesiveness	 of	
lymphocytes	by	translocating	the	β2	integrin‐binding	protein	cytohesin‐1	from	the	
membrane	 to	 the	 cytosol14.	When	 located	 at	 the	 plasma‐membrane,	 cytohesin‐1	
interacts	with	 the	 cytoplasmic	 domain	 of	 CD18,	 thereby	 activating	 LFA‐110;	 11;	 13.	
Because	 of	 the	 importance	 of	 cytohesin‐1	 for	 the	 induction	 of	 β2‐mediated	
adhesion,	 we	 also	 examined	 its	 expression	 by	 Western	 blot	 analysis.	 Figure	 2B	
shows	 CYTIP‐,	 cytohesin‐1‐	 and	 β‐actin‐specific	 immunoblots	 of	 HSV‐1‐infected	
and	mock‐infected	DCs.	CYTIP	was	rapidly	reduced	during	the	course	of	infection,	
whereas	cytohesin‐1	expression	was	only	slightly	diminished	at	later	time‐points.	
β‐actin	protein	 levels	 served	as	 loading	 control.	 Interestingly,	HSV‐1	 leads	 to	 the	
formation	of	bands	with	altered	migration	in	SDS‐PAGE	(indicated	by	small	arrows	
in	 figure	 2B	 and	 also	 in	 figure	 3B).	 Those	 additional	 bands	 might	 represent	
phosphorylated	and/or	ubiquitinated	forms	of	CYTIP.	
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To	precisely	quantify	the	loss	of	CYTIP,	we	performed	intracellular	FACS	staining	
in	mock‐infected,	HSV‐1	UV‐infected	and	HSV‐1‐infected	DCs	(figure	2C).	As	early	
as	4	hours	postinfection,	HSV‐1‐infected	DCs	already	 showed	a	highly	 significant	
reduction	of	CYTIP	 expression	 as	 compared	both	 to	HSV‐1	UV‐	 as	well	 as	mock‐
infected	DCs.	8	hours	postinfection	and	at	later	time‐points,	CYTIP	was	detectable	
only	 in	 a	 small	 proportion	 of	 infected	 DCs.	 These	 data	 demonstrate	 that	 HSV‐1	
infection	of	mature	DCs	leads	to	a	fast	and	complete	reduction	of	CYTIP,	but	not	of	
cytohesin‐1.		
	 	
	
Figure	 1.	 Dendritic	 cells	
infected	 with	 herpes	 simplex	
virus	 type	 1	 adhere	 to	
fibronectin	and	downregulate	
CYTIP	 expression.	 (A)	
Quantification	 of	 adherent	
cells	 shows	 that	as	 early	as	4	
hours	 postinfection,	 HSV‐1	
strongly	 increases	 the	
fibronectin‐adherence	 of	
infected	DCs.	Mature	DCs	were	
mock‐infected	 (white	
columns)	or	 infected	with	UV‐
inactivated	 virus	 (grey	
columns)	 or	 HSV‐1	 (black	
columns)	at	a	MOI	of	1.	At	the	
indicated	 time‐points	
postinfection	 (pi),	 cells	 were	
allowed	 to	 adhere	 to	
fibronectin‐coated	 96‐well	
plates.	 Adherence	 was	
quantified	 by	 measuring	 β‐
glucuronidase	 activity	 of	
adherent	 cells.	 	 (B)	
Fibronectin‐adhesion	 of	 HSV‐
1‐infected	 DCs	 (MOI	 1)	 is	
mediated	 by	 integrins	 and	 is	
specific	 for	 fibronectin.	 4	
hours	postinfection,	DCs	were	
treated	with	1	mM	Mn2+	or	5	
mM	EDTA	and	were	allowed	to	adhere	to	fibronectin‐coated	(black	columns)	or	gelatin‐coated	
(grey	 columns)	 96‐wells.	 Adherence	was	 quantified	 by	measuring	 β‐glucuronidase	 activity.	
Mn2+	has	no	significant	effect	on	the	adhesion	of	infected	DCs,	whereas	EDTA	completely	blocks	
adhesion.	Neither	mock‐infected	nor	HSV‐1‐infected	DCs	adhere	to	gelatin.	Error	bars	indicate	
±	 SD.	 ***P<.001,	 ns	 indicates	 not	 significant.	 Experiments	 were	 repeated	 at	 least	 3	 times	
independently.		Each	single	experiment	was	performed	in	quadruplicate.		
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Figure	2.	CYTIP	 is	rapidly	
downregulated	 in	 HSV‐1‐
infected	 DCs.	 	 (A)	 Total	
mRNA	 was	 isolated	 from	
HSV‐1	 EGFP‐infected	 (MOI	
of	 1,	 black	 columns)	 and	
mock‐infected	 (white	
columns)	 DCs	 at	 the	
indicated	 time‐points.	 The	
RNA	 was	 labeled	 and	
hybridized	 to	 Affymetrix	
Human	 Genome	 U133A	
arrays.	 The	 expression	
profile	 of	 CYTIP	 (top	
graph)	 shows	 a	 dramatic	
downregulation	 8	 and	
24	hours	 postinfection	
compared	 to	 mock‐
infected	 cells.	 The	
expression	 profile	 of	
GAPDH	 (bottom	 graph)	 is	
shown	 as	 control;	 no	
significant	 influence	 on	
gene	 expression	 could	 be	
observed.	 (B)	 DCs	 were	
mock‐infected	 or	 infected	
with	HSV‐1	 at	 a	MOI	 of	 1	
and	 harvested	 at	 the	
indicated	 time‐points	
postinfection	 (pi).	Western	
blot	 analyses	 with	
antibodies	 against	 CYTIP	
(top	 panel),	 cytohesin‐1	
(middle	panel)	and	β‐actin	
as	loading	control	(bottom	
panel)	 show	 that	 CYTIP	 is	
rapidly	 downregulated	 in	
HSV‐1‐infected	 DCs,	
whereas	 cytohesin‐1	 is	
only	 slightly	 influenced	 by	
infection.	 Small	 arrows	
indicate	the	appearance	of	
additional	 CYTIP	 bands	
with	 higher	 molecular	
masses.	 (C)	 Exact	
quantification	 of	 CYTIP	
expression	 in	 mock‐
infected	 DCs	 (white	
columns),	 cells	 treated	
with	UV‐inactivated	HSV‐1	 virions	 (grey	 columns)	 and	HSV‐1‐infected	DCs	 (MOI	 of	 1,	 black	
columns)	 by	 intracellular	 flow	 cytometry	 illustrates	 that	 CYTIP	 is	 downregulated	with	 fast	
kinetics	 only	 after	 infection	with	HSV‐1.	Error	 bars	 indicate	 ±	 SD.	 ***P<.001,	 **P<.01.	Gene	
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profiling	by	Affymetrix	analysis	(A)	was	performed	once.	Experiments	B	and	C	were	repeated	
at	least	3	times	independently.	In	B,	one	representative	experiment	is	shown.	
CYTIP	is	degraded	via	the	proteasome.	
Considering	the	early	onset	of	CYTIP	reduction	on	protein	and	mRNA	levels	after	
HSV‐1‐infection,	this	effect	is	most	likely	mediated	either	by	immediate‐early	viral	
gene	products	or	by	 tegument	components	which	are	delivered	directly	with	 the	
infection	into	the	cell.	The	virion	host	shutoff	protein	(vhs),	a	viral	mRNA‐specific	
RNase	 that	 induces	 rapid	 shutoff	 of	 host	 protein	 synthesis	 and	 degradation	 of	
cellular	 mRNAs,	 is	 contained	 in	 the	 viral	 tegument	 and	 has	 been	 postulated	 to	
contribute	to	HSV‐1	immune‐evasion27.	Therefore,	we	examined	its	effect	on	CYTIP	
using	a	vhs	deletion	mutant	virus	(HSV‐1	Δvhs).	Immunoblot	analysis	revealed	that	
even	 without	 vhs,	 CYTIP	 levels	 were	 reduced	 with	 a	 kinetic	 similar	 to	 that	 of	
wildtype	 virus	 infection	 (figure	 3A).	 In	 order	 to	 determine	 whether	 the	 loss	 of	
CYTIP	 is	 due	 to	 proteasomal	 degradation	 of	 the	 protein,	 we	 utilized	 the	
proteasome‐inhibitor	MG‐132.	Immunoblot	analyses	8	and	24	hours	postinfection	
demonstrated	 that	 treatment	 of	 HSV‐1‐infected	 DCs	 with	 10	 µM	 MG‐132	 is	
sufficient	 to	 completely	 prevent	 the	 reduction	 of	 CYTIP	 (figure	 3B).	 Notably,	
inhibition	of	the	proteasome	leads	to	enrichment	of	an	additional	band	with	higher	
molecular	weight	(marked	by	small	arrow	in	figure	3B)	both	in	mock‐	as	well	as	in	
HSV‐1‐infected	DCs,	indicating	that	this	modified	form	of	CYTIP	is	degraded	by	the	
proteasome.	 Importantly,	 its	 proportion	 is	 greater	 in	 infected	 DCs	 and	 is	 even	
detectable	 without	 proteasomal	 inhibition	 8	 hours	 postinfection,	 demonstrating	
that	 CYTIP	 degradation	 is	 increased	 after	 HSV‐1‐infection.	 In	 this	 respect	 we	
hypothesized	that	the	HSV‐1	immediate‐early	protein	ICP0	might	be	involved.	ICP0	
is	 a	 ubiquitin	 E3	 ligase	 and	 induces	 the	 proteasome‐dependent	 degradation	 of	
several	 cellular	 proteins28.	 Immunoblot	 analysis	 of	 DCs	 infected	 with	 an	 ICP0	
deletion	mutant	virus	(HSV‐1	ΔICP0)	demonstrated	that	also	this	mutant	 led	to	a	
fast	 and	 complete	 degradation	 of	 CYTIP,	 comparable	 to	 the	 kinetics	 of	wildtype‐
infection	(figure	3C).	Thus,	HSV‐1	targets	CYTIP	to	proteasomal	degradation	via	an	
unknown,	ICP0	independent	mechanism.	
	
Infection	of	mature	DCs	with	HSV‐1	induces	the	activation	of	β2	integrins.	
Due	to	the	fact	that	CYTIP	regulates	the	activation	of	β2	integrins,	we	investigated	
whether	 infected	 DCs	 show	 an	 increase	 in	 β2	 integrin	 affinity.	 Therefore	 we	
analyzed	 CD11/CD18	 affinity	 by	 FACS	 with	 the	 activation‐specific	 monoclonal	
antibody	mAB24	(figure	4A).	Two	hours	postinfection	no	difference	in	β2	integrin	
affinity	 was	 detectable	 between	 HSV‐1‐infected,	 HSV‐1	 UV‐infected	 and	 mock‐
infected	 DCs.	 As	 early	 as	 4	 hours	 postinfection,	 a	 significant	 increase	 could	 be	
observed	 only	 in	 HSV‐1‐infected	 DCs	 which	 remained	 constant	 up	 to	 24	 hours	
postinfection.	To	assess	whether	HSV‐1‐infected	DCs	also	show	increased	adhesion	
to	 typical	β2	 integrin	 ligands	and	not	only	 to	 fibronectin,	we	performed	 ICAM‐1‐
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adhesion	assays	4	hours	postinfection.	As	shown	in	figure	4B,	infected	DCs	indeed	
adhere	 significantly	 stronger	 to	 ICAM‐1	 than	 the	 mock	 control.	 Hence,	 HSV‐1	
activates	β2	integrins	on	the	DCs,	leading	to	increased	ICAM‐1‐adhesion.	
	
Figure	3.	CYTIP	is	degraded	via	
the	 proteasome,	 and	 vhs	 and	
ICP0	 do	 not	 contribute	 to	 its	
degradation.	 Western	 blot	
analyses	 were	 performed	 with	
an	 antibody	 specific	 for	 CYTIP.	
Infection	 with	 either	 a	 vhs	
deletion	mutant	virus	(A)	or	an	
ICP0	 deletion	mutant	 (C)	 leads	
to	 degradation	 of	 CYTIP	 with	
kinetics	similar	to	that	of	HSV‐1	
wildtype	 infection.	 DCs	 were	
infected	 at	 a	 MOI	 of	 1	 and	
harvested	at	the	indicated	time‐
points	 postinfection	 (pi).	 (B)	
Inhibition	of	the	proteasome	by	
the	 addition	 of	 10	 µM	MG‐132	
beginning	 1	 hour	 postinfection	
completely	 blocks	 the	 loss	 of	
CYTIP	 after	 HSV‐1‐infection.	
Notably,	 an	 additional	 band	
with	 higher	 molecular	 weight	
accumulates	 in	MG‐132	 treated	
samples.	The	enrichment	of	this	
band	 in	 HSV‐1‐infected	 DCs	 indicates	 a	 modification	 that	 is	 marked	 for	 degradation.	
Experiments	 were	 performed	 at	 least	 three	 times	 independently,	 and	 one	 representative	
experiment	is	shown.	
	
Inhibition	of	LFA‐1	activation	 in	HSV‐1‐infected	DCs	 strongly	 reduces	 their	
adhesion	to	fibronectin.	
Although	the	canonical	cellular	receptors	 for	 fibronectin	are	β1	and	β3	 integrins,	
β2	integrins	have	been	described	to	bind	fibronectin	as	well29‐31.	It	has	been	shown	
that	αMβ2	(CD11b/CD18	or	Mac‐1)	binding	promiscuity	accounts	to	a	large	extend	
for	this	binding32.	To	investigate	in	more	detail	which	β2	integrins	are	responsible	
for	 the	 increase	 of	 fibronectin‐adhesion	 after	 HSV‐1‐infection,	 we	 analyzed	 the	
expression	of	CD11a,	CD11b,	and	CD18	by	FACS.	The	surface	expression	of	 those	
integrins	was	only	marginally	altered	by	HSV‐1‐infection	and	remained	at	constant	
high	levels	of	more	than	90%	positive	cells	up	to	24	hours	postinfection	(data	not	
shown).	Using	a	CD11b	activation‐specific	antibody,	we	assayed	Mac‐1	activation	
by	FACS.	 Importantly,	although	4	hours	postinfection	HSV‐1‐infected	DCs	already	
strongly	 adhere	 to	 fibronectin	 (figure	 1A),	 at	 this	 time‐point	 Mac‐1	 is	 not	
significantly	activated	as	 compared	 to	mock‐infected	DCs	 (figure	5A).	During	 the	
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course	 of	 infection	 CD11b	 activity	 increases,	 reaching	 a	 maximum	 24	 hours	
postinfection.	
In	order	to	further	assess	the	specific	relevance	of	LFA‐1	and	Mac‐1,	we	performed	
fibronectin‐adhesion	 assays	 with	 the	 β2	 activating	 antibody	 KIM185,	 the	 LFA‐1	
blocking	 antibody	 NKI‐L15	 and	 the	Mac‐1	 blocking	 antibody	 Bear‐1.	 Four	 hours	
postinfection,	 the	 respective	 antibodies	 were	 added	 at	 a	 concentration	 of	 20	
µg/mL	(figure	5B).	The	activation	of	β2	 integrins	 in	mock‐infected	DCs	 increased	
their	 adhesion	 to	 levels	 comparable	 to	 HSV‐1‐infected	 DCs,	 demonstrating	 that	
indeed	 β2	 integrins	 mediate	 the	 adherence.	 Notably,	 the	 adhesion	 of	 HSV‐1‐
infected	DCs	 could	not	 be	 further	 increased	by	 the	 addition	 of	KIM185,	 showing	
that	 in	this	case	β2	integrins	are	already	active.	Most	 important,	the	inhibition	of	
Mac‐1	 did	 not	 significantly	 decrease	 the	 fibronectin‐adhesion	 of	 infected	 DCs,	
while	blockade	of	LFA‐1	strongly	reduced	it.	Accordingly,	LFA‐1	and	not	Mac‐1	is	
primarily	 responsible	 for	 the	 augmented	 fibronectin‐adhesion	 of	 HSV‐1‐infected	
DCs.	
Figure	4:	HSV‐1‐infection	
of	 DCs	 leads	 to	 CD18	
activation	 and	 increased	
adhesion	to	ICAM‐1.	(A)	At	
the	 indicated	 time‐points	
postinfection	 (pi),	 flow	
cytometric	 analyses	 of	
mock‐infected	 DCs	 (white	
columns),	 HSV‐1	 UV‐
infected	 (grey	 columns)	
and	 HSV‐1‐infected	 DCs	
(black	 columns)	 were	
performed	 with	 the	
CD11/CD18	 activation‐
specific	 antibody	 mAB24.	
Concomitantly	with	CYTIP	
downregulation,	 β2	
integrins	 undergo	 affinity	
maturation	 in	 HSV‐1‐
infected	DCs.	Shown	is	the	
mean	 fluorescence	
intensity	 as	 calculated	 by	
substraction	 of	 isotype	
fluorescence	 from	mAB24	
fluorescence.	 (B)	 4	 hours	
postinfection,	 DCs	 were	
allowed	 to	 adhere	 to	
ICAM‐1‐Fc	 coated	 96‐
wells	 for	 45	 min.	 After	
gentle	 washing,	
adherence	was	 quantified	
by	measuring	the	β‐glucuronidase	activity	of	the	cells.	HSV‐1‐infected	cells	adhere	significantly	
stronger	 as	 compared	 to	mock‐infected	 control	 cells.	 Error	 bars	 indicate	 ±	 SD.	 ***P<.001,	
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**P<.01,	*P<.05.	Experiments	were	repeated	at	 least	3	times	 independently.	 ICAM‐1‐adhesion	
experiments	were	performed	in	quadruplicate.	
Figure	 5:	 Activated	 LFA‐1,	 not	
Mac‐1,	 determines	 the	 fibronectin‐
adhesion	of	HSV‐1‐infected	DCs.	(A)	
Flow	 cytometric	 analyses	 of	
activated	CD11b	were	performed	in	
mock‐infected	 (white	 columns),	
HSV‐1‐UV‐infected	 (grey	 columns)	
and	 HSV‐1‐infected	 (black	
columns)	DCs	at	the	indicated	time‐
points	 postinfection	 (pi).	 While	
Mac‐1	 is	only	marginally	activated	
at	 early	 time‐points	 postinfection,	
its	 activation	 increases	 at	 later	
time‐points.	 (B)	 4	 hours	
postinfection,	 fibronectin‐adhesion	
assays	 were	 performed	 using	 20	
µg/mL	 of	 the	 β2	 activatory	
antibody	 KIM185,	 the	 LFA‐1	
blocking	 antibody	 NKI‐L15	 or	 the	
Mac‐1	 blocking	 antibody	 Bear‐1,	
respectively.	 Activation	 of	 β2	
integrins	 on	 mock‐infected	 DCs	
renders	 them	 highly	 adhesive,	
while	 it	 has	 no	 effect	 on	 HSV‐1‐
infected	DCs.	Blocking	of	Mac‐1	on	
infected	 cells	 has	 no	 significant	
effect	 on	 DC’s	 adhesion	 to	
fibronectin,	 whereas	 it	 is	 strongly	
reduced	by	 the	 inhibition	of	LFA‐1.	
Error	bars	indicate	±	SD.	***P<.001,	
**P<.01,	 *P<.05,	 ns	 indicates	 not	
significant.	 The	 experiments	 were	
repeated	 at	 least	 3	 times	
independently	and	each	single	adhesion	experiment	was	performed	in	quadruplicate.	
	 	
Enhanced	 adhesion	 of	 HSV‐1‐infected	 DCs	 correlates	 with	 diminished	
locomotion.	
Our	finding	that	HSV‐1‐infection	drastically	augments	DC	adhesion	prompted	us	to	
assess	 whether	 the	 kinetic	 of	 this	 increase	 correlates	 with	 the	 previously	
described22	decrease	of	migration.	To	this	end	we	performed	transwell	migration	
assays	 with	 fibronectin‐coated	 polycarbonate	 filters	 (figure	 6A).	 While	 neither	
mock‐infection	nor	the	treatment	with	UV‐inactivated	virions	had	an	effect	on	DC	
migration,	the	infection	with	HSV‐1	rapidly	decreased	their	chemotaxis.	Two	hours	
postinfection	the	migration	of	infected	DCs	was	only	slightly	diminished.	Strikingly,	
already	 4	 hours	 postinfection	 infected	 DCs	migrated	 approximately	 50%	 less	 in	
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comparison	 to	 their	 uninfected	 counterparts,	 indicating	 that	 the	 increase	 in	
adhesion	correlates	with	the	inhibition	of	migration.	
	
Infection	with	HSV‐1	rapidly	inhibits	DC	migration	in	3D	collagen	gels.	
Since	 the	 mechanisms	 of	 DC	 migration	 on	 2D	 and	 in	 3D	 environments	 are	
fundamentally	 different3,	 live	 cell	 videomicroscopy	 in	 3D	 collagen	matrices	 was	
performed.	In	addition,	we	investigated	the	effect	of	integrin	ligands	embedded	in	
the	gels,	thereby	emulating	more	physiological	conditions.	As	readout,	we	analyzed	
the	average	speed	of	cells	and	visualized	individual	tracks	of	DCs.	
The	migration	of	mock‐infected	DCs	was	not	significantly	altered	by	addition	of	the	
integrin	 ligands	 fibronectin	 and	 ICAM‐1	 to	 the	 collagen	 gels	 (figures	 6B,	 S2).	 In	
sharp	 contrast,	 HSV‐1‐infected	 DCs	 showed	 lower	 average	 speed	 compared	 to	
mock‐infected	 DCs	 in	 all	 conditions	 (figures	 6B,	 S2	 and	 supplementary	 videos	 1	
and	2).	However,	chemotaxis	of	infected	DCs	was	significantly	more	reduced	in	the	
presence	 of	 immobilized	 integrin	 ligands,	 indicating	 that	 enhanced	 adhesion	 to	
integrin	ligands	reciprocally	correlates	with	leukocyte	migration.		
	
Silencing	of	CYTIP	increases	DC	adhesion	and	impairs	their	migration.	
In	order	to	investigate	the	direct	effect	of	CYTIP	downregulation	on	migration,	we	
silenced	CYTIP	 in	DCs	by	RNAi	and	again	performed	3D	migration	assays.	CYTIP	
knockdown	 did	 not	 interfere	 with	 normal	 DC	 maturation,	 but	 led	 to	 a	 drastic	
reduction	 of	 CYTIP	 expression	 (figure	 S3)	 and	 enhanced	 the	 adhesion	 of	 DCs	 to	
fibronectin	 (figure	 S4),	 confirming	 data	 by	 Hofer	 and	 colleagues16.	 As	 shown	 in	
figures	6C,	S5	and	supplementary	video	1,	RNAi	of	CYTIP	had	already	some	effect	
on	the	chemotaxis	in	pure	collagen	as	compared	to	DCs	electoporated	with	a	non‐
targeting	 negative	 control	 siRNA.	 However,	 a	 strong	 reduction	 of	migration	was	
observed	 in	 fibronectin‐coated	 collagen	 gels	 (figures	 6C,	 S5,	 and	 supplementary	
video	 2),	 demonstrating	 that	 enhanced	 binding	 to	 integrin	 ligands	 impairs	 DC	
migration.	 HSV‐1‐infection	 of	 CYTIP‐silenced	 DCs	 led	 to	 further	 reduction	 of	
migration	in	both	conditions	(figure	6C).	Moreover,	 the	 inhibition	of	migration	 in	
infected	CYTIP‐silenced	DCs	was	markedly	 stronger	 in	 fibronectin‐coated	gels	as	
compared	 to	 pure	 collagen,	 again	 showing	 that	 increased	 anchoring	 to	 integrin	
ligands	retards	DC	locomotion.	
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Figure	 6:	 Chemotaxis	 of	 mature	 DCs	 is	
impaired	after	HSV‐1‐infection	and	CYTIP	
knockdown.	 (A)	 Transwell	 migration	
assays	on	fibronectin‐coated	transwells	of	
mock‐infected	 (white	 columns),	 HSV‐1	
UV‐infected	 (grey	 columns)	 and	 HSV‐1‐
infected	(black	columns)	DCs	harvested	at	
the	 indicated	 time‐points	 postinfection	
show	 that	 the	 infection	 with	 HSV‐1	
dramatically	 reduces	 DC	 chemotaxis	
towards	 CCL19.	 (B)	 The	 chemotaxis	 of	
HSV‐1	 infected	 DCs	 towards	 CCL19	 in	 a	
3D‐collagen	 matrix	 or	 in	 collagen	
matrices	containing	20	µg/mL	fibronectin	
or	 75	 µg/mL	 ICAM‐1	 Fc‐coated	 beads	 is	
decreased	 as	 compared	 to	mock‐infected	
cells	 in	 all	 conditions.	 The	 presence	 of	
immobilized	 integrin	 ligands	 in	 the	 gels	
further	 reduces	 migration	 of	 HSV‐1‐
infected	 DCs	 but	 has	 no	 influence	 on	
mock‐infected	 DCs.	 (C)	 4x106	 immature	
DCs	 were	 electroporated	 with	 10	 µg	
of	 a	 non‐
targeting	 control	 siRNA	 or	 with	 10	 µg	
siRNA	 targeting	CYTIP.	Four	hours	 later,	
maturation	 cocktail	was	 added	 and	 DCs	
were	 matured	 for	 48	 hours.	 Where	
indicated,	mature	 CYTIP‐knockdown	DCs	
were	 additionally	 infected	 with	 HSV‐1.	
Subsequently,	 DCs	 were	 used	 in	 3D	
migration	assays	 in	pure	collagen	gels	or	
in	 gels	 containing	20	µg/mL	 fibronectin.	
Silencing	 of	 CYTIP	 strongly	 impairs	
migration	 of	 DCs	 in	 collagen	 gels	
containing	 fibronectin.	 The	 infection	 of	
CYTIP‐silenced	 DCs	 further	 reduces	
chemotaxis	 in	both	 conditions,	 but	has	a	
more	 prominent	 effect	 in	 fibronectin‐
coated	 gels.	 DC	 migration	 towards	 a	
CCL19	gradient	was	monitored	by	bright‐
field	 time‐lapse	 videomicroscopy	
beginning	90	min	postinfection.	Cells	were	imaged	at	a	frame	rate	of	2	min.	The	average	speed	
of	a	cell	was	calculated	as	the	step	length/min	including	non‐moving	periods	and	displayed	in	
µm/min.	Average	 speed	was	quantified	 from	30	cells	 for	each	 condition	over	180	 frames	 (B	
and	 C).	 Error	 bars	 indicate	 ±	 SD.	 ***P<.001,	 **P<.01.	One	 representative	 experiment	 out	 of	
three	is	shown.	
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LFA‐1,	not	Mac‐1,	controls	the	3D	migration	of	HSV‐1‐infected	DCs.	
To	assess	the	impact	of	LFA‐1	and	Mac‐1	on	the	reduction	of	chemotaxis	in	HSV‐1‐
infected	DCs,	we	utilized	 the	respective	blocking	antibodies	 in	 fibronectin‐coated	
(figure	7A)	and	ICAM‐1‐containing	(figure	7B)	collagen	gels.	In	both	conditions,	the	
migration	 of	mock‐infected	 DCs	was	 not	 influenced	 by	 blocking	 LFA‐1	 or	Mac‐1	
(figures	 7A	 and	 B,	 S6A	 and	 S6B).	 In	 sharp	 contrast,	 blocking	 LFA‐1	 strongly	
enhanced	the	migration	of	HSV‐1‐infected	DCs	both	in	gels	containing	fibronectin	
(figure	 7A,	 S6A)	 and	 ICAM‐1	 (figure	 7B,	 S6B).	 The	 addition	 of	 Mac‐1	 blocking	
antibodies	 had	 no	 significant	 effect	 on	 the	 average	 speed	 of	 infected	 DCs,	 again	
indicating	 that	 Mac‐1	 plays	 a	 secondary	 role	 in	 HSV‐1‐induced	 adhesion	 to	
fibronectin	 (figure	 7A)	 and	 ICAM‐1	 (figure	 7B).	 Thus,	 in	 three‐dimensional	
migration	 of	HSV‐1‐infected	DCs,	 activated	 LFA‐1	 is	 the	main	 player	 responsible	
for	the	reduced	chemotaxis.	
	
HSV‐1‐infected	DCs	show	defective	T‐cell	detachment.	
Hofer	 et	 al.  16	 described	 CYTIP	 not	 only	 to	 be	 an	 important	 modulator	 of	 DC	
adhesion	 to	 fibronectin,	 but	 also	 as	 a	 regulator	 of	 T‐cell	 detachment.	 CYTIP	
silencing	in	mature	DCs	resulted	in	prolonged	adherence	of	T‐cells	to	DCs	and	thus	
impaired	their	T‐cell	priming	capacity.	Therefore,	we	examined	the	 interaction	of	
T‐cells	with	mock‐infected	and	HSV‐1‐infected	DCs.	CFSE	stained	bulk	T‐cells	were	
allowed	to	bind	to	immobilized	DCs.	After	washing,	bound	T‐cells	were	quantified	
by	spectrophotometry.	As	shown	in	figure	S7,	HSV‐1‐infection	of	DCs	significantly	
enhanced	the	binding	of	T‐cells.	Hence,	HSV‐1	interferes	with	the	detachment	of	T‐
cells	from	infected	DCs.	
Taken	 together,	 our	 data	 demonstrate	 that	 HSV‐1	 induces	 rapid	 degradation	 of	
CYTIP	 and	 constant	 activation	 of	 LFA‐1	 in	 infected	 DCs.	 The	 resulting	 LFA‐1‐
mediated	 adhesion	 strongly	 impairs	 migration	 and	 the	 detachment	 of	 T‐cells,	
thereby	influencing	two	hallmarks	of	DC	biology.	
	
Discussion	
	
In	 the	present	 study,	we	describe	 a	 new	mechanism	of	HSV‐1	 to	 evade	 adaptive	
immune	responses	by	manipulation	of	pivotal	DC	functions.	HSV‐1	hijacks	the	LFA‐
1	 activation	 pathway	 in	 DCs	 and	 converts	 it	 to	 be	 constitutively	 active,	 thereby	
conferring	 increased	adhesiveness	 for	ECM	proteins	to	DCs.	Cells	migrating	 in	an	
amoeboid	manner,	 such	 as	 DCs3,	 normally	 form	 only	 short‐lived	 contacts	 to	 the	
substrate,	thereby	allowing	rapid	locomotion.	By	enhancing	the	adherence	of	DCs	
to	 integrin‐ligands,	 HSV‐1	 thus	 impairs	 their	 chemotaxis.	 Furthermore	we	 show	
that	 this	 aberrant	 adhesion	 also	 inhibits	 T‐cell	 detachment.	 The	 mechanism	
responsible	for	the	modulation	of	LFA‐1	affinity	has	also	been	investigated:	during	
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the	course	of	 infection	CYTIP	 is	rapidly	degraded	by	the	proteasome,	resulting	 in	
high	affinity	LFA‐1.	
	
	
Figure	 7:	 LFA‐1	 activation	 in	 HSV‐1‐
infected	 DCs	 strongly	 reduces	 their	
chemotaxis.	The	specific	 influence	of	LFA‐1	
and	 Mac‐1	 on	 the	 adhesion	 of	 HSV‐1‐
infected	DCs	was	determined	by	adding	the	
anti‐LFA‐1	 and	 anti‐Mac‐1	 blocking	
antibodies	 NKI‐L15	 and	 Bear‐1,	
respectively	 (both	 20	 µg/mL)	 in	 collagen	
matrices	 coated	 with	 fibronectin	 (A)	 or	
containing	 immobilized	 ICAM‐1	 Fc	 (B).	 In	
both	 conditions,	 the	 migration	 of	 mock‐
infected	 DCs	 was	 not	 significantly	
influenced	 neither	 by	 LFA‐1	 nor	 Mac‐1	
blocking	 antibodies.	 In	 contrast,	 the	
inhibition	 of	 LFA‐1	 significantly	 increased	
migration	of	infected	DCs,	whereas	blocking	
of	Mac‐1	had	no	effect.	Chemotaxis	towards	
a	CCL19	gradient	was	monitored	by	bright‐
field	time‐lapse	videomicroscopy	beginning	
90	min	 postinfection	 at	 a	 frame	 rate	 of	 2	
min.	 The	 average	 speed	 from	 30	 cells	 for	
each	 condition	 over	 180	 frames	 was	
calculated	as	the	step	length/min	including	
non‐moving	 periods	 and	 displayed	 in	
µm/min.	 Error	 bars	 indicate	 ±	 SD.	
***P<.001,	**P<.01,	*P<.05.	One	representative	experiment	out	of	three	is	shown.	
	
DCs	play	the	major	role	 in	the	establishment	of	epidermal	viral	 immunity	against	
HSV‐133,	 and	 initial	delay	 in	 the	generation	of	 immune	 responses	 is	mediated	by	
interference	with	normal	DC	 functions34.	The	only	way	to	prevent	 the	virus	 from	
entering	a	latent	state	is	a	rapid	response	of	the	DC	network	to	activate	CD4+	and	
CD8+	 T‐cells	 as	 well	 as	 B‐cells34,	 leading	 to	 elimination	 of	 infected	 cells35	 and	
inactivation	 of	 virus	 particles	 by	 neutralizing	 antibodies	 before	 neurons	 are	
affected.	Hence,	the	migration	of	antigen‐presenting	DCs	from	the	sites	of	infection	
to	secondary	lymphoid	tissues	is	imperative	for	the	induction	of	antiviral	immune	
responses36,	 and	 inhibition	 of	 DC	 migration	 and	 thereby	 T‐cell	 priming	 is	 a	
powerful	way	 for	herpes	viruses	 to	evade	or	at	 least	 to	delay	 immune	responses	
until	 latency	is	established.	Eidsmo	and	colleagues	showed	that	HSV‐infected	DCs	
indeed	 are	 compromised	 in	 their	 trafficking	 capabilities	 and	 are	 largely	 absent	
from	the	migrating	population	in	vivo37.	
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Recent	publications	demonstrate	that	adhesion	is	not	a	prerequisite	for	leukocyte	
migration	in	confined	environments	such	as	the	interstitium1‐3.	Nevertheless,	since	
strong	integrin‐mediated	anchoring	of	leukocytes	overrides	pro‐migratory	signals	
and	 leads	 to	 adhesive	 arrest6,	 the	 interaction	 with	 the	 environment	 can	 be	 a	
determinant	for	their	locomotion.	Therefore,	it	is	apparent	that	the	affinity	status	
of	 integrins	 has	 to	be	 tightly	 controlled	 to	 ensure	 appropriate	 functioning	 of	 the	
immune	system.	
The	positioning	of	monocyte‐derived	cells	is	mainly	controlled	by	members	of	the	
β2	integrin	family,	and	DCs	are	much	more	restricted	in	β2	integrin	activation	than	
other	leukocytes12.	Previous	studies	 implicated	cytohesin‐110;	 11;	 13	and	CYTIP14	 in	
the	 regulation	of	β2	 integrin	affinity	 and	 integrin‐mediated	 leukocyte	adherence.	
CYTIP	 acts	 as	 a	 negative	 regulator	 of	 LFA‐1	 activation	 by	 interrupting	 the	
interaction	 with	 its	 activator	 cytohesin‐1.	 Hence,	 the	 loss	 of	 CYTIP	 results	 in	
increased	 LFA‐1	 affinity.	 For	 DCs	 it	 could	 be	 shown	 that	 CYTIP	 controls	 their	
adhesion	to	fibronectin	and	T‐cell	detachment16.	Here	we	demonstrate	that	in	HSV‐
1‐infected	 DCs,	 cytohesin‐1	 expression	 is	 only	 slightly	 altered,	 whereas	 CYTIP	
expression	is	rapidly	downregulated	and	concomitantly	β2	integrins	are	activated.	
The	 kinetic	 of	 adherence	 to	 fibronectin	 also	 reflects	 this	 finding,	 indicating	 that	
increased	 adhesion	 is	 linked	 to	 elevated	 β2	 integrin	 activation.	 Two	 hours	
postinfection,	 without	 β2	 integrin	 activation,	 infected	 DCs	 show	 only	 basal	
adhesion.	 During	 the	 course	 of	 infection	 CYTIP	 is	 reduced	 and	 the	 adhesion	 is	
drastically	 increased.	Silencing	of	CYTIP	by	RNAi	revealed	that	 indeed	the	 loss	of	
CYTIP	alone	 results	 already	 in	 augmented	adhesion.	The	 inhibition	of	LFA‐1	and	
Mac‐1	 demonstrated	 the	 dominant	 role	 of	 LFA‐1	 for	 the	 fibronectin‐adhesion	 of	
HSV‐1‐infected	DCs.	This	is	a	novel	finding,	since	it	is	generally	acknowledged	that	
in	fact	Mac‐1,	which	shows	great	binding	promiscuity,	is	mainly	responsible	for	the	
β2‐mediated	adherence	to	fibronectin32.	
Consistent	 with	 the	 data	 obtained	 from	 the	 adhesion	 assays,	 HSV‐1‐infected	
mature	 DCs	 showed	 a	 strong	 inhibition	 of	 migration,	 which	 is	 increased	 by	
immobilized	integrin	 ligands	and	with	 further	CYTIP	reduction	during	the	course	
of	infection.	The	importance	of	CYTIP	for	the	regulation	of	DC	motility	is	reflected	
by	the	fact	that	CYTIP	expression	is	drastically	upregulated	during	DC	maturation,	
i.e.	the	transition	from	their	sessile	to	their	motile	state.	Notably,	LFA‐1	normally	is	
inactive	 on	 mature	 DCs38.	 Using	 mutant	 mice	 with	 constitutively	 active	 LFA‐1,	
Semmrich	 and	 colleagues	 demonstrated	 that	 indeed	 strongly	 increased	 LFA‐1‐
mediated	adhesion	reciprocally	correlates	with	mobility39.	Accordingly,	treatment	
of	infected	DCs	with	LFA‐1	blocking	antibodies	increased	their	migration,	whereas	
blocking	of	Mac‐1	had	no	effect.	Thus,	LFA‐1‐mediated	adhesion	impairs	migration	
and,	at	 least	at	early	time‐points,	Mac‐1	 is	not	the	determinative	receptor	for	the	
integrin‐mediated	inhibition	of	chemotaxis.	
In	 the	 presence	 of	 integrin‐ligands,	 silencing	 of	 CYTIP	 resulted	 in	 a	 significant	
reduction	 of	 migration,	 demonstrating	 that	 CYTIP	 controls	 DC	 migration	 via	
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regulation	 of	 integrin‐mediated	 adhesion.	 HSV‐1‐infection	 of	 CYTIP‐knockdown	
DCs	 led	 to	 further	 inhibition	 of	 chemotaxis,	 indicating	 that	 the	 virus	might	 also	
target	additional	pathways	important	 for	DC	migration.	 In	 fact,	DCs	 infected	with	
HSV‐1	show	increased	activation	of	PI3K	(data	not	shown),	which	is	implicated	in	
cytohesin‐1	mediated,	LFA‐1	dependent	adherence	of	monocytes40	and	was	shown	
to	 activate	β2‐mediated	 integrin	adhesion	by	 inducing	membrane	 recruitment	of	
cytohesin‐141;	42.	At	later	time‐points,	the	upregulation	of	Mac‐1	activity	as	well	as	
additional	 viral	 mechanisms	 such	 as	 the	 downregulation	 of	 CCR7	 from	 the	
surface22	might	also	target	DC’s	chemotaxis,	thereby	resulting	in	further	reduction	
of	migration.	A	direct	influence	of	herpes	viruses	on	the	LFA‐1‐activating	molecule	
cytohesin‐1	has	already	been	described.	The	human	herpesvirus	8	protein	kaposin	
A	 recruits	 cytohesin‐1	 to	 the	 plasmamembrane,	 thereby	 activating	 CD1843	 and	
inducing	strong	adhesion.	In	HSV‐1	no	kaposin	A	homologue	exists,	but	influencing	
cell	adhesion	seems	to	be	a	common	herpes	virus	strategy.	
The	exact	viral	mechanisms	of	CYTIP	downregulation	remain	to	be	elucidated.	Due	
to	the	rapid	kinetic	of	CYTIP	downregulation	it	is	verisimilar	that	viral	immediate‐
early	 gene	 products	 or	 components	 of	 the	 viral	 tegument,	 which	 are	 directly	
delivered	into	the	cytoplasm	of	the	host	cell	during	infection,	are	involved.	Because	
DC	 migration	 to	 lymph	 nodes	 is	 fast	 (3	 –	 24	 hours),	 this	 early	 inhibition	 is	
mandatory	for	an	efficient	immune‐escape.	The	fact	that	UV‐inactivated	virus	had	
no	 effect	 on	 DC	 adhesion,	 CYTIP‐downregulation	 and	 the	 affinity	 status	 of	 β2	
integrins	indicates	that	viral	gene	expression	is	necessary.	Infection	with	a	mutant	
viruses	 lacking	 the	viral	RNase	 vhs,	which	 induces	 rapid	 shutoff	 of	 host	protein‐
synthesis	and	is	described	to	play	a	role	in	HSV	immune‐evasion27,	or	ICP0,	a	HSV‐
1	 immediate‐early	 proteins	 with	 ubiquitin	 E3	 ligase	 activity28,	 revealed	 that	
neither	vhs	nor	ICP0	are	involved	in	CYTIP	downregulation.	However,	inhibition	of	
the	proteasome	 completely	prevented	 the	 loss	 of	CYTIP,	demonstrating	 that	 it	 is	
degraded	 via	 the	 proteasomal	 pathway.	 HSV‐1‐infection	 of	 DCs	 leads	 to	 CYTIP	
double	 bands,	 which	 are	 enriched	 by	 MG‐132	 treatment,	 indicating	 that	 the	
additional	 bands	 are	 rapidly	 degraded	 by	 the	 proteasome.	 Many	 proteins	 are	
phosphorylated	prior	to	ubiquitination44;	therefore	it	could	be	speculated	that	the	
bands	 with	 higher	 molecular	 weight	 represent	 phosphorylated	 and/or	
ubiquitinated	CYTIP.	
HSV‐1	not	only	represses	migration	and	thereby	indirectly	the	priming	of	anti‐viral	
T‐cells,	but	also	directly	inhibits	this	process.	T‐cells	scan	antigen‐MHC	complexes	
on	DCs	by	establishing	short‐lived	and	highly	dynamic	cell‐cell	contacts	provided	
by	 cell	 adhesion	 molecules	 such	 as	 LFA‐1	 and	 ICAM‐145.	 If	 specific	 antigen	
recognition	 takes	 place	 the	 contact	 is	 prolonged	 by	 strengthening	 of	 DC‐T‐cell	
adhesion,	 leading	 to	 formation	 of	 the	 immunological	 synapse	 and	 ultimately	 the	
activation	 of	 T‐cells46.	 In	 either	 case,	 T‐cells	 need	 to	 detach	 from	 DCs	 to	 scan	
further	 DCs	 or	 to	 clonally	 expand,	 respectively.	 It	 could	 be	 shown	 that	 the	
inhibition	of	detachment	after	silencing	of	CYTIP	impairs	the	expansion	of	antigen‐
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specific	 T‐cells16,	 and	 that	 activated	 LFA‐1	 inhibits	 full	 T‐cell	 activation17;	 39.	 In	
concordance	with	those	findings,	here	we	demonstrate	that	indeed	the	detachment	
of	T‐cells	 from	HSV‐1‐infected	DCs	 is	 reduced.	 This	 is	 consentient	with	previous	
studies	 from	 our	 group,	 showing	 that	 the	 T‐cell	 stimulatory	 capacity	 of	 HSV‐1‐
infected	DCs	is	reduced47.		
	
Taken	 together,	 the	 here	presented	data	 provide	 evidence	 that	HSV‐1	 influences	
central	aspects	of	DC	biology.	By	manipulating	their	interaction	with	components	
of	 the	 interstitial	 space	 as	well	 as	 T‐cells,	HSV‐1	 targets	 two	 of	 the	most	 critical	
aspects	in	the	induction	of	adaptive	immune	responses,	i.e.	the	migration	of	DCs	to	
secondary	 lymphoid	 tissues	 and	 the	 efficient	 priming	 and	 activation	 of	 T‐cells.	
Understanding	 this	new	viral	 immune‐evasion	mechanism	might	help	 to	develop	
new	antiviral	therapies	in	the	future.	
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Supplemental	materials	and	methods	
Expression	analysis	using	Affymetrix	gene	chips	
Total	 RNA	 was	 isolated	 using	 QIAshredder	 and	 RNeasy	 Mini	 Kit	 spin	 columns	 (Qiagen,	
Hilden,	 Germany).	 Traces	 of	 genomic	 DNA	were	 removed	 by	 on‐column	 DNase	 digestion	
with	 RNase‐free	 DNase	 set	 (Qiagen).	 All	 further	 steps	 were	 performed	 according	 to	 the	
manufacturer’s	instructions	(Affymetrix,	High	Wycombe,	UK)	and	as	described	previously22.	
	
Flow	cytometry	analyses	
Intracellular	staining	of	DCs	was	performed	with	the	Cytofix/Cytoperm	kit	(BD)	according	
to	 the	 manufacturer’s	 instructions.	 Staining	 of	 activated	 CD11/CD18	 was	 performed	 as	
follows:	DCs	were	harvested	at	the	indicated	time‐points,	washed	and	resuspended	in	PBS	
with	10	mM	HEPES,	2%	BSA	(Roche,	Basel,	Switzerland)	and	10	µg/mL	of	mAB24,	CBRM1/5	
or	isotype	controls,	respectively.	Cells	were	incubated	for	10	min	at	37°C,	washed	and	fixed	
with	4%	PFA	(Carl	Roth	GmbH,	Karlsruhe,	Germany).	
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Western	blot	analyses	
Cells	were	lysed	in	buffer	containing	50	mM	tris‐HCl	pH	7.2,	137	mM	NaCl,	2	mM	EDTA,	10%	
glycerol	(all	from	Carl	Roth	GmbH,	Karlsruhe,	Germany),	1%	NP‐40	(Boehringer	Mannheim,	
Mannheim,	Germany),	1%	octyl	β‐D‐glucopyranoside,	2	mM	PMSF,	20	mM	NaF,	and	2	mM	
NaVO3	(all	from	Sigma).	Subsequent	to	SDS‐PAGE,	transfer	to	PVDF	membranes	(Millipore,	
Billerica,	 USA)	 and	 incubation	 with	 the	 appropriate	 primary	 and	 HRP‐linked	 secondary	
antibodies,	detection	was	performed	with	ECL	Plus	Western	blotting	detection	system	(GE	
Healthcare,	Freiburg,	Germany).	
	
siRNA	transfections	
RNAi	against	the	target	sequence	of	human	CYTIP	was	performed	using	10	µg	ON‐TARGET	
plus	SMARTpool	siRNA	(Dharmacon,	Lafayette,	USA).	As	control,	10	µg	of	a	non‐targeting,	
fluorescein‐labeled	 Allstars	 Negative	 Control	 siRNA	 (Qiagen)	 was	 used.	 siRNAs	 were	
delivered	 into	 immature	 DCs	 by	 electroporation	 and	 DCs	 were	 subsequently	 matured	 as	
described	previously23.	
Transwell	migration	assays	
Migration	 assays	 and	 quantification	 of	 migrated	 cells	 were	 performed	 as	 described	
previously22.	 Differing	 from	 the	 above	 mentioned	 protocol,	 the	 transwell	 inserts	 (Costar,	
London,	UK)	were	coated	over	night	with	20	µg/mL	fibronectin	(Sigma).	
	
T‐cell‐adhesion	assay	
96‐well	 microtest	 plates	 (BD	 Labware	 Europe,	 Meylan	 Cedex,	 France)	 were	 coated	 with	
0.01%	poly‐L‐Lysine.	5x105	DCs	were	added	to	the	wells	and	allowed	to	adhere	for	1	hour	at	
37°C.	 Freshly	 isolated	 bulk	 human	 T‐cells	 were	 stained	 with	 the	 Vybrant	 CFDA‐SE	 Cell	
Tracer	 Kit	 (Invitrogen)	 according	 to	 the	manufacturer’s	 instructions.	Wells	 were	 washed	
and	2x105	T‐cells	were	added	to	each	well	and	incubated	for	45	min	at	37°C.	Unbound	cells	
were	 removed	by	washing.	Quantification	of	bound	T‐cells	was	performed	using	a	Victor2	
multilabel	 counter	 (PerkinElmer,	 Jugesheim,	 Germany)	 with	 excitation	 and	 emission	
wavelengths	of	485	nm	and	535	nm,	respectively.	Normalization	was	performed	by	setting	
the	adhesion	to	mock‐infected	DCs	as	1.		
Figures	in	this	data	supplement	
Figure	 S1:	 Mature	 dendritic	 cells	 are	
efficiently	 infected	with	 herpes	 simplex	
virus	 type	 1.	 Flow	 cytometric	 analysis	
demonstrates	 that	 monocyte‐derived	
DCs	 are	 efficiently	 infected	with	HSV‐1	
EGFP	at	a	MOI	of	1.	DCs	were	analyzed	
for	expression	of	EGFP	at	 the	 indicated	
time‐points	postinfection	 (pi),	gated	on	
viable	cells.	Dashed	line	indicates	mock‐
infected	 DCs;	 solid	 line,	 HSV‐1‐infected	
DCs.	 Shown	 is	 one	 representative	
experiment	out	of	three.	
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Figure	 S2:	 Individual	
tracks	 of	 mock‐infected	
and	HSV‐1‐infected	DCs	 in	
collagen	 gels.	Mature	 DCs	
were	 either	mock‐infected	
(left	 panel)	 or	 HSV‐1‐
infected	 (right	 panel).	
Subsequent	 to	 the	
infection	 procedure,	 cells	
were	 used	 for	 3D	
migration	 assays	 in	 pure	
collagen	 gels	 (upper	
panel)	and	gels	containing	
20	 µg/mL	 fibronectin	
(lower	 panel).	 HSV‐1	
strongly	inhibits	migration	
of	 DCs	 in	 both	 conditions.	
Chemotaxis	 towards	 a	
CCL19	 gradient	 was	
monitored	 by	 bright‐field	 time‐lapse	 videomicroscopy	 beginning	 90	min	 postinfection.	 Cells	
were	 imaged	at	a	 frame	 rate	 of	2	min	 over	 180	 frames.	 Shown	are	 individual	 tracks	 of	30	
randomly	selected	cells	for	each	condition	of	one	representative	experiment	out	of	three.	
	
	
	
	
	
	
	
	
Figure	 S3:	 Efficient	 silencing	 of	 CYTIP	 in	mature	 DCs.	 cFlow	 cytometric	 analysis	 of	 CD83,	
CD86,	HLA‐DR,	CCR7	and	CYTIP	of	untreated	DCs	(upper	panel),	cells	electroporated	with	10	
µg	of	a	non‐targeting	control	siRNA	(middle	panel)	and	DCs	electroporated	with	10	µg	CYTIP	
siRNA	(lower	panel)	shows	that	maturation	of	DCs	is	not	affected	by	RNAi	of	CYTIP.	CYTIP	was	
efficiently	 silenced	by	RNAi	48	h	after	electroporation.	The	empty	profiles	 in	 the	histograms	
indicate	stainings	with	isotype	controls.	Shown	is	one	representative	experiment	out	of	three.	
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Figure	 S4:	 RNAi	 of	 CYTIP	 in	 DCs	
enhances	 their	 adhesion	 to	
Fibronectin.	 Mature	 DCs	 (mock)	
and	DCs	electroporated	with	10	µg	
of	 a	 non‐targeting	 siRNA	 (control	
siRNA)	 or	 10	 µg	 CYTIP	 targeting	
siRNA	(CYTIP	siRNA)	were	allowed	
to	 bind	 to	 fibronectin.	 RNAi	 of	
CYTIP	 significantly	 increases	 the	
adhesion	 to	 fibronectin.	Error	bars	
indicate	 ±	 SD.	 ***P<.001,	 ns	
indicates	 not	 significant.	 The	
experiment	 was	 repeated	 3	 times	
independently	 and	 each	 single	
adhesion	experiment	was	performed	in	quadruplicate.	
	
	
Figure	 S5:	 Silencing	 of	 CYTIP	 in	
mature	 DCs	 impairs	 their	
migration.	 Immature	 DCs	 were	
electroporated	 with	 10	 µg	 of	 a	
non‐targeting	 control	 siRNA	 (left	
panel)	 or	 with	 10	 µg	 siRNA	
targeting	CYTIP	(right	panel).	Four	
hours	 later,	 maturation	 cocktail	
was	added	and	DCs	were	matured	
for	48	hours.	Subsequently,	mature	
DCs	 were	 used	 in	 3D	 migration	
assays	 towards	 CCL19	 in	 pure	
collagen	 gels	 (upper	 panel)	 or	 in	
gels	 containing	 20	 µg/mL	
fibronectin	(lower	panel).	Silencing	
of	CYTIP	strongly	impairs	chemotaxis	of	DCs	in	collagen	gels	containing	fibronectin.	Migration	
was	monitored	by	bright‐field	time‐lapse	videomicroscopy.	Cells	were	imaged	at	a	frame	rate	
of	 2	 min.	 For	 each	 condition,	 30	 individual	 tracks	 of	 randomly	 selected	 cells	 of	 one	
representative	experiment	out	of	three	are	visualized.	
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Figure	 S6:	 Migration	
timecourse	 of	 mock‐
infected	 and	 HSV‐1‐
infected	DCs.	3D	migration	
assays	 of	 mock‐	 or	 HSV‐1	
infected	 DCs	 towards	 a	
CCL19	 gradient	 up	 to	 6	
hours	 postinfection	 in	 (A)	
fibronectin	 coated	 gels	 or	
(B)	gels	that	contain	ICAM‐
1‐Fc	 coated	 beads	 show	
that	 HSV‐1‐infection	
impairs	 DC	 chemotaxis.	
Where	 indicated,	 LFA‐1	
blocking	 antibody	 was	
added	 in	 a	 concentration	
of	 20	 µg/mL.	 Blockade	 of	
LFA‐1	 partially	 restores	
migration.	 Cells	 were	
imaged	at	a	 frame	 rate	of	
2	 min	 imaged	 by	 bright‐
field	 time‐lapse	
videomicroscopy.	 The	
average	 speed	 was	
calculated	 as	 the	 step	
length	 /min	 (including	
non‐moving	 periods)	 of	 30	 randomly	 selected	 cells	 and	 displayed	 in	 µm/min.	 One	
representative	experiment	out	of	three	is	shown.	
Figure	 S7:	 T‐cell	 detachment	
from	 HSV‐1‐infected	 DCs	 is	
impaired.	T‐cells	adhere	 stronger	
to	infected	DCs	as	shown	by	the	T‐
cell	adhesion	assay.	Mock‐infected	
and	 HSV‐1‐infected	 DCs	 were	
applied	 to	 poly‐L‐lysine	 coated	
96‐well	 micro‐test	 plates	 4	 h	
postinfection.	Subsequently,	CFSE‐
labeled	bulk	T‐cells	were	allowed	
to	adhere	to	 the	 immobilized	DCs	
for	 45	 min.	 After	 washing,	
adherent	cells	were	quantified	by	
measuring	CFSE‐fluorescence	in	a	
Victor2	 multilabel	 counter.	
Normalization	was	 performed	 by	
setting	 the	 adhesion	 to	 mock‐infected	 DCs	 to	 1.	 Error	 bars	 indicate	 ±	 SD.	 *P<.05.	 The	
experiment	was	repeated	3	times	independently	and	each	single	experiment	was	performed	in	
quadruplicate.	
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Abstract	
Integrins	 are	 cell	 membrane	 adhesion	 receptors	 involved	 in	 morphogenesis,	
immunity,	 tissue	 healing	 and	 metastasis.	 A	 central,	 yet	 unresolved	 question	
regarding	 the	 function	 of	 integrins	 is	 how	 these	 receptors	 regulate	 both	 their	
conformation	and	dynamic	nanoscale	organization	on	 the	membrane	 to	generate	
adhesion‐competent	microclusters	upon	 ligand	binding.	Here	we	exploit	 the	high	
spatial	(nanometer)	accuracy	and	temporal	resolution	of	single	dye	tracking	(SDT)	
to	 dissect	 the	 relationship	 between	 conformational	 state,	 lateral	 mobility	 and	
microclustering	 of	 the	 integrin	 receptor	 LFA‐1	 expressed	 on	 immune	 cells.	 We	
recently	showed	that	in	quiescent	monocytes,	LFA‐1	pre‐organizes	in	nanoclusters	
proximal	to	nanoscale	raft	components.	We	now	show	that	these	nanoclusters	are	
primarily	mobile	on	the	cell	surface	with	a	small	(~	5%)	subset	of	conformational‐
active	 LFA‐1	 nanoclusters	 pre‐anchored	 to	 the	 cytoskeleton.	 Lateral	 mobility	
resulted	 crucial	 for	 the	 formation	 of	 microclusters	 upon	 ligand	 binding	 and	 for	
stable	adhesion	under	shear‐flow.	Activation	of	high	affinity	LFA‐1	by	extracellular	
Ca2+	resulted	in	an	eight‐fold	increase	on	the	percentage	of	immobile	nanoclusters	
and	 cytoskeleton	 anchorage.	Although	having	 the	ability	 to	bind	 to	 their	 ligands,	
these	active	nanoclusters	failed	to	support	firm	adhesion	in	static	and	low	shear‐
flow	 conditions	 since	mobility	 and	 clustering	 capacity	was	 highly	 compromised.	
Altogether,	 our	 work	 demonstrates	 an	 intricate	 coupling	 between	 conformation	
and	lateral	diffusion	of	LFA‐1	and	further	underscores	the	crucial	role	of	mobility	
for	the	onset	of	LFA‐1	mediated	leukocyte	adhesion.		
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Introduction	
Integrins	are	transmembrane	α/β	heterodimeric	cell	adhesion	molecules	that	play	
critical	 roles	 in	 cell‐cell	 and	 cell‐extracellular	matrix	 interactions.	Most	 integrins	
dynamically	modulate	 their	 adhesiveness	 through	global	 conformational	 changes	
that	 define	 their	 affinity	 state	 for	 ligand	 1‐3,	 and	 by	 their	 membrane	 lateral	
organization	 in	 clusters,	 also	 known	 as	 avidity	 4‐6.	 Although	 the	mechanisms	 by	
which	 conformational	 changes	 of	 integrins	 leading	 to	 enhanced‐binding	 affinity	
have	 been	 well	 established	 1‐3;	 7;	 8,	 there	 is	 no	 consensus	 yet	 on	 how	 integrins	
control	 their	 spatial	 rearrangement	on	 the	 cell	membrane	and	 the	 role	of	 lateral	
mobility	in	cluster	formation.		
Integrin	clustering	alone	can	lead	to	increased	avidity	6	due	to	cooperative	effects	
on	 resistance	 to	 bond	 breakage	 9.	 Since	 bonds	 between	 individual	 integrins	 and	
their	ligands	can	be	broken	with	relatively	small	forces	10	clustering	appears	as	an	
important	 mechanism	 to	 reinforce	 adhesion	 via	 cooperative	 binding	 10;	 11.	 On	
leukocytes,	 rearrangement	 of	 integrins	 into	 clusters	 upon	 activation	 occurs	 by	
diffusion,	 after	 release	 of	 cytoskeleton	 constrains	 on	 integrin	motion	 12‐14.	 These	
observations	led	to	the	common	believe	that	inactive	integrins	are	anchored	to	the	
cytoskeleton	 and	 released	 when	 needed	 to	 reinforce	 binding	 12;	 15;	 16	 suggesting	
that	 integrin	 activation	 precedes	 clustering.	 However,	 this	 model	 is	 hard	 to	
conciliate	 with	 the	 fact	 that	 high	 affinity	 (extend	 integrins)	 are	 more	 prone	 to	
interact	 with	 the	 cytoskeleton	 via	 their	 cytoplasmic	 tails	 1	 leading	 to	 immobile	
integrins	that	will	compromise	their	capacity	for	lateral	diffusion,	a	process	that	is	
imperatively	required	for	clustering	4.		
A	major	integrin	involved	in	the	immune	system	is	lymphocyte	function‐associated	
antigen‐1	 (LFA‐1).	 LFA‐1	 mediates	 leukocyte	 migration	 across	 the	 endothelium	
and	within	tissues	and	the	formation	of	the	immunological	synapse	by	binding	to	
its	major	ligand	ICAM‐1	17‐19.	We	recently	showed	that	on	resting	monocytes	LFA‐1	
function	is	associated	with	its	nanoclustering	20	forming	non‐intermixed	nanoscale	
supramolecular	complexes	together	with	lipid	raft	components	21;	22.	Importantly,	a	
subset	 of	 these	 nanoclusters	 already	 contained	 primed,	 i.e.,	 extended	 LFA‐1	
molecules	prior	to	ligand	binding	20;	23.	Interestingly,	a	subset	of	high‐affinity	LFA‐1	
clusters	 has	 been	 also	 observed	 upon	 chemokine	 stimulation	 at	 the	 immediate	
contact	between	crawling	T	cells	and	endothelial	cells	 24.	Yet,	dynamic	 insight	on	
the	 spatial	 organization	 of	 LFA‐1	 nanoclusters	 is	 lacking.	 Moreover,	 how	 these	
different	 subsets	diffuse	on	 the	cell	membrane	and	cooperate	with	each	other	 to	
generate	 adhesion‐competent	microclusters	 remains	 unknown.	 Here	 we	 applied	
single	molecule	approaches	together	with	reporters	of	LFA‐1	conformational	state	
to	 dissect	 the	 relationship	 between	 conformation,	 lateral	 mobility	 and	 ligand‐
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induced	microclustering	of	LFA‐1.	
Materials	and	Methods		
Cell	 culture	 and	 labeling	 for	 single	 dye	 tracking.	 THP‐1	 monocytes	 were	
cultured	in	RPMI	1640	Dutch	modification	medium	supplemented	with	10%	fetal	
calf	 serum	and	antibioticantimycotic	 from	Gibco.	Cells	were	 labeled	with	2μg/ml	
TS2/4‐ATTO520,	 or	 0.2μg/ml	 L16‐ATTO647N	 to	 allow	 for	 single	 dye	 tracking	
experiments	 (SI	 Text,	 Fig.	 S1).	 Further	 details	 on	 substrate	 preparation,	
micropatterns,	 labeling	 conditions	 under	 different	 cation	 conditions	 and	 Cyto‐D	
treatment	are	found	in	SI	Text.		
Shear	flow	chamber	assay.	Details	of	the	experiments	are	described	in	SI	Text.		
Single	 dye	 tracking.	 Experiments	 were	 performed	 using	 a	 home‐made	 single	
molecule	 EPI/TIRF‐fluorescence	microscope.	 Samples	were	 illuminated	 either	 in	
EPI	or	TIRF	modes.	Excitation	was	provided	by	a	He:Ne	laser	(4	ms	at	633	nm,	1	
kW/cm2)	 or	 an	 Ar+‐Kr+	 laser	 (2ms	 at	 514.5nm,	 ~2	 kW/cm2).	 Fluorescence	 was	
collected	with	 a	 1.45	 NA	 oil	 immersion	 objective	 and	 guided	 into	 an	 intensified	
CCD	 camera.	 Individual	 frames	 were	 retrieved	 at	 a	 frame	 rate	 of	 10‐20	 Hz.	
Experiments	were	performed	at	37°C.	MSD	analysis	was	used	to	analyze	trajectory	
data	and	to	derive	the	short‐range	D	values.	CPD	analysis	was	performed	according	
to	Schütz	et	al	25	to	derive	the	long‐term	D	values	of	mobile	trajectories	(see	SI	Text	
for	further	details).	
Results	
LFA‐1	nanoclusters	are	mobile	on	resting	monocytes.	We	previously	 showed	
that	 LFA‐1	 forms	 distinct	 nanoclusters	 on	 resting	 monocytes	 prior	 to	 ligand	
binding	 20;	 21.	 Although	 this	 nanoscale	 organization	 resulted	 crucial	 for	 LFA‐1	
function	 20,	 their	 dynamic	 behavior	 has	 not	 been	 investigated	 yet.	 We	 applied	
Single	Dye	Tracking	(SDT)	to	follow	the	lateral	diffusion	of	individual	sub‐labeled	
LFA‐1	nanoclusters	(Fig.	S1A‐D;	SI	text)	on	resting	monocytes.	At	our	sub‐labeling	
conditions,	 individual	 intensity	 trajectories	 on	 fixed	 cells	 showed	 discrete	
photobleaching	steps	consistent	with	single	dye	detection	(Fig.	S1C,D).	Trajectories	
of	LFA‐1	nanoclusters	 labeled	with	 the	neutral	mAb	TS2/4	were	generated	 from	
multiple	 movies	 (Fig.	 1A)	 using	 a	 single	 molecule	 detection	 sensitive	 epi‐
fluorescence	 microscope	 (Fig.	 1B,C).	 At	 physiological	 cation	 conditions	 (0.4mM	
Ca2+,	 Mg2+),	 LFA‐1	 nanocluster	mobility	 did	 not	 exhibit	 uniform	 behavior.	While	
some	nanoclusters	were	highly	mobile,	others	showed	a	more	restricted	diffusion	
(Fig.	 1D).	 Individual	 trajectories	 were	 analyzed	 by	 generating	 mean‐square	
displacement	(MSD)	curves	to	obtain	the	diffusion	coefficient	D	at	short‐time	lags.	
The	 resultant	 D	 distribution	 varied	 from	 10‐3	 µm2/s	 to	 10‐1	 µm2/s	 (Fig.	 1E),	
evidencing	a	large	heterogeneity	in	lateral	mobility	with	a	small	percentage	(~5%)	
of	 stationary	 nanoclusters	 (Fig.	 S2,	 SI	 Text).	 To	 enquire	 on	 the	 type	 of	 diffusion	
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exhibited	by	the	mobile	LFA‐1	nanoclusters	over	longer	time	intervals	(~1.5	s)	we	
applied	cumulative	probability	distribution	(CPD)	analysis	25.	Using	this	approach	
we	could	separate	the	mobile	nanoclusters	in	two	groups:	(i)	slow	diffusing	with	Ds	
and	αs,	and	(ii)	fast	diffusing	with	Df	and	αf,	where	D	represents	the	short‐time	lag	
diffusion	 coefficients	 and	 α	 indicates	 the	 type	 of	 motion	 (α=1	 for	 Brownian	
diffusion;	 α<1	 for	 hindered,	 anomalous	 diffusion)	 (SI	 Text).	 The	 analysis	 also	
rendered	 the	 relative	 fractions	 of	 slow	 and	 fast	 diffusing	 nanoclusters.	 At	
physiological	 cation	 conditions,	 the	 fast	 fraction	 (~64%)	 of	 LFA‐1	 nanoclusters	
shows	Df	=	 (5.6±0.2)·10‐2	 µm2/s	and	αf	=	0.94±0.06,	 i.e.,	Brownian	 (Fig.	 1F,	Table	
S1).	The	slow	fraction	(~32%)	shows	a	diffusion	coefficient	of	Ds	=	(1.4±0.1)·10‐2	
µm2/s	and	αs	=	0.9±0.2.	Thus,	in	contrast	to	earlier	reports	about	immobile	LFA‐1	
in	 resting	 T	 cells	 12;	 15;	 16	 our	 data	 on	 resting	 monocytes	 demonstrate	 that	 at	
physiological	 cation	 conditions	 LFA‐1	 nanoclusters	 are	 primarily	 mobile	 on	 the	
plasma	membrane.		
To	confirm	that	we	 tracking	nanoclusters	on	monocytes,	we	also	determined	the	
diffusion	 of	 individual	LFA‐1	molecules	 on	monocyte‐derived	 immature	 dendritic	
cells	(imDC),	where	LFA‐1	 is	organized	in	a	random	(monomeric)	fashion	20	(Fig.	
S3A,B).	As	expected,	the	resultant	D	distribution	of	LFA‐1	on	imDCs	showed	a	clear	
shift	towards	larger	D	values	compared	to	that	on	monocytes	(Fig.	S3C).	To	relate	
the	 changes	 in	 D	 to	 the	 size	 of	 the	 moving	 particles	 we	 further	 applied	
hydrodynamic	theory	(SI	text).	Both,	the	estimated	values	of	D	for	individual	LFA‐1	
molecules	 and	 nanoclusters	 agree	 well	 with	 those	 measured	 on	 imDCs	 and	
monocytes	respectively,	supporting	our	statement	that	we	are	tracking	individual	
nanoclusters	 on	 monocytes	 (see	 SI	 text	 for	 further	 details).	 Additional	 control	
experiments	at	higher	labeling	conditions	(Fig.	S3D,E)	and	high	density	dual	color	
quantum	dot	tracking	(Fig.	S4)	further	support	our	assignment	(see	SI	text).		
Primed	 LFA‐1	 nanoclusters	 exhibit	 multiple	 diffusion	 profiles	 on	 resting	
monocytes.	We	previously	showed	that	on	resting	monocytes	~25%	of	the	LFA‐1	
nanoclusters	are	 in	 a	primed	 state	 20.	To	 investigate	 the	 lateral	mobility	of	 these	
primed	nanoclusters	we	used	the	conformation	dependent	epitope	NKI‐L16	(L16),	
which	exclusively	labels	the	extended	conformation	of	the	αL	subunit	26;	27	(Fig.	1A).	
Individual	 trajectories	 of	 L16+‐LFA‐1	 nanoclusters	 were	 generated	 (Fig.	 2A)	
together	with	the	D	histogram	(Fig.	2B).	A	considerable	higher	fraction	(~20%)	of	
L16+	nanoclusters	was	 stationary,	while	 the	 remaining	~80%	exhibited	D	 values	
similar	 to	 those	 recovered	with	 the	TS2/4	 reporter	 consistent	with	 the	 fact	 that	
primed	 nanoclusters	 constitute	 a	 subset	 of	 the	 overall	 LFA‐1	 population.		
Furthermore,	CPD	analysis	revealed	two	different	diffusion	profiles	(Fig.	2C):	one	
fraction	of	L16+	nanoclusters	(~53%)	exhibited	fast,	nearly	Brownian	diffusion	(αf	
=	 0.91±0.02),	 while	 the	 second	 fraction	 (~28%)	 showed	 slow	 and	 anomalous	
diffusion	(αs	=	0.49±0.06)	(Table	S1).	The	overall	fractions	of	stationary,	slow	and	
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fast	 diffusing	 LFA‐1	 nanoclusters	 for	 the	 two	 different	 reporters	 used	 are	
summarized	 in	 Fig.	 2D.	 These	 results	 indicate	 that	 primed	 nanoclusters	 display	
multiple	 diffusion	 behavior	 with	 stationary,	 anomalous	 and	 freely	 diffusing	
nanoclusters.	
Figure1.	 LFA‐1	
nanoclusters	 diffuse	
randomly	 on	 resting	
monocytes.	 (A)	 Schematic	
description	 of	 the	 SDT	
experiments.	 Individual	
LFA‐1	 molecules	 inside	
nanoclusters	 were	 labeled	
with	 TS2/4‐ATTO520	 or	
L16‐ATTO647N	 using	 sub‐
labeling	 conditions.	 (B)	
Selected	 frame	 from	 a	
movie	 recorded	 at	
100ms/frame.	Bright	 spots	
correspond	 to	 individual	
TS2/4‐LFA‐1	 nanoclusters.	
White	 dots	 indicate	 the	
perimeter	of	 the	cell.	Scale	
bar:	 5	 µm.	 (C)	 Selected	
LFA‐1	 nanoclusters	 at	
different	times	 to	 illustrate	
different	mobility	behavior:	
fast	 (upper	 row),	
stationary	 (middle	 row)	
and	slow	(bottom	row).	(D)	
Representative	 LFA‐1	
nanocluster	 trajectories	
displaying	 different	 lateral	
mobility,	 pseudo‐color	
coded	 according	 to	 their	
apparent	 mobility:	 fast	
(orange),	 slow	 (blue)	 and	
stationary	 (gray).	 (E)	
Normalized	semi‐log	distribution	of	D	values	at	short‐time	 lags.	The	vertical	arrow	 indicates	
the	 threshold	value	of	diffusion	Dth	above	which	 the	mobile	population	 for	CPD	analysis	has	
been	selected.	370	trajectories	from	128	cells	in	multiple	experiments.	(F)	Square	displacement	
plots	of	the	TS2/4	mobile	 fractions	at	different	time	 lags	as	obtained	 from	CPD	analysis.	157	
trajectories.	
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Figure	 2.	
Primed	 LFA‐1	
nanoclusters	
exhibit	 multiple	
diffusion	
profiles	 on	
resting	
monocytes.	 (A)	
Representative	
trajectories	 of	
primed	 LFA‐1	
nanoclusters	
labeled	 with	
L16‐ATTO647N.	
(B)	 Normalized	
semi‐log	
distribution	of	D	
values	 at	 short‐
time	 lags	 of	
L16+‐LFA‐1	
nanoclusters	
(bars)	
compared	 to	
that	of	the	 total	(TS2/4)	LFA‐1	population	(dash).	669	trajectories	 from	49	cells	on	multiple	
experiments.	(C)	Square	displacement	plots	by	 fitting	 the	CPD	of	 the	L16	mobile	 fractions	at	
different	 time	 lags	 (380	 trajectories).	 (D)	 Normalized	 fractions	 of	 stationary	 (gray),	 slow	
(blue)	and	 fast	(orange)	mobile	subpopulations	 for	 the	 total	and	primed	nanoclusters.	Error	
bars	represent	the	standard	deviation.		
Reduction	of	extracellular	Ca2+	restricts	 the	mobility	of	LFA‐1	nanoclusters.	
Low	extracellular	Ca2+	or	a	combination	of	Mg2+/EGTA	has	been	extensively	used	
to	 promote	 high	 affinity	 LFA‐1	 13;	 28.	 We	 thus	 performed	 SDT	 experiments	 as	 a	
function	of	Ca2+	reduction	to	selectively	induce	extended	nanoclusters	and	monitor	
their	lateral	mobility	on	monocytes.	Reduction	of	extracellular	Ca2+	from	0.4mM	to	
0.1mM	modestly	reduced	the	TS2/4‐LFA‐1	mobile	fraction	(Fig.	3A,G).	In	contrast,	
the	 diffusion	 of	 L16+	 nanoclusters	 remained	 unaltered	 (Fig.	 3B,H).	 Strikingly,	
further	reduction	of	Ca2+	down	to	0.04mM	increased	the	number	of	stationary	LFA‐
1	nanoclusters,	regardless	of	the	reporter	used	(Fig.	3C,D,G,H).	Hence,	the	fraction	
of	stationary	LFA‐1	nanoclusters	 increased	from	~5%	at	0.4mM	Ca2+	 to	~43%	at	
0.04mM	Ca2+	for	the	TS2/4	reporter	(Fig.	3G,	Table	S1)	and	from	~20%	to	~36%	
for	 the	 primed	 (L16+)	 nanoclusters	 (Fig.	 3H,	 Table	 S1).	 Consistent	with	 this,	 the	
binned	 histograms	 of	 the	 diffusion	 coefficients	 of	 the	 total	 and	 primed	
nanoclusters	 revealed	 a	 ~2‐fold	 increase	 in	 the	 occurrence	 of	 lowest	 diffusion	
values	when	extracellular	Ca2+	was	reduced	to	0.04mM	(red	arrows	 in	Fig.	3E,F).	
Moreover,	the	D	curve	distributions	of	the	total	and	primed	nanoclusters	decayed	
sharper	 at	 0.04mM	 implying	 a	 severe	 slowing	 down	of	mobility	 (Fig.	 3E,F).	 CPD	
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analysis	further	showed	a	significant	decrease	on	the	fast	mobile	fractions	and	an	
anomalous	 behavior	 at	 0.04mM	 Ca2+	 regardless	 of	 the	 reporter	 used	 (Fig.	 3G,H,	
Table	 S1).	 To	 rule	 out	 any	 effect	 of	 Mg2+,	 we	 repeated	 experiments	 at	 low	
extracellular	 Ca2+	 levels	 in	 the	 presence	 of	Mg2+	 and	 observed	 no	 differences	 on	
LFA‐1	mobility	 (Fig.	S5),	consistent	with	the	 fact	 that	 the	effect	of	Mg2+	 is	 locally	
confined	to	the	headpiece	of	the	integrin	1;	28.	Collectively,	these	results	reveal	that	
reduction	 of	 extracellular	 Ca2+	 dramatically	 decreases	 the	 mobility	 of	 LFA‐1	 on	
monocytes	 by	 immobilizing	 a	 large	 number	 of	 nanoclusters	 and	 severely	
restricting	the	diffusion	of	the	remaining	mobile	ones.		
Remarkably,	 the	 slopes	 of	 the	 binned	 D	 distribution	 for	 the	 total	 LFA‐1	
nanoclusters	(Fig.	3E)	became	progressively	steeper	 indicating	a	gradual	slowing	
down	of	mobility	 as	 a	 function	of	Ca2+	 reduction.	 Since	Ca2+	 depletion	 favors	 the	
extended	 form	 of	 the	 integrin	 1;	 28,	 the	 changes	 in	 diffusion	 of	 the	 whole	 LFA‐1	
population	 might	 reflect	 a	 shift	 in	 the	 conformation	 equilibrium	 from	 mainly	
inactive	 to	 the	primed	 form.	 Indeed,	 the	binned	diffusion	histograms	of	 the	 total	
and	 primed	 nanoclusters	 (Fig.	 3I)	 showed	 an	 evolution	 profile	 in	 which	 both	
distributions	 became	more	 alike	 to	 each	 other	 as	 the	 concentration	 of	 Ca2+	 was	
reduced,	until	they	remarkably	matched	each	other	at	0.04mM	Ca2+.	Moreover,	at	
0.04mM	Ca2+	 the	diffusion	behavior	of	 the	total	and	primed	nanoclusters	became	
quite	similar	to	each	other	implying	full	conversion	from	inactive	to	primed	LFA‐1	
nanoclusters	(Fig.	3G,H,I,	Table	S1).	To	further	confirm	that	the	immobilization	of	
LFA‐1	is	due	to	priming,	we	also	performed	SDT	experiments	using	Mn2+,	a	strong	
integrin	 activator	 3;	 28,	 and	 the	 activating	 antibody	 KIM185	 29.	 In	 both	 cases	 the	
stationary	population	 increased	considerably,	 similarly	 to	 the	 results	obtained	at	
low	Ca2+	conditions	(Fig.	S6).		
The	actin	cytoskeleton	regulates	 the	diffusion	of	LFA‐1	nanoclusters	at	 low	
extracellular	Ca2+	conditions.	The	 immobilization	of	LFA‐1	nanoclusters	on	 the	
cell	membrane	at	low	Ca2+	levels	suggests	their	anchoring	to	the	cytoskeleton.	We	
thus	 used	 cytochalasin	 D	 (CytoD)	 to	 test	 the	 effect	 of	 disrupting	 cytoskeletal	
interactions	 on	 LFA‐1	 diffusion.	 Treatment	 with	 CytoD	 released	 a	 significant	
fraction	 of	 stationary	 L16+	 nanoclusters	 at	 0.4mM	 Ca2+,	 Mg2+	 (Fig.	 S7)	 and	
importantly	 released	most	 of	 the	 L16+	 nanoclusters	 at	 0.04mM	 Ca2+	 (Fig.	 4A,C).	
This	 effect	 was	 extended	 to	 the	 total	 LFA‐1	 nanoclusters	 at	 0.04mM	 Ca2+	 (Fig.	
4B,C).	 These	 data	 demonstrate	 that	 at	 low	 extracellular	 Ca2+	 levels	 LFA‐1	
nanoclusters	anchor	 to	 the	 cytoskeleton	and	 suggest	 that	extracellular	activators	
such	 as	 cations	 have	 a	 potent	 role	 on	 global	 integrin	 conformation	 by	 coupling	
extracellular	stimuli	to	intracellular	signals	that	affect	integrin	lateral	mobility.		
The	decreased	mobility	of	LFA‐1	nanoclusters	at	 low	Ca2+	 levels	 correlates	
with	restricted	microclustering	compromising	cell	adhesion	and	spreading.	
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Since	 several	 studies	 suggest	 that	 LFA‐1	mobility	 is	 associated	with	 its	 ability	 to	
form	microclusters	12;	 30	we	investigated	the	effect	of	extracellular	Ca2+	on	ligand‐
induced	 LFA‐1	 clustering.	 For	 this,	 dense	 ICAM‐1	 patterned	 surfaces	 (5µm	
squares)	 were	 prepared	 using	 micro‐contact	 printing	 23.	 Clear	 accumulation	 of	
LFA‐1	to	the	ICAM‐1	regions	was	observed	at	physiological	conditions	compared	to	
that	 at	 low	 Ca2+	 levels	 (Fig.	 5A,B).	 To	 quantify	 the	 degree	 of	 clustering	 we	
separated	the	data	in	two	categories:	(i)	patches	larger	than	the	diffraction	limit	of	
our	microscope	 (~350nm	 diameter)	 and	 defined	 them	 as	microclusters	 and,	 (ii)	
smaller	 spots	with	a	 size	 limited	by	diffraction	and	defined	 them	as	nanoclusters	
(SI	text).		
From	20‐30	cells	studied	at	each	condition,	 the	number	of	L16+	microclusters	on	
ICAM‐1	regions	was	significantly	different,	with	~45%	of	the	cells	displaying	L16+	
microclusters	 at	 0.4mM	 Ca2+,	 Mg2+	 and	 ~20%	 at	 0.04mM	 Ca2+	 (Fig.	 5C).	
Interference	 reflection	microscopy	 further	 showed	 extensive	 areas	 of	 close	 cell‐
ligand	 substrate	 contacts	 at	 0.4mM	 Ca2+,	 Mg2+,	 while	 reduced	 contact	 areas	 and	
finger‐like	extensions	 (filopodia)	were	observed	at	 low	Ca2+	 levels	 (Fig.	5E‐G).	 In	
addition,	 the	 number	 of	 cells	 that	 firmly	 adhered	 at	 low	 Ca2+	 levels	 reduced	
substantially	 compared	 to	 physiological	 Ca2+	 levels	 (Fig.	 5H).	 In	 the	 case	 of	 L16+	
nanoclusters,	 we	 did	 not	 observe	 significant	 differences	 in	 the	 intensity	
distributions	(Fig.	5D)	indicating	that	low	extracellular	Ca2+	has	no	affect	on	LFA‐1	
nanoclustering.	 These	 results	 were	 further	 confirmed	 by	 transmission	 electron	
microscopy	of	whole‐mount	monocytes	(Fig.	S8).	Thus,	while	LFA‐1	nanoclustering	
remains	unperturbed	at	 low	Ca2+	 levels,	 ligand‐induced	microclustering	is	greatly	
restricted	 and	 directly	 correlated	 with	 its	 decreased	 mobility	 on	 the	 cell	
membrane.	 Furthermore,	 these	 results	demonstrate	 that	 extracellular	Ca2+	 is	 not	
only	 an	 important	 regulator	 of	 ligand	 binding	 affinity	 but	 it	 is	 also	 required	 to	
couple	 ligand	 binding	 to	 global	 conformational	 changes	 and	 downstream	 signals	
that	trigger	cell	spreading	and	adhesion	on	ligand	bearing	substrates	under	static	
conditions.		
LFA‐1	mediated	adhesion	of	monocytes	under	shear‐flow.	Since	extracellular	
Ca2+	affected	conformational	state,	lateral	mobility	and	microclustering	of	LFA‐1	on	
ICAM‐1	 bearing	 patterns,	 we	 studied	 the	 effect	 of	 extracellular	 Ca2+	 on	 cell	
adhesion	to	ICAM‐1	substrates	under	shear	flow.	At	low	shear	flow	conditions	(0.2	
dyn/cm2)	 highest	 adhesion	 was	 found	 at	 1mM	 (Mn2+,	 Ca2+,	 Mg2+),	 followed	 by	
0.4mM	(Ca2+,	Mg2+)	(Fig.	6A),	conditions	where	LFA‐1	is	laterally	mobile	and	able	
to	increase	its	avidity	state.	Remarkably,	adhesion	was	lowest	at	0.04mM	Ca2+	and	
slightly	higher	at	0.04mM	Ca2+,	1mM	Mg2+	(Fig.	6A),	a	situation	where	high‐affinity	
nanoclusters	are	generated	but	lateral	mobility	is	compromised.	Thus,	despite	that	
low	 extracellular	 Ca2+	 levels	 promote	 primed	 LFA‐1,	 the	 integrin	 is	 not	 able	 to	
support	firm	adhesion.		
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At	 higher	 shear‐flow	 conditions	 (0.5	 dyn/cm2),	 firm	 cell	 adhesion	 was	 equally	
maintained	 with	 1mM	 (Mn2+,	 Ca2+,	 Mg2+)	 (Fig.	 6B).	 However,	 cell	 adhesion	 was	
highly	dependent	of	 the	presence	of	Mg2+,	regardless	of	 the	Ca2+	 levels	used	(Fig.	
6B).	Since	low	extracellular	Ca2+	favors	the	extended	form	of	the	integrin	and	Mg2+	
increases	 the	 binding	 strength	 of	 LFA‐1	 to	 ICAM‐1	 without	 affecting	 its	 lateral	
mobility	(Fig.	S5),	these	results	indicate	that	at	higher	shear	forces	affinity	of	LFA‐1	
to	its	ligand	plays	a	more	prominent	role	than	its	lateral	mobility.	
	
	
Figure	3.	The	lateral	mobility	of	LFA‐1	
nanoclusters	is	affected	by	extracellular	
Ca2+.	(A,	C,	E):	Diffusion	coefficients	 for	
the	 total	 (TS2/4)	 LFA‐1	 population	 at	
(A)	 0.1mM	 Ca2+	 (bars)	 compared	 to	
0.4mM	 Ca2+,	Mg2+	 (dash);	 (C)	 0.04mM	
Ca2+	 (bars)	 compared	 to	 0.4mM	 Ca2+,	
Mg2+	 (dash);	 (E)	binned	distribution	of	
D	values	for	different	extracellular	Ca2+	
conditions.	The	vertical	arrow	points	to	
the	 lowest	 binned	 D	 value	 while	 the	
curved	 arrow	 highlights	 the	 slopes	 of	
the	D	values.	(B,	D,	F)	D	values	for	L16+	
nanoclusters	at	 (B)	0.1mM	Ca2+	 (bars)	
compared	 to	0.4mM	Ca2+,	Mg2+	 (dash);	
(D)	 0.04mM	 Ca2+	 (bars)	 compared	 to	
0.4mM	 Ca2+,	 Mg2+	 (dash);	 (F)	 binned	
distribution	 of	 D	 values	 for	 different	
extracellular	 Ca2+	 levels.	 (G,	 H)	
Normalized	 fractions	 of	 stationary,	
slow	and	fast	mobile	subpopulations	for	
(G)	 the	 total	 (TS2/4),	 and	 (H)	 primed	
(L16+)	 nanoclusters	 at	 different	 Ca2+	
levels.	 Error	 bars	 represent	 the	
standard	 deviation.	 (p	 values	 are	
compared	to	the	respective	populations	
at	 0.4mMCa2+,	 Mg2+:	 *	 =	 p<0.001	
compared	 to	 the	 stationary	 fraction;	#	
=	 p<0.00003	 compared	 to	 the	 fast	
fraction;	 †	 =	 p<0.03	 compared	 to	 the	
stationary	 fraction;	 ‡	 =	 p<0.001	
compared	 to	 the	 fast	 fraction).	 (I)	
Binned	 distribution	 of	 D	 values	 for	
TS2/4	 (black	 squares)	 and	 L16	 (green	
circles)	 at:	 left:	 0.4mM	 Ca2+,	 Mg2+;	
middle:	 0.1	 mM	 Ca2+;	 right:	 0.04	 mM	
Ca2+.	 TS2/4	 trajectories:	 369	 (0.4mM	
Ca2+,	 Mg2+),	 318	 (0.1mM	 Ca2+),	 129	
(0.04	 mM	 Ca2+).	 L16	 trajectories:	 669	
(0.4mM	Ca2+,	Mg2+),	656	 (0.1mM	Ca2+),	
102	(0.04	mM	Ca2+).		
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Figure	4.	 The	 actin	 cytoskeleton	 regulates	 the	 diffusion	 of	 LFA‐1	 nanoclusters	 at	 low	 Ca2+	
levels.	 (A,	 B)	 Normalized	 D	 distribution	 for	 (A)	 primed	 (L16+),	 and	 (B)	 total	 (TS2/4)	
nanoclusters	at	0.04mMCa2+,	with	cells	treated	with	CytoD	(1µg/ml)	(bars),	compared	to	the	
control	(DMSO,	1%)	(dash).	(C)	Normalized	fractions	of	stationary	(gray),	slow	(blue)	and	fast	
(orange)	 mobile	 subpopulations	 for	 L16	 (left)	 at	 0.04mM	 Ca2+	 in	 DMSO	 and	 after	 CytoD	
treatment.	 For	 this	 particular	 data	 set	 Dth=0.002µm2/s.	 Due	 to	 limited	 statistics,	 only	 the	
stationary	 fractions	 of	 TS2/4	 (right)	 in	 DMSO	 and	 after	 CytoD	 treatment	were	 estimated.	
Error	bars	represent	the	standard	deviation.	(*	=	p<0.02	compared	to	stationary	in	DMSO;	#	=	
p<0.006	compared	to	stationary	in	DMSO).	TS2/4	trajectories:	55	(DMSO)	and	35	(CytoD).	L16	
trajectories:	94	(DMSO)	and	72	(CytoD).		
	
Discussion	
Earlier	 models	 of	 LFA‐1	 regulation	 proposed	 that	 the	 molecule	 is	 inactive	 and	
confined	 to	 the	 cytoskeleton	 in	 resting	 cells	 and	 released	 from	 its	 cytoskeletal	
constrains	upon	cell	activation,	resulting	in	increased	mobility	and	clustering	12;	14‐
16.	However,	recent	work	on	resting	T	cells	demonstrated	a	more	complex	mobility	
pattern	 of	 LFA‐1	 with	 distinct	 diffusion	 profiles	 and	 different	 subsets	 of	
conformational	states	31.	Here	we	showed	that	at	physiological	cation	conditions,	
LFA‐1	nanoclusters	are	predominantly	mobile,	with	a	subset	of	nanoclusters	being	
in	 the	 extended,	 primed	 form.	 These	 primed	 nanoclusters	 showed	 stationary,	
anomalous	 and	 free	 diffusion	 behavior.	 As	 the	 L16	 epitope	 recognizes	 full	
extension	 of	 the	 αL	 subunit	 26;	 27,	 regardless	 of	 whether	 the	 ligand‐binding	
headpiece	is	closed	(intermediate	form)	or	opened	(high	affinity	form),	the	diverse	
mobility	 profiles	 recovered	 in	 our	 studies	 might	 correspond	 to	 the	 different	
binding	 states	 of	 LFA‐1.	 More	 comprehensive	 models	 describing	 different	
conformational	 states	 of	 LFA‐1	 already	 hypothesized	 the	 existence	 of	 multiple	
intermediate	states	depending	of	their	transient	interaction	with	the	cytoskeleton	
4.	Our	results	demonstrate	now	this	complexity.	We	propose	that	this	repertoire	of	
multiple	 possibilities	 offered	 by	 LFA‐1	 is	 beneficial	 for	 its	 diverse	 adhesive	
processes	dynamically	regulating	migration,	rolling	and	firm	arrest.		
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Figure	5.	LFA‐1	microclustering	and	
cell	adhesion	under	static	conditions	
depends	on	extracellular	Ca2+.	(A,	B)	
Representative	 frames	 of	 movies	
recorded	 in	TIRF	mode	of	L16+‐LFA‐
1	nanoclusters	on	monocytes	 seeded	
on	 ICAM‐1/BSA	 micropatterns,	 at	
(A)	 0.4mM	 Ca2+,	 Mg2+,	 (B)	 0.04mM	
Ca2+.	 Microclusters	 are	 surrounded	
in	 red	 while	 nanoclusters	 are	
highlighted	 by	 white	 arrows.	 Scale	
bars:	 5µm.	 (C)	 Percentage	 of	 cells	
displaying	microclusters	at	different	
cation	conditions.	Error	bars	are	the	
standard	 deviation	 from	 three	
independent	 experiments.	 (D)	
Intensity	distribution	of	nanoclusters	
on	 ICAM‐1	 regions	 at	 0.04mM	 Ca2+	
(bars)	and	0.4mM	Ca2+,	Mg2+	(dash).	
(E,	 F)	 Interference	 reflection	
microscopy	 of	 two	 representative	
monocytes	 seeded	 for	 20	 min	 on	
ICAM‐1	 substrates,	 at	 (E)	 0.4mM	
Ca2+,	 Mg2+,	 and	 (F)	 0.04	 mM	 Ca2+.	
Attachment	areas	were	 (153	±	100)	
µm2	in	(E)	and	(115	±	44)	µm2	in	(F),	
thus	 a	 reduction	 of	 75%	 in	 firm	
contact	 area.	 55	 cells	 inspected	 in	
each	 condition,	 over	 2	 separate	
experiments.	 Scale	 bars:	 5µm.	 (G)	
Histogram	 of	 firm	 cell	 attachment	
ratio	 for	 monocytes	 seeded	 for	 20	
min	on	ICAM‐1	substrates	at	0.04mM	
Ca2+	 (bars)	 and	 0.4mM	 Ca2+,	 Mg2+	
(dash).	 The	 attachment	 ratio	 was	
estimated	 by	 dividing	 the	 main	
contact	 area	 as	 measured	 by	
interference	reflection	microscopy	by	
the	corresponding	bright	field	image.	
Mean	attachment	 ratio	 is	0.70	 (σ=0.19)	 at	0.4mM	Ca2+,	Mg2+	and	0.55	 (σ=0.16)	 at	0.04mM	
Ca2+,	thus	a	reduction	to	79%	compared	to	the	total	cell	size	at	0.4mM	Ca2+.	(H)	Relative	cell	
adhesion	at	0.4mM	Ca2+,	Mg2+	(white)	and	0.04mM	Ca2+	(black)	at	different	seeding	times	on	
ICAM‐1	 substrates.	Results	 from	 two	 independent	 experiments	 from	15	different	bright	 field	
images	at	each	condition.		
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Figure	6.	
Extracellular	Ca2+	
plays	a	differential	
role	on	LFA‐1	
adhesiveness	under	
shear	flow	
conditions.	Cell	
binding	to	ICAM‐Fc	
coated	surfaces	
quantified	as	a	
percentage	of	
maximum	binding	
observed	at	1mM	
Ca2+,	Mg2+,	Mn2+	at	
(A)	0.2	dyn/cm2	and	
(B)	0.5	dyn/cm2.	
Error	bars:	
standard	deviation	
over	average	
binding	calculated	over	5	different	areas.	One	out	of	two	experiments	are	presented.		(*	=	p	<	
0.007	compared	to	1mM	Ca2+,	Mg2+,	Mn2+,	#	=	p	<	0.005	compared	to	1mM	Ca2+,	Mg2+,	Mn2+,	†	=	
p	<	0.01	compared	to	0.04	mM	Ca2+,	‡	=	p	<	0.007	compared	to	0.4mM	Ca2+.		
Our	 results	 also	 provide	 evidence	 for	 the	 strong	 effects	 of	 extracellular	 Ca2+	 on	
conformational	state,	lateral	mobility	and	ligand‐induced	microclustering	of	LFA‐1.	
While	 previous	 works	 demonstrated	 the	 importance	 of	 extracellular	 Ca2+	
regulating	 integrin	 activation	 1;	 28;	 32,	 our	 data	 prove	 that	 extracellular	 Ca2+	 also	
couples	 ligand	 binding	 to	 global	 conformational	 changes	 and	 downstream	
signaling	that	trigger	cell	spreading	and	firm	adhesion	in	the	presence	of	its	ligand.	
The	 mechanism	 by	 which	 extracellular	 Ca2+	 couples	 conformational	 changes	 to	
lateral	mobility	on	the	cell	membrane	must	be	related	to	the	profound	changes	that	
Ca2+	 transmit	 throughout	 the	 global	 structure	 of	 the	 integrin	 towards	 the	
cytoplasmic	 tails,	 by	 acting	 on	 its	 hybrid	 domain	 33.	 Swinging‐out	 of	 the	 hybrid	
domain	 upon	 lowering	 of	 extracellular	 Ca2+	 results	 in	 integrin	 extension	 and	
transmembrane	 domain	 separation	 so	 that	 both	 αL	 and	 β2	 cytoplasmic	 tails	
become	 available	 for	 interaction	 with	 other	 proteins	 on	 the	 inner	 side	 of	 the	
membrane	that	will	regulate	the	lateral	mobility	of	the	receptor	and	its	interaction	
with	the	cytoskeleton	4.	
While	 our	 SDT	 experiments	 have	 been	 performed	 in	 the	 absence	 of	 mechanical	
stimuli,	recent	simulations	predicted	that	force	accelerates	the	swinging‐out	of	the	
hybrid	domain	 facilitating	the	transition	 into	a	high‐affinity	open	headpiece	state	
33.	Low	shear‐forces	were	also	seen	 to	 induce	conformational	 changes	on	 the	α‐I	
domain	of	LFA‐1	increasing	adhesive	interactions	with	its	ligand	by	stabilizing	the	
open	conformation	of	this	domain	34.	Interestingly,	it	has	been	recently	suggested	
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that	preformed	integrin	anchorage	to	the	cytoskeleton	could	be	key	for	the	integrin	
to	load	low	forces	and	undergo	instantaneous	activation	by	surface‐bound	ligands	
35.	Our	data	demonstrate	that	in	the	resting	state	a	significant	fraction	of	LFA‐1	is	in	
primed	form	and	pre‐anchored	to	the	cytoskeleton.	Activation	of	the	 integrin	(by	
Ca2+	 removal,	Mn2+	 or	 activating	 antibodies)	 leads	 to	 an	 increase	 of	 cytoskeleton	
anchorage	 forming	nascent	 sites	 for	 adhesion	after	 ligand	engagement.	 It	will	be	
then	 expected	 that	 this	 pre‐formed	 cytoskeleton	 anchorage	 create	 the	 perfect	
scenario	 for	 tensile	 forces	 to	 facilitate/accelerate	 the	 process	 of	 leukocyte	
adhesion	on	blood	vessels.	Low	affinity,	mobile	LFA‐1	nanoclusters,	 as	 identified	
here,	might	contribute	by	diffusing	to	the	adhesion	sites	initiated	by	the	anchored	
extended	LFA‐1	subsets.		
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Supplementary	information		
Supplementary	Materials	&	Methods.	
Cell	 culture	 and	 labeling	 for	 single	 dye	 tracking.	 THP‐1	 monocytes	 were	 cultured	 in	
RPMI	 1640	 Dutch	 modification	 medium	 supplemented	 with	 10%	 fetal	 calf	 serum	 and	
antibioticantimycotic	 from	Gibco.	 THP‐1	 cells	were	 seeded	 on	 Labtek	 II	 chambered	 cover	
glasses	 coated	 with	 Fibronectin	 (Fn,	 20μg/ml).	 After	 15	 min	 of	 incubation,	 cells	 were	
washed	and	blocked	with	1%	human	serum	(HS)	for	15	min	and	washed	twice	with	buffer	A	
(RPMI‐1640),	 buffer	 B	 (PBS	 and	0.1mM	Ca2+);	 or	 buffer	 C	 (Ca2+‐	 and	Mg2+‐free	HBBS	 and	
0.04mM	 Ca2+),	 depending	 on	 the	 experiment.	 During	 the	 last	 washing	 step,	 cells	 were	
incubated	 for	 5	min	 in	 the	 corresponding	 buffer.	 Cells	 were	 labeled	with	 2μg/ml	 TS2/4‐
ATTO520	 (antibody‐dye	 ratio:	 ~1:0.3),	 or	 0.2μg/ml	 L16‐ATTO647N	 (antibody‐dye	 ratio:	
~1:0.8)	to	allow	for	single	dye	tracking	experiments	(see	sub‐labeling	conditions	for	single	
dye	tracking	and	Fig.	S1),	incubated	for	4	min	and	washed	in	the	corresponding	buffer	prior	
to	single	molecule	experiments	in	epi‐mode.	In	the	case	of	TIRF	inspection	(ventral	side	of	
the	membrane)	cells	were	labeled	in	solution	and	then	allowed	to	adhere	to	the	Fn‐coated	
coverslips	for	15	min.		All	incubation	steps	were	performed	at	37˚C.	Specific	isotype	controls	
were	always	taken	along.	
Preparation	 of	 imDC	 samples	 and	 LFA‐1	 labeling.	 imDCs	 were	 cultured	 from	 human	
peripheral	blood	monocytes.	Briefly,	monocytes	were	 isolated	by	adherence	to	plastic	and	
cultured	in	the	presence	of	IL‐4	and	GM‐CSF	(500	and	800	U/ml,	respectively)	for	10	days.	
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At	day	3,	the	phenotype	of	the	cultured	DCs	was	confirmed	by	flow	cytometry	analysis.	Cells	
were	incubated	for	20	min	on	Poly‐L‐Lysine‐coated	chambered	coverglasses	and	unbound	
cells	were	removed.	Then,	samples	were	blocked	by	15	min	incubation	with	1%	HS	in	RPMI,	
rinsed	 and	 labeled	 with	 TS2/4‐ATTO520	 at	 a	 concentration	 of	 2µm/ml	 for	 4	 min	 and	
washed	 in	 RPMI	 without	 phenol	 red	 prior	 to	 single	 molecule	 experiments	 in	 epi‐mode.	
Experiments	were	performed	on	imDCs	at	days	5‐8	after	differentiation	from	monocytes.		
Preparation	 of	 Cyto‐D	 treated	 samples.	 THP‐1	 cells	 were	 re‐suspended	 in	 buffer	 A	 or	
buffer	C	with	1μg/ml	Cyto‐D,	and	plated	on	Labtek	II	chambered	cover	glasses	coated	with	
Fn	(20μg/ml).	After	10	min	 incubation,	cells	were	washed	and	blocked	with	1%	HS	 in	the	
corresponding	buffer	for	15	min.	After	several	washing	steps	cells	were	labeled	with	TS2/4	
or	L16,	 incubated	 for	5	min	and	washed	 in	 the	 corresponding	buffer.	All	 incubation	 steps	
were	performed	at	37˚C.	Control	experiments	were	carried	out	in	0.5μg/ml	DMSO.	
Sample	 preparation	 on	 ICAM‐1	 micro‐patterned	 surfaces.	 THP‐1	 monocytes	 were	
blocked	with	1%	HS	in	RPMI‐1640	for	15	min,	washed	twice	with	buffer	A,	B	or	C	depending	
of	 the	experiment.	During	 the	 last	washing	step,	 samples	were	 incubated	 for	5	min	 in	 the	
corresponding	buffer.	L16‐Atto647N	was	added	at	a	final	concentration	of	0.125μg/ml	and	
incubated	for	5	min	at	37ºC.	Cells	were	washed	twice	with	the	corresponding	buffer.	Cells	
were	seeded	on	Fn	coated‐glasses	or	 ICAM‐1/BSA	micro‐patterns	 23	 incubated	 for	15	min	
and	washed	with	the	corresponding	buffer	prior	to	TIRF	inspection.	
Sample	 preparation	 using	Mn2+	 and	 KIM185	 activators.	 Fc‐receptors	 on	 THP‐1	 cells	
were	 blocked	 with	 1%HS,	 followed	 by	 sub‐labeling	 with	 non‐blocking	 TS2/4‐Atto488	 in	
solution.	 Cells	 were	 extensively	 washed	 in	 Ca2+	 ‐	 Mg2+	 ‐free	 HBSS	 (Sigma	 Aldrich),	
substituted	with	0.4mM	Ca2+	and	0.4mM	Mg2+,	 to	remove	non‐bound	antibody	conjugates.		
After	washing,	cells	were	resuspended	in	a)	HBSS	+	0.4mM	Ca2+	and	0.4mM	Mg2	b)	HBSS	+	
0.4mM	Ca2+	and	0.4mM	Mg2	+	1mM	Mn2+	or	c)	HBSS	+	0.4mM	Ca2+	and	0.4mM	Mg2	+	5µg/ml	
β2	 activating	 antibody	 KIM185	 (mIgG1).	 Cells	 were	 seeded	 on	 Fn‐coated	 Labtek	 cover	
glasses	for	10	min	at	37°C.	When	using	KIM185	activating	antibody,	cells	were	incubated	5	
min	at	RT	prior	to	seeding	on	Fn.	 Imaging	was	performed	in	TIRF‐mode	and	movies	were	
retrieved	at	a	frame	rate	of	10Hz.	
Sample	preparation	for	TEM	inspection.	THP‐1	cells	were	incubated	in	HBSS	containing	
0.4mM	or	0.04	mM	Ca2+	and	allowed	to	spread	on	glass	coverslips	covered	by	a	thin	layer	of	
poly‐l‐lysine	 (PLL)‐coated	Formvar	 for	1	h	at	37°C,	washed	 to	 remove	unbound	cells,	and	
immediately	fixed	with	1%	PFA	for	15	min.	Subsequent	Ab	and	gold	labeling	was	performed	
as	already	published	20.	After	gold	labeling	and	fixation,	the	specimens	were	dehydrated	and	
transferred	 from	the	glass	onto	copper	grids	as	already	published	20.	The	specimens	were	
observed	in	a	JEOL	1010	transmission	electron	microscope	operating	at	60–80	kV.	For	each	
cell	several	areas	were	analyzed	at	random.	
Shear	flow	chamber	assay.	Coverslips	were	coated	with	10μg/ml	Protein	A	for	2	hours	at	
37˚C	and	washed	with	PBS.	10μg/ml	recombinant	ICAM‐1‐Fc	and	3%	HS	was	added	at	4ºC.	
Bio‐functionalized	coverslips	were	assembled	 in	a	37˚C	Focht	 flow	chamber	and	mounted	
on	 the	stage	of	an	 inverted	phase	contrast	microscope.	THP‐1	cells	were	washed	 in	HBBS	
(Ca2+‐	and	Mg2+‐free)	and	re‐suspended	and	incubated	in	A	(HBSS,	1mM	Mn2+,	Ca2+,	Mg2+),	B	
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(HBSS,	0.04mM	Ca2+)	and	C	(HBSS,	0.04mM	Ca2+	and	0.4mM	Mg2+)	buffers	for	15	min	before	
infusion	 in	 the	 flow	chamber	using	a	 syringe	pump.	Cells	were	allowed	 to	 accumulate	 for	
60s	at	stress	rates	of	0.2‐0.5	dyn/cm2.	After	washing,	adherent	cells	were	counted	 from	5	
microscopic	imaging	fields.	In	blocking	experiments,	10μg/ml	NKI‐L15	was	included	(5	min	
incubation	at	37ºC).		
Sample	preparation	for	two‐color	quantum	dot	tracking.	Streptavidine‐coated	Quantum	
dots	(Invitrogen)	were	added	to	an	equimolar	solution	of	biotinylated	TS2/4	antibody	and	a	
50	 excess	 of	 free	 biotin	 (Gibsco)	 in	 order	 to	 obtain	 a	 1:1	 TS2/4‐Qdot	 ratio.	 After	 >2	 h	
incubation	at	4ºC,	cells	were	 incubated	with	an	equimolar	solution	of	Qdot655‐TS2/4	and	
Qdot585‐TS2/4	conjugates.	Before	 imaging,	non‐bound	conjugate	was	extensively	washed	
out.	 Qdots	were	 excited	 using	 the	 488nm	 line	 of	 an	 Ar/Kr	 laser.	 Simultaneous,	 two‐color	
imaging	 was	 achieved	 using	 a	 beam	 splitter	 that	 projected	 Qdot655	 (red)	 and	 Qdot585	
(green)	 emissions	 onto	 an	 EMCCD	 camera	 (30ms	 per	 frame).	 Finally,	 a	 custom‐designed	
image	registration	method	was	used	to	map	the	relative	positions	of	the	585	and	655	Qdots	
over	the	time	course	of	data	acquisition.	The	accuracy	on	the	determination	of	the	center	of	
mass	position	of	the	Qdots	was	15nm.	
Fluorescence	 trajectory	 analysis.	 Two‐dimensional	 trajectories	 of	 individual	 LFA‐1	
fluorescent	 spots	 in	 the	 focal	 plane	 were	 obtained	 using	 custom‐made	 single‐particle	
tracking	 software	 based	 on	 colloidal	 particle	 tracking	 algorithms	 36	 translated	 to	MatLab.	
Trajectories	 ≥	 13	 frames	were	 retained	 for	 analysis.	MSD	 versus	 time	 lag,	 tlag,	 plots	were	
generated	for	all	possible	tlag	intervals	throughout	each	trajectory.	The	slope	of	the	linear	fit	
through	the	first	three	or	four	points	in	the	MSD	plots	was	determined,	and	the	relationship	
MSD=4Dtlag	 was	 used	 to	 derive	 the	 short	 range	 diffusion	 coefficient	 D.	 Semi‐logarithmic	
histograms	of	the	D	values	were	finally	built.		
Determination	 of	 the	 stationary	 fraction	 of	 trajectories.	 For	 each	 distribution	 of	 D	
values,	the	size	of	the	stationary	population	has	been	estimated	by	scaling	the	D	distribution	
of	 immobile	 nanoclusters	 on	 fixed	 cells	 (Fig.	 S2)	 to	 the	 first	 bar	 (D≤0.001µm2/s)	 of	 the	
histogram	of	experimental	D	values	obtained	on	living	cells.	The	overlapping	area	between	
both	 distributions	 has	 been	 then	 taken	 as	 the	 stationary	 fraction	 of	 trajectories	 on	 living	
cells,	PSTAT	and	estimated	as:			
	
where	Ntotal	 is	the	number	of	trajectories	in	the	given	data	set	and	N<0.001	 is	the	fraction	of	
Ntotal	with	D<0.001µm2/s.	R	is	obtained	from	the	data	set	of	immobile	nanoclusters	on	fixed	
cells	 (Fig.	 S2)	 and	 corresponds	 to	 the	 fraction	of	N<0.001	 to	 the	 total	 number	 of	 stationary	
nanoclusters	on	fixed	cells.		
Cumulative	 probability	 distribution	 (CPD)	 analysis.	 To	 enquire	 on	 the	 long‐term	
diffusion	 behavior	 (>1.5	 s)	 of	 mobile	 trajectories	 we	 applied	 the	 CPD	method	 25.	 Mobile	
trajectories	were	first	selected	from	the	entire	data	set	as	those	displaying	D	>	Dth	(see	note	
on	 determination	 of	 the	 minimum	 detectable	 diffusion	 coefficient).	 Unless	 specified	
PSTAT  N0.001R
100
Ntotal
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otherwise,	CPD	analysis	was	performed	on	trajectories	with	length	≥	21	frames,	where	Dth	=	
0.006µm2/s.	 For	 those	 trajectories,	 we	 then	 generated	 CPD	 functions	 for	 square	
displacements	at	different	time	lags	25.	The	CPD	of	square	displacements	was	 fitted	with	a	
two‐component	Fick’s	law	based	function	as	a	model:	
	
where	P(r2,t)	 is	 the	probability	 that	a	particle	starting	at	 the	origin	will	be	 found	within	a	
circle	of	radius	r	at	time	lag	t.	During	our	analysis,	a	two‐component	fitting	was	always	more	
appropriated	 since	 the	 square	 residuals	 reduced	 more	 than	 10fold	 as	 compared	 to	 one	
component	 fitting.	 From	 the	 fitting,	 a	 set	 of	 three	 parameters	was	 obtained:	 a	 fraction	 of	
slow‐diffusing	molecules	 (s),	 a	mean	square	displacement	of	 this	 slow	 fraction	 (rs2)	 and	 a	
mean	square	displacement	of	the	fast‐diffusing	fraction	(rf2)	of	molecules.	When	the	values	
of	 s,	 rs2	 and	 rf2	 obtained	 from	 these	 fits	 were	 plotted	 versus	 the	 time	 lag,	 the	 diffusion	
behavior	of	the	respective	slow‐	and	fast‐diffusing	populations,	and	their	relative	sizes	were	
obtained.	The	square	displacements	of	both	slow	and	fast	fractions	were	finally	fitted	with	a	
anomalous	 diffusion	 function	 using	 the	 relation	 21	 r(t)2=Γtα+Δ02,	where	 r(t)2	 is	 the	 square	
displacement	of	 the	 component	 in	question	 (slow	or	 fast)	 at	 time	 lag	 t,	Γ	 is	 the	 transport	
coefficient,	α	 is	 the	anomalous	parameter	and	Δ02	 is	 the	square	displacement	offset	at	t=0.	
Diffusion	values	of	the	slow	Ds	and	fast	Df	populations	were	obtained	by	fitting	the	first	four	
points	of	 square	displacement	plots	using	 the	 relation	 r(t)2=4Ds,ft+Δ02.	 In	 summary,	 as	 the	
result	of	 the	 fitting	we	obtained	diffusion	coefficients	Ds,f	and	 the	parameter	αs,f	 indicating	
the	mode	of	motion	(α=1	corresponds	to	free,	Brownian	diffusion	and	α<1	corresponds	to	
hindered,	 anomalous	 diffusion)	 for	 slow	 and	 fast	 mobile	 populations	 respectively.	 The	
errors	 in	the	square	displacements	were	estimated	by	boostrapping	(resampling	residuals	
approach),	the	errors	bars	represent	2	times	the	standard	deviation	originated	from	fitting	
procedures.		
The	 final	 fraction	 of	 stationary,	 slow	 and	 fast	 mobile	 trajectories	 were	 determined	 as	
follows.	 The	 stationary	 fraction	 was	 estimated	 as	 described	 above,	 i.e.,	 by	 scaling	 the	 D	
distribution	of	stationary	nanoclusters	on	fixed	cells	to	the	first	bar	(D<0.001µm2/s)	in	the	
histogram	of	the	experimental	data	set.	The	fit	parameter	s	obtained	from	the	CPD	analysis	
corresponds	 to	 the	 slow	 fraction	 of	 mobile	 nanoclusters	 and	 was	 re‐scaled	 to	 the	 total	
population	 of	 trajectories.	 The	 fast	 mobile	 fraction	 was	 then	 extracted	 from	 subtracting	
stationary	and	slow	from	the	total	population.		
Nano‐	and	micro‐cluster	 intensity	analysis.	Spot	brightness	analysis	was	performed	on	
the	 first	 frame	 of	 each	movie	 obtained	 in	 TIRF	mode.	 The	 brightness	 of	 each	 diffraction‐
limited	 spot	 (nanocluster)	 from	 multiple	 movies	 was	 defined	 as	 the	 (background‐
subtracted)	 sum	 of	 the	 intensities	 of	 all	 the	 pixels	 within	 the	 spot.	 The	 number	 of	 spots	
larger	than	the	diffraction	limit	(microcluster)	was	counted	on	a	semi‐automated	fashion.		
Sub‐labeling	conditions	 for	single	dye	tracking.	Since	single	dye	 tracking	requires	sub‐
labeling	conditions,	we	adjusted	the	labeling	such	that	on	average	one	fluorescent	spot	per	
P(r2, t) 1 s  exp  r
2
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~	4 m2	was	observed.	In	the	case	of	TS2/4‐ATTO520	this	was	achieved	with	2μg/ml	(with	
antibody‐dye	ratio:	~1:0.3)	and	for	L16‐ATTO647N	with	0.2μg/ml	(with	antibody‐dye	ratio:	
~1:0.8).	 In	 these	 conditions,	 one	 or	 two	 photobleaching	 steps	 were	 observed	 for	 both	
TS2/4‐ATTO520	and	L16‐ATTO647N	(Fig.	S1C,D)	consistent	with	single	molecule	labeling.		
The	 measured	 lateral	 mobility	 on	 monocytes	 corresponds	 to	 LFA‐1	 nanocluster	
diffusion	and	not	 to	 individual	LFA‐1	molecules.	 Previous	work	 from	 our	 group	 using	
transmission	 EM	 and	 superresolution	 near‐field	 scanning	 optical	 microscopy	 (NSOM)	
showed	that	LFA‐1	is	organized	in	nanoclusters	on	monocytes	20;	21.	Yet,	in	living	cells	there	
could	be	a	dynamic	situation	with	rapid	interconversion	between	clustered	and	monomeric	
states.	 While	 SDT	 allows	 recording	 trajectories	 of	 individual	 moving	 particles,	 the	 sub‐
labeling	 conditions	 required	 for	 tracking	 prevent	 to	 discriminate	 individual	 LFA‐1	
molecules	 from	 nanoclusters.	 Thus,	 to	 convincingly	 demonstrate	 that	 we	 follow	 the	
diffusion	 of	 individual	 LFA‐1	 nanoclusters	 on	monocytes	we	 provide	 below	 the	 following	
arguments.	
1.‐	 We	 determined	 the	 diffusion	 of	 individual	 LFA‐1	 molecules	 on	 monocyte‐derived	
immature	 dendritic	 cells	 (imDC),	 where	 LFA‐1	 is	 organized	 in	 a	 random	 (monomeric)	
fashion	(Fig.	S3A,B)	20.	Fig.	S3C	shows	the	distributions	of	diffusion	constants	obtained	for	
individual	LFA‐1	on	imDCs,	together	with	that	obtained	on	monocytes.	As	clearly	seen	from	
Fig.	 S3C	 the	 entire	 histogram	 of	 LFA‐1	 on	 imDCs	 is	 shifted	 to	 larger	 D	 values,	 with	
Df=(0.1±0.004)	 µm2/s,	 compared	 to	 Df=(0.056±0.004)	 µm2/s	 obtained	 on	 monocytes	
(quantified	 using	 CPD	 analysis).	 The	 faster	 diffusion	 of	 LFA‐1	 on	 imDCs	 as	 compared	 to	
monocytes	is	consistent	with	a	different	spatial	organization	of	LFA‐1	in	these	cells.		
To	 further	quantify	 these	observations	we	 estimated	 the	dependence	between	 the	 size	 of	
our	 moving	 object	 (LFA‐1	 monomers	 or	 nanoclusters)	 and	 its	 diffusion	 constant	 using	
hydrodynamic	theory.	The	diffusion	constant	D	of	an	impermeable	cylinder	of	radius	R	and	
height	 h,	 moving	 in	 the	 membrane	 with	 viscosity	 µ,	 and	 in	 contact	 with	 a	 less	 viscous	
(aqueous)	medium	with	viscosity	µ’,	is	given	by	37:	
D  (KBT /4h)(ln(h /'R)  y) 	
where	 KB	 is	 the	 Boltzmann	 constant,	 T	 is	 the	 absolute	 temperature	 and	 y	 is	 the	 Euler	
constant.	The	weak	dependence	between	the	diffusion	D	and	the	size	of	the	object	R	in	this	
model	 is	consistent	with	 the	shift	 in	 the	diffusion	constants	observed	between	the	overall	
LFA‐1	population	of	monocytes	and	imDs.	Taking	R	as	the	half	size	of	the	LFA‐1	molecule	2	
and	 that	of	 nanoclustered	LFA‐1	 21,	 and	 introducing	 appropriate	 values	 of	µ	 and	µ’	 38,	we	
find	that	Dindividual	=	0.097	µm2/s	and	Dcluster=0.060µm2/s,	which	is	in	nice	agreement	with	the	
short	time	lag	diffusions	obtained	for	the	fast	mobile	populations	on	imDCs	and	monocytes	
respectively	 (using	 CPD	 analysis).	 	 Similarly,	 we	 find	 Dindividual=0.024µm2/s	 and	
Dcluster=0.016µm2/s	 for	 the	 slow	 mobile	 populations,	 in	 excellent	 agreement	 with	 the	
experimental	 data	 obtained	 on	 imDC	 (0.024µm2/s)	 and	 monocytes	 (0.014µm2/s).	 	 Thus,	
these	data	are	fully	consistent	with	the	fact	that	we	are	tracking	nanoclusters	on	monocytes.	
2.‐	 In	separate	control	experiments	we	 increased	the	 labeling	conditions	of	LFA‐1	on	both	
live	monocytes	and	imDC	with	the	aim	of	determining	the	number	of	labeled	molecules	per	
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fluorescence	 spot,	 while	 still	 being	 able	 to	 manually	 track	 diffusing	 spots	 over	 time.		
Individual	fluorescence	time	trajectories	were	generated	from	multiple	diffusing	spots	and	
the	number	of	 photobleaching	 steps	per	 spot	was	 determined.	 	 In	 the	 case	of	monocytes,	
several	 discrete	 photobleaching	 steps	 were	 identified	 (Fig.	 S3D)	 while	 single	 steps	 were	
found	on	imDC	(Fig.	S3E).	Moreover,	the	intensity	distribution	on	monocytes	showed	a	long	
tail	towards	high	intensity	values	while	the	corresponding	distribution	on	imDC	exhibited	a	
much	 narrower	 distribution	 consistent	with	 the	 emission	 of	 individual	molecules.	 	 These	
results	 on	 living	 cells	 thus	 further	 support	 our	 statement	 that	 LFA‐1	 organizes	 in	
nanoclusters	on	monocytes	while	its	organization	on	imDCs	is	random.		
3.‐	 To	 assess	 the	 stability	 of	 LFA‐1	 nanoclusters	 on	 monocytes	 we	 performed	 two‐color	
quantum	dot	(Qdot)	tracking	at	high	label	densities	following	a	methodology	similar	to	that	
described	by	Low‐Nam	et	al	39.	Two‐dimensional	fluorescence	trajectories	of	spatially	close	
Qdots	 (red	 and	 green)	 were	 generated	 and	 the	 separation	 distance	 between	 Qdots	 was	
plotted	 a	 function	 of	 time	 (Fig.	 S4).	 In	 conditions	 in	which	 an	 individual	molecule	would	
enter	a	nanocluster,	the	separation	distances	between	Qdots	should	decrease	and	maintain	
below	 70nm	 (the	 size	 of	 the	 nanoclusters	 as	 measured	 by	 NSOM)	 while	 exhibiting	
correlated	motion	39.	In	contrast,	large	variations	on	the	separation	distance	and	absence	of	
correlated	motion	indicate	only	random	coincidence	events.	 	 In	our	experiments	we	never	
observed	 correlated	motion	 and	 the	 separation	 distances	 varied	 randomly	 (Fig.	 S4),	with	
only	 a	 few	 events	 occurring	 at	 distances	 below	 70nm,	 and	 having	 a	 persistence	 time	 of	
(50±35)	 ms,	 which	 is	 shorter	 than	 the	 frame	 rate	 used	 in	 the	 series	 of	 experiments	
described	in	the	main	body	of	the	manuscript	(100ms	per	frame).		Thus,	these	experiments	
indicate	 that	 LFA‐1	 nanoclusters	 on	monocytes	 are	 stable	 during	 the	 observation	 time	 of	
our	experiments.	
4.‐	Work	 from	 the	Wilson’s	 Lab	has	 shown	 that	 the	 equilibrium	 situation,	 as	 obtained	 on	
static	 images,	 contains	 indirect	 information	about	 the	 residence	 time	of	 receptors	 in	 their	
clustered	and	monomeric	states	40;	41.	For	instance,	simulations	on	the	highly	clustered	EGF	
receptor	(as	observed	from	transmission	EM)	showed	that	even	when	individual	receptors	
diffuse	 on	 the	 cell	 membrane	 (with	 D	 values	 characteristic	 for	 those	 of	 transmembrane	
proteins,	i.e.,	0.09µm2/s),	clustering	of	the	EGF	receptor	as	observed	from	TEM	images	can	
be	reproduced	in‐silico	provided	that	the	probability	to	enter	in	a	protein	island	(in	our	case	
a	 LFA‐1	 nanocluster)	 is	 much	 higher	 than	 the	 probability	 associated	 with	 exiting	 the	
nanocluster,	 i.e.,	 P=0.9992	vs.	 P=0.0008	 respectively	 in	 the	 reported	 simulations	 41.	These	
simulations	 thus	 indicate	 that	 for	 high	 clustering	 to	 be	 observed	 on	 static	 images,	 the	
interconversion	between	individuals	and	clusters	must	be	very	small.	In	our	particular	case,	
this	means	that	clusters	are	rather	stable	(i.e.,	the	probability	of	an	individual	LFA‐1	to	leave	
a	nanocluster	 is	vanishingly	small)	so	that	during	the	observation	times,	characteristic	 for	
SDT	experiments,	the	large	majority	of	the	LFA‐1	molecules	will	reside	in	nanoclusters	with	
few	LFA‐1	molecules	(~10%)	diffusing	as	monomers.	With	the	sub‐labeling	conditions	used,	
the	probability	of	 labeling	 individual	LFA‐1	molecules	not	associated	with	nanoclusters	 is	
then	negligible.		
5.‐	At	our	SDT	conditions	(10‐20	fs,	~2.5s	observation	times	per	trajectory)	and	considering	
the	diffusion	coefficient	of	 individual	LFA‐1	molecules,	we	should	have	been	able	to	detect	
individual	as	well	as	nanoclusters	of	LFA‐1	diffusing	on	the	cell	surface	of	monocytes,	if	both	
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populations	(monomers	and	clusters)	were	present.	From	our	new	data	on	imDCs,	we	can	
take	 Dindividual	 =	 0.1µm2/s.	 Considering	 that	 the	 density	 of	 fluorescent	 spots	 is	 ρ~2.3	
spots/µm2,	kon	 to	 join	a	nanocluster	can	be	estimated	as	~2D.	ρ=0.23s‐1.	Thus,	 the	average	
time	for	an	individual	LFA‐1	to	find	a	cluster	is	4.3	s,	which	is	longer	than	our	observation	
time,	and	thus	easily	observable	in	our	experiments.	Yet,	we	only	find	a	small	percentage	of	
D	 values	 above	 0.1µm2/s	 (<	 8%),	 confirming	 again	 that	 the	 reported	 D	 values	 largely	
correspond	to	those	of	LFA‐1	nanoclusters.	As	such,	the	short	tail	of	the	D	values	>0.1µm2/s	
could	correspond	to	individual	LFA‐1	molecules	not	associated	with	nanoclusters	while	the	
main	D	distribution	corresponds	to	the	diffusion	of	individual	LFA‐1	nanoclusters.		
The	measured	lateral	mobility	corresponds	to	LFA‐1	nanocluster	diffusion	and	not	to	
LFA‐1	diffusion	inside	nanoclusters.	Single	particle	tracking	approaches	can	in	principle	
record	the	mobility	of	both	LFA‐1	diffusion	within	nanoclusters	and	diffusion	of	the	LFA‐1	
nanoclusters	themselves.	However,	the	set‐up	requirements	for	measuring	one	or	the	other	
are	different	42‐44.	 In	general,	 to	measure	 free	diffusion	 in	an	unlimited	space	there	are	no	
demands	on	the	instrument	in	terms	of	spatial	and	temporal	resolution	43.	However,	 if	the	
molecule	 is	 constrained	 in	 its	 motion,	 both	 high	 spatial	 and	 temporal	 resolution	 are	
required	to	measure	restricted	diffusion.	For	surface	diffusion	with	diffusion	coefficient	D,	
the	required	temporal	resolution	is	related	to	the	size	of	the	restricted	area	by	Δt	<	Lx2/4D	
and	the	spatial	resolution	should	be	smaller	than	the	size	of	the	restricted	area	Δx	<	Lx	42;	43.	
For	instance,	if	one	would	attempt	to	measure	the	diffusion	of	LFA‐1	inside	the	nanoclusters,	
the	 spatial	 resolution	must	 be	Δx	 <	 80nm,	which	 corresponds	 to	 the	 physical	 size	 of	 the	
nanoclusters	 21	 and	Δt	 <	 1.6ms	 (assuming	 a	 diffusion	 coefficient	 of	 0.1µm2/s).	While	 the	
spatial	 resolution	 in	 our	 experimental	 conditions	 is	 in	 principle	 sufficient	 (30‐40nm,	 see	
below),	our	 temporal	 resolution	 is	 limited	by	 the	use	of	 single	 fluorescent	dyes,	 signal‐to‐
noise	ratios	and	camera	settings	to	50‐100ms/frame.	In	these	conditions,	the	characteristic	
restricted	diffusion	 as	 expected	 for	 individual	 LFA‐1	diffusion	within	 a	 nanocluster	 is	 not	
observable.	In	contrast,	the	temporal	resolution	and	spatial	localization	accuracy	of	our	set‐
up	is	adequate	for	measuring	both	random	and	anomalous	diffusions	of	the	nanoclusters,	as	
shown	 in	 the	 histograms	 of	 Fig.	 1‐5.	 Therefore,	 under	 our	 experimental	 conditions	 the	
measured	diffusions	reported	in	here	correspond	to	those	of	the	entire	LFA‐1	nanoclusters.			
Position	accuracy	of	the	single	molecule	epi‐fluorescence	set‐up.	The	position	accuracy	
of	 the	 set‐up	 has	 been	 determined	 in	 two	 ways:	 first	 using	 an	 estimation	 based	 on	 the	
formalism	described	by	Thompson	et	al	45	and	second,	by	measuring	directly	the	diffusion	
coefficient	of	stationary	nanoclusters	on	fixed	cells.	In	the	first	case,	the	position	accuracy	is	
given	by	45:	
	
where	N	is	the	number	of	collected	photons	per	molecule	per	frame	(N=225),	a	is	the	pixel	
size	 (a=0.135µm),	 b	 is	 the	 background	 noise	 per	 pixel	 (b=10),	 and	 s	 is	 the	 standard	
deviation	 of	 the	 point‐spread	 function	 for	 wide	 field	 microscopy	 (s	 ~120	 nm).	 For	 each	
dimension,	the	estimated	position	accuracy	for	sub‐labeled	L16+	nanoclusters	(labeled	with	
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ATTO647N)	on	fixed	cells	was	found	~25	nm.	In	the	case	of	TS2/4	the	estimated	position	
accuracy	was	slightly	lower	due	to	the	lower	quantum	yield	of	ATTO520.		
In	the	second	case,	the	position	accuracy	has	been	determined	from	a	direct	measurement	
taking	the	offset	at	the	origin	of	a	 linear	fit	to	the	mean	square	displacement	(MSD)	curve.	
The	MSD	offset	<	r(0)2>	=	Δ02/2d	where	Δ02	is	the	intercept	of	the	linear	fit	to	the	MSD	curve,	
and	d	 corresponds	 to	 the	number	of	dimensions	 in	which	 the	diffusion	 takes	place	 46.	We	
determined	 Δ02	 from	 the	MSD	 of	 individual	 L16‐ATTO647N	 conjugates	 on	 glass	 and	 sub‐
labeled	 L16+	 nanoclusters	 on	 fixed	 cells.	 For	 each	 dimension,	 the	 resulting	 position	
accuracies	were	37nm	for	single	molecules	immobilized	on	glass	and	47nm	for	sub‐labeled	
nanoclusters	 on	 fixed	 cells.	 These	 values	 are	 well	 below	 the	 diffraction	 limit	 of	 the	
microscope	 and	 comparable	 to	 other	 single	 dye	 tracking	 studies	 25;	 47;	 48.	 Since	 the	
experimental	values	are	slightly	lower	than	the	estimated	ones,	we	take	these	experimental	
position	 accuracies	 to	 further	 determine	 the	minimum	detectable	 diffusion	 coefficients	 of	
individual	trajectories.		
	
Determination	of	the	minimum	detectable	diffusion	coefficient.	The	diffusion	constant	
D	of	a	probed	object	is	calculated	from	the	linear	fit	through	the	mean‐square‐displacement	
(MSD)	 versus	 time	 lag	 points.	 The	 errors	 in	 the	MSD	 points	will	 depend	 on	 the	 position	
accuracy	 of	 the	 set‐up	 and	 on	 the	 trajectory	 length.	 Experimentally,	 we	 determined	 the	
minimum	 detectable	 diffusion	 coefficient	 by	 directly	 measuring	 individual	 trajectories	 of	
immobilized	 TS2/4‐ATTO520	 and	 L16‐ATTO647N	 LFA‐1	 nanoclusters	 on	 fixed	 cells.	 The	
corresponding	distributions	of	D	values	are	shown	in	Fig.	S2.	We	define	Dth	as	the	minimum	
detectable	 diffusion	 value	 and	 corresponds	 to	 the	 95th	 percentile	 of	 the	 distribution	 of	
diffusion	 coefficients	 of	 the	 specific	 label	 (TS2/4	 or	 L16)	 imaged	 on	 fixed	 cells.	 For	
trajectories	with	a	minimum	length	of	21	frames,	Dth=0.006µm2/s	and	for	trajectories	with	a	
minimum	 length	 of	 13	 frames,	 Dth=0.01µm2/s.	 	 We	 thus	 used	 these	 Dth	 values	 to	
discriminate	the	mobile	fraction	of	LFA‐1	nanoclusters	that	were	further	investigated	with	
the	CPD	method.	
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Supplementary	Table	S1.	
Diffusion	 coefficients,	 α	 values	 and	 different	mobility	 populations	 for	 the	 TS2/4	 and	 L16	
reporters	at	different	extracellular	cation	conditions.	Data	shown	correspond	to	THP‐1	cells,	
except	the	last	raw	which	correspond	to	diffusion	values	obtained	on	imDCs).		
*	Ds,f	and	αs,f		and	their	respective	fractions	were	not	determined	due	to	limited	
statistics.	
	
	
	
	
	
	
	
Ab Treatment N Ds 
(10-2 
m2/s)
s Df 
(10-2 
m2/s)
f % 
stationa
ry 
% 
slow 
% fast
TS2/4 0.4mM 
(Ca2+, Mg2+) 
369 1.4±0.5 0.9±0.2 5.6±0.2 0.94±0.06 5.0 ± 1.4 32 ± 6 64 ± 7 
TS2/4 0.1mM Ca2+ 318 1.5±0.4 0.9±0.4 7.9±0.1 0.8±0.2 6.2 ± 1.7 45 ± 9 48 ± 9
TS2/4 0.04mM 
Ca2+ 
129 0.8±0.3 0.7±0.2 7.3±0.1 0.61±0.09 43 ± 10 34±14 23 ± 6 
TS2/4 0.04mM 
Ca2+ + 
DMSO 
55* - - - - 40 ± 13 - - 
TS2/4 0.04mM 
Ca2+ +CytoD 
35* - - - - 5 ± 5 - - 
L16 0.4mM 
(Ca2+, Mg2+) 
669 1.7±0.1 0.49±0.0
6 
8.1±0.1 0.91±0.02 19 ± 3 28 ± 4 53 ± 4 
L16 0.1mM Ca2+ 656 0.98±0.03 0.61±0.0
5 
7.6±0.1 0.89±0.01 17 ± 2 23 ± 4 60 ± 4 
L16 0.04mM 
Ca2+ 
102 0.29±0.04 1.0±0.2 3.5±0.4 0.66±0.09 36 ± 8 37±13 27 ± 6 
L16 0.04mM 
Ca2+ + 
DMSO 
94 0.12±0.04 0.8±0.2 9.0±0.2 0.77±0.05 30 ± 8 
 
37±11 33 ±5 
L16 0.04mM 
Ca2+ +CytoD 
72 0.7±0.02 0.46±0.0
8 
5.6±0.2 0.95±0.05 10 ±5 55±10 35 ± 8 
TS2/4 
(imD
C) 
0.4mM 
(Ca2+, Mg2+) 
276 2.4±0.09 0.9±0.09 10±0.4 0.93±0.02 10 ±2.9 20 ± 4 69 ±6 
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Supplementary Figures 
Fig.	S1.	LFA‐1	nanocluster	
organization	 on	
monocytes	 and	 sub‐
labeling	 conditions	 for	
single	 dye	 tracking.	 (A)	
Superresolution	 near‐field	
scanning	 optical	
microscopy	(NSOM)	 image	
at	 the	 cell	 surface	 of	
monocytes	 using	 mAb	
TS2/4‐Alexa647.	 Cells	
were	allowed	to	adhere	on	
polyL‐lysine	 coated	
coverslips	for	20	min	at	37	
°C.	 After	 washing,	 cells	
were	 fixed	 in	 2%	 PFA	 at	
room	 temperature.	 The	
sample	 was	 incubated	
with	 CLSM‐buffer	
containing	 2%	 human	
serum	 to	 block	 Fc‐
receptors.	LFA‐1	was	labeled	with	10µg/mL	mAb	TS2/4,	which	ensured	maximum	labeling	of	
LFA‐1	 (saturation	 conditions	 as	 determined	 by	 flow	 cytometry).	 The	 optical	 resolution	
(~80nm)	of	NSOM	allowed	imaging	of	individual	spots	of	LFA‐1	distributed	on	the	cell	surface.	
Scale	bar:	1µm.	(B)	Intensity	count‐rate	distribution	of	LFA‐1	nanoclusters	(220	spots)	(gray)	
over	 multiple	 cells	 and	 of	 individual	 Abs.	 non‐specifically	 attached	 to	 the	 glass	 surface	
(dashed).	Spot	sizes	were	determined	using	the	full‐width‐at‐half‐maximum	(FWHM)	of	a	2‐D	
Gaussian	fit	to	the	intensity	profile.	Brightness	of	each	spot	(kcounts/s)	was	then	defined	as	the	
background‐corrected	 average	 over	 all	 pixels	within	 the	 FWHM.	 The	 long	 extension	 of	 the	
brightness	distribution	towards	high	 intensity	count	rates	is	indicative	of	LFA‐1	clustering	on	
the	 cell	 surface.	 (C)	Representative	examples	of	one‐	or	 two‐	 step	photobleaching	of	TS2/4‐
ATTO520	(left)	and	L16‐ATTO647N	(right)	on	the	surface	of	fixed	cells.	The	intensity	profiles	of	
individual	 LFA‐1	 spots	 imaged	 for	 ~30	 s	 show	 the	 characteristic	 discrete	 steps	 of	
photobleaching	 of	 individual	 dye	molecules	 (one	 or	 two	 steps	 in	 the	 examples	 given).	 (D)	
Intensity	distribution	of	 sub‐labeled	L16+‐LFA‐1	nanoclusters	 (170	 spots)	over	multiple	cells.	
The	 percentage	 of	 one,	 two	 or	 three	 L16‐ATTO647N	 per	 nanocluster	 was	 derived	 from	
Gaussian	fittings	to	the	sub‐labeled	LFA‐1	distribution:	one:	52%	(blue),	two:	25%	(magenta),	
three:	18%	(orange)	and	the	remaining	(5%)	containing	a	higher	number	of	L16‐ATTO647N.		
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Fig.	 S2.	 Normalized	 diffusion	 histograms	 of	 TS2/4‐	 (A)	 and	 L16+‐	 (B)	 sub‐labeled	 LFA‐1	
nanoclusters	 on	 fixed	 cells	 for	 different	 trajectory	 lengths.	 After	 appropriate	 labeling,	 cells	
were	fixed	with	2%	PFA	in	PBS	and	kept	in	fixative	during	measurements.	TS2/4	trajectories:	
122	with	a	length	≥	13	frames.	L16	trajectories:	214	with	a	length	≥	13	frames	and	119	with	a	
length	 ≥	21	 frames.	 *	denotes	 the	boundary	of	Dth	 for	 the	minimum	 trajectory	 length	of	21	
frames	(L16	)	and	13	frames	(TS2/4).	Since	TS2/4	was	labeled	with	ATTO520	(shorter	lifetime	
and	 lower	 quantum	 yield	 than	ATTO647N),	 shorter	 and	 lower	 number	 of	 trajectories	were	
obtained	 and	 thus	 analysis	 performed	 with	 trajectories	 >	 13	 frames.	 Estimation	 of	 the	
stationary	population	of	 the	whole	data	set	on	 living	cells	at	different	cation	conditions	was	
performed	by	taking	as	reference	the	histograms	obtained	in	fixed	cells	(A,	B).  
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Fig.	S3.	Static	and	dynamic	 imaging	of	LFA‐1	at	different	 labeling	conditions	confirms	LFA‐1	
nanoclustering	 on	monocytes.	Nanometer	 scale	 spatial	organization	of	LFA‐1	on	monocytes	
(A)	 and	 imDCs	 (B)	 as	 inspected	 with	 transmission	 electron	 microscopy	 (TEM)	 (2).	 On	
monocytes	LFA‐1	 is	highly	clustered	while	on	 imDCs	LFA‐1	 is	monomeric	(2).	(C)	Normalized	
distribution	of	diffusion	constants	of	TS2/4	 labeled	LFA‐1	on	 imDCs	 (bars),	compared	 to	 the	
distribution	of	LFA‐1	nanoclusters	on	monocytes	(dotted	envelope	lines).	276	trajectories	from	
32	different	imDCs	and	370	trajectories	from	128	THP‐1	cells	were	analyzed.	The	distribution	
of	individual	LFA‐1	on	imDCs	is	significantly	shifted	to	larger	D	values	compared	to	monocytes,	
consistent	 with	 a	 different	 spatial	 organization	 of	 LFA‐1	 on	 both	 cell	 types.	 (D)	 (left):	
Representative	 examples	 of	 two	 fluorescence	 time	 trajectories	 recorded	 on	 live	monocytes	
labeled	with	TS2/4‐ATTO488	 (antibody:dye	 labeling	 efficiency	1:1.2	as	determined	with	 the	
Nano‐drop)	at	higher	labeling	conditions	showing	multiple	and	discrete	photobleaching	steps.	
(Middle):	 Intensity	 distribution	 over	multiple	 trajectories	 on	monocytes	 showing	 a	 long	 tail	
towards	 large	 intensity	values,	 consistent	with	nanoclustering.	The	 inset	 shows	 the	 intensity	
distribution	corresponding	to	the	first	photobleaching	step.	(Right):	Distribution	of	the	number	
of	photobleaching	steps	per	fluorescent	spot.	Since	the	antibody:dye	ratio	is	1.2,	the	number	of	
steps	corresponds	approximately	 to	 the	number	of	 labeled	LFA‐1	molecules	per	nanocluster.	
(E)	Counterpart	results	obtained	on	live	imDC	under	similar	high	labeling	conditions	as	in	D.	In	
contrast	 to	monocytes,	 a	 single	 step	 photobleaching	 is	 found	 on	 imDC	 consistent	with	 the	
random	organization	of	LFA‐1	on	these	cells.		
	
	
Fig.	 S4.	 Dual	 color	
Qdot	 tracking	
shows	 no	 evidence	
of	 LFA‐1	 molecules	
entering	 or	 leaving	
a	 nanocluster.	 (A)	
Still	 frame	 of	 a	
movie	 showing	
individual	 LFA‐1	
nanoclusters	
labeled	 with	 either	
green	 (585)	 or	 red	
(655)	 quantum	
dots;	 and	 sample	
time	 series	 of	 two	
Qdots	 (red	 and	
green)	 spatially	
close	 in	 time	 (see	
white	 arrows).	 (B)	
Full	reconstruction	of	the	2D	green	and	red	trajectories	 in	time	of	the	two	Qdots	shown	 in	A.		
High	 labeling	conditions	have	been	used	to	 increase	the	probability	of	observing	such	events.	
Yet,	no	correlated	motion	was	ever	observed.	(C)	Examples	of	separation	distances	obtained	for	
three	 pairs	 of	 seemly	 closed	 Qdots,	 showing	 large	 and	 random	 variations	 in	 the	 relative	
positions	between	Qdots.		
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Fig.	 S5.	 Mg2+	 does	 not	
influence	 the	 lateral	
mobility	 of	 LFA‐1	
nanoclusters	 at	 low	
Ca2+	 conditions.	 (A,B)	
Normalized	distribution	
of	 D	 values	 for	 the	
primed	 L16+‐	 LFA‐1	
nanoclusters	at	0.04mM	
Ca2+	 (A)	 and	 0.04mM	
Ca2+,	1mM	Mg2+	(B).	(C)	
Binned	distribution	of	D	
values	 at	 0.04mM	 Ca2+	
in	 the	 absence	 (yellow	
circles)	 or	 presence	 of	
1mM	 Mg2+	 (green	
triangles).	 (D)	
Normalized	 fractions	of	
stationary	 and	 mobile	
trajectories	at	0.04	mM	
Ca2+	 (black)	 and	
0.04mM	 Ca2+,	 1mM	
Mg2+	(dark	gray).	For	comparison,	the	fraction	of	stationary	and	mobile	trajectories	at	0.4mM	
Ca2+,	Mg2+	(light	gray)	obtained	 in	the	same	set	of	experiments	are	also	 included.	Number	of	
trajectories:	 115	 from	7	 cells	at	0.04mM	Ca2+,	237	 trajectories	 from	 8	 cells	at	 0.04mMCa2+,	
1mM	Mg2+	 and	 229	 trajectories	 from	 6	 cells	 at	 0.4mM	 Ca2+,	Mg2+.	 Trajectory	 length	 ≥	 13	
frames.	Dth=	0.003µm2/s	as	determined	 from	the	distribution	of	D	values	on	 fixed	cells	under	
similar	excitation	conditions.	Separation	of	stationary	from	mobile	trajectories	was	performed	
using	Dth=0.003µm2/s,	 so	 that	 trajectories	with	D	 ≤0.003µm2/s	were	 classified	as	 stationary	
and	trajectories	with	D	>	0.003µm2/s	were	considered	as	mobile.	Populations	marked	with	*	
were	 considered	 significantly	 different	 from	 the	 corresponding	 stationary	 and	 mobile	 at	
0.4mM	Ca2+,	Mg2+,	with	p<0.001.	
	
Fig.	S6.	The	number	of	 stationary	LFA‐1	nanoclusters	 is	unregulated	by	 integrin	activators,	
such	as	Mn2+	and	activating	antibodies.	(A,B)	Normalized	distribution	of	D	values	 for	TS2/4‐
ATTO488	LFA‐1	nanoclusters	at	0.4mM	Ca2+/Mg2+	+	1mM	Mn2+	 (A)	and	0.4mM	Ca2+/Mg2+	+	
KIM185	(B),	obtained	using	TIRF	illumination	on	the	ventral	side	of	monocytes.	(C)	Normalized	
fractions	of	stationary,	slow	and	fast	mobile	trajectories	recovered	from	CPD	analysis	for	Mn2+	
(dark	gray)	and	KIM185	(black).	For	comparison,	similar	fractions	at	0.4mM	Ca2+,	Mg2+	(light	
gray)	obtained	 in	the	same	set	of	experiments	are	also	 included.	Number	of	trajectories:	482	
from	 6	 cells	 at	 0.4mM	 Ca2+/Mg2+	 +	 1mM	 Mn2+;	 300	 trajectories	 from	 9	 cells	 at	 0.4mM	
Ca2+/Mg2+	 +	 KIM185;	 and	 464	 trajectories	 from	 12	 cells	 at	 0.4mM	 Ca2+/Mg2+	 from	 two	
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separate	 experiments.	Trajectory	 length	 ≥	 13	 frames.	 Separation	 of	 stationary	 from	mobile	
trajectories	was	performed	using	Dth=0.002µm2/s.		
	
	
	
	
	
	
	
	
	
Fig.	S7.	Effect	of	cytoskeleton	disruption	on	the	mobility	of	primed	L16+‐LFA‐1	nanoclusters	at	
0.4mM	Ca2+,	Mg2+	conditions.	(A)	Normalized	distribution	of	the	D	values	of	CytoD	treated	cells	
(bars)	 and	 untreated	 (dashed	 lines).	 (B)	Normalized	 fraction	 of	 stationary	 trajectories	 for	
CytoD	treated	and	untreated	cells.	*	=	p	<	0.04.	Number	of	trajectories:	66	 for	CytoD	treated	
and	669	for	untreated	cells.	Trajectory	length	>	13	frames.	
	
Fig.	 S8.	 The	 organization	 of	 LFA‐1	 in	 nanoclusters	 remains	 unaltered	 at	 0.04mM	 Ca2+	
conditions.	 THP‐1	 monocytes	 were	 specifically	 labeled	 with	 10	 nm	 gold	 and	 treated	 for	
Transmission	 Electron	Microscopy	 (TEM).	 Representative	 processed	 digital	 TEM	 images	 of	
TS2/4	 labeled	 LFA‐1,	 for	 cells	 treated	 at	 0.4mM	 Ca2+	 (A)	 and	 0.04mM	 Ca2+	 (B),	 where	
nanoclusters	of	different	size	 (i.e.,	number	of	particles/nanocluster)	are	 shown	 in	a	different	
color.	Scale	bar	=	100nm.	(C)	Quantitative	analysis	of	the	distribution	of	gold	particles	labeling	
LFA‐1.	Digital	 images	were	processed	by	a	 custom‐written	 software	based	on	Labview.	Gold	
labels	were	counted,	and	coordinates	were	assigned	to	each	 feature.	The	partitioning	of	gold	
labels	 in	nanoclusters	of	various	 sizes	 (i.e.,	number	of	particles/nanocluster)	was	quantified.	
Nanoclusters	 were	 defined	 when	 gold	 particles	 were	 within	 75	 nm	 from	 their	 nearest	
neighboring	particles.	The	percentage	of	gold	particles	 involved	 in	the	formation	of	a	certain	
nanocluster	size	was	then	calculated.	
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Summary	
The	 plasma	membrane	 (PM)	 is	 a	 highly	 complex	 fluid	 system,	 in	 which	
different	 compartments	 coexist	 in	 a	 dynamic	 fashion	 and	 regulate	 receptor	
function.	Integrins	are	transmembrane	(TM)	adhesion	receptors	that	are	essential	
for	 cell‐matrix	 and	 cell‐cell	 interactions.	Recently,	we	 showed	 that	 the	 leukocyte	
specific	 integrin	 lymphocyte	 function‐associated	 antigen‐1	 (LFA‐1)	 resides	 in	
nanoclusters	 with	 a	 specific	 but	 distinct	 nanoscale	 organization	 proximal	 to	
domains	enriched	in	glycosylphosphatidyl‐inositol	anchored	proteins	(GPI‐APs)	in	
quiescent	monocytes.	Lateral	mobility	of	LFA‐1	nanoclusters	and	their	respective	
conformational	 state	were	 interlinked	 and	 crucial	 for	 ligand	 binding.	 In	 view	 of	
recent	 findings	 that	 PM	 lipids	 can	 influence	 receptor	 function,	 the	 question	 is	
emerging	how	integrins	are	regulated	in	the	context	of	the	lipid	nanoenvironment.	
Here	 we	 studied	 LFA‐1	 function	 and	 dynamics	 by	 single	 dye	 tracking,	 upon	
depletion	of	cholesterol	and	sphingomyelin	(SM).	Our	results	emphasize	a	critical	
but	 distinct	 role	 of	 cholesterol	 and	 SM	 in	 regulating	 LFA‐1	 binding,	 as	 well	 as	
lateral	 diffusion	 and	 confinement,	 without	 affecting	 the	 integrity	 of	 LFA‐1	
nanoclusters.	Cholesterol	mainly	contributes	to	maintain	the	proper	interaction	of	
the	LFA‐1	α	and	β	chains,	while	SM	essentially	mediates	interaction	of	LFA‐1	with	
the	 cytoskeleton.	 Altogether,	 our	 work	 demonstrates	 for	 the	 first	 time	 how	
cholesterol	and	SM	contribute	to	regulate	LFA‐1	function	within	the	native	PM	and	
proposes	 a	 novel	 view	 on	 the	 regulation	 of	 integrin	 activity	 that	 goes	 beyond	
classical	affinity	and	avidity	regulation.	
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Introduction	
The	PM	is	composed	of	a	lipid	bilayer	consisting	of	hundreds	of	different	
lipid	species,	containing	TM	proteins	and	proteins	associated	with	outer	or	 inner	
leaflet	 lipids.	 In	 the	 modern	 view	 of	 the	 PM,	 proteins	 and	 lipids	 can	 locally	
segregate	 into	 PM	 compartments	 that	 dynamically	 interact	 with	 each	 other	 to	
regulate	protein	and	lipid	function	1;	2.	
The	best	described	PM	compartments	are	the	so	called	“rafts”	that	are	rich	
in	cholesterol,	sphingomyelin	(SM)	and	embed	GPI‐APs	2.	Raft	domains	are	readily	
assembled	in	artificial	membranes	and	in	membrane	preparations	2,	however	their	
existence	 in	 living	membranes	remains	controversial.	Nevertheless,	 the	existence	
of	specific	 lipid	nanodomains	consisting	of	 the	glycosphingolipids	GM1	and	GM3,	
as	well	as	SM‐rich	clusters	has	recently	been	detected	3;	 4.	The		 importance	of	the	
specific	 lipid	environment	 in	regulating	receptor	 function	was	highlighted	by	 the	
findings	 that	 the	 activation	 state	 of	 an	 ion	 channel	 was	 directly	modified	 by	 its	
surrounding	 lipids	 5,	 and	 that	 the	 ganglioside	 GM3,	 but	 not	 other	 related	 lipids,	
directly	 influenced	 the	 allosteric	 	 transition	 of	 the	 epidermal	 growth	 factor	
receptor	from	an	inactive	to	an	active	signaling	dimer	6.	Similar,	cholesterol	locally	
sequesters	 proteins	 involved	 in	 signal	 transduction	 7	 or	 induces	 conformational	
changes	 of	 glycolipid	 headgroups	 by	 direct	 interaction,	 thereby	 modulating	
receptor	function	8.	Besides	cholesterol,	also	de	novo	synthesized	ceramides	(Cer)	
as	well	as	shinghomyelinase	(SMase)	induced	hydrolysis	of	SM	into	Cer	influences	
receptor	 function	 by	 formation	 of	 Cer‐enriched	 microdomains	 in	 artificial	
membranes	 9.	 Cer‐enriched	 microdomains	 can	 significantly	 affect	 membrane	
curvature	and	stability	due	to	very	tight	packing	of	molecules,	thereby	promoting	
pore	formation,	membrane	fusion	and	vesicle	budding	9.	Moreover,	breakdown	of	
SM	into		Cer	partially	displaces	cholesterol	from	rafts,	which	is	accompanied	by	a	
release	of	cholesterol	from	the	membrane	10;	11.		 	
Several	 studies	 have	 demonstrated	 a	 dependency	 of	 protein	 and	 lipid	
dynamics	on	the	cholesterol	and	SM	content	in	the	PM	12‐14.	The	hydrophobic	TM	
regions	of	proteins	are	in	direct	contact	with	the	lipid	nanoenvironment	of	the	PM	
and	 are	 therefore	 prone	 to	 modulation	 by	 lipids.	 As	 a	 classical	 TM	 receptor,	
integrins	mediate	cell‐cell	and	cell‐matrix	interactions	and	play	a	fundamental	role	
during	cell	adhesion	and	migration.	Integrins	are	heterodimers	composed	of	an	α	
and	 β	 subunit	 and	 their	 regulation	 occurs	 via	 conformational	 changes	 that	 alter	
affinity	 for	 ligand	 or	 via	 dynamic	 redistribution	 in	 the	 membrane	 that	 locally	
increases	 the	 receptor	 density	 (i.e.	 valency)	 leading	 to	 increased	 avidity	 15.	 The	
lipids	 in	 which	 integrins	 are	 embedded	 are	 likely	 to	 influence	 these	
rearrangements;	however,	how	 this	occurs	 is	 still	 largely	unknown.	Recent	work	
indicated	 that	 both	 Talin	 and	 Kindlin‐3,	 which	 are	 involved	 in	 integrin	 affinity	
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regulation,	require	anchoring	to	the	PM	inner	leaflet	lipids	via	phosphatidylinositol	
4,5‐bisphosphate	 (PIP2)	 16;	 17.	 Additionally,	 Moore	 et	 al	 showed	 that	 the	
phospholipids	of	the	inner	PM	directly	influence	the	affinity	of	Talin‐1	towards	the	
β3	 chain	 and	 thereby	 regulating	 β3	 activation	 18,	 indicating	 that	 integrins	 are	
sensitive	to	changes	in	their	surrounding	lipid	nanoenvironment.		
Lymphocyte	 function‐associated	 antigen	 1	 (LFA‐1,	 αLβ2)	 is	 a	 leukocyte	
specific	 integrin	 that	 mediates	 firm	 arrest	 on	 the	 endothelium	 and,	 within	 the	
lymph	 nodes,	 cell	 tethering	 and	 the	 formation	 of	 the	 immunological	 synapse,	 by	
binding	 its	 major	 ligand	 ICAM‐1	 19.	 By	 exploiting	 high	 resolution	 imaging	
techniques,	we	recently	showed	that	LFA‐1	on	quiescent	monocytes	organized	 in	
well‐defined	 nanoclusters	 and	 that	 a	 fraction	 of	 these	 nanoclusters	 contained	
exclusively	high	affinity	LFA‐1	20.	In	contrast	to	earlier	findings	where	active	LFA‐1	
on	 T	 cells	 associated	 with	 rafts	 upon	 cytoskeletal	 release	 21,	 these	 nanoclusters	
reside	in	proximity	to	domains	enriched	in	GPI‐APs,	without	physical	 intermixing	
22.	 By	 exploiting	 single	 dye	 tracking	 (SDT)	we	 showed	 that	 lateral	 diffusion	 and	
conformation	 of	 LFA‐1	 nanoclusters	 are	 highly	 interlinked:	 LFA‐1	 was	 mainly	
mobile,	with	small	and	fast	diffusion	profiles,	while	a	small	fraction	of	high‐affinity	
LFA‐1	was	 anchored	 to	 the	 cytoskeleton	 (23,	 chapter	6).	 Upon	 ligand	 encounter,	
LFA‐1	 nanoclusters	 diffused	 in	 a	 non‐directed	 fashion	 and	 fused	 with	 ligand‐
engaged	LFA‐1	to	grow	into	larger	ligand	binding	sites	24.		
In	our	previous	studies	we	have	also	demonstrated	an	 important	 role	of	
cholesterol	in	mediating	LFA‐1	‐	GPI‐AP	interconnectivity	at	the	nanoscale	and	the	
formation	of	larger	raft‐based	adhesion	sites	upon	ligand	binding	22;	 25.	Moreover,	
others	have	reported	the	loss	of	β2‐integrin	mediated	adhesion	due	to	reduction	of	
SM	levels	in	leukocytes	26.	Although	this	emphasizes	an	essential	role	of	cholesterol	
and	SM	in	maintaining	β2	integrin	function,	how	these	distinct	lipid	species	modify	
integrin	function	in	the	native	PM	remains	largely	unknown.	
In	 this	 study,	we	 investigated	 the	 contribution	 of	 SM	 and	 cholesterol	 on	
different	levels	of	LFA‐1	regulation	in	the	PM	of	living	human	monocytes.	While	the	
integrity	of	LFA‐1	nanoclusters	was	maintained	in	the	absence	of	cholesterol	and	
SM,	 we	 show	 that	 both	 lipids	 were	 essential	 for	 proper	 diffusion	 of	 LFA‐1	
nanoclusters	and	subsequent	binding	 to	 ICAM‐1.	Moreover,	we	demonstrate	 that	
SM	 and	 cholesterol	 contribute	 to	 different	 extents	 to	 LFA‐1	molecular	 structure	
and	 influence	 LFA‐1	 dynamics	 by	 distinct	 underlying	 mechanism.	 These	 results	
suggest	a	fundamental	interplay	of	cholesterol	and	SM	with	LFA‐1	in	the	native	PM	
that	 provides	 a	 proper	 lipid	 nanoenvironment	 that	 facilitates	 integrin‐mediated	
adhesion.   
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Materials	and	Methods	
Antibodies	and	Reagents		
The	 mouse	 mAbs	 against	 αL	 integrin	 were	 NKI‐L15	 27,	 NKI‐L16	 28	 and	 TS	 2/4	 (kindly	
provided	by	E.	Martz).	The	mouse	mAbs	 against	β2	were	KIM185	 (kindly	provided	by	M.	
Robinson,	 Celltech,Slough,	 United	 Kingdom)	 29	 and	 L19	 27	 and	 against	 β1	 TS2/16	 30.	 For	
confocal	microscopy	we	included	CD55	(clone	IA10,	Pharmingen)	and	CD71	(clone	B3/25).	
GM1	was	labeled	with	recombinant	Cholera	Toxin	Subunit	B	Alexa	Fluor®	647	Conjugated	
(Molecular	 Probes®).	 To	monitor	 cell	 viability	we	 used	AnnexinV‐FITC	 (BD	 Pharmingen)	
and	 propidium	 iodide	 (SIGMA).	 Secondary	 stainings	 were	 performed	 with	 Alexa	 488–
conjugated	goat	anti–mouse	 IgG2a	and	Alexa	647–conjugated	goat	anti–mouse	 IgG1	(both	
Invitrogen).	Cell	surface	labeling	for	FRAP	experiments	were	performed	using	the	non‐toxic	
PKH67	Green	Fluorescent	Cell	 Linker	Kit	 (SIGMA).	Cholesterol	was	depleted	by	Methyl‐β‐
cyclodextrin	 (MCD)	 (SIGMA)	 and	 SM	 by	 sphingomyelinase	 from	 Staphylococcus	 aureus	
(Merck,	Calbiochem®).	Cytochalasin	D	(SIGMA)	was	used	at	5μg/ml	and	incubated	for	5	min	
prior	to	measurements.			
Cells	and	drug	treatment	
THP‐1	monocytes	were	cultured	 in	suspension	 in	RPMI	1640	medium	supplemented	with	
10%	fetal	calf	serum	(Gibco).	1	day	prior	to	experiment,	cells	were	split	to	a	concentration	
of	0.4x10e6/ml.	For	SPT	studies,	cells	were	cultured	in	phenol‐red	free	RPMI	1640	medium	
(Gibco)	supplemented	with	10%	fetal	calf	serum.	
For	MCD	treatment	THP‐1	cells	were	incubated	for	30	min	at	37°C	in	10mM	MCD	(in	RPMI	
1640	without	serum).	In	case	of	SMase	treatment,	THP‐1	cells	were	incubated	for	60	min	at	
37°C	in	0.05U/ml	SMase.		
Flow	Cytometry		
For	 flow	 cytometry	 analysis,	 cells	 were	 incubated	 (30	 min,	 4°C)	 in	 PBS,	 0.5%	 BSA,	 and	
0.01%	 sodium	azide,	with	 different	mAbs	 (5	 µg/ml),	 followed	by	 incubation	with	AF647‐
coupled	goat	anti‐mouse	IgG	antibody	(invitrogen)	for	30	min	at	4°C.	For	GM1	labeling,	cells	
were	 incubated	with	 CtxAF647	 for	 20min	 at	 4°C.	 The	 relative	 fluorescence	 intensity	was	
measured	on	a	FACS‐Calibur.	Isotype‐specific	controls	were	included.		
	
Fluorescent	Bead	Adhesion	Assay	
Carboxylate‐modified	 streptavidin‐coated	 TransFluorSpheres	 (488/645	 nm,	 1µmØ;	
invitrogen)	were	 coated	with	 ICAM‐1‐Fc,	 and	 the	 bead	 adhesion	 assay	was	 performed	 as	
described	31.	Briefly,	 the	 fluorescent	beads	were	coated	with	biotinylated	goat	anti‐human	
Fc	 antbodies	 and	 subsequently	 with	 ICAM‐1‐Fc	 chimeras.	 This	 guarantees	 the	 outwards	
orientation	 of	 the	 ICAM‐1	molecules	with	 respect	 to	 the	 bead	 surface.	 After	 each	 coating	
step,	 several	 thorough	 washing	 steps	 ensure	 that	 the	 excess	 of	 unbound	 molecules	 is	
washed	 away.	 For	 the	 incubation,	 a	 ratio	 of	 20	 beads	 per	 cell	was	 used.	 The	 blocking	 or	
stimulating	 Abs	 were	 preincubated	with	 the	 cells	 before	 adding	 the	 ligand‐coated	 beads.	
Adhesion	was	determined	as	 the	percentage	of	cells	 that	bound	fluorescent	beads	by	 flow	
cytometry	on	an	FACSCalibur	(BD).		
Electron	Microscopy	Labeling	Procedure	
For	transmission	electron	microscope	analysis,	THP‐1	cells	were	allowed	to	spread	on	glass	
coverslips	covered	by	a	thin	layer	of	poly‐l‐lysine	(PLL)‐coated	Formvar	for	15	min	at	37°C,	
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washed	 to	 remove	 unbound	 cells,	 and	 immediately	 fixed	with	 1%	 PFA	 for	 15	min	 at	 RT.	
When	MCD	and	SMase	were	applied,	drug	treatment	was	performed	prior	to	cell	stretching.	
Subsequent	Ab	and	gold	labeling	was	performed	as	reported	elsewhere	32.	
Analysis	of	Gold	Particle	Distribution	Pattern	
After	gold	 labeling	and	 fixation,	 the	specimens	were	dehydrated	and	 transferred	 from	the	
glass	 onto	 copper	 grids	 as	 already	 published	 32.	 The	 specimens	were	 observed	 in	 a	 JEOL	
1010	transmission	electron	microscope	(Welwyn	Garden	City,	United	Kingdom),	operating	
at	60–80	kV.	Because	monocytes	widely	 spread,	 the	membrane	available	 for	gold	particle	
analysis	 represented	up	 to	60–70%	of	 the	whole	 labeled	plasma	membrane.	For	each	cell	
several	 areas	were	 analyzed	 at	 random.	The	 digital	 images	 of	 electron	micrographs	were	
processed	by	custom‐written	software	based	on	Labview	(National	Instruments,	Austin,	TX)	
as	already	described	32.	
Confocal	Microscopy	
For	co‐patching	experiments,	THP‐1	cells	were	stained	at	4°C	with	5μg/ml	anti–LFA‐1	mAb	
(clone	 NKI‐L15	 or	 TS2/4),	 CD55	 or	 CD71	 and	 Ctx‐AF647.	 Isotype‐specific	 controls	 were	
always	 included.	 Secondary	 stainings	 were	 performed	 for	 30	 min	 at	 4°C,	 followed	 by	
patching	of	 the	secondary	antibody	at	15°C	 for	1	h	and	subsequent	 fixation	with	1%	PFA.	
Cells	 were	 mounted	 onto	 poly‐l‐lysine–coated	 glass	 coverslips.	 Cells	 were	 analysed	 by	
Olympus	 FV1000	 Confocal	 Laser	 Scanning	 Microscope	 and	 signals	 were	 collected	
sequentially	to	avoid	bleed	through.	Co‐localization	of	LFA‐1	with	GM1	was	determined	by	
the	Manders	coefficients	M1	(0	=	no	co‐localization	and	1=100%	co‐localization).	
Fluorescence	Recovery	after	Photobleaching	(FRAP)		
Fluorescence	 Recovery	 after	 Photobleaching	 was	 performed	 on	 a	 LSM510	 meta	 confocal	
laser	 scanning	 microscope	 (Zeiss,	 Germany)	 with	 a	 63x,	 1.45NA	 oil	 objective.	 AF488	
fluorescence	was	 excited	 at	 488	 nm	 (argon	 laser),	while	 the	 emission	was	 collected	with	
500‐550nm	bandpass	 filter	 adjusted	 through	mirrors.	 FRAP	experiments	were	performed	
using	a	2	μm	diameter	circular	region	of	interest	in	the	basal	plane	of	the	plasma	membrane.	
Photobleaching	was	performed	operating	at	100%	of	laser	power	by	scanning	the	bleached	
ROI	for	2	iterations,	yielding	in	a	total	bleach	time	of	0.10	s	and	an	average	fluorescence	loss	
of	~50%.		Recoveries	were	collected	at	time	intervals	of	250	ms	for	LFA‐1	and	100	ms	for	
PKHdye	measurements.	 Fluorescence	 intensity	 values	 of	 the	 bleached	 area,	 as	well	 of	 an	
unbleached	area	of	similar	size	within	the	same	cell,	were	exported	from	the	Zeiss	software	
and	analyzed	in	Origin.	After	background	correction	and	normalization	to	t0	using	a	method	
that	is	known	as	double	normalization	33,	the	data	file	(approximately	10‐15	curves	for	each	
condition)	was	averaged	to	create	a	single	curve.	The	single	postbleach	curves	were	 fitted	
with	 the	 following	 model:	
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21)(  tt eAeAytI   	 were	 y0	 is	 the	 mobile	
fraction	 and	 –A1	 and	 –A2	 are	 the	 fraction	 sizes	 of	 the	 two	 subpopulations.	 The	 halftime	
recovery	values	were	calculated	with *2ln2/1 t .		
Plasmids	and	Transfection	
The	 FRET	 conformation	 reporter	 constructs	 αL‐ECFP	 and	 β2‐EYFP	 with	 short	 and	 long	
linkers	between	the	cytoplasmic	tails	and	the	fluorescent	protein	were	essentially	prepared	
as	 described	 by	 Kim	 et	 al	 34.	 THP‐1	 cells	 were	 transfected	 by	 electroporation	 using	 the	
Neon®	Transfection	device	 (Invitrogen)	and	transfection	materials	 (Invitrogen)	according	
to	manufacturer´s	 instructions.	Briefly,	1x10e6	cells	were	 transfected	with	a	 total	of	20ug	
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plasmid	 DNA	 (in	 a	 ratio	 of	 αL‐ECFP:β2‐EYFP	 of	 1:3).	 Electroporation	 was	 performed	 at	
1300V,	20ms	and	2	pulses.	After	electroporation,	cells	were	plated	in	serum‐	and	antibiotic	‐
free	medium	for	3	hours	at	37°C.	Subsequently,	fetal	calf	serum	and	antibiotics	were	added	
to	 the	medium	 and	 cells	 were	 cultured	 for	 18	 hours.	 Expression	 levels	 of	 β2‐EYFP	were	
evaluated	by	FACS.	Drug	treatment	was	performed	as	described	above.		
Förster	resonance	energy	transfer	(FRET)	
FRET	experiments	were	performed	using	a	BD	pathway	inverted	wide‐field	microscope	(BD	
Biosciences)	 equipped	 with	 a	 20X	 0.75	 N.A.	 objective	 (Olympus	 LUCPLFLN).	 A	 mercury	
metal	 halide	 lamp	 combined	 with	 excitation	 filter	 (440/10)	was	 used	 to	 excite	 CFP.	 The	
fluorescence	emission	was	 filtered	using	a	dichroic	mirror	(458‐DiO1)	and	filters	(479/40	
and	542/27	 for	CFP	and	YFP	emission	 resp.)	Emission	was	 collected	by	a	high	 resolution	
cooled	CCD	camera	(1344x1024	pix,	0.32	um/pix).		
Labeling	and	sample	separation	for	single	dye	tracking	
Fc‐receptors	on	THP‐1	cells	were	blocked	with	1%HS,	 followed	by	sub‐labelling	with	non‐
blocking	TS2/4‐Atto488	 in	 solution.	Cells	were	extensively	washed	 in	serum‐free/phenol‐
red	 free	 medium.	 After	 washing,	 cells	 were	 seeded	 on	 fibronectin‐coated	 Labtek	
coverglasses	for	10	minutes	at	37°C.	 	When	cells	were	depleted	of	cholesterol	or	SM,	drug	
treatment	was	performed	prior	to	imaging	and	the	drugs	remained	present	for	the	time	of	
the	experiment.	 Imaging	was	performed	at	 the	ventral	plasma	membrane	 in	 total	 internal	
reflection	 (TIRF)	 mode	 using	 an	 Olympus	 IX71	 inverted	 microscope	 equipped	 with	 a	
Cell^TIRF	 illuminator.	 CytoD	was	 added	 to	 the	 imaging	medium	and	 incubated	 for	 5	min	
37°C	prior	to	imaging.		
Single	molecule	microscopy	
TIRF	imaging	for	SPT	was	performed	using	an	Olympus	IX71	inverted	microscope	equipped	
with	a	Cell^TIRF	illuminator	with	3	motorized	channels	for	491,561	an	640	nm	(solid	state	
lasers,	each	100mW)	and	150×	1.45	N.A.	oil	objective.	TIRF	excitation	was	provided	by	491	
laser	 with	 excitation	 and	 fluorescence	 emission	 filtered	 using	 a	 CMR‐U‐M4TIR‐SBX	
quadruple	(405/491/561/640)	filter	set	(Olympus).	Emission	was	collected	by	an	electron	
multiplying	 CCD	 camera	 (Hamamatsu	 ImagEM).	 The	 sample	 temperature	 (34‐36	 °C)	was	
maintained	by	a	stage	heater	(Pecon).		Images	were	acquired	at	10	fames/s	for	a	total	of	200	
frames.		
Data	analysis.		
The	 data	 was	 analyzed	 following	 a	 method	 as	 described	 in	 [20].	 In	 brief,	 the	 intensity	
profiles	of	 the	LFA‐1	signals	were	 fitted	to	two‐dimensional	Gaussian	profiles	yielding	the	
fluorescence	 intensity	 with	 an	 uncertainty	 of	 <20%	 [20].	 The	 signals	 were	 validated	 as	
individual	 emitting	 LFA‐1	 molecules	 by	 observing	 the	 intensity	 in	 time	 and	 determine	
single‐step	photobleaching	events.	Trajectories	were	constructed	from	the	positional	shifts	
of	molecules	in	consecutive	images.	The	lateral	diffusion	of	Brownian	particles	in	a	medium	
characterized	 by	 a	 diffusion	 constant	 D	 is	 described	 by	 the	 cumulative	 probability	
distribution	function	for	the	square	displacements,	r2	35;	36:		
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Eq.1	
P(r2,	tlag)	describes	the	probability	that	the	Brownian	particle	starting	at	the	origin	
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will	 be	 found	 within	 a	 circle	 of	 radius	 r	 at	 time	 tlag.	 This	 mono‐exponential	 fit	 did	 not	
accurately	 describe	 the	 data	 obtained	 for	 LFA‐1	 and	 from	 the	 trajectories	 it	 was	 already	
seen	 that	 there	 were	 two	 populations	 of	 receptors	 with	 different	 type	 of	 trajectories.	
Provided	that	the	system	under	study	segregates	into	three	components	Eq.	1	becomes	36:		
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Describing	 the	data	with	 this	 tri‐exponential	 fit	 results	 in	 three	receptor	populations	with	
each	their	mean	square	displacements	(MSDi	=	r12	,r22	and	r32)	and	the	size	of	the	relative	
fractions,	α,β	(1	–α‐β)	respectively.	We	considered	r32	immobile	on	the	timescale	measured.	
The	 cumulative	 probability	 distributions	 P(ri2,	 tlag)	 were	 constructed	 for	 each	 time	 lag	
from	the	single‐molecule	trajectories,	obtained	from	25	different	cells	(for	each	condition),	
by	 counting	 the	 number	 of	 square	 displacements	 with	 values	 ≤r2,	 and	 subsequent	
normalization	by	the	total	number	of	data	points	37.	Probability	distributions	with	N	>	5000	
data	 points	 were	 least‐square	 fit	 to	 Eq.	 2,	 resulting	 in	 a	 parameter	 set	 {	 r12(tlag),	
r22(tlag),α,β),	for	each	time	lag,	tlag,	between	0.100	and	4s.	The	data	for	different	tlags	were	
constructed	from	the	same	dataset	taken	with	tlag=100	ms	by	taking	the	1‐step	(tlag=100	
ms),	2‐step	(tlag=200	ms)	up	to	the	n‐step	(tlag=n*100	ms)	displacements.	This	approach	of	
fitting	 leads	 to	 a	 robust	 estimation	 of	 the	mean‐square	 displacements	 ri2	 even	when	 the	
mobility	 is	 not	 purely	 random38.	 The	 cumulative	 probability	 distributions	 P(ri2,	 tlag)	were	
compared	between	the	different	conditions	using	the	Two‐sample	Kolmogorov‐Smirnov	test	
function	in	Matlab	(The	Mathworks,	USA).	
Mobility	analysis	
The	mode	of	diffusion	and	the	diffusion	coefficient	of	the	respective	populations	of	
molecules	were	determined	by	 fitting	 the	Mean	Square	Displacement	 (ri2)	versus	tlag	plots	
with	 different	 models	 for	 diffusion.	 To	 analyze	 the	mode	 of	 diffusion,	 trajectories	 longer	
than	13	images	were	selected.	The	(ri2,tlag)	plots	were	fitted	by	a	free	diffusion	model,		
ri2	(tlag)	=	4D	tlag+4σ2																																																																																													Eq.3	
and	a	model	describing	confined	diffusion	39,	
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where	Dinit	 is	 the	 initial	diffusion	coefficient	 for	small	 time‐lags	and	L	represents	 the	side‐
length	of	a	square	domain.		
Statistics	
The	data	were	compared	using	Student’s	t‐test.		
	
Results	
Binding	of	LFA‐1	to	ICAM‐1	on	monocytes	depends	on	SM	and	cholesterol	
We	 have	 previously	 demonstrated	 that	 cholesterol	 depletion	 by	 MCD	
impaired	 binding	 of	 LFA‐1	 to	 its	 ligand	 ICAM‐1	 and	 altered	 the	 nanoscale‐
distribution	 of	 LFA‐1	 and	GPI‐APs	 20;	 22.	 SM	 is	 the	most	 common	 sphingolipid	 in	
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eukaryotic	 membranes	 and	 affects	 cytoskeletal	 organization	 during	 β2	 integrin‐
mediated	 adhesion	 in	 neutrophils,	 but	 how	 exactly	 SM	 contributes	 to	 LFA‐1	
function	on	monocytes	is	largely	unknown	26.	To	understand	how	sensitive	LFA‐1	
function	is	to	local	changes	in	the	lipid	nanoenvironment	we	depleted	monocytes	
of	 cholesterol	by	methyl‐β‐cyclodextrin	 (MCD)	or	converted	endogenous	SM	 into	
Cer	by	recombinant	SMase	9	and	subsequently	measured	their	binding	to	ICAM‐1	
Fc	 coated	 fluorescent	 beads	 (Fig.	 1).	 In	 untreated	 cells,	 more	 than	 40%	 of	
monocytes	spontaneously	bound	ICAM‐1,	and	this	interaction	was	specifically	LFA‐
1	mediated,	as	shown	by	the	effective	block	in	the	presence	of	an	anti‐	αL	blocking	
mAb.	In	contrast,	depletion	of	cholesterol	and	SM	reduced	the	binding	to	ICAM‐1	to	
less	than	20%.	In	all	conditions,	a	basal	aspecific	binding	of	10%	remained,	which	
was	 not	 mediated	 by	 LFA‐1	 or	 other	 integrins,	 as	 shown	 by	 Ca2+	 depletion	 via	
EDTA.	MCD	and	SMase	were	applied	at	optimal	concentration	at	which	the	cells	did	
not	display	signs	of	necrosis	or	apoptosis	(Fig.	S1).		These	results	demonstrate	that	
not	only	cholesterol,	but	also	SM	is	essential	for	LFA‐1	function	in	monocytes.		
Cholesterol	depletion	affects	epitopes	on	the	αL,	β2	and	β1	–	chain	
We	 have	 previously	 shown	 that	 despite	 impaired	 LFA‐1	 function	 upon	
MCD	treatment,	the	expression	levels	and	conformational	state	of	LFA‐1	were	not	
affected	 by	 this	 treatment	 22.	 To	 determine	 whether	 these	 parameters	 are	 also	
sensitive	 to	 SM	 levels,	 we	 here	 compare	 the	 binding	 of	 αL	 specific	 antibodies,	
including	the	activation	reporter	antibody	L16	28,	antibodies	recognizing	epitopes	
on	 the	 β2	 chain,	 as	 well	 as	 an	 antibody	 against	 a	 different	 integrin	 as	 control,	
before	and	after	SMase	and	MCD	treatment	(Fig.	2A).	In	agreement	with	previous	
results,	we	did	not	observe	significant	changes	in	expression	levels	of	total	LFA‐1,	
as	 determined	 by	 the	 αL	 specific	 neutral	mAb	TS2/4,	 or	 the	 expression	 of	 high‐
affinity	(extended)	LFA‐1	upon	MCD	treatment	(Figure	2B).	 In	spite	of	stable	cell	
surface	levels	of	LFA‐1,	the	epitope	of	the	blocking	antibody	L15	was	slightly,	but	
significantly	reduced	upon	treatment	with	MCD.	Reduced	epitope	availability	was	
more	apparent	 for	the	activating	anti‐β2	mAb	KIM185	that	was	strongly	reduced	
by	cholesterol	depletion,	while	total	β2	expression,	as	determined	by	blocking	anti‐
β2	mAb	L19,	 did	not	 change	upon	 treatment	 (Fig.	 2C).	A	 trend	 towards	 reduced	
KIM185	epitope	availability	was	also	observed	upon	SM	depletion;	however	these	
changes	 were	 not	 significant.	 MCD	 treatment	 also	 showed	 a	 reduction	 of	 the	
TS2/16	epitope	on	the	integrin	β1	chain,	suggesting	that	integrin	β	chains	may	in	
general	be	sensitive	to	the	presence	of	cholesterol	(Fig.	2C).	In	contrast	to	the	effect	
of	MCD	 on	 several	 integrin	 epitopes,	 no	 reduction	 in	 the	 expression	 of	 the	 raft‐
associated	sphingolipid	GM1	(Fig.	S2)	was	observed.	This	suggests	that	cholesterol	
and	 SM	 depletion	 did	 not	 induce	 global	 depletion	 of	 raft	 components	 from	 the	
membrane,	 but	 rather	 induced	 structural	 changes.	 Cholesterol	 depletion	 most	
likely	 alters	 the	 lipid	 nanoenvironment	 in	 which	 LFA‐1	 nanoclusters	 are	
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embedded,	 resulting	 in	 structural	 changes	 within	 the	 LFA‐1	 molecule	 and	
subsequent	masking	of	some	epitopes,	while	total	LFA‐1	levels	remains	unaltered.	
Proximity	of	LFA‐1	to	GM1	is	dependent	on	cholesterol	and	SM	
High	 resolution	 techniques	 have	 revealed	 that	 on	 quiescent	 monocytes	
LFA‐1	 forms	 tightly	 organized	 nanoclusters	 that	 reside	 in	 proximity	 to	 areas	
enriched	 in	 GPI‐APs	 and	 GM1	 20;	 22;	 25.	 Cholesterol	 depletion	 destroys	 this	
association	 and	prevents	 the	 formation	 of	 adhesion	 nucleation	 sites	 upon	 ligand	
encounter	22.	To	 investigate	whether	SM	depletion	had	a	similar	effect	on	the	co‐
distribution	 of	 LFA‐1	 and	 the	 lipid	 raft	 marker	 GM1,	 we	 performed	 antibody‐
capping	 and	 confocal	microscopy.	 As	 already	 demonstrated	 20,	 when	 co‐capping	
was	induced	on	unperturbed	monocytes,	LFA‐1	completely	co‐localized	with	GM1	
to	the	same	extent	as	for	the	lipid	raft–associated	GPI‐anchored	protein	CD55	(Fig.	
S3).	By	contrast,	the	non‐raft	marker	CD71	was	completely	excluded	from	the	lipid	
raft	patches.	When	co‐capping	was	induced	upon	depletion	of	cholesterol	and	SM,	
the	 co‐distribution	 was	 visually	 reduced	 (Fig.	 3A).	 Next,	 we	 quantified	 the	 co‐
localization	of	LFA‐1	with	GM1	(Figure	3B).	The	co‐localization	coefficient	for	LFA‐
1	with	GM1	in	unperturbed	cells	was	 found	to	be	0.78,	where	1	 indicates	 full	co‐
localization.	 	 In	 contrast,	 co‐localization	 upon	 drug	 treatment	 was	 significantly	
reduced	 (MCD	 =	 0.57	 and	 SMase	 =	 0.67),	 suggesting	 an	 increasing	 exclusion	 of	
LFA‐1	 from	 lipid	 raft	 domains	 upon	 cholesterol	 and	 SM	depletion.	 These	 results	
show	that	the	proximity	of	LFA‐1	to	GM1	enriched	domains	and	their	connectivity	
are	dependent	both	on	SM	and	cholesterol.				
	
Figure	1:	LFA‐1	binding	capacity	on	
monocytes	 is	 strongly	 reduced	 upon	
cholesterol	 and	 SM	 depletion.	 (A)	
Adhesion	of	human	monocytes	(THP‐
1)	 was	 determined	 using	 ICAM‐1‐Fc	
coated	 fluorescent	 beads	 at	 37°C,	
upon	treatment	with	MCD	(10mM)	or	
SMase	(0.05U/ml).	The	%	of	adhesion	
represents	 the	 amount	 of	 cells	 that	
have	 bound	 beads	 as	 determined	 by	
flow	 cytometry.	 NKI‐L15	 mAb	 was	
used	 to	block	LFA‐1.	The	data	 shows	
one	 representative	 experiment	 of	 4	
+/‐	 SD.	 P‐	 values	were	 compared	 to	
untreated	cells	in	medium,	*	<	0.0346.		
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Depletion	 of	 cholesterol,	 but	 not	 SM,	 resulted	 in	 increased	 vicinity	 of	 the	
cytoplasmic	tails,	without	affecting	the	integrity	of	LFA‐1	nanoclusters	
	
Cholesterol	depletion	resulted	in	strong	reduction	of	the	KIM185	epitope	
of	the	integrin	β2	chain,	and	in	reduction	of	the	αL‐specific	epitope	recognized	by	
the	mAb	L15.	These	results	suggested	that	changes	in	 the	lipid	nanoenvironment	
led	 to	 structural	 alterations	within	 the	 LFA‐1	molecule,	 despite	 similar	 levels	 of	
extended	 (L16+)	 LFA‐1.	 To	 further	 understand	 the	 changes	 induced	 upon	
cholesterol‐depletion,	 we	 made	 use	 of	 a	 conformation‐dependent	 Fluorescence	
Resonance	 Energy	 Transfer	 (FRET‐)	 pair.	 THP‐1	 cells	 were	 transfected	 with	 a	
FRET	pair	consisting	of	αL‐ECFP	and	β2‐EYFP,	where	ECFP	and	EYFP	were	fused	
to	 the	 C‐termini	 of	 the	 integrin	 cytoplasmic	 tails	 34.	 Close	 vicinity	 between	 the	
cytoplasmic	tails	resulted	in	an	inter‐subunit	FRET	signal,	which	is	reduced	upon	
activation	and	separation	of	 the	cytoplasmic	tails	(Fig.S4).	Transfected	cells	were	
depleted	of	cholesterol	or	SM	and	imaged	by	confocal	microscopy.	The	FRET	signal	
was	determined	as	the	ratio	of	the	fluorescent	intensity	of	β2‐EYFP/αL‐ECFP.	We	
found	a	significant	 increase	 in	FRET	signal	upon	cholesterol	depletion,	 indicating	
that	the	treatment	caused	 increased	vicinity	between	the	cytoplasmic	 tails	of	αL‐
ECFP	 and	 β2‐EYFP.	 A	 long	 linker	 between	 the	 C‐termini	 of	 αL/β2	 and	 the	
fluorescent	protein	 served	as	a	 control	 to	determine	 the	unspecific	 inter‐subunit	
FRET	signal,	which	was	greatly	increased	upon	replacement	of	the	long	by	a	short	
spacer	 (Fig.	 4A‐B).	 In	 unperturbed	monocytes,	 the	 FRET	 signal	was	 as	 expected	
low,	 as	 i)	 the	 transfected	 FRET	 pair	was	 diluted	 by	 endogenous	 non‐fluorescent	
LFA‐1	molecules	and	ii)	a	significant	portion	of	LFA‐1	in	monocytes	prevails	in	the	
extended	(L16+)	conformation,	with	separated	cytoplasmic	tails	(Fig.	S4).	
	
To	determine	whether	 the	 increase	 in	FRET	 signal	 upon	MCD	 treatment	
resulted	from	a	tighter	packing	of	LFA‐1	molecules	within	the	LFA‐1	nanoclusters,	
leading	 to	 increased	 inter‐subunit	 and	 inter‐heterodimer	 FRET,	we	 analyzed	 the	
distribution	 of	 LFA‐1	 within	 the	 cell	 membrane	 upon	 drug	 treatment.	 After	
cholesterol	and	SM	depletion,	monocytes	were	specifically	labeled	for	LFA‐1	with	
10‐nm	 gold	 beads	 for	 transmission	 electron	 microscopy	 (TEM)	 (Fig.	 4B).	 No	
apparent	 difference	 in	 distribution,	 or	 density	 within	 LFA‐1	 nanocluster	 was	
visible.	Next,	custom‐written	software	was	employed	to	assign	coordinates	to	each	
gold	particle	and	to	calculate	the	interparticle	distances	using	a	nearest	neighbor	
(nn)	 distance	 algorithm.	 The	 nn	 distance	 values	were	 calculated	 for	 each	 image	
and	subsequently,	the	nn	distances	were	divided	into	 four	classes:	0–50,	50–100,	
100‐150	and	>	150	nm,	and	the	percentage	of	nn	distance	values	falling	into	each	
class	were	plotted	for	each	condition	(Fig.	4C).	
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Figure	 2:	
Cholesterol	depletion	
by	 MCD	 affects	
epitopes	 on	 the	 αL,	
β2	 and	 β1	 ‐	 chain.	
(A)	 Schematic	
representation	of	the	
domains	 of	 LFA‐1	
and	 indicated	 the	
epitopes	 of	 the	 αL‐	
specific	 mAb	 L15,	
L16	 and	 TS2/4,	 the	
common	 β2	 mAb	
KIM185	and	L19	and	
the	 β1	mAb	 TS2/16.	
Relative	 expression	
of	 (B)	 αL–specific	
epitopes	 and	 (C)	 of	
β1‐	 and	 β2‐	 specific	
epitopes	 after	
treatment	with	MCD	
(10mM)	 and	 SMase	
(0.05U/ml),	 assessed	
by	 flow	 cytometry.	 Changes	 in	 the	mean	 fluorescent	 intensity	 are	 displayed	 as	 relative	 to	
untreated	samples	(expression	levels	in	untreated	cells	were	set	as	=	1,	indicated	by	the	dotted	
line).	The	data	represent	the	average	+/‐	SEM	of	5	independent	experiments.	*		<	0.015,	relative	
to	untreated.		
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Figure	 3:	 Depletion	 of	 cholesterol	 and	 SM	 reduces	 co‐capping	 of	 LFA‐1	 with	 GM1	 on	
monocytes	(THP‐1).	(A)	Confocal	microscopy	analysis	of	co‐capping	of	LFA‐1	(L15	labeled)	and	
GM1	(CTx‐AF647).	Receptor	co‐capping	and	staining	were	performed	as	described	in	Material	
and	Methods	 after	 treatment	with	MCD	 (10mM)	 or	 SMase	 (0.05U/ml.	 (B)	 To	 quantify	 the	
degree	 of	 co‐localization	 between	 LFA‐1	 with	 GM1,	 the	 Manders	 coefficients	 (M1)	 was	
calculated	 with	 the	 Image	 J	 plug‐in	 JACoP	 40.	 M1	 can	 vary	 between	 0	 and	 1	 (1	 =	 co‐
localization).	Results	are	representative	of	multiple	cells	in	two	independent	experiments.).	P‐	
values	were	compared	to	untreated	cells,	***	<	0.005.	
	
Analysis	of	the	nn	values	did	not	show	a	difference	in	distribution	between	
gold‐labeled	 LFA‐1	 molecules,	 suggesting	 that	 at	 the	 resolution	 limit	 of	 this	
approach	 determined	 by	 size	 of	 the	 gold	 particles	 (10nm),	 no	 tighter	 packing	 of	
molecules	upon	depletion	of	cholesterol	and	SM	could	be	observed.	Moreover,	the	
analysis	 showed	 that	 cholesterol	 and	 SM	 were	 not	 essential	 to	 preserve	 the	
integrity	 of	 LFA‐1	 nanoclusters.	 The	 increased	 FRET	points	 towards	 a	 structural	
change	 within	 the	 LFA‐1	 heterodimer	 induced	 by	 lipid	 remodeling,	 leading	 to	
increased	interaction	of	the	cytoplasmic	tails,	albeit	a	lack	of	a	net	decrease	in	LFA‐
1	 extension.		
This	 is	 the	 first	 report	of	 increased	 integrin	 cytoplasmic	 tail	 interaction,	without	
observing	a	loss	of	the	extended	conformation.	In	summary,	these	data	show	that	
cholesterol	depletion	induced	structural	changes	of	the	LFA‐1	molecule	that	result	
in	increased	interaction	of	the	cytoplasmic	tails,	while	leaving	the	integrity	of	LFA‐
1	nanoclusters	unaffected.		
	
Lateral	 mobility	 of	 LFA‐1	 in	 the	 membrane	 of	 monocytes	 is	 sensitive	 to	
cholesterol	and	SM	
	
We	 have	 recently	 shown	 that	 LFA‐1	 nanoclusters	 on	 monocytes	 are	
primarily	mobile,	with	a	small	fraction	of	high‐affinity	(extended)	LFA‐1	anchored	
to	the	cytoskeleton	(23,	chapter	6).	To	investigate	how	the	lipid	nanoenvironment	
affects	 the	 mobility	 of	 LFA‐1,	 we	 performed	 fluorescence	 recovery	 after	
photobleaching	(FRAP)	experiments	of	LFA‐1	upon	cholesterol	extraction	by	MCD	
and	SM	depletion	by	conversion	 into	Cer	by	SMase.	The	 lateral	mobility	of	LFA‐1	
was	measured	 by	 the	 neutral	mAb	 TS2/4	 coupled	 to	 AF488,	 as	 its	 epitope	was	
insensitive	 to	 lipid	 alterations.	 After	 drug	 treatment,	 the	 cells	 were	 seeded	 on	
fibronectin	 coating	 and	 only	 stretched	 cells	 were	 included	 for	 measurement.	 In	
untreated	cells,	we	observed	70%	of	 recovery	of	LFA‐1	after	bleaching	 (Fig.	5A).	
The	recovery	was	greatly	reduced	upon	cholesterol	and	SM	depletion.	Moreover,	
the	 curve	 of	 MCD	 treated	 cells	 shows	 a	 slower	 initial	 diffusion	 than	 the	 rest,	
indicating	that	cholesterol	depletion	clearly	affected	diffusion	of	LFA‐1.	To	ensure	
that	 cholesterol	 and	 SM	 depletion	 did	 not	 result	 in	 unwanted	 global	 changes	
affecting	 the	 diffusion	 of	 LFA‐1	 nanoclusters,	 we	 measured	 the	 recovery	 after	
bleaching	 of	 fluorescent	 PKH	 dye	 that	 due	 to	 its	 lipophilic	 tails	 inserts	 into	 the	
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membrane	 of	 living	 cells,	 without	 affecting	 cell	 viability	 (Fig.	 5B).	 The	 results	
showed	 a	much	 faster	 recovery	 of	 the	 PKH	 dye	 in	 comparison	 to	 LFA‐1	 and	 no	
differences	in	recovery	upon	drug	treatment,	indicating	that	unspecific	changes	did	
not	affect	the	diffusion	of	this	lipophilic	probe.	The	mobile	fractions	of	LFA‐1	and	
the	PKH	dye	were	determined	using	a	two‐component	fitting	and	demonstrated	a	
significant	decrease	 	 in	 the	mobile	 fraction	of	 LFA‐1	upon	drug	 treatment,	while	
the	PKH	dye	mobile	fraction	remained	similar	(Fig.	5C).	Besides	a	decrease	of	the	
remaining	 LFA‐1	 mobile	 population,	 we	 also	 observed	 changes	 in	 the	 diffusion	
coefficients	upon	drug	treatment	(Fig.	5D).	The	halftime	of	recovery	of	LFA‐1	was	
slightly	reduced	from	4.85	s	in	unperturbed	cells,	to	3.58	s	and	4.13	s	in	MCD	and	
SMase	 treated	 cells,	 respectively.	 These	 results	 show	 that	 the	mobile	 fraction	 of	
LFA‐1	was	 clearly	 reduced	upon	 cholesterol	 and	 SM	depletion	 and	 the	 strongest	
effect	 on	 the	 diffusion	 coefficients	 could	 be	 observed	 upon	 MCD	 treatment,	
indicating	that	LFA‐1	lateral	mobility	is	sensitive	to	cholesterol	and	SM.	
	
Multiple	LFA‐1	pools	with	distinct	lateral	mobility	are	affected	by	cholesterol	
and	SM	depletion	
	
Our	FRAP	data	showed	a	strong	overall	reduction	in	LFA‐1	lateral	mobility	
upon	 cholesterol	 and	 SM	 depletion	 and	 prompted	 us	 to	 further	 explore	 the	
underlying	 changes	 in	 LFA‐1	 nanocluster	 diffusion	 at	 the	 single	 molecule	 level.	
Recently,	we	performed	extensive	single	dye	tracking	(SDT)	studies	and	observed	
a	 complex	 diffusion	 behavior	 of	 LFA‐1	 nanoclusters	 on	monocytes,	 consisting	 of	
multiple	 LFA‐1	 pools	 with	 distinct	 lateral	 mobility	 patterns	 (23,	 chapter	 6).	 To	
determine	the	effect	of	an	altered	lipid	nanoenvironment	on	the	multiple	modes	of	
LFA‐1mobility	and	their	confinement	within	the	PM,	we	applied	SDT	to	follow	the	
lateral	diffusion	of	sub‐labeled	LFA‐1	nanoclusters	on	monocytes	before	and	after	
alteration	of	cholesterol	and	SM	levels.		
	
At	sub‐labeling	conditions	with	the	neutral	TS2/4	coupled	to	Atto488	dye,	
LFA‐1	nanoclusters	were	tracked	in	the	ventral	plasma	membrane	in	TIRF	mode,	
at	 a	 frame‐rate	 of	 100ms	 (Fig.	 6A).	 Trajectories	 were	 constructed	 from	 the	
positional	shifts	of	 the	molecules	 in	consecutive	 images.	 In	untreated	monocytes,	
LFA‐1	 nanoclusters	 exhibited	 a	 confined	 diffusion	 behavior	 (Fig.	 6B).	 Upon	
cholesterol	and	SM	depletion,	a	clear	increase	in	LFA‐1	confinement	could	be	seen	
in	 the	 trajectories,	 in	 contrast	 to	 unperturbed	 cells	 (Figure	 6B).	 Next,	 the	
trajectories	were	analyzed	by	plotting	the	cumulative	probability	(Pǂ )	of	the	square	
displacements	(see	materials	and	methods)	36	at	different	time	lags.	As	shown	for	
timelag	 5,	 the	 cumulative	 probability	 distribution	 (CPD)	 of	 the	 square	
displacements	was	different	in	the	absence	of	cholesterol	and	SM,	as	compared	to	
the	 unperturbed	 sample,	 highlighting	 a	 clear	 change	 in	 mobility	 upon	 drug	
treatment	(Fig.	S5).				
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The	cumulative	probability	(Pǂ )	of	the	square	displacements	was	fitted	to	a	
three‐component	model	at	different	time	lags,	reflecting	three	receptor	fractions	36.	
This	 step	 was	 repeated	 over	 the	 first	 10	 time	 lags	 for	 each	 condition,	 and	 the	
fraction	sizes	were	averaged	(Fig.	6C).	In	control	monocytes,	around	20±4%	of	the	
LFA‐1	nanoclusters	were	 immobile,	while	41±5	%	showed	 slow	and	37±3%	 fast	
diffusion.	To	display	changes	in	fraction	sizes	due	to	cholesterol	and	SM	depletion,	
we	calculated	the	fraction	sizes	relative	to	the	fractions	of	unperturbed	cells	(Fig.	
6D).	After	cholesterol	and	SM	depletion,	we	observed	a	shift	from	the	fast	towards	
the	slow	moving	fraction,	with	an	increase	of	18±2%	upon	MCD	and	16±1%	upon	
SMase	 treatment.	 Interestingly,	 the	 immobile	 fraction	 was	 also	 reduced	 upon	
cholesterol	extraction	(‐10±2%)	and	even	more	pronounced	upon	the	conversion	
of	SM	into	Cer	by	SMase	(‐19±3%).	Next,	 in	order	to	determine	the	mean		square	
displacement	 (MSD)	 of	 the	 slow	 and	 fast	 moving	 LFA‐1	 nanoclusters,	 we	 fitted	
over	 the	 first	 40	 time	 lags	 using	 the	 three‐component‐model	 while	 fixing	 the	
average	 fraction	 sizes.	 The	 mobility	 was	 characterized	 by	 plotting	 the	 MSDs	
against	 the	 respective	 time	 lags	 for	 the	 slow	 moving	 (Fig.	 6E)	 and	 fast	 moving	
population	(Fig.	6F),	in	unperturbed,	cholesterol	and	SM	depleted	monocytes.	The	
MSD	 plots	 show	 a	 clear	 reduction	 in	 diffusion	 and	 an	 increase	 in	
compartmentalization	 of	 both	 slow	 and	 fast	 moving	 populations	 of	 LFA‐1	
nanoclusters	upon	drug	treatment,	compared	to	unperturbed	cells.	
Fitting	 the	 data	 with	 a	 model	 for	 confined	 diffusion	 39	 retrieved	 the	
diffusion	coefficient	D	for	the	slow	(Dslow)	and	fast	(Dfast)	moving	populations	and	
the	 area	 of	 confinement	 L	 for	 each	 fraction	 (Lslow	 and	 Lfast)	 (Table	 1).	 The	 data	
shows	 a	 reduction	 in	 diffusion	 values	 of	 Dfast	 from	 0.05	 േ	 7.05E‐4	 μm2/s	 in	
unperturbed	to	0.03	േ	7.41E‐4	μm2/s	in	cholesterol	and	0.03	േ	0.001	μm2/s	in	SM	
depleted	cells.	The	changes	in	Dslow	were	negligibly	small.	Besides	changes	in	Dfast,	
we	observed	an	increase	in	confinement	for	the	fast	moving	LFA‐1	population	from	
1.28	േ	0.01	μm	in	unperturbed	cells,	to	1.1	 േ 	0.02	μm	MCD	and	1.079	േ	0.038	μm	
in	 SMase	 treated	 cells.	 A	 similar	 trend	was	 observed	 for	 the	 confinement	 of	 the	
slow	moving	population	as	well.			
Taken	 together,	 cholesterol	 and	 SM	depletion	 induced	 a	 shift	 in	 fraction	
size	from	immobile	and	fast	towards	slow	moving	LFA‐1	nanoclusters	with	respect	
to	unperturbed	cells.	Moreover,	our	results	showed	a	clear	reduction	in	diffusion	
coefficient	values	and	increased	compartmentalization	of	LFA‐1	nanoclusters	upon	
lipid	alteration.	These	results	emphasize	that	the	different	pools	that	constitute	to	
LFA‐1	mobility	are	differentially	sensitive	to	SM	and	cholesterol	levels.	Cholesterol	
depletion	 affected	 both	 immobile	 and	 fast	 mobile	 LFA‐1,	 while	 SM	 depletion	
mainly	 affected	 the	 immobile	 pool,	 overall	 leading	 to	 an	 increase	 in	 the	 slow	
mobile	pool	LFA‐1.		
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Figure	4:	Cholesterol	depletion	increases	
interaction	 of	 αL	 and	 β2	 cytoplasmic	
tails,	 without	 affecting	 the	 integrity	 of	
LFA‐1	nanoclusters.	(A)	Monocytes	(THP‐
1)	 were	 transfected	 with	 αL‐ECFP	 and	
β2‐EYFP.	 ECFP	 and	 EYFP	were	 fused	 to	
the	C‐termini	 of	 the	 cytoplasmic	 tails	 of	
αL	and	β2,	respectively.	Vicinity	between	
the	cytoplasmic	tails	resulted	in	an	inter‐
subunit	FRET	signal.	The	data	show	one	
representative	experiment	(n=20‐40	cells	
per	 condition),	 +/‐	 SD.	 (B)	 Monocytes	
were	 specifically	 labeled	 for	 LFA‐1	with	
10‐nm	 gold	 for	TEM	 (see	Materials	 and	
Methods),	 after	 treatment	 with	 MCD	
(10mM)	 or	 SMase	 (0.05U/ml).	 10‐nm	
gold	 particles	 are	 visible.	Bar=	 200	 nm.	
(C)	 Gold	 labels	 were	 counted	 and	
coordinates	 were	 assigned	 to	 each	
feature.	The	inter‐particle	distances	were	
calculated	using	a	nearest	neighbor	(nn)	
distance	 algorithm	 by	 custom‐written	
software.	 nn	 distance	 values	 were	
calculated	 for	each	 image.	Subsequently,	
the	nn	distances	were	divided	 into	 three	
classes:	0–50,	50–100,	and	100	nm,	and	
the	 percentage	 of	 nn	 distance	 values	
falling	 into	each	 class	were	plotted.	The	
data	 shows	 one	 representative	
experiment	of	3	+/‐	SD.	
	
Cytoskeletal	constraints	on	LFA‐1	diffusion	are	largely	mediated	by	SM		
	
The	 actin	 cytoskeleton	 imposes	 restrictions	 on	 the	 diffusion	 of	
transmembrane	 proteins,	 by	 direct	 interaction,	 or	 indirectly	 by	 so	 called	 actin	
corrals	 that	 limit	 diffusion	 to	 certain	 areas	within	 the	membrane	 41;	 42.	We	 have	
recently	shown	that	on	quiescent	monocytes,	bent	and	extended	LFA‐1	essentially	
show	similar	lateral	mobility	patterns	with	the	exception	of	a	fraction	of	extended	
LFA‐1	(L16+)	pre‐anchored	to	the	cytoskeleton 23.		
	
	
Long spacer FRET pair Short spacer FRET pair
A
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C
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Figure	 5:	 Depletion	 of	
cholesterol	 and	 SM	
reduces	mobility	 of	 LFA‐1	
in	 the	 membrane	 of	
monocytes.	 THP‐1	 cells	
were	 treated	 with	 MCD	
(10mM)	 or	 SMase	
(0.05U/ml)	 prior	 and	
during	the	experiment.	(A)	
The	 lateral	 mobility	 of	
LFA‐1	 was	 measured	 by	
FRAP	 using	 TS2/4	
conjugated	 to	 AF488.	 (B)	
The	 membrane	 was	
fluorescently	 labeled	 with	
PKH	 dye	 to	 determine	 the	
mobility	 of	 membrane	
lipids	after	cholesterol	and	
SM	 depletion	 by	 FRAP.	
Error	bars	 show	 the	SD	of	
the	mean.	 (C)	 The	mobile	
fractions	 of	 LFA‐1	 and	
PKH	dye	FRAP	curves	were	
determined	using	a	 two‐component	model	 (see	materials	and	methods).	 (D)	The	halftime	of	
recovery	of	LFA‐1	was	 calculated	as	described	 in	materials	and	methods.	FRAP	 curves	were	
averaged	 from	12‐15	 curves	 of	3	 independent	 experiments	 and	were	acquired	at	37°C.	The	
error	bars	represent	the	SD.		
To	 understand	 how	 the	 cytoskeleton	 and	 the	 lipid	 environment	 are	
coupled	 to	 modulate	 the	 diffusion	 of	 LFA‐1,	 we	 performed	 SDT	 of	 LFA‐1	
nanoclusters	 upon	 cholesterol	 and	 SM	 depletion	 in	 the	 presence	 of	 the	 actin	
polymerization	inhibitor	Cytochalasin	D	(CytoD).	Addition	of	CytoD	to	monocytes	
resulted	in	a	relative	reduction	in	immobile	(‐44±10%)	and	slow	mobile	(‐31±8%)	
and	a	 large	 increase	 in	the	fast	mobile	 fraction	of	LFA‐1	(+56±6%),	 in	relation	to	
unperturbed	cells	(Fig.	7A).	This	demonstrated	that	the	immobile	and	slow	moving	
populations	of	LFA‐1	nanoclusters	 in	the	presence	of	normal	cholesterol	and	SM	
levels	are	partially	restricted	in	their	mobility	by	the	actin	cytoskeleton.		
Depletion	of	 cholesterol	 resulted	 in	a	 redistribution	of	LFA‐1	 from	 immobile	and	
fast	 mobile	 LFA‐1	 towards	 the	 slow	 mobile	 fraction	 (+18±2%,	 Figure	 6D),	
highlighting	an	involvement	of	cholesterol	in	maintaining	the	immobilized,	as	well	
as	 the	highly	mobile	 fractions	of	LFA‐1.	By	adding	CytoD	 to	 cholesterol	depleted	
cells,	we	observed	a	partial	 recovery	of	 the	 fast	mobile	 fraction	 (+35±10%)	by	a	
small	reduction	of	the	immobile	(‐5±10%)	and	mainly	the	slow	mobile	fraction	(‐
27±11%)	 in	 relation	 to	 cholesterol	 depletion	 only,	 similar	 to	 CytoD	 treatment	 of	
unperturbed	 cells,	 highlighting	 an	 involvement	 of	 the	 cytoskeleton	 in	 restricting	
LFA‐1	nanocluster	diffusion.		
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Figure	6:	Diffusion	of	LFA‐1	nanoclusters	is	cholesterol	and	SM	dependent.	(A)	Selected	frame	
from	a	movie	recorded	at	100ms/frame	 in	TIRF	mode.	Bright	spots	correspond	 to	 individual	
LFA‐1	 nanoclusters	 labeled	with	 TS2/4‐Atto488.	 Scale	 bar:	 10μm	 (B)	Representative	 LFA‐1	
trajectories	 of	 untreated,	 and	 cholesterol	 or	 SM	 depleted	 cells,	 illustrating	 different	 lateral	
mobility.	(C)	Normalized	fractions	of	immobile,	slow	and	fast	mobile	subpopulations	of	LFA‐1	
nanoclusters	 in	untreated	monocytes.	 (D)	Relative	 changes	 in	 fraction	 sizes	 after	 treatment	
with	 MCD	 (10mM)	 or	 SMase	 (0.05U/ml)	 in	 comparison	 to	 unperturbed	 cells.	 Error	 bars	
represent	the	SD.	MSD	data	of	single	LFA‐1	nanoclusters	versus	tlag	of	(E)	the	slow	and	(F)	the	
fast	mobile	population	of	untreated	and	 cholesterol	or	SM‐depleted	 cells.	The	 slow	and	 fast	
diffusing	components	were	fitted	with	a	confined	diffusion	function.	The	fittings	are	overlaid	in	
red.	The	reduced	Chi‐Sqr	values	were	never	higher	than	2.127E‐6.	
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Conversion	of	SM	into	Cer	also	resulted	in	an	increase	of	slow	mobile	LFA‐
1,	however	in	contrast	to	cholesterol	depletion,	this	mainly	resulted	from	a	release	
of	 the	 immobile	 fraction	 (‐19±3%)	 and	 a	 clear	 shift	 towards	 the	 slow	 mobile	
fraction	(+16±1%),	and	only	from	a	small	contribution	of	the	fast	mobile	fraction	(‐
7±1%,	 Figure	 6D).	 Addition	 of	 CytoD	 to	 SM	 depleted	 cells	 did	 not	 result	 in	
prominent	 changes	 in	 fraction	 size	 (Figure	 7A).	 This	 was	 in	 strong	 contrast	 to	
CytoD	treatment	on	cholesterol	depleted	cells,	indicating	that	while	both	depletion	
of	 cholesterol	 and	 SM	 alter	 diffusion	 of	 LFA‐1	 and	 their	 confinement	 in	 the	
membrane,	the	underlying	molecular	changes	must	be	different.	
	
Table	 1:	 The	 slow	 and	 fast	 moving	 fractions	 of	 LFA‐1	 (labeled	 with	 TS2/4	 Atto488)	 of	
untreated	and	cholesterol	or	SM	depleted	cells	were	analyzed	by	CPD.	The	square	displacement	
values	were	 fitted	with	 a	 confined	 diffusion	model.	The	 parameter	Dslow	 and	Dfast	 (diffusion	
coefficient	 for	the	slow	and	 fast	moving	 fraction,	respectively),	as	well	as	Lslow	and	Lfast	(side‐
length	of	a	square	domain)	were	retrieved	from	the	confined	diffusion	model.		
	
Next,	 we	 plotted	 the	 MSD	 against	 the	 respective	 time	 lags	 for	 the	 slow	
moving	 and	 fast	moving	 fraction	 in	 unperturbed	 and	CytoD	 treated	 cells	 (Figure	
7B).	 Besides	 the	 relative	 changes	 in	 fraction	 size,	 actin	 cytoskeleton	 disruption	
altered	 the	 diffusion	 mode	 of	 the	 fast	 mobile	 fraction	 from	 confined	 to	 free,	
showing	 an	 involvement	 of	 the	 cytoskeleton	 in	 confining	 the	 diffusion	 of	 LFA‐1	
nanoclusters.	 Despite	 gain	 of	 free	 diffusion,	 the	 diffusion	 coefficients	 did	 not	
increase	 (Table	2),	 In	 fact,	 the	diffusion	 coefficient	 of	 the	 fast	moving	 fraction	of	
LFA‐1	 (Dfast)	 was	 slightly	 decreased	 upon	 CytoD	 addition,	 which	 most	 likely	
resulted	from	side	effects	of	the	treatment	(Table	2	&Figure	7B).	Addition	of	CytoD	
to	cholesterol	depleted	cells	changed	the	diffusion	mode	of	the	fast	moving	fraction	
from	confined	to	free,	similar	to	the	CytoD	treatment	in	unperturbed	cells,	but	did	
not	 restore	 the	 diffusion	 coefficients	 measured	 in	 unperturbed	 cells	 (Table	 2	
&Figure	 7C).	 Due	 to	 the	 change	 of	 diffusion	 mode	 from	 confined	 to	 free	 (in	
unperturbed	 cells	 +	 CytoD	 and	 in	 cholesterol‐depleted	 cell	 +	 CytoD),	we	 did	 not	
obtain	values	for	Lfast.	Finally,	we	disrupted	the	actin	cytoskeleton	in	SM	depleted	
L	slow[μm]	 D	slow[μm2/s] L	fast [μm]	 D	fast	[μm2/s] trajectories
untreated 0.326±
0.002
0.012±
4.78E‐4
1.280±
0.012
0.05±
7.05E‐4
362
MCD 0.28±
0.003
0.008±
4.92E‐4
1.097±
0.019
0.033±
7.41E‐4
250
SMase 0.276±
0.003
0.011±
6.89E‐4
1.069±
0.028
0.033±
0.001
240
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cells	(Table	2	&Figure	7D).	In	contrast	to	untreated	and	cholesterol	depleted	cells,	
addition	of		
	
Figure	7:	Cytoskeletal	constraints	on	LFA‐1	diffusion	are	 largely	mediated	by	SM.	Cells	were	
treated	 for	 5	min	 with	 5ug/ml	 CytoD,	 or	 with	 MCD	 or	 SMase	 +	 CytoD	 prior	 and	 during	
measurement.	(A)	Relative	changes	in	fraction	sizes	after	treatment	with	CytoD	in	comparison	
to	unperturbed	cells,	or	MCD‐	or	SMase‐	pretreated	 cells.	Error	bars	 represent	 the	 standard	
deviation.	(B)	MSD	plots	of	untreated	and	cholesterol	or	SM	depleted	cells.	The	slow	and	 fast	
mobile	population	of	untreated	+/‐	CytoD,	and	cholesterol	or	SM‐depleted	cells	+/‐	CytoD	are	
displayed.	The	slow	and	fast	diffusing	components	were	fitted	with	a	confined	or	free	diffusion	
function.	The	 fitting	 is	 shown	 (red	 line).	The	reduced	Chi‐Sqr	values	were	never	higher	 than	
4.912E‐5.	
	
CytoD	to	SMase	treated	cells	slightly	increased	the	diffusion	coefficients	of	the	fast	
moving	fractions,	without	altering	the	confinement	area	and	the	diffusion	mode.																														
	
Taken	 together,	 these	 data	 demonstrate	 that	 changes	 in	 the	 lipid	
nanoenvironement	affect	the	mobility	of	LFA‐1	nanoclusters,	detected	by	SDT,	on	
different	 levels	at	 the	nanoscale.	As	extensively	described	earlier,	 the	mobility	of	
LFA‐1	nanoclusters	 follows	 immobile,	slow	and	fast	mobile	diffusion	(Figure	6C),	
in	which	the	immobile	fraction	can	be	attributed	to	engagement	of	extended	LFA‐1	
with	 the	 cytoskeleton	 (23,	 chapter	 6),	 Our	 data	 presented	 here	 show	 a	 relative	
change	 in	 fraction	 size	 upon	 depletion	 of	 SM	 and	 cholesterol	 towards	 the	 slow	
moving	 population.	 Cholesterol	 depletion	 releases	 LFA‐1	 from	 the	 cytoskeleton,	
untreated
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but	 to	 a	 slightly	 higher	 extent	 also	 reduces	 the	mobile	 fractions.	 In	 contrast,	 SM	
depletion	mainly	releases	LFA‐1	from	the	cytoskeleton,	with	a	smaller	contribution	
of	the	fast	mobile	fraction	in	increasing	the	slow	mobile	LFA‐1.	The	redistribution	
of	 the	 fractions	 resulted	 in	 an	 overall	 reduction	 of	 the	 diffusion	 coefficients	 and	
slight	 increase	 in	LFA‐1	confinement,	 similar	upon	SM	and	cholesterol	depletion.	
Moreover,	 our	 data	 showed	 that	 the	 cytoskeleton	 imposes	 constraints	 on	 the	
immobile	and	slow	mobile	population	of	LFA‐1	in	unperturbed	cells,	and	to	a	lower	
extend	in	cholesterol	depleted	cells,	as	the	general	confinement	of	LFA‐1	could	be	
released	upon	CytoD	treatment,	without	major	effects	on	the	diffusion	coefficients.	
In	contrast,	conversion	of	SM	into	Cer	showed	a	different	effect	on	the	nanoscale	
diffusion,	as	upon	CytoD	treatment,	LFA‐1	essentially	remained	confined,	but	with	
a	small	increase	in	diffusion	coefficients.		Our	results	emphasize	that	both	SM	and	
cholesterol	contribute	to	regulate	LFA‐1	diffusion,	however	via	different	molecular	
mechanisms.	
	
Table	 2:	 The	 slow	 and	 fast	 moving	 fractions	 of	 LFA‐1	 (labeled	 with	 TS2/4	 Atto488)	 of	
unperturbed	cells	+	cytoD,	and	cholesterol	or	SM	depleted	cells	+	CytoD	were	analyzed	by	CPD.	
The	 square	 displacement	 values	were	 fitted	with	 a	 confined	 and	 free	 diffusion	model.	 The	
parameter	Dslow	and	Dfast	(diffusion	coefficient	for	the	slow	and	fast	moving	fraction),	as	well	as	
Lslow	 and	 Lfast	 (side‐length	 of	 a	 square	 domain)	were	 retrieved	 from	 the	 confined	 diffusion	
model.	 *	 indicates	 that	 in	 these	 cases,	 the	 free	 diffusion	model	was	 applied	 to	 retrieve	 the	
diffusion	coefficient	Dfast	and	therefore	no	value	Lfast	could	be	obtained.			
	
Discussion	
In	 the	 current	 study	 we	 investigated	 how	 changes	 in	 the	 lipid	
nanoenvironment	 influence	different	modes	of	 LFA‐1	 regulation	 (affinity,	avidity,	
proximal	 distribution	 to	 GM1	 enriched	 domains	 and	 lateral	 mobility),	 and	 how	
these	components	contribute	to	LFA‐1‐mediated	adhesion	in	monocytes.		
L	slow [μm]	 D	slow[μm2/s] L	fast [μm]	 D	fast	[μm2/s] trajectories
Untreated 0.384	±
0.004
0.0082±
4.4E‐4
1.28±
0.014
0.052±
6.68E‐4
109
Untreated
+CytoD
0.434±
0.004
0.007±
5.05E‐4
* 0.038±
5.84E‐4
65
MCD 0.25±
0.003
0.0094±
8.61E‐4
0.827±
0.026
0.031±
0.002
88
MCD
+CytoD
0.349±
0.006
0.009±
4.49E‐4
* 0.032±
8.92E‐4
109
SMase 0.24±
0.003
0.0074±
6.74E‐4
1.1±
0.05
0.027±
9.06E‐4
94
SMase
+CytoD
0.263±
0.002
0.014±
0.001
1±
0.02
0.039±
0.001
101
Chapter	7	
197	
	
Our	data	showed	that	LFA‐1	binding	to	ICAM‐1	was	greatly	impaired	upon	
depletion	 of	 cholesterol	 and	 SM,	 without	 changing	 the	 affinity	 status	 of	 LFA‐1.	
Depletion	of	cholesterol	reduced	the	availability	of	a	αL	specific	epitope	located	at	
the	binding	groove,	and	a	membrane	proximal	epitope	on	the	β2	chain.	Moreover,	
loss	 of	 cholesterol	 induced	 an	 increased	 interaction	 of	 the	 integrin	 cytoplasmic	
tails,	without	 a	 loss	 in	 net	 extension	 of	 the	molecule	 or	 changes	 in	 nanodomain	
integrity.	As	cholesterol,	 SM	appeared	not	 to	be	essential	 for	 the	maintenance	of	
LFA‐1	 nanoclusters,	 but	 in	 contrast,	 its	 depletion	 did	 not	 cause	 significant	
structural	 changes	nor	 increased	cytoplasmic	 tail	 interaction,	pointing	 towards	a	
different	 role	 of	 SM	 in	 regulating	 LFA‐1	 function.	 The	 distinct	 effects	 of	 SM	 and	
cholesterol	depletion	on	LFA‐1	structure	were	reflected	in	LFA‐1	dynamics.	While	
both	 cholesterol	 and	 SM	 depletion	 caused	 slowing	 down	 and	 increased	
confinement	of	LFA‐1	diffusion,	cholesterol	depletion	caused	changes	that	could	be	
partially	resolved	by	disruption	of	the	actin	cytoskeleton.	In	contrast,	conversion	of	
SM	into	Cer	already	partially	released	immobilized	LFA‐1	from	the	cytoskeleton.	
Changes	 in	cholesterol	content	 in	model	membranes	are	known	to	affect	
the	 preferential	 formation	 of	 complexes	 between	 cholesterol	 and	 sphingolipids,	
thereby	forming	a	liquid	ordered	(Lo)	phase	in	contrast	to	the	surrounding	liquid‐
disordered	 phase	 (Ld)	 43.	 A	 large	 body	 of	 evidence	 suggests	 that	 interactions	 of	
cholesterol	with	 lipids	 (such	as	SM)	and	proteins	 (such	GPI‐APs)	also	govern	 the	
organization	of	membrane	rafts	in	living	membranes	2.	
The	reduction	of	the	membrane	proximal	epitope	of	the	mAb	KIM185	on	
the	 β2	 chain	 upon	 cholesterol	 depletion	 might	 indicate	 a	 dependency	 of	 the	
KIM185	 epitope	 on	 cholesterol;	 however	 this	 seems	 unlikely	 as	 cholesterol	 is	
inserted	 deeply	 into	 the	 PM.	 Besides,	 we	 also	 observed	 a	 small,	 but	 significant	
reduction	of	a	αL	specific	epitope	at	the	binding	groove.	This	rather	suggests	that	
cholesterol	 depletion	 perturbs	 the	 lipid	 nanoenvironment	 where	 LFA‐1	
nanoclusters	are	embedded,	leading	to	structural	changes	of	the	TM	region	that	are	
propagated	 into	 overall	 structural	 modifications	 that	 cause	 the	 masking	 of	 the	
KIM185	epitope.	A	similar	masking	of	 the	KIM185	epitope	has	been	observed	by	
the	 different	 α	 chains	 of	 the	 β2	 integrin‐constellations.	 The	 slightly	 different	
structures	of	 the	α	chains	 led	 to	a	partial	masking	of	 the	KIM185	epitope	on	 the	
corresponding	 β2	 chain	 44,	 indicating	 that	 this	 epitope	 could	 be	 sensitive	 to	
structural	changes	related	to	the	α‐chain.		
The	 absence	 of	 cholesterol	 might	 also	 induce	 tighter	 packing	 of	 LFA‐1	
heterodimers	inside	the	LFA‐1	nanoclusters	and	masking	of	the	KIM185	epitope	by	
adjacent	integrins.	However,	such	changes	would	most	likely	have	caused	also	the	
reduction	 of	 other	 epitopes	 due	 to	 steric	 hindrance,	 which	 we	 did	 not	 detect.	
Moreover,	 at	 the	 resolution	 limit	 of	 our	 approach,	 given	 by	 the	 size	 of	 our	 gold	
particles	that	detected	LFA‐1	(10	nm),	we	did	not	observe	tighter	packing	within	
the	LFA‐1	nanoclusters.	However,	the	results	of	our	FRET	experiment	suggest	that	
the	integrin	cytoplasmic	tails	are	brought	closer	to	each	other	(increase	of	FRET),	
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while	the	amount	of	extended	LFA‐1	remained	stable.	While	this	does	not	exclude	
a	shift	from	high‐affinity	(extended)	towards	intermediate	(extended)	LFA‐1,	since	
both	conformations	are	L16+	28,	this	is	the	first	report	of	an	increase	in	cytoplasmic	
tail	 interaction,	without	a	shift	 from	extended	 towards	bent	 (L16‐)	LFA‐1.	As	 the	
structure	 of	 the	 cytoplasmic	 tails	 of	 LFA‐1	 is	 not	 clearly	 resolved	 yet	 45,	 it	 will	
require	further	studies	to	determine	whether	this	extended	LFA‐1	with	“unusual”	
interacting	cytoplasmic	tails	reflects	a	natural	conformation	of	LFA‐1	or	whether	it	
is	a	product	of	cholesterol	depletion.		
As	 cholesterol	 reduces	 the	 deformation	 of	 the	 lipid	 bilayer	 under	
hydrophobic	mismatch	(when	the	embedded	TM	region	of	a	protein	is	smaller	than	
the	width	of	the	bilayer)	by	forcing	the	α	helixes	of	TM	proteins	to	stretch,	instead	
of	 tilting	46,	 it	 is	possible	 that	 the	 lack	of	cholesterol	might	 induce	changes	 in	 the	
tilting	angle	of	the	α	helices	of	the	α	or	β	chain,	that	are	in	turn	translated	to	the	
cytoplasmic	tails	and	would	explain	the	increase	in	FRET	signal	that	we	detected.	
Cholesterol	 might	 also	 directly	 interact	 with	 TM	 proteins	 via	 a	 cholesterol	
recognition	domain	 (CRAC‐motif)	 at	 the	membrane	 interface	 47.	Moreover,	direct	
interaction	 of	 a	 conserved	 so	 called	 “snorkeling	 residue”	 at	 the	 PM/cytosolic	
interface	of	integrins	with	the	phospholipid	headgroups	ensures	a	critical	crossing	
angle	 of	 the	 integrin	TM	 segment	 and	 thus	 regulates	 integrin	 signaling	 48.	 These	
findings	 emphasize	 that	 integrins	 are	 sensitive	 to	 modifications	 of	 the	 lipid	
nanoenvironment	 in	 general,	 potentially	 by	 direct	 and	 indirect	 interactions	with	
cholesterol.		
Conversion	 of	 SM	 into	 Cer	 strongly	 influences	 the	 organization	 and	
dynamical	 properties	 of	 the	 PM	 by	 and	 induces	 the	 formation	 of	 Cer‐enriched	
microdomains	 9.	 Since	 Cer	 displaces	 cholesterol	 from	 cholesterol‐enriched	
domains	 10;	 11,	 conversion	 of	 SM	 into	 Cer	 in	 native	 membranes	 also	 affects	 the	
lateral	 organization	 of	 cholesterol.	 Similar	 to	 cholesterol	 depletion,	 LFA‐1	
nanodomain	 integrity	 was	 maintained	 upon	 SM	 depletion,	 however	 with	 a	
reduction	 in	co‐distribution	with	GM1	enriched	domains.	This	highlights	 that	 the	
maintenance	of	LFA‐1	nanoclusters	is	independent	of	SM	and	cholesterol,	while	the	
depletion	 of	 these	 PM	 compartments	 disturbs	 the	 interconnectivity	 that	 is	
important	for	the	final	formation	of	larger	ligand	induced	adhesion	sites	22.	While	
SM	 contributed	 to	 the	 same	 extent	 to	 LFA‐1	 function,	we	 only	 observed	 a	 trend	
towards	a	reduction	of	the	KIM185	epitope.	In	fact,	this	might	have	been	partially	
caused	 by	 displacement	 of	 cholesterol	 by	 Cer,	 instead	 of	 a	 loss	 in	 SM.	 Further	
experiments	will	be	required	to	determine	the	degree	of	extraction	of	cholesterol	
and	SM	from	the	membrane	upon	MCD	and	SMase	treatment,	 to	clearly	attribute	
the	observed	changes	to	the	loss	of	one	lipid	species.	In	contrast	to	cholesterol,	SM	
depletion	 did	 not	 cause	 increased	 interaction	 of	 the	 cytoplasmic	 tails.	 Thus,	
cholesterol	influences	LFA‐1	structure,	while	SM	most	likely	does	not,	indicating	a	
difference	 in	 the	 underlying	 mechanisms	 that	 contribute	 to	 the	 loss	 of	 LFA‐1	
mediated	binding.	
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In	 the	 PM,	 large	 scale	 actin‐based	 corrals	 and	 TM	 proteins	 anchored	 to	
such	 corrals	 impose	 confinement	 on	 proteins	 and	 lipid	 diffusion	 41.	 At	 a	 smaller	
scale,	confinement	of	raft	associated	proteins	and	lipids	has	been	demonstrated	by	
transient	 association	with	 SM	and	 cholesterol	 enriched	domains,	 as	 reported	 for	
GPI‐APs	 49.	 We	 recently	 identified	 different	 diffusion	 regimes	 of	 LFA‐1	
nanoclusters	 on	monocytes	 (23,	 2012,	 chapter	6).	 The	 overall	 diffusion	 of	 these	
nanoclusters	 depended	 on	 LFA‐1	 conformation,	 with	 low	 affinity	 integrins	
diffusing	 essentially	 in	 a	 random	 fashion,	 while	 primed	 (L16+)	 nanoclusters	
exhibited	 stationary,	 slow	 mobile	 and	 random	 diffusion	 on	 the	 surface	 of	
monocytes	 (23,	 chapter	6).	 Diffusion	 of	 unanchored	 LFA‐1	 serves	 as	 a	 pool	 that	
freely	 diffuses	 to	 the	 sites	 of	 adhesion,	 likely	 initiated	 by	 subsets	 of	 anchored	
extended	LFA‐1,	and	is	therefore	essential	for	proper	ligand	binding	23;	24.			
	Here,	 in	 line	 with	 our	 previous	 work,	 we	 observed	 different	 diffusion	
profiles	 for	 LFA‐1	 (23,	 chapter	 6),	 while	 imaging	 at	 the	 cell	 ventral	 side	 in	 TIRF	
mode	and	calculation	of	the	diffusion	coefficients	over	40	timelags,	resulted	in	an	
essentially	 confined	 diffusion	 behavior.	 Upon	 actin	 cytoskeleton	 disruption,	 we	
observed	a	large	redistribution	of	the	immobile	and	slow	mobile	fraction	towards	
the	fast	mobile	fraction	of	LFA‐1.	As	the	immobile	fraction	is	assigned	to	extended	
LFA‐1	 that	 is	 anchored	 to	 the	 cytoskeleton	 (23,	 chapter	6),	 our	 new	data	 suggest	
that	the	slow	mobile	population	was	hindered	by	larger	actin	based	confinements.	
Upon	CytoD	treatment,	the	diffusion	coefficient	of	fast	LFA‐1	was	slightly	reduced,	
despite	 the	 loss	of	confinement,	 likely	caused	by	collision	of	more	 fast	molecules	
that	were	previously	confined	by	the	actin	network,	as	reported	by	others	50.	
Cholesterol	depletion	 led	 to	a	redistribution	of	 immobile	and	 fast	mobile	
towards	 slow	moving	 LFA‐1	 nanoclusters,	with	 an	 overall	 reduction	 in	 diffusion	
coefficients	 and	 increase	 in	 receptor	 confinement.	While	 the	 effect	 of	 cholesterol	
depletion	on	diffusion	is	highly	contradictory	in	the	literature,	our	data	essentially	
support	 the	 studies	 finding	 a	 decrease	 in	 protein	 and	 lipid	 diffusion	 coefficients	
upon	 depletion	 of	 cholesterol	 by	 MCD	 12;	 14.	 Recent	 studies	 showed	 that	 high	
concentrations	 of	 MCD	 abrogated	 GPI‐nanoclusters,	 while	 lower	 concentrations	
left	 GPI‐AP	 nanoclusters	 intact,	 but	 affected	 their	 local	 distribution	 and	 domain	
size	and	reduced	the	turnover	of	 these	domains	51;	 52.	This	graded	effect	suggests	
that	 cholesterol	 interacts	 with	 GPI‐APs	 at	 multiple	 levels,	 by	 passive	 GPI‐AP‐
cholesterol	interaction	and	by	regulating	the	activity	of	the	cortical	actin	network	
51.	GPI‐APs	and	LFA‐1	show	are	a	co‐distribution	in	the	PM,	therefore	cholesterol	
depletion	likely	also	affects	LFA‐1	distribution	and	dynamics.			
In	 line	 with	 this,	 our	 data	 indicate	 that	 cholesterol	 depletion	 acts	 on	
different	levels	that	affect	LFA‐1	diffusion.	We	observed	a	loss	of	a	small	fraction	of	
immobilized	pre‐anchored	LFA‐1,	which	might	have	been	caused	by	the	structural	
modifications	 on	 the	 cytoplasmic	 tails	 of	 LFA‐1	 upon	 cholesterol	 depletion,	
impairing	 interaction	 with	 cytoskeletal	 components.	 The	 reduction	 of	 the	 fast	
mobile	 fraction	 of	 LFA‐1	 was	 caused	 by	 actin,	 likely	 by	 a	 stabilizing	 effect	 of	
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cholesterol	depletion	on	 the	cortical	actin	by	sequestering	PIP2	that	 is	necessary	
for	 F‐actin	 turnover,	 as	 reported	 by	 others	 53.	 Supporting	 this	 notion,	 cytoD	
addition	 greatly	 recovered	 the	 fast	 mobile	 fraction	 from	 the	 remaining	
immobilized	and	slow	mobile	LFA‐1	pools	and	released	confinement,	as	diffusion	
became	 essentially	 free.	 As	 we	 and	 others	 have	 reported	 a	 correlation	 between	
LFA‐1	 conformation	 and	 its	 respective	 diffusion	 (23,	 chapter	6,	 54),	 alternatively,	
the	 increase	 in	 slow	mobile	 LFA‐1	 could	have	 resulted	 also	 from	a	 shift	 of	 high‐
affinity	 towards	 intermediate	 affinity	 LFA‐1	 (both	 L16+)	 that	 interacts	 with	 the	
cytoskeleton,	 as	 reported	 for	 intermediate	 LFA‐1	 in	 T	 cells	 54.	 Such	 an	
intermediate,	extended	LFA‐1,	that	anchors	to	the	cytoskeleton	has	been	proposed	
in	a	model	by	Dustin	et	al	55.	According	to	this	model,	on	resting	cells	there	might	
be	two	intermediate‐affinity	forms	of	LFA‐1,	one	anchored	to	the	cytoskeleton	via	
cytoskeletal	interactors	(such	as	Talin	or	RapL),	and	one	mobile.	The	unaltered	L16	
expression,	 increased	FRET	signal	and	reduction	of	KIM185	are	consistent	with	a	
shift	 of	 the	 high	 affinity	 form	 towards	 the	 intermediate‐affinity	 state	 upon	
cholesterol	depletion.	Furthermore,	the	increase	of	slow	mobile	LFA‐1	and	overall	
reduced	mobility	as	seen	from	the	dynamic	data	are	consistent	with	the	notion	that	
this	 newly	 generated	 intermediate	 state	 is	 transiently	 anchored	 to	 the	
cytoskeleton.	Indeed,	CytoD	treatment	increases	the	fast	mobile	population	of	LFA‐
1	and	its	diffusion	becomes	free.	In	contrast	to	the	proposed	model	by	Dustin	et	al	
55,	we	rather	observe	an	increase	in	slow	mobile	LFA‐1,transiently	anchored	LFA‐1.	
The	 structural	 modification	 of	 the	 LFA‐1	 cytoplasmic	 tails	 induced	 upon	
cholesterol	 depletion	 might	 prevent	 a	 full	 immobilization	 of	 LFA‐1,	 but	 rather	
favor	transient	interactions	with	the	actin	cytoskeleton.		
Conversion	 of	 SM	 into	 Cer	 and	 the	 formation	 of	 Cer‐enriched	
microdomains	is	thought	to	drive	the	structural	reorganization	in	lipid	membranes	
and	 segregation	 of	 signaling	 proteins	 into	 such	 domains	 9.	 Formation	 of	 Cer‐
enriched	domains	affected	the	diameter	and	fluidity	of	model	membranes	9;	10.	Our	
data	showed	that	SM	depletion	released	the	 immobile	 fraction	of	LFA‐1	 from	the	
cytoskeleton	and	reduced	LFA‐1	diffusion	coefficients	and	increased	confinement.	
As	 SM	 depletion	 did	 not	 alter	 LFA‐1	 structure	 as	 seen	 in	 the	 FRET	 analysis,	 the	
interaction	 of	 LFA‐1	 with	 the	 cytoskeleton	 seems	 to	 be	 directly	 affected	 by	 SM	
levels,	potentially	by	mediating	 the	 targeting	of	LFA‐1	 regulatory	proteins	 to	 the	
proximal	 lipid	 nanoenvironment.	 Conversion	 of	 SM	 into	 Cer	 seems	 to	 cause	
changes	beyond	actin	cytoskeleton	induced	confinements,	potentially	by	formation	
of	 larger	 Cer‐enriched	 microdomains	 with	 altered	 fluidity,	 that	 upon	 formation	
embed	 LFA‐1	 molecules.	 In	 contrast	 to	 cholesterol	 depletion,	 disruption	 of	 the	
actin	cytoskeleton	in	SM	depleted	cells	did	not	result	in	a	shift	towards	fast	mobile		
LFA‐1	or	 to	 the	 free	diffusion	mode,	but	 resulted	 in	a	 slight	 increase	 in	diffusion	
coefficients.	 This	 increase	 could	 be	 a	 consequence	 of	 a	 loss	 of	 actin	 corrals,	 that	
restrict	the	diffusion	of	proteins	trapped	in	lipid	domains	41,	such	as	Cer‐enriched	
microdomains.	Our	data	are	in	line	with	previous	findings	showing	that	leukocyte	
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adhesion	 on	 neutrophils	 was	 impaired	 upon	 Cer	 production,	 due	 to	 a	 defect	 of	
cytoskeletal	organization	and	inside‐out	signaling	26	and	show	that	this	was	likely	
caused	 by	 the	 decreased	 interaction	 of	 LFA‐1	 with	 the	 cytoskeleton	 upon	 SM	
depletion.			
	
Taken	 together,	 SM	 and	 cholesterol	 contribute	 to	 maintain	 the	 balance	
between	 immobile,	 slow	 and	 fast	 mobile	 LFA‐1	 in	 monocytes.	 Low‐affinity	
unanchored	LFA‐1	most	 likely	serves	as	a	pool	 that	 freely	diffuses	 to	 the	sites	of	
adhesion,	which	are	 initiated	by	subsets	of	anchored	extended	LFA‐1	that	suit	 to	
work	 as	 nascent	 adhesion	 sites	 evolving	 into	 larger	 ligand‐induced	 adhesion	
clusters.	Shifting	the	balance	towards	slow	mobile	LFA‐1	upon	SM	and	cholesterol	
depletion	thus	impairs	 i)	the	initiation	of	adhesion	sites	by	reducing	the	 levels	of	
anchored	 extended	 LFA‐1,	 and	 ii)	 the	 levels	 of	 mobile	 integrins	 that	 have	 the	
increased	capacity	to	freely	move	to	the	sites	of	pre‐anchored	extended	integrins	
to		reinforce	adhesion.		
In	summary,	this	study	provides	evidence	that	LFA‐1	function	is	regulated	
by	 its	 direct	 interaction	 with	 SM	 and	 cholesterol	 within	 the	 PM.	 Our	 data	
emphasizes	 a	 critical	 role	 for	 cholesterol	 in	 maintaining	 LFA‐1	 structural	
properties	and	its	respective	diffusion,	as	depletion	of	cholesterol	by	MCD	rather	
imposed	 restraints	 on	 LFA‐1	 diffusion	 by	modification	 of	 actin	 based	 structures.	
Moreover,	our	data	strongly	suggest	a	novel	and	critical	role	 for	SM	in	regulating	
LFA‐1	diffusion	by	mediating	its	interaction	with	the	cytoskeleton.			
Cells	 might	 actively	 be	 involved	 in	 altering	 diffusion	 of	 PM	 proteins	 by	
dynamically	 modifying	 the	 lipid	 content	 of	 the	 PM	 in	 response	 to	 metabolic	
changes	 such	 as	 occurring	 during	 cell	 differentiation,	 or	 during	 disease	 56.	
Moreover,	 formation	 of	 Cer‐enriched	 microdomains	 upon	 activation	 of	
endogenous	 SMase	 has	 been	 reported	 in	 response	 to	 external	 stimuli,	 or	 by	
secretion	 of	 SMase	 by	 pathogens,	 thereby	 promoting	 pathogen	uptake	 by	 locally	
altering	the	PM	membrane	57;	58,	and	is	therefore	highly	relevant	in	vivo.	Triggering	
of	 LFA‐1/ICAM‐1	 in	 T	 cells	 has	 been	 shown	 to	 activate	 among	 other	 signaling	
pathways	 also	 acid	 SMase	 59.	 This	 indicates	 that	 conversion	 of	 SM	 into	 Cer	 as	 a	
response	 to	 external	 stimuli	 might	 be	 actively	 used	 by	 cells	 to	 modulate	 LFA‐1	
mediated	adhesion.	
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Abbreviations:	
LFA‐1,	 lymphocyte	 function‐associated	 antigen‐1;	 PM,	 plasma	 membrane;	 TM,	
transmembrane;	 SM,	 sphingomyelin;	 GPI‐APs,	 glycosylphosphatidyl‐inositol	
anchored	 proteins;	 Cer,	 Ceramide;	 SMase,	 sphingomyelinase;	 MCD,	 methyl‐β‐
cyclodextrin;	mAb,	 monoclonal	 antibody;	 SDT,	 single	 dye	 tracking;	MSD,	 mean	
square	displacement;	CPD,	cumulative	probability	distribution.	
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Figure	S1: Viability	of	monocytes	was	not	
affected	by	 cholesterol	and	 SM	depletion.	
After	 1	 hour	 treatment	 of	 monocytes	
(THP‐1	cells),	SMase	(0.05U/ml)	or	30	min	
treatment	with	MCD	 (10mM),	 AnnexinV‐
FITC	 and	 propidium	 iodide	 (PI)	 were	
added	 to	 determine	 the	 percentage	 of	
apoptosis	 and	 necrosis,	 respectively.	
PI/AnnV	 negative	 cells	 represent	 the	 live	
cell	 population.	 Changes	 in	 cell	 viability	
are	 displayed	 as	 relative	 to	 untreated	
samples	 (expression	 levels	 in	 untreated	
cells	were	set	as	=	100%). 
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Figure	S2: Cholesterol	and	SM	
depletion	do	not	affect	GM1	cell	
surface	expression.	GM1	(detected	
by	fluorescent	cholera	toxin	
subunit	B)	after	treatment	with	
MCD	(10mM)	for	30	min	or		
0.05U/ml	SMase	for	1	hour	at	
37°C,	assessed	by	flow	cytometry.	
Changes	in	the	mean	fluorescent	
intensity	are	displayed	as	relative	
to	untreated	samples	(expression	
levels	in	untreated	cells	were	set	
as	=	1.	indicated	by	the	dotted	
line).	The	data	represent	the	
average	+/‐	SEM	of	5	independent	
experiments.		
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DIC CD71 mergeGM1
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Figure	S3:	Confocal	
microscopy	analysis	of	
co‐capping	of	LFA‐1	(L15	
labeled)	and	GM1	on	
untreated	monocytes	
(THP‐1).	Receptor	
copatching	and	staining	
were	performed	as	
described	in	Material	and	
Methods.	CD55	and	CD71	
are	positive	and	negative	
lipid	rafts	marker,	
respectively.	Results	are	
representatives	of	
multiple	cells	in	three	
independent	
experiments.		
	
	
	
	
	
	
	
	
	
Figure	S4:	LFA‐1	conformation	reporter	FRET	pair.	THP‐1	cells	were	transfected	with	a	FRET	
pair	consisting	of	αL‐ECFP	and	β2‐EYFP,	where	ECFP	and	EYFP	were	fused	to	the	C‐termini	of	
the	 integrin	 cytoplasmic	 tails.	 Close	 vicinity	 between	 the	 cytoplasmic	 tails	 (as	 in	 the	 bent,	
inactive	molecule)	results	 in	an	 inter‐subunit	FRET	 signal,	which	 is	reduced	upon	activation	
and	 separation	of	 the	 cytoplasmic	 tails	 (as	 in	 the	 intermediate,	extended	molecule)	and	 lost	
upon	full	activation.	
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Figure	 S5:	 Cumulative	
probability	 distribution	
(P(r2))	 of	 the	 square	
displacements	(r2)	of	LFA‐1	at	
tlag	 5.	 Individual	 LFA‐1	
nanoclusters,	 labeled	 with	
TS2/4‐Atto488,	 were	
recorded	with	a	 framerate	of	
100ms,	over	200	frames.	THP‐
1	cells	were	treated	with	MCD	
(10mM)	or	SMase	(0.05U/ml)	
prior	 and	 during	 the	 time	 of	
the	experiment.	The	PSD	were	
described	 with	 a	 tri‐
exponential	 fit	 giving	 three	
Mean	 Square	 Displacements	
(ri2(t))and	the	fraction	size.	
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General	Discussion	and	Future	Perspectives	
During	 their	 life	 cycle,	DCs	have	 to	migrate	 from	 the	blood	 to	 the	 tissue	
and	subsequently	via	the	lymphatic	vessels	to	the	lymph	nodes	in	order	to	present	
antigen	 to	 naïve	 lymphocytes	 and	 to	 mount	 an	 efficient	 immune	 response.	
Trafficking	 of	 immune	 cells	 is	 orchestrated	 by	 adhesion	 receptors	 that	 allow	
interaction	 with	 the	 surrounding	 environment,	 as	 well	 as	 chemokine	 receptors	
that	transmit	directional	cues	to	immune	cells.	On	their	route	to	the	lymph	nodes,	
DCs	are	exposed	to	alternating	environments	that	require	specific	adaptations.		
Regulation	of	adhesive	properties	at	different	steps	during	the	DC	life	cycle	
Monocytes	and	DCs	undergo	metabolic	changes	during	DC	differentiation	
and	maturation	 that	 are	 also	 reflected	 in	 up‐	 and	 downregulation	 of	 cell	 surface	
receptors	and/or	changes	in	receptor	activity.	Chemokine	receptor	expression	on	
monocytes	is	completely	different	compared	to	mature	DCs.	So	do	monocytes	and	
immature	 DCs	 express	 the	 chemokine	 receptors	 CCR1,CCR2,CCR5	 and	 CXCR1,	
which	are	required	for	pro‐inflammatory	chemotaxis	in	the	tissues,	while	maturing	
DCs	upregulate	CCR7,	the	receptor	for	the	lymphoid	chemokines	CCL19	and	CCL21	
1.	 In	 contrast,	 the	 integrin	 LFA‐1	 remains	 expressed	 at	 similar	 levels	 during	
differentiation	of	monocyte‐derived	DCs,	but	only	monocytes	express	high‐affinity	
(extended)	and	functional	LFA‐1	2.	While	LFA‐1	plays	an	important	role	for	rolling	
and	firm	adhesion	during	transendothelial	migration	of	monocytes	into	the	tissue,	
the	question	whether	integrins	are	essential	for	DC	function	is	highly	controversial.		
Supporting	 a	 role	 for	 LFA‐1	 in	 DCs	 are	 studies	 showing	 that	 the	major	
ligands	for	LFA‐1	and	VLA‐4	(ICAM‐1	and	VCAM‐1)	are	expressed	in	the	lymphatic	
tissues	 and	 are	 upregulated	 during	 inflammation,	 suggesting	 that	 interaction	
between	integrins	on	immune	cells	and	the	lymphatic	endothelial	cells	takes	place	
1.	In	contrast,	it	was	reported	that	in	the	steady	state,	DCs	from	integrin	knock‐out	
mice	 migrate	 from	 the	 tissue	 to	 the	 lymph	 nodes	 similar	 to	 wildtype	 DCs,	
suggesting	 that	 integrins	 are	 not	 essential	 for	 migration	 of	 DCs	 in	 vivo	 3.	 A	
reactivation	stimulus	specific	for	LFA‐1,	such	as	chemokines	triggering	inside‐out	
signaling,	on	DCs	had	not	been	identified	yet.	In	chapter	4	I	demonstrate	that	high‐
affinity	 and	 functional	 LFA‐1	 could	 be	 transiently	 restored	 in	 monocyte‐derived	
DCs	 (moDCs)	 upon	 exposure	 to	 the	 lymphoid	 chemokine	 CCL21,	 suggesting	 a	
functional	 role	 for	 LFA‐1	 on	DCs,	when	 encountering	with	 CCL21	 in	 vivo.	 CCL19	
and	CCL21	represent	the	dominant	chemokines	in	the	lymph	nodes	and	lymphatic	
vessels	 and	 at	 least	 the	 expression	 of	 CCL21	 is	 increased	 during	 inflammation	 4.	
Our	results	support	and	further	extend	the	findings	by	Quast	and	colleagues	who	
reported	 that	CCL19,	 induces	a	general	β2	 integrin	activation	epitope	on	mature	
human	 moDCs	 5.	 Moreover,	 we	 showed	 that	 antigen‐loaded	 moDCs	 that	 were	
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injected	into	human	lymph	nodes	of	melanoma	patients	contained	elevated	levels	
of	high‐affinity	LFA‐1,	in	contrast	to	non‐injected	moDCs.	These	data	confirm	that	
upon	 entering	 the	 CCL21‐rich	 milieu	 of	 the	 lymph	 nodes,	 LFA‐1	 becomes	
reactivated	 on	DCs.	One	 explanation	 for	 the	 loss	 of	 LFA‐1	 function	 upon	 in	 vitro	
differentiation	of	monocytes	 towards	DCs	might	be	 the	 lack	of	activation	stimuli,	
such	as	chemokines,	that	are	present	in	vivo.		
Besides	 the	 reactivation	of	LFA‐1	on	DCs	by	CCL21,	 I	 show	 in	chapter	4	
that	 DCs	 only	 bind	 to	 ICAM‐1	 under	 shear	 stress	 conditions	 in	 the	 presence	 of	
CCL21,	 and	 at	 much	 lower	 values	 than	 monocytes.	 This	 most	 likely	 reflects	
different	 adaptations	 of	monocytes	 and	DCs	 for	 their	 respective	 environment.	 In	
healthy	 individuals,	 the	 shear	 stress	 in	 the	 blood	 stream	 varies	 between	 1‐4	
dynes/cm2.	 Monocytes	 do	 not	 need	 to	 actively	 migrate	 through	 the	 blood,	 but	
follow	passively	the	blood	stream.	To	adhere	to	the	endothelium,	it	requires	almost	
instant	 activation	 of	 their	 integrins	 triggered	 by	 endothelium‐presented	
chemokines,	 accompanied	 by	 firm	 adhesion	 within	 milliseconds.	 Moreover,	 this	
process	 is	 greatly	 facilitated	 when	 integrins	 are	 recruited	 to	 the	 site	 of	 ligand	
encounter	to	locally	enhance	avidity,	thereby	giving	resistance	to	bond	breakage	6;	
7.	 Interestingly,	LFA‐1	on	monocytes	 is	preassembled	 in	nanoclusters	of	100‐150	
nm	in	size,	in	the	absence	of	chemokines.	One	third	of	LFA‐1	nanoclusters	contain	
exclusively	 high‐affinity	 (extended)	 LFA‐1	 2.	 A	 subset	 of	 high‐affinity	 LFA‐1	
clusters	has	also	been	observed	on	T	cells	that	are	crawling	on	chemokine	bearing	
endothelial	cells	8.	In	contrast	to	T	cells	that	require	the	presence	of	chemokines	or	
other	activation	cues	for	integrin	activation	and	clustering,	monocytes	reside	in	a	
pro‐adhesive	 state	 that	 is	 further	 augmented	 upon	 chemokine	 encounter	 9.	
Additionally,	the	forces	created	by	the	shear	flow	of	the	blood	stream	are	predicted	
to	accelerate	the	swinging‐out	of	the	hybrid	domains	facilitating	the	transition	into	
a	 fully	 extended	 and	 high‐affinity	 LFA‐1	 with	 an	 open	 headpiece	 10.	 While	 the	
disposition	of	monocytes	and	the	blood	stream	favor	adhesiveness,	 less	is	known	
about	 integrins	 on	DCs	 and	 the	 environment	 of	 the	 lymphatics.	 LFA‐1	 on	DCs	 is	
randomly	distributed	on	the	cell	surface,	not	favoring	high	avidity	interactions,	and	
LFA‐1	 is	 inactive	 (bent	 conformation).	 In	 contrast	 to	 the	blood	stream,	 the	shear	
stress	 values	 present	 in	 the	 tissues	 (interstitium)	 and	 the	 lymphatic	 vessels	 are	
much	 lower,	 in	 the	 range	 of	 0.08	 dynes/cm2,	 most	 likely	 not	 contributing	 to	
adhesion	 strengthening	 by	 external	 forces.	 Moreover,	 it	 was	 reported	 that	 the	
kinetics	 of	 DC	 transmigration	 are	 completely	 different	 to	 the	 blood	 stream,	
requiring	 rather	 hours	 than	 minutes	 1.	 Still,	 blocking	 of	 ICAM‐1	 and	 VCAM‐1	
impaired	the	entry	of	DCs	to	the	lymphatics	and	subsequently	the	initiation	of	an	
immune	 response,	 suggesting	 that	 integrins	 are	 required	 for	 the	 transmigration	
into	 the	 initial	 lymphatics	 11.	My	 results	 presented	 in	 chapter	4	 are	 in	 line	with	
these	findings,	predicting	a	role	of	LFA‐1	during	the	DC	life	cycle.	Since	interstitial	
migration	(3D)	does	not	require	functional	integrins,	integrins	are	rather	required	
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as	inducible	anchors,	such	as	during	entry	into	the	lymphatics	during	inflammation	
when	 CCL21	 becomes	 secreted	 12.	 Moreover,	 constitutively	 active	 LFA‐1	 on	 DCs	
has	 a	 negative	 impact	 on	 the	 immune	 response	 13.	 Despite	 prolonged	 DC‐T	 cell	
encounter,	 the	 T	 cell	 mediated	 immune	 response	 was	 impaired,	 suggesting	 that	
LFA‐1	on	DCs,	in	contrast	to	monocytes,	has	to	be	inactive,	or	transiently	active	to	
allow	a	proper	immune	response	to	be	mounted.			
Taken	 together,	 due	 to	 the	 environmental	 and	 physiological	 changes	
during	 DC	 differentiation	 and	 maturation	 it	 is	 likely	 that	 integrin	 regulation	 in	
different	locations	follows	distinct	kinetics.		
Modification	of	LFA‐1adhesive	properties	by	herpes	simplex	virus‐1	
A	 tight	 balance	 between	 adhesion	 and	 migration	 are	 prerequisite	 for	
encounters	 with	 integrin	 ligands	 and	 on	 the	 other	 hand	 de‐adhesion	 and	 cell	
motility.	 Integrins	 mediate	 the	 connection	 between	 the	 cytoskeleton	 and	 the	
extracellular	matrix	 14;	 15,	 and	 the	 strength	 of	 these	 interactions	 determines	 the	
speed	of	migration.			
During	amoeboid	cell	migration,	DCs	form	only	short‐lived	contacts	to	the	
substrate,	 thereby	 favoring	 cell	 migration.	 In	 contrast,	 strong	 adhesion	 is	
negatively	 correlated	 with	 cell	 motility.	 In	 chapter	 5	 we	 describe	 how	 the	
pathogen	 herpes	 simplex	 virus	 1	 (HSV‐1)	 modifies	 LFA‐1	 adhesive	 properties,	
thereby	 impairing	 migration	 of	 DCs	 to	 the	 lymph	 nodes	 and	 delaying	 viral	
detection	 by	 the	 immune	 system.	 Besides	 the	 epithelial	 cell	 layer,	 HSV‐1	 infects	
immature	 skin	 DCs	 that	 most	 likely	 die	 upon	 infection	 16;	 17.	 It	 is	 assumed	 that	
bystander	DCs	take	up	the	antigen	of	apoptotic	DCs	and	mature	upon	encountering	
of	inflammatory	danger	signals,	and	subsequently	migrate	to	the	lymph	nodes	16;	18.	
Previously	 it	 was	 shown	 that	 infection	 of	 mature	 moDCs	 with	 HSV‐1	 led	 to	
increased	 adhesion	 and	 the	 formation	 of	 cell‐clusters	 19;	 20.	 In	 chapter	 5	 we	
demonstrate	that	infection	with	HSV‐1	increased	the	adhesion	of	infected	mature	
moDCs	to	 integrin	 ligands	through	the	constitutive	activation	of	LFA‐1	 leading	to	
reduced	 cell	 motility.	 2‐4	 hours	 after	 infection	with	 HSV‐1,	 mature	 DCs	 showed	
impaired	chemotaxis	towards	a	gradient	of	CCL19.	In	line	with	our	findings,	it	was	
demonstrated	 that	 HSV‐1	 infected	 DCs	 are	 absent	 in	 the	 lymph	 nodes	 in	 vivo,	
indicating	that	HSV‐1	indeed	utilizes	this	strategy	for	immune	evasion	21.	Infection	
with	HSV‐1	increased	the	binding	capacity	of	mature	moDCs	to	ICAM‐1	and	FN,	as	
well	as	migration	in	a	3D	collagen	matrix,	containing	immobilized	integrin	ligands.	
In	both	situations,	binding	 to	FN	and	 ICAM‐1	could	be	blocked	by	addition	of	an	
LFA‐1	blocking	antibody.	This	was	a	surprise,	since	FN	is	a	classical	ligand	for	β1,	
but	not	for	β2	integrins.	However,	several	studies	reported	cross‐talk	between	β1	
and	β2	integrins:	β2	integrins	on	FN	coating	were	found	activated	22,	and	immature	
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DCs	selectively	recruited	β2	integrins	to	podosomes	23.	Moreover,	it	was	reported	
that	the	activation	of	LFA‐1	led	to	decreased	β1	integrin	mediated	adhesion	24.	This	
integrin	 crosstalk	 could	 account	 for	 binding	 of	 LFA‐1	 to	 FN	 upon	 infection	 of	
mature	moDCs	with	HSV‐1.		
As	demonstrated	in	chapter	3,	activation	of	LFA‐1	on	DCs	is	transient	and	
requires	 encounter	 with	 CCL21.	 In	 general,	 activation	 of	 β2	 integrins	 by	
conformational	changes	triggered	by	inside‐out	signaling	are	much	more	restricted	
on	DCs,	 than	 on	 other	 cell	 types	 5.	 However,	 infection	 by	 HSV‐1	 virus	 overrides	
those	 requirements,	without	 increasing	 the	amount	of	 cell	 surface	LFA‐1.	 Inside‐
out	 signaling	 comprises	 of	 a	 complex	 network	 of	 intracellular	 signaling	 events,	
with	binding	of	 talin	 to	 the	 cytoplasmic	 tail	 of	 the	β2	 chain	 as	 the	most	 integrin	
proximal	event.	Binding	of	talin	separates	the	cytosplasmic	legs	and	induces	large	
conformational	changes	leading	to	integrin	activation	25.	Besides	talin,	cytohesin‐1	
was	described	as	the	only	direct	interaction	partner	able	to	activate	β2	integrins	5;	
26;	27.	Next	to	cytohesin‐1,	LFA‐1	function	is	regulated	by	the	cytohesin‐	interacting	
protein	 (CYTIP),	 which	 is	 upregulated	 during	 DC	 maturation	 28.	 Upon	 integrin	
signaling,	 CYTIP	 becomes	 recruited	 to	 the	 plasma	membrane	 and	 interacts	with	
Cytohesin‐1.	 This	 complex	 translocates	 to	 the	 cytosol,	 thereby	 terminating	
activation	 of	 LFA‐1	 28.	 In	 addition	 CYTIP	 plays	 a	 role	 regulating	 leukocyte	
trafficking	29	and	the	adherence	of	DCs	to	FN	30,	which	is	in	line	with	the	effects	of	
HSV‐1‐infection	of	DCs.	Additionally,	we	showed	in	chapter	5	that	infection	of	DCs	
with	 HSV‐1	 led	 to	 degradation	 of	 CYTIP,	 while	 the	 protein	 levels	 of	 cytohesin‐1	
were	 not	 affected.	 By	 degradation	 of	 CYTIP,	 the	 negative	 regulator	 of	 LFA‐1	
mediated	 adhesion	 is	 switched	 off,	 resulting	 in	 constitutive	 activation	 of	 LFA‐1	
leading	to	 increased	adhesion	and	the	 loss	of	DC	motility,	as	demonstrated	 in	3D	
collagen	experiments.	Moreover,	in	the	case	of	successful	migration	of	infected	DCs	
to	 the	 lymph	 nodes,	 constitutively	 active	 LFA‐1	 on	 DCs	 impairs	 T	 cell	 mediated	
immunity	13.	In	summary,	HSV‐1	has	developed	a	strategy	of	immune	escape	that	
nicely	 illustrates	 the	 consequences	 of	 constitutively	 active	 LFA‐1	 on	 DCs	 by	
disrupting	 the	 balance	 between	 adhesion	 and	 migration,	 thus	 impairing	 DC	
trafficking,	as	well	as	priming	of	immune	cells.		
Protein	interactions	of	LFA‐1	associated	with	DC	differentiation	
DC	 differentiation	 is	 accompanied	 by	 metabolic	 changes	 leading	 to	
differential	expression	of	genes	and	proteins	31.	The	development	of	bioinformatics	
tools	 for	 biological	 studies	 that	 predict	 protein‐protein	 interactions	 based	 on	
findings	 from	 the	 literature,	 protein	 structure	 and	databases,	 as	well	 as	 custom‐
written	and	topic‐specific	networks,	has	greatly	facilitated	the	analysis	of	complex	
protein	 interactions	 32‐34.	 In	 the	 last	 decades,	much	work	 has	 been	 dedicated	 to	
elucidate	 the	 complex	 network	 of	 protein	 interactions	 associated	 with	 integrins	
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during	 signaling	 and	 adhesion,	 from	 various	 cell	 types	 34.	 In	 chapter	3	 I	 used	 a	
proteomic	 approach	 coupled	 to	 mass‐spectrometric	 analysis	 to	 understand	 the	
molecular	changes	accompanied	with	downregulation	of	LFA‐1	 function	and	 loss	
of	 LFA‐1	 nanodomains	 during	 DC	 differentiation.	 In	 contrast	 to	 other	 integrin‐
related	proteomic	studies,	I	performed	a	specific	LFA‐1	IP	in	the	absence	of	cross‐
linking	 ligands	 on	 primary	 human	 monocytes	 and	 immature	 moDCs,	 without	
overexpression	of	LFA‐1.	My	results	in	chapter	3	show	a	clear	difference	in	LFA‐1	
associated	 proteins	 between	 monocytes	 and	 DCs.	 Surprisingly,	 fewer	 proteins	
were	 found	 associated	 with	 LFA‐1	 in	 monocytes	 than	 in	 DCs.	 Moreover,	 the	
repertoire	of	binding	partners	greatly	varied	throughout	DC	differentiation.	Among	
the	binding	partners,	I	identified	several	candidates,	that	are	found	to	interact	with	
other	integrins,	or	that	are	associated	with	adhesion.	Each	of	these	proteins	could	
potentially	 alter	 LFA‐1	 function;	 therefore	 more	 experiments	 will	 be	 needed	 to	
validate	 these	 candidates	 and	 to	 investigate	 whether	 they	 play	 a	 role	 in	
downregulation	 of	 LFA‐1	 function	 and	 loss	 of	 LFA‐1	 nanodomains.	 Among	 the	
potential	LFA‐1	binding	proteins	 in	monocytes,	 I	did	not	 identify	 tetraspanins	or	
Glycosyl‐phosphatidylinositol‐anchored	proteins	(GPI‐APs)	that	have	the	potential	
to	segregate	proteins	into	microdomains	(see	chapter	2).	This	might	suggest	that	
these	 interactions	 are	 relatively	 weak,	 or	 are	 not	 the	 primary	 cause	 of	 LFA‐1	
clustering	 in	monocytes.	 In	 fact,	several	studies	reported	 that	homo‐clustering	of	
proteins	in	the	membrane	is	rather	caused	by	electrostatic	interactions	35	and	the	
degree	of	clustering	can	be	modified	by	the	presence	of	intracellular	ions	36.		
In	DCs,	I	 found	members	of	the	lectin	family	(Gal‐3	and	Gal‐9)	associated	
with	 LFA‐1.	 Interestingly,	 as	 highlighted	 in	 chapter	2,	 lectin	microdomains	have	
the	potential	to	segregate	glycoproteins	in	the	cell	membrane.	Especially	Galectin‐
3	is	known	to	crosslink	integrins	in	the	PM,	thereby	altering	their	function.	Shortly	
upon	 onset	 of	 DC	 differentiation	 in	 the	 presence	 of	 IL‐4	 and	 GM‐CSF,	 Galectin‐3	
gets	secreted	and	binds	back	to	the	cell	surface	(our	unpublished	data).	Our	data	
suggest	that	association	of	LFA‐1	with	other	binding	partners,	e.g.	galectins,	could	
be	 involved	 in	 the	 loss	of	 nanodomain	 formation	 in	DCs,	due	 to	 steric	hindrance	
preventing	electrostatic	interactions	between	adjacent	LFA‐1	heterodimers.					
Despite	the	identification	of	known	integrin	associated	proteins	among	the	
LFA‐1	 binding	 candidates,	 the	 overlap	 of	 our	 data‐sets	 with	 integrin‐based	
networks	such	as	the	adhesome	is	relative	small.	This	is	mainly	due	to	the	fact	that	
our	 study	was	 performed	 in	 the	 absence	 of	 ligand,	 solely	 describing	 the	 steady‐
state	situation	where	fewer	proteins	are	expected	to	be	directly	linked	to	integrins.	
Secondly,	the	adhesome	or	the	pro‐adhesive	signaling	network	34;	37	are	comprised	
of	 integrin‐associated	 proteins	 derived	 from	 various	 cell	 types.	 As	 expression	 of	
proteins	is	differentially	regulated	among	cell	types,	only	a	fraction	of	the	proteins	
reported	in	a	network	are	also	present	in	the	cell	type	of	interest.	This	emphasizes	
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a	disadvantage	of	current	protein	networks	and	pathways	in	general	and	the	need	
of	cell	type	specific	information.	
LFA‐1	dynamics	in	the	context	of	the	native	plasma	membrane	in	monocytes	
Regulation	 of	 adhesion	 has	 its	 origin	 at	 the	 molecular	 scale	 within	 the	
plane	 of	 the	 PM,	 where	 proteins	 and	 lipids	 interact	 in	 a	 dynamic	 fashion.	 In	
chapter	6	we	 show	 that	 at	 physiological	 concentrations	 of	 Ca2+	 and	Mg2+,	 LFA‐1	
nanoclusters	 on	 monocytes	 exhibit	 different	 diffusion	 profiles	 (slow	 and	 fast	
mobile),	with	a	small	fraction	of	high‐affinity	LFA‐1	anchored	to	the	cytoskeleton.	
This	is	in	contrast	to	earlier	studies	reporting	that	integrins	in	the	resting	state	are	
pre‐anchored	 to	 the	 cytoskeleton	 and	 released	 upon	 activation	 38‐40.	 In	 line	with	
our	 results,	 recent	 work	 reported	 that	 different	 conformations	 of	 LFA‐1	 show	
distinct	 diffusion	 profiles	 on	 T	 cells	 41.	 This	 suggests	 that	 LFA‐1	 in	 different	
conformations	 possess	 specific	 dynamics	 and	 allows	 regulation	 at	 the	 nanoscale	
level.	 In	 line	 with	 our	 data,	 it	 was	 suggested	 that	 high	 affinity	 LFA‐1	 that	 is	
anchored	 to	 the	 cytoskeleton	 facilitates	 rapid	 interaction	 of	 leukocytes	with	 the	
endothelium	in	the	presence	of	high	shear	stress	in	the	blood	stream	42.				
Furthermore,	 in	 chapter	 6	 we	 describe	 how	 external	 factors,	 such	 as	
extracellular	Ca2+	 and	Mg2+	 influence	 the	dynamics	of	 LFA‐1	 in	 the	membrane	of	
monocytes.	 Ca2+	 and	 Mg2+	 play	 an	 important	 role	 in	 integrin	 function,	 e.g.	 by	
binding	 directly	 to	 LFA‐1	 and	 changing	 conformation	 and	 affinity	 43.	 Removal	 of	
Ca2+	 seems	 to	 favor	 extended	 LFA‐1	 and	 together	 with	 addition	 of	 Mg2+	 favors	
ligand	binding	 44;	 45,	while	high	concentrations	of	extracellular	Ca2+	 impair	 ligand	
binding	 45;	 46.	 In	 contrast,	 addition	 of	 Ca2+	 has	 been	 reported	 to	 induce	
microclusters	of	LFA‐1	on	T	cells,	 thereby	 increasing	integrin	avidity	47.	The	data	
presented	in	chapter	6	explain	the	apparent	dual	role	of	Ca2+	on	LFA‐1	adhesion,	
by	revealing	the	underlying	conformation‐coupled	dynamics	of	LFA‐1	at	different	
extracellular	Ca2+	concentrations.	Upon	reduction	of	extracellular	Ca2+	the	mobility	
of	LFA‐1	was	greatly	 reduced	and	 the	 immobile	population,	 assigned	 to	 the	high	
affinity	 conformation	 of	 LFA‐1,	 was	 largely	 increased	 and	 coupled	 to	 the	
cytoskeleton.	 Conformational	 changes	 of	 LFA‐1	 by	 Ca2+	 reduction,	 leading	 to	 full	
extension	 of	 the	 molecule,	 were	 translated	 into	 global	 dynamical	 changes	 that	
allowed	 interactions	with	 the	 cytoskeleton,	while	 the	 effect	 of	 extracellular	Mg2+	
was	 restricted	 to	 the	headpiece	 of	 LFA‐1.	 Increase	 of	 immobile	 and	 slow	mobile	
populations	increase	avidity,	while	high	concentrations	of	extracellular	Ca2+	inhibit	
affinity.	Dependent	on	the	chosen	experimental	read‐out,	either	changes	in	avidity	
or	 affinity	 were	 monitored	 upon	 Ca2+	 addition/reduction,	 leading	 to	 apparent	
opposing	 results.	 At	 physiological	 ion	 concentrations	 of	 ~1mM	 48,	 a	 balance	
between	 affinity,	 avidity	 and	mobility	 allows	 proper	 LFA‐1	 function.	 Changes	 in	
extracellular	ion	concentration	have	a	direct	impact	on	affinity	and	avidity,	thereby	
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forming	another	regulatory	mechanism	in	integrin	function.	Physiological	changes	
in	ion	concentration	have	been	observed	during	wound	healing	49‐51,	or	in	several	
carcinomas,	 that	 lead	 to	 changes	 in	 cell	 adhesion	 and	 cell	 migration	 52‐54.	 This	
demonstrates	a	clear	relation	between	changes	in	LFA‐1	mobility	at	the	nanoscale,	
variations	in	physiological	ion	concentrations	and	altered	integrin	function	in	vivo.	
In	 chapter	 6	 we	 showed	 that	 integrin	 conformation,	 mobility	 and	
anchoring	 to	 the	 cytoskeleton	 are	 highly	 interlinked.	 In	 chapter	 7	 I	 further	
expanded	 our	 study	 to	 the	 influence	 of	 membrane	 lipids	 on	 LFA‐1	 dynamics	 in	
monocytes.	Loss	of	cholesterol	and	SM	led	to	a	shift	from	fast	towards	slow	mobile	
LFA‐1,	 with	 an	 overall	 reduction	 in	 diffusion	 coefficients	 and	 an	 increase	 in	
confinement.	Interestingly,	while	both	cholesterol	and	SM	depletion	impaired	LFA‐
1	 function,	 only	 the	 loss	 of	 cholesterol	 induced	 structural	 changes	 in	 the	 LFA‐1	
molecule	 leading	 to	 increased	 interaction	of	 the	 cytoplasmic	 tails,	without	 losing	
the	 extended/intermediate	 conformation.	 Cholesterol	 might	 be	 essential	 to	
stabilize	the	LFA‐1	α	chain	within	the	PM,	thereby	regulating	LFA‐1	conformation	
and	diffusion.	Upon	depletion	 of	 cholesterol,	 the	KIM185	 epitope	 on	 the	 β	 chain	
decreased,	 most	 likely	 by	 masking	 of	 the	 epitope	 by	 the	 integrin	 α	 chain,	 as	
reported	by	others	 55.	My	results	are	supported	by	 the	presence	of	 two	potential	
cholesterol	 binding	 motifs,	 Cholesterol	 recognition/interaction	 amino	 acid	
consensus	 (CRAC)	 motifs	 56	 at	 the	 membrane/cytoplasm	 interface	 within	 the	
integrin	 α	 chain	 (Figure	 1).	Many	proteins	 that	 interact	with	 cholesterol	 contain	
such	CRAC	motifs,	as	recently	shown	also	for	G‐protein	coupled	receptors	57.		
Moreover,	 the	 results	are	 in	 line	with	 recent	 findings	 from	other	groups	
that	reported	an	important	role	of	lipids	in	regulating	membrane	receptor	function	
by	 regulation	 receptor	 clustering	 or	 conformation	 58;	 59.	 In	 the	 relative	 small	
transmembrane	 region	 with	 a	 low	 dielectric	 environment,	 the	 single	 α‐helical	
domains	of	α	and	β	chains	interact	with	each	other	by	electrostatic	interactions	60;	
61.	 Recent	 studies	 revealed	 polar	 interaction	 of	 the	 so	 called	 outer	 membrane	
association	clasp	(OMC)	in	the	α	and	β	chain	with	the	membrane	itself	62.	The	OMC	
is	 important	 for	regulation	of	 the	TM	interface	and	mutation	of	 the	OMC	leads	to	
constitutive	activation	of	LFA‐1.This	demonstrates	that	 lipids	act	 in	synergy	with	
LFA‐1	to	regulate	cell	adhesion.	
Taken	 together,	 I	 show	 in	 chapter	 7	 that	 alterations	 of	 the	 integrin	
proximal	lipid	nanoenvironment	are	translated	into	changes	in	integrin	dynamics.	
Both	 the	 loss	 of	 cholesterol	 and	 SM	 greatly	 influenced	 LFA‐1	 function;	 however,	
the	underlying	molecular	events	were	different,	as	we	could	 learn	 from	studying	
LFA‐1	mobility	upon	SM	and	cholesterol	depletion.	Nevertheless,	slowing	down	of	
LFA‐1	and	receptor	confinement	 impaired	the	population	of	LFA‐1	that	assists	 in	
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growing	 out	 of	 newly	 formed	 adhesion	 sites	 and	 as	 a	 consequence	 avidity	 was	
greatly	reduced	in	both	cases	(Figure	1).	
	
Figure	 1:	 Amino	 acid	 (AA)	 sequence	 of	 the	 transmembrane	 and	 cytoplasmic	 region	 of	 αL	
(CD11a).	The	TM	region	is	marked	in	red	and	the	cytoplasmic	region	is	highlighted	in	blue.	A	
sequence	of	5	AAs	has	not	been	designated	to	any	region	with	certainty	yet.	Assuming	that	this	
short	region	of	5AAs	is	inserted	into	the	PM,	the	TM	region	contains	two	potential	CRAC	motifs,	
with	 lysine	at	the	transmembrane	 interface.	With	the	5AAs	belonging	to	the	cytosolic	region,	
one	 potential	 CRAC	 motif	 remains,	 again	 with	 a	 lysine	 positioned	 at	 the	 transmembrane	
interface.	
The	data	 presented	 in	 chapter	7	 also	 give	 insight	 into	 the	 relation	 between	 the	
lipid	nanoenvironment	and	 the	different	 fractions	 that	constitute	LFA‐1	mobility.	
The	 literature	 provides	 evidence	 that	 affinity	 and	 avidity	 of	 integrins	 can	 be	
regulated	by	interactions	with	distinct	microdomains,	such	as	lipid	rafts,	TEMs	or	
lectin	microdomains.	In	chapter	2	we	summarize	these	interactions	and	highlight	
the	relevance	of	the	proximal	distribution	of	integrins	and	microdomains.	25%	of	
LFA‐1	 nanoclusters	 on	 monocytes	 show	 a	 distinct,	 but	 proximal	 distribution	 to	
domains	 enriched	 in	 GPI‐APs	 63.	 Cholesterol	 depletion	 destroyed	 this	 proximity	
and	as	a	consequence	ligand	binding	was	inhibited,	indicating	a	functional	relation	
63.	 In	 terms	 of	 dynamics,	 recent	 finding	 suggest	 that	 lipids	 and	 proteins	 can	 get	
confined	 by	 transient	 association	 into	 SM	 and	 cholesterol	 enriched	 domains	 64,	
which	are	 independent	of	 the	cytoskeleton	 65,	while	at	a	 larger	scale,	actin‐based	
corrals	 impose	 confinement	 on	 proteins,	 outside	 such	 confinement	 zones	 66.	 In	
chapter	 6	 we	 showed	 that	 LFA‐1	 mobility	 exhibits	 besides	 a	 small	 fraction	 of	
immobile,	slow	and	fast	mobile	diffusion	profiles.	One	possible	explanation	for	the	
presence	of	the	slow	mobile	population	could	be	trapping	of	LFA‐1	in	raft	domains	
that	 cause	 slowing	 down	 and	 hindered	 diffusion	 due	 to	 the	 higher	 viscosity	 in	
these	 areas.	 Indeed,	 GPI‐APs	 also	 exhibit	 slow	 and	 fast	 mobile	 fractions	 and	
slowing	down	of	diffusion	 is	 correlated	with	 the	entry	 into	GM1‐rich	domains	 64.	
However,	 the	 data	 presented	 in	 chapter	7	 show	 a	 different	 behavior	 for	 LFA‐1.	
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Instead	of	a	shift	from	slow	towards	fast	mobile	LFA1,	cholesterol	depletion	led	to	
a	 relative	 increase	 in	 the	 slow	 mobile	 fraction.	 In	 addition,	 actin	 cytoskeleton	
disruption	 recovered	 part	 of	 the	 mobile	 population	 of	 LFA‐1	 and	 changed	 the	
diffusion	mode	 from	confined	towards	 free.	Moreover,	upon	application	of	CytoD	
in	unperturbed	cells,	part	of	immobile	and	slow	LFA‐1	mobile	shifted	towards	the	
fast	mobile	 fraction.	These	results	suggest	 that	 the	slow	mobile	 fraction	of	LFA‐1	
cannot	be	 caused	 solely	by	 trapping	 in	 areas	of	 higher	 viscosity	 as	predicted	 for	
rafts,	 but	 rather	 also	 by	 involvement	 of	 cytoskeletal	 constraints.	 Whether	 the	
cytoskeleton	anchors	LFA‐1	in	cholesterol	containing	microdomains,	as	suggested	
for	 other	 receptors	 67,	 causing	 complete	 and	 transient	 immobilization	 of	 LFA‐1	
represents	an	interesting	field	for	further	investigation.		
Future	perspectives	
Regulation	of	LFA‐1	occurs	at	different	levels,	such	as	affinity,	avidity,	mobility	and	
proximity,	but	also	interactions	with	lipids	and	proteins	within	the	cell	membrane	
and	external	factors	influence	each	of	these	steps.	Moreover,	LFA‐1	function	seems	
to	be	differentially	regulated	on	distinct	cell	types.	Studies	from	different	fields	of	
biology	 and	 biophysics	 use	 LFA‐1	 as	 a	model	 system	 to	 explore	 its	 function	 and	
regulation.	 The	 future	 challenge	 will	 be	 to	 combine	 the	 findings	 from	 different	
fields,	such	as	proteomics,	microscopy	and	biochemical	experiments,	and	to	create	
consensus	on	 the	 fundamental	steps	 in	LFA‐1	regulation.	Moreover,	 investigation	
of	 LFA‐1	with	 systems	mimicking	 the	 physiological	 conditions	 will	 be	 of	 crucial	
importance	in	understanding	LFA‐1	function	on	different	cell	types.	Especially	for	
the	 understanding	 of	 LFA‐1	 function	 during	 the	 DC	 lifecycle,	 application	 of	
intravital	 microscopy	 to	 follow	 DCs	 during	 translymphatic	 migration	 as	 well	 as	
within	the	lymph	nodes	will	be	of	great	help.			
Of	great	importance	will	also	be	the	identification	of	key	signaling	molecules	and	
their	direct	visualization	during	the	onset	and	duration	of	adhesion	events,	using	
microscopy	techniques	with	high	spatial	and	temporal	resolution.	
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Figure	2:	Changes	in	LFA‐1	dynamics	upon	cholesterol	and	SM	depletion.	In	the	steady‐state,	a	
fraction	of	LFA‐1	resides	proximal	to	domains	enriched	in	GPI‐APs	forming	hotspot	regions	for	
cell	 adhesion	 and	 diffuses	 in	 a	 free/random	 fashion	 within	 the	 membrane	 of	 monocytes,	
thereby	assisting	in	the	formation	of	ligand‐induced	nucleation	sites.	Upon	SM	and	cholesterol	
depletion,	 LFA‐1	 diffusion	 is	 decreased	 and	 confinement	 increased,	 resulting	 in	 impaired	
formation	of	nucleation	sites.			
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Summary	
Our	body	 is	 under	 constant	 attack	by	pathogens,	 such	 as	bacteria,	 virus,	
fungi	and	parasites,	as	well	as	by	our	own	body	cells	that	can	transform	into	life‐
threatening	cancer	cells.	The	coordinated	response	of	our	immune	system	is	meant	
to	protect	us	from	invading	pathogens	and	to	eradicate	mutated	body	cells.		
In	 vertebrates,	 such	 as	 humans,	 defense	 against	 microbes	 is	 mediated	 by	 early	
reactions	 of	 innate	 immunity	 and	 later	 responses	 of	 adaptive	 immunity.	DCs	are	
component	of	innate	and	adaptive	immunity	and	by	keeping	the	balance	between	
immunity	and	tolerance	they	take	center	stage	in	immunity.		
During	 immune	 surveillance	 and	 during	 an	 immune	 response,	 immune	
cells	constantly	traffic	through	our	body	and	scan	for	pathogens	and	cancer	cells.	
Trafficking	 of	 immune	 cells	 is	 orchestrated	 by	 adhesion	 receptors	 that	 allow	
interaction	 with	 the	 surrounding	 environment	 and	 mediate	 adhesion	 and	
migration	events.	The	immune	cell‐	specific	adhesion	receptor	leukocyte‐function‐
associated	antigen‐1	(LFA‐1)	plays	an	essential	role	in	immunity,	as	several	critical	
adhesion	steps	during	the	initiation	of	an	immune	response	require	LFA‐1.		
Within	 the	 plasma	 membrane	 LFA‐1	 resides	 in	 different	 conformational	 states	
with	 different	 affinities	 to	 its	 ligand	 intercellular	 adhesion	molecule‐1	 (ICAM‐1):	
bent,	 low‐affinity	and	variable	extended	 conformations	with	high	affinity.	During	
in‐vitro	differentiation	of	blood‐derived	monocytes	(DC‐precursors)	towards	DCs,	
LFA‐1	remains	expressed	at	similar	levels,	but	only	monocytes	express	functional	
active	(extended)	LFA‐1.		Interestingly,	also	the	cell‐surface	organization	of	LFA‐1	
dramatically	 changes	 during	 DC	 differentiation.	 While	 on	 monocytes	 functional	
active	LFA‐1	resides	 in	 tightly	organized	nanoclusters,	 the	 loss	of	LFA‐1	 function	
on	DCs	 is	associated	with	the	loss	of	LFA‐1	nanoclusters	and	results	 in	a	random	
cell	surface	distribution.			
The	 role	 of	 LFA‐1	 in	 the	 DCs	 life‐cycle	 remains	 highly	 controversial	 as	
many	 studies	 have	 exploited	 monocyte‐derived,	 in‐vitro	 cultured	 DCs	 (moDCs),	
which	might	be	phenotypically	different	from	naturally	occurring	DCs.	Considering	
the	 importance	 of	 LFA‐1	 for	 other	 immune	 cells,	 it	 is	 of	 great	 interest	 to	
understand	whether	LFA‐1	plays	a	 role	 in	 the	DC	 life‐cycle,	as	monocyte‐derived	
ex‐vivo	cultured	DCs	are	currently	tested	as	cell‐based	anti‐cancer	vaccines.		
Therefore,	the	aim	of	thesis	was	to	investigate	how	LFA‐1	function	and	its	
cell	 surface	 organization	 are	 regulated	 in	 the	 context	 of	 the	 plasma	 membrane	
environment	in	monocytes	and	DCs.	Moreover,	we	investigated	whether	functional	
active	LFA‐1	could	be	restored	on	moDCs.		
Chapter	 2	 gives	 an	 overview	 on	 the	 different	 plasma	 membrane	
compartments	 and	 how	 they	 interact	 with	 integrins	 to	 regulate	 their	 function.	
Moreover,	 this	 chapter	 introduces	 two	 new,	 in	 our	 view	 so	 far	 underestimated	
concepts	 in	 integrin	regulation:	proximity	of	plasma	membrane	compartments	at	
the	nanoscale	level	and	lateral	mobility	of	integrins.		 	 	 	
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In	 chapter	 3	 we	 exploited	 proteomics	 to	 identify	 LFA‐1	 interacting	
proteins	in	monocytes	and	DCs	in	order	to	understand	the	molecular	changes	that	
could	 lead	 to	 the	 loss	of	LFA‐1	 function	 in	DCs.	We	created	a	LFA‐1	 interactome	
(network	 of	 LFA‐1	 interacting	 proteins)	 for	 monocytes	 and	 DCs.	 Our	 data	
emphasizes	 that	 the	 LFA‐1	 interactome	 dramatically	 changes	 during	 DC	
differentiation,	suggesting	essentially	different	regulation	mechanisms	of	LFA‐1	in	
those	 cell	 types.	Moreover,	we	 identified	 several	potentially	novel	LFA‐1	binding	
candidates.		 	 	 	
In	chapter	4	we	show	that	CCL21,	a	DC‐attracting	protein	present	 in	the	
lymphatic	system	and	the	lymph	nodes,	restores	functional	active	(extended)	LFA‐
1	 on	 DCs.	 Interestingly,	 ex	 vivo	 DCs	 (moDCs	 isolated	 from	 human	 lymph	 nodes	
after	intra‐nodal	injection)	show	elevated	levels	of	extended	LFA‐1.	This	suggests	
that	 in	 vivo,	 DC	 LFA‐1	 becomes	 activated	 by	 environmental	 cues	 (potentially	
chemokines	such	as	CCL21)	that	maintain	LFA‐1	active	and	extended,	while	during	
in‐vitro	 cell	 culture	 LFA‐1	 becomes	 inactive	 and	 resides	 in	 a	 bent,	 inactive	
conformation.		 	
Chapter	 5	 shows	 how	 herpes	 simplex	 virus	 1	 (HSV‐1)	 impairs	 DC	
migration	by	promoting	integrin‐mediated	adhesion,	thereby	delaying	the	immune	
response.	 Infection	 of	 mature	 DCs	 with	 HSV‐1	 increases	 integrin	 β2	 ‐mediated	
adhesion,	 including	 LFA‐1,	 and	 immobilization	 of	 DCs.	 This	 occurred	 via	
degradation	of	the	cytohesin‐1	deactivating	protein	CYTIP.		 	
In	chapter	6	and	7	we	used	a	high‐resolution	microscopy	technique	called	
“single	 dye	 tracking”	 to	 investigate	 the	 dynamics	 of	 LFA‐1	 in	 the	 membrane	 of	
monocytes.	 Chapter	 6	 describes	 how	 conformational	 state	 and	 dynamics	 are	
coupled	 and	 how	 the	 extracellular	 environment	 can	 shift	 the	 balance	 between	
different	 dynamical	 states,	 as	 well	 as	 LFA‐1	 function	 by	 adjusting	 extracellular	
calcium	levels.		 	 	 	
Finally,	 in	 chapter	 7	 we	 report	 that	 different	 lipid	 species,	 such	 as	
cholesterol	 and	 sphingomyelin	 affect	 to	 a	 different	 extent	 LFA‐1	 structure	 and	
function,	and	consequently	the	dynamics	of	LFA‐1	in	the	native	plasma	membrane.		
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Ons	 lichaam	 wordt	 voortdurend	 aangevallen	 door	 pathogenen	 zoals	 bacteriën,	
schimmels	 en	 parasieten	 maar	 kan	 ook	 worden	 bedreigd	 door	 cellen	 van	 het	
lichaam	 zelf	 als	 deze	 veranderen	 (muteren)	 in	 levensbedreigende	 kankercellen.	
Het	menselijk	lichaam	bestrijdt	al	deze	gevaren	met	behulp	van	ons	afweersysteem	
of	 immuunsysteem.	Bij	 gewervelde	 dieren,	 dat	 is	 inclusief	 de	mens,	 is	 de	 reactie	
van	 het	 immuunsyteem	 op	 dergelijke	 bedreigingen	 globaal	 opgebouwd	 uit	 twee	
fasen:	 een	vroege	 fase	 van	 aangeboren	 afweer	en	 een	 latere	 fase	van	verworven	
afweer	die	is	toegespitst	op	de	aard	van	de	bedreiging.	Dendritische	cellen	(DC’s)	
zijn	cellen	van	het	 immuunsysteem	die	belangrijk	zijn	voor	zowel	de	aangeboren	
afweer	alsmede	voor	het	verkrijgen	van	de	verworven	immuniteit.	Daarnaast	zijn	
deze	 cellen	 cruciaal	 voor	 het	 behouden	 van	 de	 balans	 tussen	 het	 tolereren	 van	
eigen	 cellen	 en	 het	 afstoten	 van	 ongewenste	 indringers.	 DC’s	 worden	 op	 dit	
moment		 in	 ons	 lab	 gebruikt	 in	 kankertherapieën	 welke	 als	 doel	 hebben	 een	
afweerreactie	 tegen	 kankercellen	 te	 bewerkstelligen.	 Om	 overal	 te	 kunnen	
surveilleren	op	de	aanwezigheid	van	indringers	of	kankercellen	moeten	DC’s	zich	
continue	door	het	lichaam	verplaatsen.	Voor	deze	migratie	gebruiken	DC’s	eiwitten	
op	 het	 celoppervlakte	 genaamd	 adhesiereceptoren.	 Deze	 receptoren	 stellen	 de	
DC’s	in	staat	een	interactie	aan	te	gaan	met	hun	omgeving	en	zich	te	verplaatsen.	In	
dit	proefschrift	wordt	een	adhesiereceptor	van	het	type	“integrine”onderzocht	met	
de	naam	LFA‐1	(Leukocyte	Function‐Associated	antigen‐1)	welke	een	centrale	rol	
speelt	bij	de	migratie	en	functie	van	diverse	immuuncellen	waaronder	DC’s.	LFA‐1	
op	het	oppervlakte	van	een	immuuncel	kan	een	interactie	aangaan	met	zijn	ligand	
ICAM‐1	(InterCellular	Adhesion	Molecule‐1)	op	een	andere	cel.	De	affiniteit,	ofwel	
bindingssterkte,	 van	 LFA‐1	 voor	 zijn	 ligand	 wordt	 bepaald	 door	 de	
vorm/conformatie	 waarin	 het	 eiwit	 zich	 op	 het	 oppervlakte	 bevindt.	 Wanneer	
LFA‐1	 in	 een	 gebogen	 toestand	 verkeerd	 is	 de	 affiniteit	 voor	 ICAM‐1	 laag	 maar	
wanneer	 het	 eiwit	 is	 uitgestrekt	 is	 de	 affiniteit	 voor	 ICAM‐1	 hoog.	 Tijdens	 de	
vorming	van	DC’s	uit	monocyten	uit	het	bloed	blijft	de	hoeveelheid	LFA‐1	op	het	
oppervlakte	 gelijk	 maar	 verandert	 de	 conformatie	 van	 LFA‐1	 van	 vooral	
actief/gestrekt	 naar	 meer	 inactief/gebogen	 LFA‐1.	 Daarnaast	 verandert	 ook	 de	
organisatie	 van	 LFA‐1	 op	 het	 DC	 oppervlakte.	 In	 monocyten		 zijn	 de	 LFA‐1	
moleculen	gegroepeerd		in	nano‐domeinen	terwijl	ze	in	DC’s	meer	verspreid	over	
het	celoppervlakte	aanwezig	zijn.	Gedurende	de	levenscyclus	van	de	DC	wordt	de	
adhesiesterkte	van	LFA‐1	dus	gereguleerd	door	een	verandering	in	conformatie	en	
organisatie.	Op	deze	manier	kan	de	migratie	van	DC’s	worden	beïnvloed.		Het	doel	
van	 het	 onderzoek	 beschreven	 in	 dit	 proefschrift	 was	 te	 onderzoeken	 hoe	 de	
functie	en	organisatie	van	LFA‐1	is	gereguleerd	door	de	locale	eigenschappen	van	
het	celmembraan	in	monocyten	en	DC’s.		 	 	
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Hoofdstuk	2	geeft	een	overzicht	van	de	literatuur	tot	dusver	met	betrekking	tot	de	
samenstelling	 en	 organisatie	 van	 het	 celmembraan	 en	 hoe	 dit	 de	 organisatie	 en	
functie	 van	 integrines	 zoals	 LFA‐1	kan	beïnvloeden.		Bovendien	 introduceren	we	
hier	twee	naar	onze	mening	zwaar	onderschatte	factoren	voor	de	regulatie	van	de	
functie	 van	 integrines:	 “nanodomein‐distributie”	 en	 “laterale	 mobiliteit	 van	
integrines”.			
In	hoofdstuk	3	onderzoeken	we	met	welke	eiwitten	LFA‐1	een	interactie	aangaat	
in	monocyten	en	DC’s	 om	 te	 kunnen	begrijpen	welke	moleculaire	veranderingen	
verantwoordelijk	 zouden	 kunnen	 zijn	 voor	 het	 verlies	 van	 functie	 van	 LFA‐1	 in	
DC’s.	Onze	data	laat	zien	dat	LFA‐1	aan	andere	eiwitten	is	gebonden	in	monocyten	
ten	opzichte	van	DC’s	wat	een	verschil	in	regulatie	van	LFA‐1	in	deze	celtypen	doet	
vermoeden.	Onder	de	gevonden	eiwitten	bevinden	zich	ook	enkelen	waarvan	nog	
niet	bekend	was	dat	ze	een	interactie	met	LFA‐1	kunnen	aangaan.		 	 	
In	hoofdstuk	4	 laten	we	zien	dat	CCL21,	een	eiwit	 	uitgescheiden	door	cellen	 in	
lymfeknopen	om	immuuncellen	zoals	DC’s	aan	te	trekken,	de	actieve	conformatie	
van	LFA‐1	op	DC’s	kan	herstellen.	Daarnaast	laten	we	zien	dat	DC’s	ingespoten	in	
patiënten	en	vervolgens	weer	geïsoleerd	uit	de	lymfeknoop	van	deze	patiënten	ook	
daadwerkelijk	meer	LFA‐1	in	de	actieve	conformatie	hebben.	Deze	data	suggereren	
ook	dat	omgevingssignalen	zoals	CCL21	de	activatie	van	LFA‐1	kunnen	reguleren.	
In	hoofdstuk	5	wordt	beschreven	hoe	Herpes	simplex	virus	1	(HSV‐1)	de	migratie	
van	DC’s	remt	door	de	adhesie	van	DC’s	aan	hun	omgeving	middels	integrines	van	
het	β2‐type	te	verhogen.	Onze	data	laten	zien	dat	HSV‐1	dit	doet	door	afbraak	van	
het	eiwit	CYTIP‐1	(cytohesin‐1	deactivating	protein).	 	 	 	
In	hoofdstuk	6	en	7	 gebruiken	we	geavanceerde	microscopie	om	 te	bestuderen	
hoe	 LFA‐1	 beweegt	 in	 het	 celmembraan.	 Hoofdstuk	 6	 beschrijft	 hoe	 de	
conformatie	 van	 LFA‐1	 en	 de	 beweging	 in	 het	 membraan	 zijn	 gerelateerd.	 En	
verder	hoe	calcium	 in	de	directe	omgeving	van	de	cel	de	mobiliteit	van	LFA‐1	 in	
het	 membraan	 en	 de	 activatie	 van	 LFA‐1	 kan	 beïnvloeden.		 In	 hoofdstuk	 7	
onderzoeken	we	ook	nog	hoe	lipiden	(vetten)componenten	van	het	celmembraan	‐		
in	 het	 bijzonder	 de	 lipiden	 cholestrol	 en	 sphingomyeline	 ‐en	 de	 conformatie,	
mobiliteit	en	functie	van	LFA‐1	kunnen	beïnvloeden.		
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